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Summary 
The indigenous gut microbiota exerts many beneficial tasks for the host including nutrient 
degradation, development of a functional immune system as well as protection from enteric 
infections and is therefore indispensable for health. Upon disturbances such as antibiotic intake, 
fluctuations in microbial diversity and density (dysbiosis) can occur, which renders the host more 
susceptible to infections with enteric pathogens like Salmonella enterica serovar Typhimurium (S. 
Tm). S. Tm induces severe gut inflammation which is accompanied by pathogen overgrowth 
(‘blooming’) and massive dysbiosis. Dysbiosis observed in human patients which is also a hallmark of 
inflammatory bowel diseases is generally characterized by Enterobacteriaceae overgrowth. Recently, 
first insights into the underlying mechanisms have been obtained: On the one hand, anaerobic 
electron acceptors, ethanolamine and iron selectively foster pathogen growth. On the other hand, 
the microbiota can experience collateral damage by the antimicrobial defense reaction, e.g. 
neutrophils which infiltrate the gut lumen in response to Salmonella-induced inflammation. Yet, it is 
still unclear which of these mechanisms is more important for the induction of dysbiosis and 
pathogen ‘blooming’: the altered nutritional environment or differential killing by the inflammatory 
immune response. Furthermore, it has remained elusive, how the environment of an inflamed gut 
impacts on individual species of a normal microbiota. Due to the high complexity of the gut 
microbiota, it is difficult to address functions of individual bacteria in host-pathogen-microbiota 
interactions. Therefore, gnotobiotic mouse models with reduced microbial complexity are needed. 
Thus, our group has established a novel gnotobiotic mouse model termed the Oligo-Mouse-
Microbiota (Oligo-MM12) which is based on 12 murine bacterial isolates. Interestingly, the Oligo-
MM12 consortium covers 5 eubacterial main phyla (Firmicutes, Bacteroidetes, Actinobacteria, 
Verrucomicrobia and Proteobacteria) and was able to confer colonization resistance against an 
avirulent Salmonella strain. Preliminary work that was conducted before I joined the group included 
isolation and characterization of the Oligo-MM12 strains, the establishment of strain-specific 
fluorescence in situ hybridization (FISH) probes as well as stable association of germfree C57BL/6J 
mice with the Oligo-MM12 consortium. 
One major aim of my doctoral thesis was to establish strain-specific quantitative real-time PCR 
(qPCR) assays that allow for quantification of individual Oligo-MM12 bacteria as well as pathogens 
and other gut commensals. In addition, the course of wildtype Salmonella infection in the Oligo-
MM12 model as well as the influence of nutrients provided by an inflammatory milieu on Salmonella 
‘blooming’ and concomitant microbiota shifts (dysbiosis) should be investigated. Furthermore, the 
importance of infiltrating neutrophils during Salmonella-induced dysbiosis should be assessed. In 
addition, it was aimed to compare the effect of infections with S. Tm, Clostridium difficile (C. difficile), 
Summary 
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Citrobacter rodentium (C. rodentium) and T-cell-induced colitis on individual microbiota species using 
the Oligo-MM12 model.  
Using qPCR assays, I could show that the Oligo-MM12 once administered orally, colonized the gut of 
germfree mice and was additionally vertically transmitted across filial generations which enables 
breeding of mice stably associated with the Oligo-MM12. Furthermore community composition across 
animal facilities was similar, which is a pre-requisite for comparable host-microbe interaction studies. 
Remarkably, wildtype S. Tm (S. TmWT) infection induced severe colitis at day 4 post infection in Oligo-
MM12 mice. Colitis was accompanied by Salmonella ‘blooming’ and drastic dysbiosis. Interestingly, 
the Oligo-MM12 strains showed different abundance upon S. Tm induced colitis. Individual members 
of the phyla Bacteroidetes, Verrucomicrobia and Proteobacteria were drastically reduced, whereas 
Firmicutes strains were less affected by S. Tm induced inflammation and some strains even seemed 
to benefit from colitis. Especially Enterococcus faecalis KB1 thrived in the inflamed gut. The 
performance of Oligo-MM12 strains positively correlated with the presence of genes for sporulation, 
iron acquisition, anaerobic respiration and ethanolamine utilization in their genome sequences. 
Infection experiments with S. Tm mutants deficient in siderophore production, anaerobic nitrate and 
tetrathionate respiration as well as ethanolamine utilization underlined a particular importance of 
anaerobic respiration and ethanolamine utilization for S. Tm overgrowth and concomitant microbiota 
shifts. Antibody mediated depletion of neutrophils favored dysbiosis. This suggests that neutrophils 
may not play a role in inducing dysbiosis and Salmonella ‘blooming’.  
We additionally compared other colitis models with S. Tm-induced colitis. Interestingly in contrast to 
S. Tm infection, infection with C. rodentium and T-cell-induced colitis only caused mild inflammation 
and no or just moderate changes in Oligo-MM12 composition. However, after infection with C. 
difficile dysbiosis and pathogen ‘blooming’ was apparent. Remarkably, C. difficile-induced 
inflammation caused similar shifts in Oligo-MM12 composition compared to S. Tm.  
In conclusion, these data suggest that the Oligo-MM12 is not damaged by neutrophils but 
outcompeted by S. Tm which profits from an inflammatory milieu and its associated nutritional 
environment – especially, from anaerobic electron acceptors and ethanolamine. Furthermore, 
individual Oligo-MM12 species behaved differently in the presence of severe colitis. Genes involved in 
sporulation, anaerobic respiration, ethanolamine utilization and iron acquisition might contribute to 
survival during harsh conditions present in the inflamed gut. Interestingly, upon infection with 
different enteric pathogens and T-cell-induced colitis, there were parallels between microbiota shifts, 
indicating a conserved pattern of dysbiosis during gut inflammation. These findings could contribute 
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to the identification of general biomarkers for dysbiosis and the development of novel therapeutic 
concepts for Salmonellosis and inflammation-induced dysbiosis. 
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Zusammenfassung 
Die indigene Darm-Mikrobiota ist für die Gesundheit von großer Bedeutung: Sie unterstützt die 
Verdauung, trägt zur Entwicklung eines funktionalen Immunsystems bei und schützt vor 
Darminfektionen. Antibiotikatherapien oder andere exogene Störungen verändern die Diversität und 
Dichte der Darmbakterienzusammensetzung substanziell (Dysbiose). Infolgedessen wird der 
Organismus anfälliger für Infektionen mit darmpathogenen Erregern wie zum Beispiel Salmonella 
enterica serovar Typhimurium (S. Tm). S. Tm verursacht eine schwere Darmentzündung, die mit 
einem übermäßigen Salmonellenwachstum (‘blooming‘) und Dysbiose einhergeht. Dysbiose, die in 
Patienten auftritt und auch ein Kennzeichen für chronisch-entzündliche Darmerkrankungen darstellt, 
ist hauptsächlich charakterisiert durch ein Überhandnehmen von Bakterien der Familie 
Enterobacteriaceae. Es konnte bisher gezeigt werden, dass einerseits Mechanismen wie die 
anaerobe Atmung, die Verwertung von Ethanolamin, sowie Eisenaufnahme ein sogenanntes 
Salmonella-‘blooming‘ begünstigen. Andererseits könnte die Darm-Mikrobiota von neutrophilen 
Granulozyten, die während einer Salmonellen-vermittelten Darmentzündung in das Darmlumen 
emigrieren, stark geschädigt werden. Bis heute ist nicht abschließend geklärt, was für das 
Überhandnehmen eines Erregers und die damit verbundene Dysbiose entscheidender ist: Nährstoffe, 
die gehäuft in einem Entzündungsmilieu vorkommen und das selektive Wachstum von Erregern 
begünstigen oder das Töten von kommensalen Darmbakterien, welches von Effektoren des 
Immunsystems vermittelt wird. 
Außerdem ist bis heute wenig darüber bekannt, wie sich eine Darmentzündung auf einzelne Arten 
einer gesunden Darm-Mikrobiota auswirkt. Aufgrund der hohen Komplexität der 
Darmbakterienzusammensetzung ist es äußerst schwierig, genaue Erkenntnisse über die 
Interaktionen der einzelnen Bakterien mit ihrem Wirt und einem Erreger zu gewinnen. Aus diesem 
Grund werden sogenannte gnotobiotische Tiermodelle verwendet, die eine definierte und weniger 
komplexe Darmbakterienzusammensetzung aufweisen. Unsere Arbeitsgruppe hat daher die Oligo-
Mouse-Microbiota (Oligo-MM12) etabliert. Dieses neue gnotobiotische Mausmodell basiert auf 12 
Bakterien, die aus Mäusen isoliert wurden. Bemerkenswerterweise repräsentieren die Oligo-MM12 
Stämme 5 eubakterielle Hauptphyla (Firmicutes, Bacteroidetes, Actinobacteria, Verrucomicrobia und 
Proteobacteria). Es konnte gezeigt werden, dass die Oligo-MM12 eine Kolonisierungsresistenz 
gegenüber einem avirulenten Salmonellenstamm vermittelt. Zu Beginn meiner Arbeit waren die 
Oligo-MM12 Stämme bereits isoliert und charakterisiert, spezifische Sonden für die Fluoreszenz in situ 
Hybridisierung (FISH) etabliert, sowie keimfreie C57BL/6J Mäuse mit dem Oligo-MM12 Konsortium 
assoziiert. 
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Ziel meiner Doktorarbeit war es, ein auf quantitativer real-time PCR (qPCR) basierendes Verfahren 
zur Detektion einzelner Oligo-MM12 Stämme, anderer Erreger und weiterer kommensalen 
Darmbakterien zu etablieren. Des Weiteren sollte untersucht werden, wie sich eine Infektion mit S. 
Tm auf die Oligo-MM12 auswirkt und welchen Einfluss Nährstoffe, die während einer 
Darmentzündung vorherrschen, auf Salmonella-‘blooming‘ und Dysbiose haben. Auch der Beitrag 
von neutrophilen Granulozyten zur Salmonella-induzierten Dysbiose sollte erforscht werden. Ein 
weiteres Ziel der Arbeit war es, die Auswirkung von Infektionen mit S. Tm, Clostridium difficile (C. 
difficile), Citrobacter rodentium (C. rodentium) und T-Zell induzierter Kolitis auf einzelne Arten der 
Oligo-MM12 zu untersuchen.  
Ich konnte zeigen, dass die Oligo-MM12 nach einmaliger Verabreichung den Darm von keimfreien 
Mäusen besiedelt und nach erfolgreicher Besiedlung vertikal über viele Filialgenerationen übertragen 
wird, was die Zucht von stabil kolonisierten Oligo-MM12 Mäusen ermöglicht. Außerdem war die 
Oligo-MM12 Zusammensetzung in verschiedenen Tierhaltungen sehr ähnlich, was eine Voraussetzung 
für die Vergleichbarkeit verschiedener Studien ist.  
Die Infektion von Oligo-MM12 Mäusen mit einem Wildtyp Salmonellenstamm führte an Tag 4 nach 
der Infektion zu einer schweren Darmentzündung. Bemerkenswerterweise, war dafür keine 
Antibiotikavorbehandlung, die eine mögliche darmbakterienvermittelte Kolonisierungsresistenz 
brechen könnte, erforderlich. Die Kolitis wurde von einem drastischen Überwachsen von Salmonella 
und Dysbiose begleitet, wobei Oligo-MM12 Stämme, die zu den Phyla Bacteroidetes, Verrucomicrobia 
und Proteobacteria gehören, stark abnahmen, Firmicutes hingegen weniger beeinträchtigt waren 
und Stämme wie Enterococcus faecalis von der Entzündung sogar profitierten. Des Weiteren fanden 
wir heraus, dass das Überleben einzelner Oligo-MM12 Stämme mit dem Vorhandensein von 
Fitnessgenen korreliert, welche zur Sporulation, anaeroben Atmung und Ethanolaminverwertung 
beitragen. Infektionsexperimente mit Salmonellenstämme, die außerstande waren Siderophore zu 
bilden, Nitrat und Tetrathionat zu veratmen oder Ethanolamin zu verwerten, brachten die 
Erkenntnis, dass gerade anaerobe Atmung und Ethanolamin essentiell für Salmonella-‘blooming‘ und 
die Induktion der Dysbiose sind. Außerdem, begünstigt die Antikörper-basierte Depletion von 
neutrophilen Granulozyten die Entstehung von Dysbiose, was darauf schließen lässt, dass neutrophile 
Granulozyten eher vor Salmonella-induzierter Dysbiose schützen. 
Zudem haben wir andere Kolitis-Modelle mit Salmonella-induzierter Kolitis verglichen. Im Gegensatz 
zur S. Tm-Infektion, verursachte eine, durch die Infektion mit C. rodentium und T-Zell-induzierte 
Kolitis in Oligo-MM12 Mäusen eine milde Darmentzündung, welche nur zu einer geringen 
Abweichung der Darmbakterienzusammensetzung führte. Eine durch eine C. difficile-Infektion 
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verursachte Kolitis rief dagegen ähnliche Veränderungen wie Salmonella in der Oligo-MM12 
Zusammensetzung hervor. 
Auf Basis meiner Arbeit konnte festgestellt werden, dass kommensale Darmbakterien während einer 
S. Tm-induzierten Kolitis von neutrophilen Granulozyten nicht direkt getötet werden. Vielmehr wird 
die Darm-Mikrobiota von S. Tm aus dem Feld geschlagen, da S. Tm besonders von Stoffen wie Nitrat, 
Tetrathionat und Ethanolamin, die in einem Entzündungsmilieu vorkommen, profitiert und die 
Mikrobiota überwächst. Gene, die in kommensalen Bakterien vorkommen und wichtig für 
Sporulation, anaerobe Atmung, Ethanolaminverwertung und Eisenaufnahme sind, begünstigen 
möglicherweise das Überleben der Darmbakterien im entzündeten Darm. Interessanterweise 
konnten Parallelen zwischen Veränderungen in der Darmbakterienzusammensetzung aufgrund von 
Infektionen mit verschiedenen darmpathogenen Erregern und einer T-Zell-induzierten Kolitis 
festgestellt werden, was auf ein konserviertes Muster von Dysbiose während einer Darmentzündung 
schließen lässt. Diese Erkenntnisse könnten dazu beitragen generelle Biomarker für Dysbiose zu 
finden und neue Therapiekonzepte für die Behandlung der Salmonellose und Dysbiose zu entwickeln. 
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1. Introduction 
1.1 Elucidation of gut microbiota functions using gnotobiotic mouse models 
1.1.1 General functions of a healthy gut microbiota 
The intestinal tract of humans and other mammalians is colonized by a highly diverse and complex 
bacterial community, the microbiota. The bacteria increase in diversity and abundance along the 
digestive tract (Hooper and Macpherson 2010) and reach an enormously amount of 1012 cells per 
gram of large intestinal content (Marchesi and Shanahan 2007). Several thousands of years of co-
evolution and symbiosis attributed the gut microbes special tasks that are essential for human health 
and wellbeing. Besides influencing gut motility as well as shaping the gut architecture by reducing 
cecal size and supporting microvilli formation (Falk et al. 1998), the gut microbiota contributes to the 
development of a functional immune system (Hooper et al. 2012). For example, commensals trigger 
production of secretory immunoglobulin A (Macpherson and Uhr 2004) and antimicrobial peptides 
via activation of Paneth cells (Vaishnava et al. 2008), induction of regulatory T-cells (Atarashi et al. 
2013) and differentiation of TH17 cells (Atarashi et al. 2008). Furthermore, commensal bacteria 
protect against food allergen sensitization (Stefka et al. 2014). A disturbed microbiota was associated 
with allergic diseases and obesity (Baothman et al. 2016, Simonyte et al. 2016). 
In addition to the educative effects on the immune system, the metabolic activity of the gut 
microbiota contributes to nutrition of the host (Nicholson et al. 2012). Microbiota produces 
metabolites such as vitamins (Said 2011), amino acids (Zheng et al. 2011) and carbohydrates (Flint et 
al. 2012). Moreover, the microbiota catabolizes complex, nutrient derived fibers and long-chained 
sugars into simple sugars as well as short-chain fatty acids (SCFAs) like butyrate (Donohoe et al. 
2014), acetate and propionate (Caspari and Macy 1983). Butyrate has been shown to be the primary 
energy source of colonocytes (Donohoe et al. 2012). Consumption of butyrate by colonocytes 
renders the epithelium hypoxic, which strengthens barrier function (Kelly et al. 2015) as well as 
favors growth of obligate anaerobic bacteria such as Clostridia (Rivera-Chávez et al. 2016). The 
microbiota also provides protection against bacterial infection (Buffie and Pamer 2013, Stecher et al. 
2013). This protective effect is termed colonization resistance (CR) and is on the one hand mediated 
by occupation of vacant niches, competition for nutrients or by production of inhibitory and toxic 
substances as well as immune stimulation. Taken together, the microbiota fulfills essential and highly 
versatile tasks including the protection from pathogens. However, under certain circumstances 
pathogens manage to break CR and induce disease. 
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1.1.2 Composition of the gut microbiota: from health to dysbiosis and disease 
A balanced microbial community in the healthy gut is basically characterized by domination of 
anaerobic bacteria such as members of the phyla Bacteroidetes and Firmicutes, whereas 
Proteobacteria, Actinobacteria and Verrucomicrobia are less abundant (Eckburg et al. 2005, Ley et al. 
2005). Interestingly, the microbial composition between man and mice is similar at the phylum level. 
However, there are differences at the genus level: humans are preferentially colonized by Prevotella, 
Faecalibacterium and Ruminococcus, whereas the microbiota of mice is enriched in Lactobacillus, 
Alistipes, Turicibacter and Mucispirillum (Krych et al. 2013, Nguyen et al. 2015). 
Exogenic factors like antibiotics (Maurice et al. 2013) as well as changes in diet (Agus et al. 2016) can 
disturb this equilibrium and induce shifts in microbial composition termed dysbiosis which are 
paralleled by reduction of bacterial diversity (Dethlefsen et al. 2008) and are associated with 
increased susceptibility to infections with enteric pathogens (Ubeda and Pamer 2012). In addition, 
chronic inflammation as well as acute infections could be also linked to dysbiosis. Interestingly, 
dysbiosis observed in irritable bowel syndrome (Kerckhoffs et al. 2011, Carroll et al. 2012) and IBD 
(Crohn’s disease and Ulcerative colitis) (Baumgart et al. 2007, Frank et al. 2007) as well as after 
antibiotic treatment (Spees et al. 2013), chemically induced colitis (Lupp et al. 2007) or infection with 
enteric pathogens (Stecher et al. 2007, Barman et al. 2008) was commonly characterized by a drastic 
increase of Proteobacteria (‘blooming’), whereas abundance of Bacteroidetes and Firmicutes was 
decreased (Winter and Bäumler 2014).  
1.1.3 Analysis tools 
Dysbiosis associated with diseases is primarily discovered in cohorts of patients by investigating 
microbial composition in fecal samples (Table 1, samples from humans). In order to recapitulate and 
study the importance of certain microbes in human diseases, germfree mice can be further 
associated with selective patient-derived bacterial consortia (Faith et al. 2010, Goodman et al. 2011, 
Faith et al. 2014). So called gnotobiotic (Greek: gnotos ‘known’ and bios: ‘life’) mice are then used for 
more specific and targeted microbiota analyses (Clavel et al. 2016). So far, there is no standardized 
microbiota for gnotobiotic mice that can be shared between research facilities. An investigation 
conducted by Rausch and colleagues revealed that the microbiota composition of laboratory mice 
differs between animal facilities (Rausch et al. 2016). Hence, results obtained by different 
investigations might be biased by differences in base line microbiota composition observed between 
different animal facilities. 
To date, most microbiota analyses are based on 16S rRNA gene sequencing using next generation 
sequencing (NGS) techniques and reference data bases which enable assigning certain reads to 
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published 16S rRNA gene sequences and thereby determine bacteria. In addition, strain-specific 
quantitative real-time PCR (qPCR) can be used to quantify and detect bacteria (Ganesh et al. 2013).  
1.1.4 Defined microbial consortia for gnotobiotic mouse models 
Since the gut microbiota is highly complex harboring up to 1000 different species (Marchesi and 
Shanahan 2007), it is challenging to mechanistically investigate host-microbe as well as microbe-
microbe interactions in the intestine. Thus, animal models with reduced microbiota complexity 
ranging from one or two community members to intermediate complexity emerged in the past few 
years (Freter and Abrams 1972, Klaasen et al. 1991, Bry et al. 1996, Dewhirst et al. 1999, Mahowald 
et al. 2009, Becker et al. 2011, McNulty et al. 2011). The advantage of such gnotobiotic animal 
models is that the microbiota harbors known bacterial strains that can be composed according to the 
basic of the scientific problem investigated (Yi and Li 2012, Clavel et al. 2016). These models have 
mostly been based on bacteria isolated from humans (humanized microbiota model). Although 
humanized animal models may manifest as valuable research tools for studding disease associated 
host-microbe interactions (Turnbaugh et al. 2009, Faith et al. 2011), the successful colonization of 
human bacterial isolates to animals is dependent on genetic background (Wos-Oxley et al. 2012) and 
might not reflect true mutualistic microbiota-host effects developed by long-term co-evolution 
between host-specific bacteria and their host. It has been shown that humanized animal models do 
not recapitulate several aspects of gut physiology and immune maturation compared to association 
with indigenous microbiota (Chung et al. 2012). This problem can be overcome by using germfree 
mice associated with murine bacterial isolates. The microbiota from mice and humans is highly 
comparable at the phylum level, however there are marked differences in lower taxonomical levels 
(Ley et al. 2005, Oh et al. 2010) and functional categories (Xiao et al. 2015). In the past, a consortium 
of mouse-gut-derived bacteria termed the Altered Schaedler Flora (ASF) that consisted of 8 murine 
bacterial isolates has been widely used (Dewhirst et al. 1999, Geuking et al. 2011, Natividad et al. 
2013, Collins et al. 2014). Unfortunately, this consortium is not available in public strain collections.  
1.1.5 The Oligo-Mouse-Microbiota 
We have recently developed a novel consortium based on 12 murine isolates, termed the Oligo-
mouse-microbiota (Oligo-MM12) that confers partial colonization resistance against an avirulent S. 
Tm strain (Brugiroux et al. 2016). It was aimed to create a defined consortium of gut commensals 
that resembles the microbiota of conventional mice at the phylum level (Figure 1). By using a 
genome-informed design based on comparative (meta)genome analysis, we added additional 
bacteria which increased CR against S. Tm. We thereby show that the Oligo-MM12 is a basic model 
microbiota that can be reduced or expanded by additional bacteria in order to investigate host-
microbe or microbe-microbe interactions during enteric infection and other diseases.  
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Linnenbrink and co-workers analyzed microbiota compositions of wild mice and showed that 
Bacteroidetes, Firmicutes, Deferribacteres and Proteobacteria were the dominating phyla in the 
mouse gut (Linnenbrink et al. 2013). Remarkably, the 12 mouse-adapted Oligo-MM12 strains cover a 
spectrum of 5 eubacterial phyla identified by Linnenbrink and colleagues (Firmicutes, Bacteroidetes, 
Actinobacteria, Verrucomicrobia and Proteobacteria but not Deferribacteres). All Oligo-MM12 strains 
were deposited in the German type culture collection (DSMZ) and are publically available. To this 
end, protocols for cryopreservation as well as FISH probes for individual Oigo-MM12 were established 
and the genome of each Oligo-MM12 strain is available. 
 
Figure 1: Phylogenetic placement and representation of the Oligo-MM12 strains in conventional mice. The 
16S rRNA sequences of the 12 Oligo-MM strains (red) as well as the 8 strains of the Altered Schaedler Flora 
(blue; ASF356, ASF360, ASF361, ASF457, ASF492, ASF500, ASF502 and ASF519) (Dewhirst et al. 1999) were 
compared against a set of 865 full-length high quality 16S rRNA gene sequences from 2 types of conventional 
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unmanipulated SPF mice (Stecher et al. 2007). All sequences were aligned against the SILVA database version 
111 NR (Quast et al. 2013) using MEGABLAST (version 2.2.28+) on a 97 % identity level, yielding 47 different 
taxonomic identities. The best hit of each of the 47 taxonomies from the database was used for the generation 
of a multiple sequence alignment using Infernal. A phylogenetic tree was generated using fasttree (Price et al. 
2009). The number of sequences per taxonomic identity in the conventional mice is indicated (e.g. mice=20). 
The Oligo-MM12 strains represent 10 of the 19 bacterial families (and candidate families), detected in this CON 
microbiota. Families represented only in CON mice include the Desulfovibirionaceae, Desulfonatronaceae (both 
δ-Proteobacteria), Deferribacteraceae (Deferribacteres phylum), Porphyromonadaceae, Rikenellaceae, 
Prevotellaceae (Bacteroidetes phylum), Peptococcacaceae and Anaeroplasmataceae (Firmicutes phylum). It 
should be noted that ASF457 is a representative of the Deferribacteraceae and ASF519 is a representative of 
the Porphyromonadaceae. Oligo-MM12 and the ASF8 consortia together cover 12 of the 19 abundant families in 
this CON microbiota. Figure and figure legend taken from (Brugiroux et al. 2016). 
 
1.2 Salmonella enterica serovar Typhimurium pathogenesis and disease 
1.2.1 Pathogenesis of Salmonella enterica serovar Typhimurium is dependent on type 3 
secretion systems 
S. Tm is a facultative anaerobic, non-spore-forming, Gram-negative food-borne pathogen belonging 
to the class of Gamma-Proteobacteria and is among the most clinically important serotypes that 
causes salmonellosis in humans with millions of infections every year worldwide (WHO 2013 (Mead 
et al. 1999, Flockhart et al. 2016). The infection is usually self-limiting, however in very young, old or 
immunocompromised patients the S. Tm infection can become life-treating with several thousands of 
deaths per year (WHO 2013 (Schulte and Hensel 2016).  
After oral uptake, S. Tm has to overcome host clearances such as stomach acid, the indigenous 
microbiota which provides colonization resistance (CR) as well as the mucus layer by using flagella 
and chemotaxis (Stecher et al. 2004). Upon reaching the epithelium, S. Tm adheres to polarized 
epithelial cells using a giant non fimbrial adhesin SiiE encoded on Salmonella pathogenicity island 4 
(SPI-4). Expression of SPI-4 genes is co-regulated with expression of SPI-1 invasion genes (Gerlach et 
al. 2007). SPI-1 encodes a type 3 secretion system (T3SS-1) that injects effector proteins into the host 
cell (Kaiser et al. 2012). Secretion of T3SS-1 effector proteins is essential for bacterial uptake into 
epithelial cells that is associated with rearrangement of the action cytoskeleton (Patel and Galán 
2005) and induction of an inflammatory response (Hapfelmeier et al. 2004). In addition to T3SS-1 
mediated invasion, S. Tm can also be taken up by dendritic cells which shuttle S. Tm across the 
epithelial barrier (Figure 2) (Rescigno et al. 2001). Once inside a host cell, S. Tm is surrounded by a 
vacuole made of plasma membrane, the so called Salmonella-containing vacuole (SCV) (Portillo et al. 
1992) where S. Tm survives and replicates. In order to switch to this intracellular live style, S. Tm 
makes use of a second type 3 secretion system (T3SS-2). T3SS-2 effector protein secretion induces 
inhibited fusion of SCV with lysosomes in macrophages (Uchiya et al. 1999), intracellular replication, 
enhancement of inflammation and systemic dissemination (Hapfelmeier and Hardt 2005). SPI-1 and 2 
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T3SSs additionally contribute to long-term infection and spread (Lawley et al. 2006). Moreover, S. Tm 
is able to form non-replicative, antibiotic resistant persister cells which reside within SCVs in 
macrophages. These persister cells might serve as a reservoir for relapsing infection (Helaine et al. 
2014). After reaching an abundance of 108 bacteria per gram feces, S. Tm is effectively transmitted to 
the next host via the oral fecal route (Lawley et al. 2008). Transmission is additionally controlled be 
the indigenous microbiota.  
It is worth mentioning, that most mechanistic studies of S. Tm infection have been done in the 
streptomycin pre-treated S. Tm infection model (Barthel et al. 2003), where the microbiota is 
manipulated by antibiotic treatment prior to infection (Stecher et al. 2007). In this model, antibiotic-
induced dysbiosis renders mice susceptible to S. Tm induced colitis that is dependent on functional 
T3SSs (Hapfelmeier et al. 2005). Although the streptomycin pre-treated mouse model is excellent for 
mechanistic studies regarding host-pathogen interaction, it is not adequate for studying all aspects of 
microbiota-pathogen interactions since microbiota composition is influenced by antibiotic treatment. 
Therefore, in order to obtain unbiased insights into microbiota-pathogen interactions at the single 
species level, the gnotobiotic Oligo-MM12 model was used in this study.  
1.2.2 S. Tm invades the gut ecosystem and induces inflammation 
As already outlined before in section 1.2.1, S. Tm has to break CR of the indigenous microbiota in 
order to successfully colonize and infect the host. Ferreyra and colleagues proposed that during 
infection there are five stages of microbiota-pathogen interaction: At stage 1, the healthy and 
complex microbiota mediates CR by occupying niches. Upon changes in bacterial diversity and 
density (moderate dysbiosis) that can be induced by disturbances such as antibiotics or changes in 
diet, the pathogen can colonize (stage 2). At stage 3, the pathogen expands and benefits from 
available nutrients (expansion phase). Stage 4 is characterized by pathogen outgrowth (‘blooming’ 
phase) that is accompanied by inflammation and massive dysbiosis. After clearing the pathogen in 
stage 5 the microbiota recovers from dysbiosis (resilience) (Ferreyra et al. 2014). The first 4 stages of 
ecosystem invasion are visualized in Figure 2. 
CR which is mediated by niche occupation, competition for nutrients, by direct inhibition using 
antimicrobial peptides or T6SS mediated killing (Russell et al. 2014) and by stimulation of the 
immune defense can be overcome by the application of antibiotics (Barthel et al. 2003). It could be 
recently shown that antibiotic treatment facilitates S. Tm infection by depletion of Clostridia which is 
followed by a decrease in butyrate concentration and increased oxygenation of the epithelium. This 
oxygenation promotes S. Tm growth in a cytochrome oxidase dependent manner in early stages of 
infection (Rivera-Chávez et al. 2016). Furthermore, after antibiotic treatment, S. Tm as well as 
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Clostridium difficile (another enteric pathogen) profit from microbiota-liberated mucosal 
carbohydrates like fucose and sialic acid (Ng et al. 2013). Antibiotic treatment also increases luminal 
galactarate and glucarate concentrations by leading to increased oxygenation of galactose and 
glucose, sugars selectively consumed by Salmonella (Faber et al. 2016). In addition, hydrogen that is 
produced by the unperturbed indigenous microbiota (Maier et al. 2013) boosts S. Tm growth and 
ecosystem invasion of S. Tm in early stages of infection. This effect was absent after antibiotic 
treatment, showing a link between specific metabolites provided by the microbiota and pathogen 
adaptation. Gnotobiotic mice used in this study were based on a low complex type of microbiota 
(LCM mice) (Stecher et al. 2010). Besides taking advantage of sugars, oxygenation and hydrogen 
during early stages of infection (stages 2 and 3), S. Tm induces gut inflammation via T3SS activity 
which creates an inflammatory milieu and is accompanied by Salmonella ‘blooms’ during later stages 
of infection (stage 4). S. Tm induced colitis causes dysbiosis (Stecher et al. 2007) and is characterized 
by infiltrating neutrophils (Loetscher et al. 2012). However, until now the impact of severe S. Tm 
induced gut inflammation on single species of the gut microbiota remains elusive. 
1.2.3 S. Tm profits from an inflammatory gut milieu and outcompetes the indigenous 
microbiota 
S. Tm induces acute gut inflammation by invading epithelial cells and survival in mucosal 
macrophages (Winter et al. 2010) which is followed by dramatic changes in microbiota composition 
as well as Salmonella ‘blooms’. It has been shown that S. Tm thrives in the inflamed gut by profiting 
from the inflammatory milieu. In contrast to anaerobic commensals, S. Tm is able to use anaerobic 
electron acceptors that are generated during respiratory burst mediated by neutrophils attracted to 
the site of infection (Winter et al. 2010, Lopez et al. 2012). The most important anaerobic electron 
acceptors are tetrathionate (S4O62-) and nitrate (NO3-). Toxic hydrogen sulfide (H2S) produced by the 
microbiota is converted into thiosulfate (S2O32-) by the mucosa (Levitt et al. 1999, Furne et al. 2001). 
During intestinal inflammation which is accompanied by neutrophil infiltration and the presence of 
reactive oxygen species, S2O32- is further oxidized to tetrathionate (S4O62-) (Winter et al. 2010). 
Nitrate forms from NO that is generated by iNOS which further reacts with reactive oxygen species 
such as superoxide O2- produced by neutrophils (PHOX dependent) or by the epithelium (Winter et 
al. 2013) to peroxynitrite (ONOO-) which can isomerize to nitrate (NO3-) (Szabó et al. 2007). S. Tm 
even actively seeks for energetically favorable regions were anaerobic electron acceptors or 
glycoconjugates are present using flagella-mediated motility and chemotaxis (Stecher et al. 2008, 
Rivera-Chávez et al. 2013). Ethanolamine that is liberated from dying epithelial and is selectively used 
by Salmonella serves as energy source for tetrathionate respiration (Thiennimitr et al. 2011).  
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In addition to respiratory burst, antimicrobial peptides are released upon S. Tm infection. Infection of 
macrophages induces IL-23 expression which leads to T-cell dependent induction of IL-17 and IL-22 
(Godinez et al. 2009). T-cell dependent cytokine production is essential for recruitment of 
neutrophils (Godinez et al. 2008) and for secretion of antimicrobials like lipacalin-2 (LCN-2). LCN-2 
that is secreted by epithelial cells and neutrophils hampers iron uptake by sequestering bacterial 
siderophores like enterochelin (Flo et al. 2004, Berger et al. 2006, Raffatellu et al. 2009). 
Siderophores are needed for iron scavenging which is an essential micronutrient. Free iron 
concentrations in the host is restricted by iron-binding proteins like transferrin or ferritin (Andrews 
2000). Besides enterochelin, S. Tm produces salmochelin a glycosylated variant of enterochelin which 
is not bound by LCN-2 (Raffatellu et al. 2009). Thus, salmochelin production provides a fitness 
advantage in the presence of LCN-2. In addition, low dietary iron intake was protective against 
enteric infection in a mouse model (Kortman et al. 2015). S. Tm is also resistant to host-mediated 
zinc sequestration by neutrophil dependent secretion of calprotectin (Liu et al. 2012). This resistance 
is conferred by expression of a high affinity zinc transporter (ZnuABC). Furthermore, S. Tm resists 
RegIIIβ, an antimicrobial peptide which is induced in enteric S. Tm infection and kills commensal gut 
bacteria while paving the way for Salmonella (Stelter et al. 2011). Moreover, sialic acid catabolism 
favors S. Tm outgrowth and dysbiosis during inflammation (Huang et al. 2015).  
However, the inflammatory host response is not only beneficial for S. Tm. On the one hand, immune 
defense that was thought to limit pathogen-invasion can actually promote infection by providing a 
growth advantage over the gut microbiota. On the other hand, during S. Tm infection granulocytes 
(mostly neutrophils) impose a tight bottleneck on the gut luminal pathogen population (Maier et al. 
2014). Transmigrated granulocytes kill up to 99.999% of the luminal Salmonella population and only 
a subpopulation of Salmonella survives and thrives later in the inflamed gut, profiting from the 
inflammatory milieu. Until now it is unknown how infiltrating neutrophils impact on commensal 
bacteria and which nutritional factor of an inflammatory milieu (Figure 2) contributes most to S. Tm 
‘blooming’ and dysbiosis.  
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Figure 2: S. Tm ecosystem invasion and infection. A healthy and complex microbiota confers colonization 
resistance (CR) and protects from infection (stage 1). Upon disturbances of the microbiota (dysbiosis) induced 
by e.g. antibiotics, S. Tm colonizes the gut (stage 2). S. Tm profits from microbiota derived hydrogen (H2), 
increased oxygenation, and sugars and expands in the already inflamed gut (stages 2 and 3). At stage 4, S. Tm 
induces systemic infection and severe inflammation including recruitment of dendritic cells (DC), macrophages 
(Mɸ) and neutrophils which is accompanied by S. Tm ‘blooming’ and massive dysbiosis. During this late stage of 
infection, S. Tm profits from nitrate (NO3-) and tetrathionate (S4O62-) respiration as well as from ethanolamine 
(EA) derived from dying epithelial cells.  
 
1.3 Interactions of other enteric pathogens and the gut microbiota 
1.3.1 Citrobacter rodentium, a model for human enteropathogenic Escherichia coli 
infection 
Enteropathogenic Escherichia coli (EPEC) is an important pathogen inducing diarrheal disease in 
infants causing illness and morbidity (Nataro and Kaper 1998, Kotloff et al. 2013). EPEC has been 
shown to adhere to epithelial cells using bundle-forming pili (BFP) (Cleary et al. 2004). This adherence 
is further strengthened by T3SS mediated translocation of translocated intimin receptor (Tir) to the 
mammalian cell which induces formation of ‘attaching and effacing’ lesions (Kenny et al. 1997). In 
order to model EPEC induced pathology in humans which is a bad mouse-colonizer, mouse models of 
EPEC induced pathology are based on infections with Citrobacter rodentium (C. rodentium). 
Interestingly, C. rodentium causes transmissible colon hyperplasia in mice (Luperchio and Schauer 
2001). The pathogenesis is comparable to EPEC infection in humans. It is characterized by intimate 
attachment of the pathogen to enterocytes, pedestral formation and effacement of microvilli 
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(‘attaching and effacing’ lesion) (Mallick et al. 2012). In mice, C. rodentium infection causes colitis 
and induces microbiota shifts mainly characterized by increased abundance of facultative anaerobic 
bacteria belonging to the Enterobacteriaceae family (Lupp et al. 2007). Interestingly, commensal 
lactobacilli protect against C. rodentium infection (Vong et al. 2015). Furthermore, viable bacteria in 
fermented dairy products reduced colonic crypt hyperplasia upon C. rodentium infection by 
stabilizing the abundance of Ruminococcus and Turicibacter (Collins et al. 2014). This indicates that 
the microbiota plays a role in protection against C. rodentium infection. 16S rRNA amplicon 
sequencing of the microbiota revealed that C. rodentium infection is associated with changes in 
mucosally adherent as well as luminal microbiota. In particular, increased abundance of 
Proteobacteria, Deferribacteres and Clostridia as well as decreased abundance of Lactobacillus were 
observed (Hoffmann et al. 2009). However, data how C. rodentium alters microbial composition at 
the single species level are lacking (Table 1). 
1.3.2 Clostridium difficile, a leading cause of antibiotic associated diarrhea (AAD) 
Nosocomially acquired infections with Clostridium difficile (C. difficile) are associated with antibiotic 
therapy and have become a major health concern worldwide (Rupnik et al. 2009). While a healthy 
gut microbiota provides CR against C. difficile infection, antibiotic therapy increases the risk of 
acquiring C. difficile infection and disease (Britton and Young 2014). Especially C. difficile ribotype 027 
spreads rapidly. This ribotype is linked to increased severity of disease and mortality (Valiente et al. 
2014). Persistent infection correlates with a dysbiotic microbiota (Ananthakrishnan 2011). 
Interestingly, transfer of fecal samples from healthy donors ameliorated disease in patients (van 
Nood et al. 2013), indicating the beneficial potential of a healthy microbiota. Pathology of C. difficile 
depends on expression of different toxins such as toxin A (tcdA) and toxin B (tcdB) which are 
glycosyltransferases that inactivate Rho, Rac as well as Cdc42 involved in actin polymerization and 
regulation of the cell cycle (Voth and Ballard 2005). It was speculated that ribotype 027 produces 
more toxin A and B because it lacks tcdC which is a negative regulator of these toxins (Warny et al. 
2005) and thereby increases virulence. However, this is controversial since Aitken and colleagues 
could not confirm hyper-virulence of ribotype 027 (Aitken et al. 2015). Besides toxin A and toxin B, C. 
difficile ribotypes can additionally express a binary toxin (CDT) which exerts actin-specific ADP-
ribosyltransferase activity and is encoded by cdtA (enzymatic domain) and cdtB (binding domain) 
(Stubbs et al. 2000). CDT which is expressed by two-third of the C. difficile strains including ribotype 
027 is thought to further aggravate C. difficile-induced disease (Barbut et al. 2005, McEllistrem et al. 
2005, Valiente et al. 2014). Toxins are only produced by vegetative cells, not by spores (Lawley et al. 
2009), underlining the importance of spore germination for pathogenesis. Germination is dependent 
on bile acids (Sorg and Sonenshein 2010) which is modulated by the microbiota (Narushima et al. 
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2006, Ridlon et al. 2006). Manipulation of the microbiota with broad-spectrum antibiotics reduces 
abundance of Lachnospiraceae and Ruminococcaceae which correlates with decreased 
concentrations of secondary bile acids in the gut. Secondary bile acid producers like Clostridium 
scindens increased CR against C. difficile infection (Buffie et al. 2015, Theriot et al. 2016). 
Furthermore, cohort studies conducted with patients that had received fecal microbiota 
transplantation revealed that protective microbial taxa belong to the Bacteroides spp., 
Parabacteroides spp., Alistipes, Ruminococcaceae, Clostridium cluster IV and XIVa (Faecalibacterium 
prausnitzii, Roseburia intestinalis, Eubacterium rectale), Lachnospiraceae, Peptostreptococcaceae 
and Verrucomicrobiaceae and negatively correlate with C. difficile colonization. In contrast, the 
abundance of Lactobacillus spp., Streptococcaceae, Enterobacteriaceae, Enterococcus spp., 
Salmonella spp., Sutterella spp. and Verrucomicrobia correlates positively with C. difficile 
colonization (Seekatz and Young 2014). 
1.4 Dysbiosis and inflammatory bowel diseases 
Inflammatory bowel diseases (IBD) include Crohn’s disease (CD) and Ulcerative Colitis (UC). 
Especially, IBD are emerging in countries of the western world. IBD are characterized by barrier 
disruption, chronic inflammation and dysbiosis (Vivinus-Nébot et al. 2014, Ridler 2016, Willing et al. 
2016). The incidence of IBD has been further associated with genetic predisposition and western diet 
rich in fat and sugars (Agus et al. 2016). Furthermore, the epithelial barrier, innate and adaptive 
immunity, environmental factors and the microbiota apparently play a key role in the pathogenesis 
of IBD (Xavier and Podolsky 2007).  
Compositional microbiota analysis of samples obtained from inflamed guts revealed that Bacteroides 
spp. and Fusobacteria are increased in CD patients, whereas Proteobacteria and Firmicutes are 
increased in UC patients (Forbes et al. 2016). In addition, butyrate-producing bacteria like Blautia 
faecis, Roseburia inulinivorans, Ruminococcus torques, Clostridium lavalense, Bacteroides uniformis 
and Faecalibacterium prausnitzii are reduced and bacteria belonging to the genera Actinomyces and 
Bifidobacterium are enriched in CD patients (Takahashi et al. 2016). Patients suffering from UC 
display reduced diversity of Clostridium cluster IV and decreased abundance of bacteria involved in 
butyrate and propionate metabolism like Ruminococcus bromii, Eubacterium rectale, Roseburia spp., 
and Akkermansia spp.. In contrast, increased abundance of Fusobacterium spp., Peptostreptococcus 
spp., Helicobacter spp., Campylobacter spp. and C. difficile is observed in patients suffering from UC 
(Rajilic-Stojanovic et al. 2013). However, until now it remains elusive whether dysbiosis observed 
during IBD is cause or consequence of the disease (Buttó and Haller 2016). Interestingly, some 
microbiota members protect the host from colitis. For example Bacteroides thetaiotaomicron as well 
Introduction 
12 
 
as B. fragilis have evolved beneficial immune modulatory properties (Hoffmann et al. 2015, Chu et al. 
2016) and Faecalibacterium prausnitzii mediates anti-inflammatory activity (Sokol et al. 2008). 
1.5 Common changes in microbiota composition upon enteric infection and 
inflammatory bowel diseases 
In the past years, it has become evident that IBD as well as pathogen induced inflammation are 
accompanied by microbiota shifts and decreased bacterial diversity. Shifts have in common that the 
abundance of obligate anaerobic bacteria is decreased. This gives way to overgrowth of facultative 
anaerobic bacteria (Winter and Bäumler 2014). Thus, shifts were mainly characterized by 
Enterobacteriaceae (Proteobacteria) ‘blooms’ (Lupp et al. 2007, Stecher et al. 2007, Seekatz and 
Young 2014) and reduced abundance of butyrate producing bacteria such as Blautia faecis, Roseburia 
inulinivorans, Ruminococcus torques, Clostridium lavalense, Bacteroides uniformis, Faecalibacterium 
prausnitzii, Ruminococcus bromii, Eubacterium rectale and Roseburia spp (Rajilic-Stojanovic et al. 
2013, Takahashi et al. 2016). However, studies conducted so far were mostly done in different animal 
models or are obtained from human patients (Table 1). In order to investigate parallels and 
mechanisms of dysbiosis induced by infections or chronic inflammation, it is key to make use of 
standardized and highly defined microbial minimal consortia with strain-specific analysis tools. In this 
thesis, we compare dysbiosis induced by infection or chronic inflammation using gnotobiotic mice 
associated with the Oligo-MM12. 
Table 1: Changes in microbiota composition upon enteric infection and inflammatory bowel 
diseases 
Pathology Enriched or positively 
correlated bac. taxa 
Depleted or negatively 
correlated bac. taxa 
Organism / 
analysis method 
Reference 
S. Tm infection Proteobacteria, 
Enterococcus spp., 
Salmonella 
Bacteroidales, 
Firmicutes, Verrucomicrobia, 
Deferribacteres, 
Lactobacillus spp., 
Clostridium spp., Bacteroides 
spp. 
C57BL/6J mice (strep. 
pre-treated mouse) / 
16S rRNA sequencing 
and culturing 
(Stecher et al. 
2007) 
S. Tm infection Enterococcus spp., 
Salmonella 
Bacteroidetes, Firmicutes, 
Barnesiella spp. 
129/SvJ mice (no 
antibiotic prior to 
infection) / 16S rRNA 
sequencing 
(Kaiser et al. 
2013) 
S. Tm infection Salmonella  Anaerostipes caccae, 
Bifidobacterium longum, 
Blautia producta, Bacteroides 
thetaiotaomicron, 
Clostridium ramosum, E. coli, 
C. butyricum, Akkermansia 
muciniphila 
C3H mice (human 
bacteria SIHUMI) / 
strain-specific qPCR 
(Ganesh et al. 
2013) 
S. Tm infection Catenibacterium, 
Xylanibacter 
Prevotella Swine / 16S rRNA 
sequencing and qPCR 
(Bearson et al. 
2013) 
S. Tm infection Clostridium perfringens, 
Salmonella 
Eubacterium rectale, 
Clostridium coccoides, 
FvB mice (no 
antibiotic prior to 
(Barman et al. 
2008) 
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Pathology Enriched or positively 
correlated bac. taxa 
Depleted or negatively 
correlated bac. taxa 
Organism / 
analysis method 
Reference 
Lactobacillus spp., 
Bacteroides spp. 
infection) / qPCR 
C. rodentium 
infection 
Enterobacteriales  Bacteroidales, Clostridiales  C57BL/6J mice / 16S 
rRNA sequencing 
(Lupp et al. 
2007) 
C. rodentium 
infection 
Deferribacteres, 
Proteobacteria  
Lactobacillaceae C57BL/6J mice / 16S 
rRNA sequencing 
(Hoffmann et 
al. 2009) 
C. difficile 
infection 
Ruminococcus gnavus, 
Klebsiella pneumoniae 
Bifidobacterium longum Human infants / 
TTGE* + 16S rRNA 
sequencing 
(Rousseau et 
al. 2011) 
C. difficile 
infection 
 Ruminococcaceae, 
Lachnospiraceae 
Human / 16S rRNA 
sequencing 
(Antharam et 
al. 2013) 
C. difficile 
infection 
Firmicutes, Proteobacteria, 
Actinobacteria 
Bacteroidetes Human / microarray 
+ 16S rRNA 
sequencing 
(Manges et al. 
2010) 
C. difficile 
infection 
Lactobacillus spp., 
Streptococcaceae, 
Enterobacteriaceae, 
Enterococcus spp., 
Salmonella spp., Sutterella 
spp., Verrucomicrobia 
Bacteroides spp., 
Parabacteroides spp., 
Alistipes, Ruminococcaceae, 
Clostridium cluster IV and 
XIVa (Faecalibacterium 
prausnitzii, Roseburia 
intestinalis, Eubacterium 
rectale), Lachnospiraceae, 
Peptostreptococcaceae, 
Verrucomicrobiaceae 
Human (after fecal 
transplantation). 
(Seekatz and 
Young 2014) 
CD  Bacteroidetes, Fusobacteria  Human / 16S rRNA 
sequencing 
(Forbes et al. 
2016) 
CD Actinomyces, 
Bifidobacterium 
Bacteroides, Eubacterium, 
Faecalibacterium 
Ruminococcus (Blautia faecis, 
Roseburia inulinivorans, 
Ruminococcus torques, 
Clostridium lavalense, 
Bacteroides uniformis and 
Faecalibacterium prausnitzii) 
butyrate producer 
Human / 16S rRNA 
sequencing 
(Takahashi et 
al. 2016) 
UC Proteobacteria, Firmicutes  Human / 16S rRNA 
sequencing 
(Forbes et al. 
2016) 
UC Fusobacterium spp., 
Peptostreptococcus spp., 
Helicobacter spp., 
Campylobacter spp., C. 
difficile 
Ruminococcus bromii, 
Eubacterium rectale, 
Roseburia spp., and 
Akkermansia spp., 
Clostridium cluster IV 
Human / 
phylogenetic 
microarray 
(Rajilic-
Stojanovic et 
al. 2013) 
 
IBD Alphaproteobacteria; 
Actinobacteria (Actinomyces 
oxydans); 
Gammaproteobacteria; 
Betaproteobacteria 
(Pseudomonas spp.), 
Firmicutes, Bacilli (B. 
lichenifromis) 
 
Firmicutes, Lachnospiraceae 
(Clostridium spp.); 
Bacteroidetes, 
Bacteroidales (B. 
thetaiotaomicron, Alistipes 
spp.)  
 
Human / qPCR (Frank et al. 
2007) 
S. Tm: Salmonella Typhimurium, C. rodentium: Citrobacter rodentium, C. difficile: Clostridium difficile, CD: 
Crohn’s disease, UC: ulcerative colitis, IBD: inflammatory bowel disease, Strep.: streptomycin, *TTGR: PCR-
temporal temperature gradient gel electrophoresis, bac.: bacterial  
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1.6 Aims of the study 
The composition of the gut microbiota is highly complex and several aspects of host-pathogen-
microbiota interactions still remain elusive. In order to investigate mechanisms underlining such 
interactions, we established a novel mouse derived bacterial consortium termed the Oligo-mouse-
microbiota (Oligo-MM12) that is constituted of 12 bacterial isolates which cover the main eubacterial 
phyla (Brugiroux et al. 2016).  
(1) The first aim of my thesis was to establish strain-specific qPCR assays that allow for absolute 
quantification of the 12 individual Oligo-MM strains. In addition for specific research question, qPCR 
assays should be also extended to quantification of 7 ASF strains, Salmonella Typhimurium, 
Citrobacter rodentium, Helicobacter typhlonius, Clostridium difficile, Clostridium scindens, Escherichia 
coli, Streptococcus danieliae and Staphylococcus xylosus in complex consortia. qPCR was chosen 
because it is a fast, affordable and sensitive method for absolute quantification of individual bacterial 
species. This method shall then be employed to monitor bacterial colonization in gnotobiotic mice 
over time, analyze vertical transmission, microbial stability over generations, changes in microbial 
composition upon exposure to different diet and compare Oligo-MM12 composition between 
different animal facilities. 
S. Tm induces acute gut inflammation engaging effector protein secretion via type 3 secretion 
systems which is followed by dramatic changes in microbiota composition (dysbiosis) as well as 
Salmonella overgrowth (‘blooming’). Recently, first insights into the underlying mechanisms have 
been obtained: On the one hand, anaerobic electron acceptors like nitrate and tetrathionate, 
ethanolamine and iron are selectively used by the pathogen conferring a fitness advantage over the 
indigenous microbiota. On the other hand, the microbiota might experience collateral damage by 
neutrophils which infiltrate the gut lumen in response to Salmonella-induced inflammation. 
However, it is still unclear which of these mechanisms is more important for the induction of 
pathogen ‘blooming’ and concomitant dysbiosis: the altered nutritional environment or differential 
killing by the inflammatory immune response. Furthermore, it has remained elusive how the 
environment of an inflamed gut impacts on individual species of a normal microbiota, which 
properties are important for survival in the inflamed gut and whether or how the microbiota is able 
to recover from inflammation induced dysbiosis (resilience).  
(2) The second aim was to study the course of S. Tm infection in the gnotobiotic Oligo-MM12 model. 
Furthermore, the influence and importance of single nutrients provided by an inflammatory milieu as 
well as long-term infection should be investigated using strain-specific qPCR assays as well as S. Tm 
strains deficient in nitrate and tetrathionate respiration, ethanolamine utilization, siderophore 
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production and functional type 3 secretion systems (T3SSs). Functional genomic analysis of Oligo-
MM12 genome sequences should be performed to identify genes of commensals characteristic for 
survival in the inflamed gut. In addition, besides the influence of an inflammatory milieu, I aimed to 
investigate the role of neutrophils in dysbiosis during Salmonella-induced inflammation by antibody-
mediated depletion of neutrophils and mice deficient in extravasation of neutrophils.  
Pathogen infection as well as chronic inflammation correlates with decreased abundance of obligate 
anaerobic bacteria and increased abundance of Proteobacteria. However, data showing the fate of 
individual bacteria during dysbiosis at the species level are lacking so far. Studies have been 
performed in different animal models or are patient-derived and employ different analysis tools 
(Table 1). Thus, I wanted to identify differences and common effects between infections with 
different pathogens and chronic inflammation on the gut microbiota using the same model 
microbiota and analysis tools. 
(3) My third aim was to compare the influence of infections with S. Tm, C. rodentium, C. difficile as 
well as T-cell-induced colitis on individual microbiota species using the defined Oligo-MM12 model 
and strain-specific qPCR assays. 
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2. Material and Methods 
2.1 Strains and plasmids 
2.1.1 Strains 
Table 2: Mouse derived bacterial strains constituting the Oligo-Mouse-Microbiota (Oligo-MM12) 
Strain 
ID Taxonomy at species level DSM No. Isolated by Publication 
YL2 Bifidobacterium longum  subsp. animalis 26074 Yvonne Loetscher (Brugiroux et al. 2016) 
YL27 ‘Muribaculum intestinale’ 28989 Yvonne Loetscher (Brugiroux et al. 2016) 
YL31 Flavonifractor plautii 26117 Yvonne Loetscher (Brugiroux et al. 2016) 
YL32 Clostridium clostridioforme 26114 Yvonne Loetscher (Brugiroux et al. 2016) 
YL44 Akkermansia muciniphila 26127 Yvonne Loetscher (Brugiroux et al. 2016) 
YL45 ‘Turicimonas caecimuris’ 26109 Yvonne Loetscher (Brugiroux et al. 2016) 
YL58 Blautia coccoides 26115 Yvonne Loetscher (Brugiroux et al. 2016) 
I46 Clostridium innocuum 26113 Ricco Robbiani (Brugiroux et al. 2016) 
I48 ‘Bacteroides caecimuris’ 26085 Ricco Robbiani (Brugiroux et al. 2016) 
I49 Lactobacillus reuteri 32035 Ricco Robbiani (Brugiroux et al. 2016) 
KB1 Enterococcus faecalis 32036 Sandrine Brugiroux (Brugiroux et al. 2016) 
KB18 ‘Acutalibacter muris’ 26090 Sandrine Brugiroux (Brugiroux et al. 2016) 
 
Table 3: Salmonella, E. coli and Yersinia enterocolitica strains 
Strains strain ID Genotype Reference 
S.TmWT SB300 S. Tm strain S1344 (Hoiseth and Stocker 1981) 
S.TmAvir M557 ΔinvG; sseD::aphT (Hapfelmeier et al. 2004) 
S.TmSPI-1 SB161 ΔinvG (Kaniga et al. 1994) 
S.TmSPI-2 M556 sseD::aphT (Hapfelmeier et al. 2004) 
MBE1 MBE1 narZ::cat This study 
MBE2 MBE2 narG::cat This study 
MBE3 MBE3 napA::aphT This study 
MBE4 MBE4 narZ::cat (P22-phage lysate of MBE1 on SB300) This study 
MBE5 MBE5 ΔnarZ This study 
Material and Methods 
17 
 
Strains strain ID Genotype Reference 
MBE6 MBE6 ΔnarZ; narG::cat This study 
S.TmNi. MBE7 ΔnarZ; narG::cat; napA::aphT This study 
S.TmNi. + Te. MBE8 ΔnarZ; narG::cat; napA::aphT; ttrS::tet This study 
MBE9 MBE9 entA::cat This study 
S.TmEntA MBE10 entA::cat (P22-phage lysate of MBE9 on SB300) This study 
MBE11 MBE11 eutC::aphT This study 
S.TmEA MBE12 eutC::aphT (P22-phage lysate of MBE11 on SB300) This study 
E.coli DH5α   Invitrogen 
HB 1852S WA-CS    (Stojiljkovic et al. 1999) 
WA-TS   ybtA::aphT (Pelludat 1999) 
Clostridium difficile DH196  (Studer et al. 2016) 
Citrobacter rodentium DBS100  
(Schauer and Falkow 
1993, Schauer et al. 
1995) 
Helicobacter typhlonius CCUG48335T  (Brasseit et al. 2016) 
 
2.1.2 Plasmids 
Table 4: Plasmids used for λ red and Flp recombination 
Plasmid Function Genotype Reference 
pKD3 Harbors a chloramphenicol resistance gene (cat) 
cat with FRT sites, 
AmpR 
(Datsenko and Wanner 
2000) 
pKD4 Harbors a kanamycin resistance gene (aphT) aphT with FRT sites, AmpR 
(Datsenko and Wanner 
2000) 
pKD46 Harbors 2,154 nt (31088–33241) of phage λ, enzymes for recombinaction 
araC, ParaB γ, β and 
exo, repA101ts, AmpR 
(Datsenko and Wanner 
2000) 
pCP20 Harbors FLP-recombinase FLP
+, λ cI857+, λ pR 
Repts, AmpR, CmR 
(Cherepanov and 
Wackernagel 1995) 
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Table 5: Plasmids harboring 16S rRNA full length gene sequences 
Plasmid Backbone Taxonomy and strain ID Digest* Reference 
pM1411 pSB-Bluescript Clostridium spp. ASF356 NotI (Brugiroux et al. 2016) 
pM1412 pSB-Bluescript Lactobacillus intestinalis ASF360 NotI (Brugiroux et al. 2016) 
pM1413 pSB-Bluescript Lactobacillus murinus ASF361 NotI (Brugiroux et al. 2016) 
pM1414 pSB-Bluescript Mucispirillum schaedleri ASF457 NotI (Brugiroux et al. 2016) 
pM1417 pSB-Bluescript Parabacteroides goldsteinii ASF519 NotI (Brugiroux et al. 2016) 
pM1452 pCR2.1-topo Bifidobacterium longum subsp. animalis YL2 HindIII (Brugiroux et al. 2016) 
pM1456 pCR2.1-topo Flavonifractor plautii YL31 HindIII (Brugiroux et al. 2016) 
pM1457 pCR2.1-topo Clostridium clostridioforme YL32 HindIII (Brugiroux et al. 2016) 
pM1459 pCR2.1-topo Akkermansia muciniphila YL44 HindIII (Brugiroux et al. 2016) 
pM1460 pCR2.1-topo ‘Turicimonas caecimuris’ YL45 NcoI (Brugiroux et al. 2016) 
pSAB3 pJET1.2 ‘Muribaculum intestinale’ YL27 NotI (Brugiroux et al. 2016) 
pSAB4 pJET1.2 Blautia coccoides YL58 HindIII (Brugiroux et al. 2016) 
pSAB6 pJET1.2 Clostridium innocuum I46 NotI (Brugiroux et al. 2016) 
pSAB7 pJET1.2 ‘Bacteroides caecimuris’ I48 HindIII (Brugiroux et al. 2016) 
pSAB8 pJET1.2 Lactobacillus reuteri I49 HindIII (Brugiroux et al. 2016) 
pSAB9 pJET1.2 Enterococcus faecalis KB1 NotI (Brugiroux et al. 2016) 
pSAB10 pJET1.2 Clostridium spp. ASF502/SB2 NotI (Brugiroux et al. 2016) 
pSAB12 pJET1.2 ‘Acutalibacter muris’ KB18 HindIII (Brugiroux et al. 2016) 
pSAB13 pJET1.2 Pseudoflavonifactor spp. ASF500 NotI (Brugiroux et al. 2016) 
pMB1 pJET1.2 Salmonella Typhimurium HindIII This study 
pMB2 pJET1.2 Citrobacter rodentium DBS100 NotI This study 
pMB4 pJET1.2 Helicobacter typhlonius CCUG48335T NotI This study 
pMB5 pJET1.2 Clostridium difficile DH196 NotI This study 
pMB6 pJET1.2 Clostridium scindens ATCC35704 NotI This study 
*The indicated restriction enzymes were used to linearize vectors that contain strain-specific 16S rRNA gene 
sequences. 
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2.2 Buffers, media and Oligonucleotides 
2.2.1 Buffers and media 
Buffers and media were made up in desalted water (dH2O), autoclaved at 121°C and 1 bar for 20 min 
-if not indicated differently- and prepared according to the following recipes: 
Table 6: Luria-Bertani (LB) medium 
Components Per liter medium 
NaCl 5 g 
Yeast extract  5 g 
Tryptone  10 g 
All components were dissolved in dH2O. 
Table 7: LB agar 
Components Per liter medium 
NaCl 5 g 
Yeast extract  5 g 
Tryptone  10 g 
Agar 15 g 
All components were dissolved in dH2O. 
Table 8: LB 0.3 M NaCl 
Components Per liter medium 
NaCl 17.53 g 
Yeast extract  5 g 
Tryptone  10 g 
All components were dissolved in dH2O. 
Table 9: Peptone-glycerol broth 
Components Per liter broth 
Peptone  20 g 
Glycerol 50 ml 
All components were dissolved in dH2O. 
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Table 10: M9 medium 
Components Final concentration 
Na2HPO4 · 2H2O  40 mM 
KH2PO4  20 mM 
NaCl  9 mM 
NH4Cl  2 g/l 
D-glucose  2 g/l 
MgSO4  1 mM 
CaCl2  100 μM 
Thiamine  10 mg/ml 
Histidine  500 mg/l 
Optional NaNO3 20 mM 
All components were dissolved in dH2O. 
Table 11: Mucin broth 
Components Per liter medium 
Type II porcine mucin  2.5 g 
Morpholino propanesulfonic acid (MOPS) 
Sodium 9.25 g 
MgSO4 0.265 g 
Optional: NaNO3 or Na2O6S4 · 2H2O 40 mM 
Trace elements (1,000x) 1 ml 
Trace elements  Final concentration 
CaCl2 · 2H2O 0.3 mM 
ZnSO4 · 7H2O 0.1 mM 
FeSO4 · 7H2O 0.045 mM 
Na2SeO3 0.2 mM 
Na2MoO4 · 2H2O 0.2 mM 
MnSO4 · H2O 2 mM 
CuSO4 · 5H2O 0.1 mM 
CoCl2 · 6H2O 3 mM 
NiSO4 · 6H2O 0.1 mM 
All components were dissolved in dH2O. The 1,000x trace element stock was autoclaved separately. 
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Table 12: Akkermansia medium (AAM) without mucin 
Components Per liter medium 
Brain Heart Infusion  18.5 g 
Trypticase soy broth 15 g 
Yeast extract 5 g 
K2HPO4 2.5 g 
Hemin 1 mg 
Glucose 0.5 g 
Autoclave and add the following components under sterile 
conditions: 
Na2CO3 (5% stock solution)¤ 0.4 g 
Cysteine hydrochloride# 0.5 g 
Menadione# 0.5 g 
Complement inactivated FCS# 3 % 
All components but hemin, that was resuspended in ethanol p.a. and supplemented with NaOH until dissolved 
and menadione, which was resuspended in ethanol p.a. were dissolved in dH2O. ¤ Autoclaved. # Sterile filtered. 
The following Tables 13 - 17 list ingredients needed for the preparation of Chromazurol S (CAS) agar: 
Table 13: CAS stock solution A 
Components Per 60ml 
Chromazurol S 60.5 mg 
1 mM FeCl3 · 6H2O dissolved in 10 
mM HCl 10 ml 
Chromazurol S was dissolved in 50 ml of dH2O and subsequently 10 ml of FeCl3 solution were added. 
Table 14: CAS stock solution B 
Component Per 40 ml 
Hexadecyltrimethylammonium 
bromide (HDTMA) 72.9 mg 
HDTMA was dissolved in 40 ml of dH2O and subsequently solution A was added under constant stirring. 
Solution B was finally autoclaved. 
Table 15: 10x LB medium 
Components Per 200 ml 
Tryptone 20 g 
Yeast extract 10 g 
NaCl 10 g 
Components were dissolved in 200 ml of dH2O and autoclaved. 
Material and Methods 
22 
 
Table 16: 10x MM9 
Components Per 200 ml 
KH2PO4 0.6 g 
NH4Cl 2 g 
Components were dissolved in 200 ml of dH2O. 
Table 17: PIPES agar 
Components Per 850 ml 
dH2O 500 ml 
10x MM9 100 ml 
Agar 15 g 
1,4-Piperazinediethanesulfonic acid 
(PIPES)  31.1 g 
PIPES was added under constant stirring, the pH was adjusted to 6.8 using NaOH pellets and dH2O was added 
ad 850 ml. The solution was subsequently autoclaved and allowed to cool down to 50°C. The following already 
sterile watery solutions were then added: 30 ml of 10x LB (autoclaved), 10 ml of 20% glucose (sterile filtered), 2 
ml of 1 M MgSO4 (sterile filtered), 2 ml of 1 M Na2SO4 (autoclaved), 1 ml of 0.1 M CaCl2 and 100 ml of CAS stock 
solution A + B. The CAS agar was finally poured in petri dishes. 
Table 18: 10x phosphate Buffered Saline (PBS) 
Components Per liter buffer 
NaCl 80 g 
KCl 2 g 
Na2HPO4 unhydrated 6.1 g 
KH2PO4 2.4 g 
All components were dissolved in dH2O. 
Table 19: TE Buffer 
Components Final concentration 
Tris 10 mM 
EDTA 1 mM 
All components were dissolved in ddH20 (Ampuwa). pH was adjusted to 8.0 with HCl. 
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Table 20: 4% Paraformaldehyde (PFA) 
Components Per liter buffer 
ddH2O 300 ml 
PFA 40 g 
1 M NaOH 100 µl 
10x PBS in ddH2O, pH 7.4 100 ml 
Components were heated up to 60 °C and stirred vigorously until PFA is dissolved. DdH2O (Ampuwa) was filled 
up to 1 l and pH was adjusted. Buffer was sterile filtered and stored at -20 °C. 
Table 21: TFB1 buffer 
Components Volume 
Potassium acetate 0.29 g 
MnCl2 · 4H2O 2 g 
1 M RbCl 10 ml 
1 M CaCl2 1 ml 
Glycerol 87% 17.2 ml 
ddH2O (Ampuwa) Ad 100 ml 
pH was adjusted to 7.0 and filter sterilized. 
Table 22: TFB2 buffer 
Components Volume 
1 M NaMOPS pH 7.0 1 ml 
1 M RbCl 1 ml 
1 M CaCl2 7.5 ml 
Glycerol 87% 17.5 ml 
ddH2O (Ampuwa) Ad 100 ml 
pH was adjusted to 7.0 and filter sterilized. 
Table 23: 50x TAE buffer 
Components Per 5 l buffer 
Tris 1,210 g 
Glacial acetic acid 285.5 ml 
0.5 M EDTA pH 8.0 500 ml 
dH2O ad 5 l 
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Table 24: 10x loading dye 
Components Final concentration 
Sucrose 40% 
Bromphenol blue 0.25% 
Xylene Cyanol 0.25% 
 
Table 25: SOC medium 
Components Per 250 ml medium 
Tryptone 5 g 
Yeast extract 1.25 g 
NaCl 0.125 g 
250 mM KCl 2.5 ml 
Ad 250 ml with ddH2O (Ampuwa), adjust pH to 7.0 with 5 M NaOH 
and autoclave. 
1 M glucose (sterile filtered) 5 ml 
 
Table 26: 20% glycerol-palladium solution 
Components Per 50 ml solution 
100% glycerol 10 ml 
Palladium crystals Tip of spatula 
ddH20 40 ml 
After autoclaving, the warm solution (60°C) was imported in the anaerobic tent. 
Table 27: Lysis buffer for DNA extraction (Stool kit, Qiagen) 
Components Final concentration 
Tris 20 mM 
EDTA 2 mM 
Triton X 100 1% 
Adjust pH to 8.0 with HCl, autoclave and add: 
Lysozyme 20 mg/ml 
Components were dissolved in ddH2O (Ampuwa) 
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Table 28: Extraction buffer for DNA extraction (Turnbaugh/Ubeda) 
Components Final concentration 
Tris  200 mM 
NaCl 200 mM 
EDTA 20 mM 
Components were dissolved in ddH20 (Ampuwa). pH was adjusted to 8.0 using HCl and the solution was finally 
autoclaved. 
Table 29: PBT 
Components Per 200 ml 
BSA fraction V 200 mg 
TM 10 tergitol 200 µl 
1x PBS ad 200 ml 
Solution was sterile filtered. 
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2.2.2 Oligonucleotides 
Table 30: Oligonucleotides and hydrolysis probes for qPCR 
Primers and corresponding 
probe 
(targeted strain) 
Sequence 5’ - 3’ Tm°C GC% Length (bp) 
Ampl. 
(bp) 
Isol46_Exonucl.2_fwd CGGATCGTAAAGCTCTGTTGTAAG 58 45.8 24  
Isol46_Exonucl.3_rev GCTACCGTCACTCCCATAGCA 59 57.1 21  
Probe3_Isol46 
(Clostridium innocuum I46) FAM-AAGAACGGCTCATAGAGG-BHQ1 70 50.0 18 68 
Isol49_Exonucl._fwd GCACTGGCTCAACTGATTGATG 59.0 50.0 22  
Isol49_Exonucl._rev CCGCCACTCACTGGTGATC 59.0 63.2 19  
Probe_Isol49 
(Lactobacillus reuteri I49) HEX-CTTGCACCTGATTGACGA-BHQ1 69.0 50.0 18 64 
YL58_Exonucl._fwd GAAGAGCAAGTCTGATGTGAAAGG 58.0 45.8 24  
YL58_Exonucl._rev CGGCACTCTAGAAAAACAGTTTCC 59.0 45.8 24  
Probe_YL58 
(Blautia coccoides YL58) FAM-TAACCCCAGGACTGCAT-BHQ1 69.0 52.9 17 74 
YL27_Exonucl.2_fwd TCAAGTCAGCGGTAAAAATTCG 58.0 40.9 22  
YL27_Exonucl.2_rev CCCACTCAAGAACATCAGTTTCAA 59.0 41.7 24  
Probe2_YL27 
‘Muribaculum intestinale’ YL27) HEX-CAACCCCGTCGTGCC-BHQ1 70.0 73.3 15 67 
YL31_Exonucl.2_fwd AGGCGGGATTGCAAGTCA 59.0 55.6 18  
YL31_Exonucl.3_rev CCAGCACTCAAGAACTACAGTTTCA 59.0 44.0 25  
Probe2_YL31 
(Flavonifractor plautii YL31) FAM-CAACCTCCAGCCTGC-BHQ1 70.0 66.7 15 80 
YL32_Exonucl.2_fwd AATACCGCATAAGCGCACAGT 58.0 47.6 21  
YL32_Exonucl.2_rev CCATCTCACACCACCAAAGTTTT 59.0 43.5 23  
Probe2_YL32 
(Clostridium clostridioforme YL32) HEX-CGCATGGCAGTGTGT-BHQ1 69.0 60.0 15 63 
KB1_Exonucl._fwd CTTCTTTCCTCCCGAGTGCTT 59.0 52.4 21  
KB1_Exonucl._rev CCCCTCTGATGGGTAGGTTACC 60.0 59.1 22  
Probe_KB1 
(Enterococcus faecalis KB1) FAM-CACTCAATTGGAAAGAGGAG-BHQ1 70.0 45.0 20 88 
YL2_Exonucl._fwd GGGTGAGTAATGCGTGACCAA 59.0 52.4 21  
YL2_Exonucl._rev CGGAGCATCCGGTATTACCA 59.0 55.0 20  
Probe_YL2 
(Bifidobacterium longum subsp. 
animalis YL2) 
HEX-CGGAATAGCTCCTGGAAA-BHQ1 69.0 50.0 18 77 
KB18_Exonucl.2_fwd TGGCAAGTCAGTAGTGAAATCCA 58.0 43.5 23  
KB18_Exonucl.2_rev TCACTCAAGCTCGACAGTTTCAA 59.0 43.5 23  
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Primers and corresponding 
probe 
(targeted strain) 
Sequence 5’ - 3’ Tm°C GC% Length (bp) 
Ampl. 
(bp) 
Probe2_KB18 
(‘Acutalibacter muris’ KB18) FAM-CTTAACCCATGAACTGC-BHQ1 69.0 47.1 17 69 
YL44_Exonucl._fwd CGGGATAGCCCTGGGAAA 59.0 61.1 18  
YL44_Exonucl._rev GCGCATTGCTGCTTTAATCTTT 60.0 40.9 22  
Probe_YL44 
(Akkermansia muciniphila YL44) HEX-TGGGATTAATACCGCATAGTA-BHQ1 69.0 38.1 21 65 
YL45_Exonucl._fwd AGACGGCCTTCGGGTTGTA 59.0 57.9 19  
YL45_Exonucl._rev CGTCATCGTCTATCGGTATTATCAA 58.0 40.0 25  
Probe_YL45 
(‘Turicimonas caecimuris’ YL45) FAM-ACCACTTTTGTAGAGAACGA-BHQ1 69.0 40.0 20 73 
Isol48_Exonucl._fwd GGCAGCATGGGAGTTTGCT 60.0 57.9 19  
Isol48_Exonucl._rev TTATCGGCAGGTTGGATACGT 58.0 47.6 21  
Probe_Isol48 
(‘Bacteroides caecimuris’ I48) HEX-CAAACTTCCGATGGCGAC-BHQ1 69.0 55.6 18 79 
ASF356_Exonucl.2_fwd CGGCAAGGTAAGCGATATGTG 59.0 52.4 21  
ASF356_Exonucl.2_rev CGCTTTCCTCTCCTGTACTCTAGCT 60.0 52.0 25  
Probe2_ASF356 
(Clostridium spp. ASF356) 
FAM-TAACTTAAGGATAGCATAACGAACT-
BHQ1 69.0 32.0 25 88 
ASF360_Exonucl.4_fwd TGAGTGCTAAGTGTTGGGAGGTT 59.0 47.8 23  
ASF360_Exonucl.4_rev CGGAGTGCTTAATGCGTTAGCT 60.0 50.0 22  
Probe4_ASF360 
(Lactobacillus intestinalis ASF360) FAM-CCGCCTCTCAGTGCT-BHQ1 70.0 66.7 15 63 
ASF361_Exonucl._fwd TCGGATCGTAAAACCCTGTTG 59.0 47.6 21  
ASF361_Exonucl._rev ACCGTCGAAACGTGAACAGTT 58.0 47.6 21  
Probe_ASF361 
(Lactobacillus murinus ASF361) 
HEX-TAGAGAAGAAAGTGCGTGAGAG-
BHQ1 70.0 45.5 22 66 
ASF457_Exonucl._fwd GACTGGAACAACTTACCGAAAGGT 59.0 45.8 24  
ASF457_Exonucl._rev CAGGTCTCCCCAACTTTTCCT 58.0 52.4 21  
Probe_ASF457 
(Mucispirillum schaedleri ASF457) FAM-TAATGCCGGATGAGTTATA-BHQ1 69.0 36.8 19 85 
ASF500_Exonucl._fwd AGGCGGGACTGCAAGTCA 59.0 61.1 18  
ASF500_Exonucl._rev CAAATGCAGGCCACAGGTT 58.0 52.6 19  
Probe_ASF500 
(Pseudoflavonifactor spp. ASF500) HEX-ATGTGAAAACCACGGGC-BHQ1 68.0 52.9 17 57 
ASF502_Exonucl.3_fwd GACCCCAGTACCGCATGGTA 59.0 60.0 20  
ASF502_Exonucl.3_rev TCAGACGCGGGCCTATCTTA 59.0 55.0 20  
Probe3_ASF502(SB2) 
(Clostridium spp. ASF502/SB2) HEX-AGAGGTAAAAACTGAGGTGGT-BHQ1 69.0 42.9 21 63 
ASF519_Exonucl._fwd TGTGGCTCAACCATAAAATTGC 59.0 40.9 22  
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Primers and corresponding 
probe 
(targeted strain) 
Sequence 5’ - 3’ Tm°C GC% Length (bp) 
Ampl. 
(bp) 
ASF519_Exonucl._rev GCATTCCGCCTACCTCAAATAT 58.0 45.5 22  
Probe_ASF519 
(Parabacteroides goldsteinii ASF519) HEX-TTGAAACTGGTTGACTTGAG-BHQ1 69.0 40.0 20 67 
Salmo_Exonucl._fwd TGGGAAACTGCCTGATGGA 59.0 52.6 19  
Salmo_Exonucl._rev CTTGCGACGTTATGCGGTATT 59.0 47.6 21  
Probe_Salmo 
(Salmonella SL1344) FAM-ATAACTACTGGAAACGGTGGC-BHQ1 70.0 47.6 21 67 
C.rod_Exonucl._fwd GGGACCTTCGGGCCTCTT 60.0 66.7 18  
C.rod_Exonucl._rev TCACCAACAAGCTAATCCCATCT 59.0 43.5 23  
Probe_C.rod 
(Citrobacter rodentium DBS100) HEX-CCACCGGATGTGCC-BHQ1 70.0 71.4 14 57 
H.typh_Exonucl.2_fwd CAGCTCGGCTGAGCACTCTA 58.0 60.0 20  
H.typh_Exonucl.2_rev GACTTGACGTCGTCCTCACCTT 59.0 54.5 22  
Probe2_H.typhlonius 
(Helicobacter typhlonius 
CCUG48335T) 
HEX-AGACTGCCTTCGTAAGG-BHQ1 68.0 52.9 17 68 
C.diff_Exonucl._fwd TCGGTGCCGCAGCTAAC 58.0 64.7 17  
C.diff_Exonucl._rev AGTTTCACTCTTGCGAGCGTACT 58.0 47.8 23  
Probe_C.difficile 
(Clostridium difficile DH196) HEX-CATTAAGTACTCCGCCTGGG-BHQ1 70.0 55.0 20 62 
C.scin_Exonucl._fwd TGCAAGCCAGATGTGAAAGC 59.0 50.0 20  
C.scin_Exonucl._rev AGCCACGCAGTTCCAAATG 58.0 52.6 19  
Probe_C.scindens 
(Clostridium scindens ATCC35704) HEX-CTCAACCCCGGGACT-BHQ1 69.0 66.7 15 61 
E.coli_Exonucl._fwd GGACCTTCGGGCCTCTTG 59 66.7 18  
E.coli_Exonucl._rev CCTTTACCCCACCTACTAGCTAATCC 60 50.0 26  
Probe_E.coli(Mt1B1) 
(Escherichia coli Mt1B1) FAM-ATCGGATGTGCCCAGAT-BHQ1 69 52.9 17 64 
Strep._Exonucl._fwd CAACTGCATCACTACCAGATGGA 59 47.8 23  
Strep._Exonucl._rev CGCCTAGGTGAGCCTTTACCT 59 57.1 21  
Probe_Strep.daniel. 
(Streptococcus danieliae ERD01G) HEX-CTGCGTTGTATTAGCTAGTAG-BHQ1 69 42.9 21 69 
Staph._Exonucl._fwd GGAGCTAATACCGGATAACATTTAGAA 58 37.0 27  
Staph._Exonucl._rev CCATCTATAAGTGATAGCAAAACCATCT 58 35.7 28  
Probe_Staph.xylosus 
(Staphylococcus xylosus 33R13C) HEX-CGCATGGTTCTAAAGTG-BHQ1 69 47.1 17 75 
Univ_Exonucl.3_fwd TGCAYGGYYGTCGTCAGC 59.0 63.9 18  
Univ_Exonucl.3_rev CRTCRTCCYCRCCTTCCTC 59.0 63.2 19  
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Primers and corresponding 
probe 
(targeted strain) 
Sequence 5’ - 3’ Tm°C GC% Length (bp) 
Ampl. 
(bp) 
Probe2_Univ 
(All bacteria but C. difficile) HEX-AACGAGCGCAACCC-BHQ1 70.0 64.3 14 143 
Probe3_Univ* 
(All bacteria listed) HEX-ARCGAGCGYAACCC-BHQ1 70.0 64.3 14 143 
*For samples including template DNA of C. difficile, the combination of Univ_Exonucl.3_fwd/rev3 + 
Probe3_Univ was used, since Probe2_Univ cannot detect C. difficile; Tm°C: melting temperature in °C, 
determined using Primer Express 3 (MGB protocol, Applied Biosystems, Life Technologies, USA), note: minor 
groove binder (MGB) protocol was chosen; GC%: guanine and cytosine content as percentage of all nucleotides 
constituting the oligo-nucleotide; length: length of the oligo-nucleotide in base pairs; ampl.: amplicon size that 
is amplified by the given primer pair, indicated in base pairs; FAM (6-carboxyfluoresceine); HEX (6-
carboxyhexafluoresceine); BHQ1 (black hole quencher 1).  
Table 31: Primers used for construction of Salmonella mutants  
Designation Sequence 5’ - 3’ Construction of Amplicon size (bp) 
narZ-fwd-ko 
AATGGTTTAACGCCAAATCGACAGGATGGCGGAAA
ATTTATCGAAGCAGGAGAAATGTCatatgaatatcctcc
ttagtt 
  
narZ-rev-ko 
GGTGTGACAGCCAATACATTTATCGAGATTCAGTAC
CATCCCAACCTGTGAGCGTATTTtgtgtaggctggagctg
cttc 
MBE1 (narZ::cat)  
narZ fwd-check up GCGTCGTAAGCCTAAACA   
narZ rev-check up CCGGTCCAGACGTTTTTA  3948 
narG-fwd-ko 
CTTAGTTAAGCAATGTCGATTTATCAGAGAGCCGTA
AGGTTCCACACAGGAGAAACCCGatatgaatatcctcctt
agtt 
  
narG-rev-ko 
GGTATGACAGCCGATGCACTTATCGAGATTCAGCA
CCATGCCGACTTGTGAACGAATTTtgtgtaggctggagct
gcttc 
MBE2 (narG::cat)  
narG fwd-check up TTCTCACGCCCATTCAGC   
narG rev-check up CCAGACGTTTTTACAGGT  3921 
napA-fwd-ko 
GGCGTACTGGCGGTGTCGCTGGTTTATCACCAGCA
GGATGAGCAAGGTGAGGAAACACCatatgaatatcctc
cttagtt 
 
  
napA-rev-ko 
ACATCACGCAGGAAGCGGCGGCGGCCATTTTGGG
GTTTCGCTGTACGGGACATAACGCGtgtgtaggctgga
gctgcttc  
 
MBE3 (napA::aphT)  
napA fwd-check up ACAATTGAGTCAGTACGC   
napA rev-check up GCTGGCGAAGACATTTTC  2756 
ttrS fwd-check up CGGCTTGTTGTTGATCTAA   
ttrS rev-check up CCCAGACTTTCCAGTAAAA  1873 
entA-fwd-ko 
CTGGCGAAAAACCCGACCATTGACGCCTGGTGGGC
GCTGCTTTCTCGCGGGGTAGAGTAatatgaatatcctcct
tagtt 
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Designation Sequence 5’ - 3’ Construction of Amplicon size (bp) 
entA-rev-ko 
AGTGTTCTGACTGGTAGCGTTCAATTCATCCAGCGT
TAAATGCCGTTTCCAGATCATCGtgtgtaggctggagctg
cttc 
MBE9 (entA::cat)  
entA fwd-check up GTAAAGTACACGGCGATAT   
entA rev-check up TAAACAATGCCCAGATGCG  932 
eutC-fwd-ko 
GTCTGACCAAACGGGCGGGCGATCCGTCACTGTTC
TTCTGATGACGCGGGGATAACACCatatgaatatcctcc
ttagtt 
  
eutC-rev-ko 
ATCACGCGCATGGCAGTCACTGAAGGTCGAATTAA
ATCTAATGCAGGCATGATGTCTCCtgtgtaggctggagct
gcttc MBE11 (eutC::aphT)  
eutC fwd-check up CTGGAAACGATGGGCATTAT   
eutC rev-check up TAATTTAAGTTCCCGCGCAA  1086 
Genes of interest were replaced by either chloramphenicol (cat) or kanamycin (aphT) resistance genes using 
the λ red recombination system (Datsenko and Wanner 2000). PCR products were generated with primers 
harboring a homology region adjacent to the gene of interest (capital letters) and a sequence targeting the 
plasmids pKD3 (cat) and pKD4 (aphT, small letters) (Table 4). Check-up primers were used to verify correct 
insertion of the antibiotic cassette.  
Table 32: Further oligonucleotides used in this study 
Designation Sequence 5’ - 3’ Purpose Reference 
fD1 CGATATCTCTAGAAGAGTTTGATCCTGGCTCAG Amplification of bacterial 16S rRNA genes 
(Weisburg et al. 
1991) 
fD2 CGATATCTCTAGAAGAGTTTGATCATGGCTCAG Amplification of bacterial 16S rRNA genes 
(Weisburg et al. 
1991) 
rP1 GATATCGGATCCACGGTTACCTTGTTACGACTT Amplification of bacterial 16S rRNA genes 
(Weisburg et al. 
1991) 
pJet1-FP ACTACTCGATGAGTTTTCGG Amplification of insert in pJET1.2 vector Fermentas 
pJet1-RP TGAGGTGGTTAGCATAGTTC Amplification of insert in pJET1.2 vector Fermentas 
 
2.3 Chemicals, antibodies and devices 
2.3.1 Chemicals 
Table 33: Chemicals used in this study 
Compound Supplier 
ABTS substrate  Merck (Darmstadt) 
Acetic acid Roth (Karlsruhe) 
Agar BD (Heidelberg) 
Agarose Bio&Sell (Feucht) 
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Compound Supplier 
L-(+)-arabinose Sigma-Aldrich (Munich) 
BDTM CompBeads BD (Franklin Lakes, USA) 
BD FACSTM Lysing Solution BD (Franklin Lakes, USA) 
Brain Heart Infusion Oxoid, Thermo Fisher Scientific biosciences (St. Leon-Rot) 
Bromphenol blue Sigma-Aldrich (Munich) 
Bovine serum albumin (BSA) PAA Laboratories GmbH (Austria) 
BSA fraction V Roth (Karlsruhe) 
CaCl2 Roth (Karlsruhe) 
CaCl2 · 2H2O Merck (Darmstadt) 
Chloroform Roth (Karlsruhe) 
Chromazurol S Roth (Karlsruhe) 
CloneJETTM PCR Cloning kit Fermentas, Thermo Scientific (USA) 
CoCl2 · 6H2O Merck (Darmstadt) 
Columbia agar with sheep blood plus Oxoid, Thermo Fisher Scientific Biosciences (St. Leon-Rot) 
CuSO4 · 5H2O Merck (Darmstadt) 
Cysteine (-L) Hydrochloride Monohydrate Sigma-Aldrich (Munich) 
ddH2O (Ampuwa) Fresenius Kabi (Bad Homburg) 
ddH2O used for qPCR reactions Gibco, Life Technologies (UK) 
dNTPs Fermentas, Thermo Scientific (USA) 
DAPI Roth (Karlsruhe) 
Dipyridyl Sigma-Aldrich (Munich) 
DreamTaq PCR Master Mix (2x) Fermentas, Thermo Scientific (USA) 
DTPA Sigma-Aldrich (Munich) 
EDTA Biomol (Hamburg) 
EGTA Sigma-Aldrich (Munich) 
Eosin Y solution Sigma-Aldrich (Munich) 
Ethanol p.a. Roth (Karlsruhe) 
Ethidium bromide Sigma-Aldrich (Munich) 
FastStart Essential DNA Probes Master Roche (Mannheim) 
FastStart Taq polymerase Roche (Mannheim) 
FCS Biochrom AG (Berlin) 
FeCl3 · 6H2O Merck (Darmstadt) 
FeSO4 · 7H2O Roth (Karlsruhe) 
GeneRuler 1kb DNA Ladder Thermo Fisher Scientific biosciences (St. Leon-Rot) 
GeneRuler DNA ladder mix (100bp) Thermo Fisher Scientific biosciences (St. Leon-Rot) 
D-glucose Roth (Karlsruhe) 
Glycerol  Roth (Karlsruhe) 
HCl Roth (Karlsruhe) 
Hemin Sigma-Aldrich (Munich) 
Hexadecyltrimethylammonium bromide (HDTMA) Sigma-Aldrich (Munich) 
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Compound Supplier 
Histidine Sigma-Aldrich (Munich) 
H2O2 Merck (Darmstadt) 
HRP-streptavidin  IBA (Göttingen) 
K2HPO4 Roth (Karlsruhe) 
KCl Fluka, Sigma-Aldrich (Munich) 
KH2PO4 Roth (Karlsruhe) 
Lipocalin-2 standard R&D Systems (Wiesbaden-Nordenstadt) 
Lysozyme from hen egg Sigma-Aldrich (Munich) 
MacConkey agar Oxoid, Thermo Fisher Scientific Biosciences (St. Leon-Rot) 
Menadione Sigma-Aldrich (Munich) 
MgSO4 Roth (Karlsruhe) 
MnSO4 · H2O Roth (Karlsruhe) 
MnCl2 · 4H2O Merck (Darmstadt) 
Morpholino propanesulfonic acid (MOPS) Sodium Sigma-Aldrich (Munich) 
Type II porcine mucin Sigma-Aldrich (Munich) 
NaCl Roth (Karlsruhe) 
Na2CO3 Merck (Darmstadt) 
Na2HPO4 unhydrated  Roth (Karlsruhe) 
Na2HPO4 · 2H2O Roth (Karlsruhe) 
Na2MoO4 · 2H2O Merck (Darmstadt) 
NaNO2 Sigma-Aldrich (Munich) 
NaNO3 Roth (Karlsruhe) 
NaOH Roth (Karlsruhe) 
NaOH pellets Merck (Darmstadt) 
Na2O6S4 · 2H2O Sigma-Aldrich (Munich) 
Na2SeO3 Sigma-Aldrich (Munich) 
Na2SO4 Merck (Darmstadt) 
NH4Cl Merck (Darmstadt) 
NiSO4 · 6H2O Merck (Darmstadt) 
N-naphThylethylenediamine dihydrochloride 
monomethanolate (NEDD) Sigma-Aldrich (Munich) 
Normal goat serum Biozol (Eching) 
O.C.T. Sakura Finetek (Torrance) 
Palladium chloride Sigma-Aldrich (Munich) 
Paraformaldehyde (PFA) Roth (Karlsruhe) 
Phalloidin Interchim (Mannheim) 
Phenol:chloroform:isoamylalcohol (25:24:1) Roth (Karlsruhe) 
Piperazin Ethansulfonsäure (PIPES) Roth (Karlsruhe)  
Potassium acetate Roth (Karlsruhe) 
Oligonucleotides  Metabion (Martinsried) 
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Compound Supplier 
Peptone Oxoid, Thermo Fisher Scientific Biosciences (St. Leon-Rot) 
Q5Tm Hot Start High-Fidelity polymerase New England BioLabs (Frankfurt am Main) 
RbCl Roth (Karlsruhe) 
Restriction enzymes + buffers Fermentas, Thermo Scientific (USA) 
Rotimount Roth (Karlsruhe) 
Sabouraud dextrose agar Oxoid, Thermo Fisher Scientific Biosciences (St. Leon-Rot) 
Sodium acetate Roth (Karlsruhe) 
Sodium dodecyl sulfate (SDS) Serva (Heidelberg) 
Sucrose Sigma-Aldrich (Munich) 
Sulfanilamide  Merck (Darmstadt) 
SYTOX green Invitrogen, Thermo Fisher Scientific Biosciences (St. Leon-Rot) 
SYTOX red Life Technologies, Thermo Scientific (USA) 
Thiamine hydrochloride Roth (Karlsruhe) 
TM 10 tergitol Chemika (Australia) 
Tris MP Biomedicals (Eschwege) 
Triton Roth (Karlsruhe) 
Trypticase soy broth Oxoid, Thermo Fisher Scientific biosciences (St. Leon-Rot)  
Tryptone  Roth (Karlsruhe) 
Tween Sigma-Aldrich (Munich) 
VCL3 Sigma-Aldrich (Munich) 
Vectashield Enzo life science (UK) 
Vector’s Hämalaun solution Roth (Karlsruhe) 
VirkonS V.P. Produkte (Schlüchtern) 
Xylene Roth (Karlsruhe) 
Xylene Cyanol Sigma-Aldrich (Munich) 
Yeast extract  MP Biomedicals (Eschwege) 
Yeast t-RNA Roche (Mannheim) 
ZnSO4 · 7H2O Merck (Darmstadt) 
 
Table 34: Antibiotics used in this study 
Antibiotic Supplier Final concentration 
Ampicillin Roth (Karlsruhe) 100 µg/ml 
Chloramphenicol Roth (Karlsruhe) 30 µg/ml 
Kanamycin sulfate Roth (Karlsruhe) 30 µg/ml 
Streptomycin sulfate Roth (Karlsruhe) 50 or 100 µg/ml as indicated 
Tetracycline hydrochloride Roth (Karlsruhe) 12.5 µg/ml 
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2.3.2 Antibodies 
Table 35: Antibodies used for lipocalin-2 ELISA (mouse lipocalin-2/NGAL detection kit (R&D, 
DY1857) 
Antibody Origin Supplier Final concentration 
Lipocalin-2 capture antibody Rat R&D, Part 842440 1:200 
Lipocalin-2 detection antibody (biotinylated) Rat R&D, Part 842441 1:200 
 
Table 36: Antibodies used for depletion of neutrophils and FACS analysis 
Antibody Origin Supplier Final amount or dilution  
α-mouse G-CSF (clone: # 67604; depletion) Rat R&D Systems 10 µg per mouse  
Rat IgG1 (clone: # 43414, isotype control) Rat R&D Systems 10 µg per mouse  
α- m Ly-6G (clone: 1A8; depletion) Rat BioXCell 150 µg per mouse  
Rat IgG2a (clone: 2A3; isotype control) Rat BioXCell 150 µg per mouse  
α-CD45-PerCP (clone: 30-F11) Rat Biolegend 1:100 
α-CD11b-APC-Cy7 (clone: M1/70) Rat Biolegend 1:200 
α-Ly-6G-Pacific Blue (clone: 1A8) Rat Biolegend 1:200 
α-Ly-6C-FITC (clone: AL-21) Rat BD 1:400 
α-CD3-PE (clone: 17A2) Rat Biolegend 1:200 
α-CD16/CD32 (93) Rat eBioscience 1:100 
 
 
Table 37: Antibodies used for immuno-fluorescence staining of neutrophils 
Antibody Origin Supplier Final amount or dilution  
Rat-anti CD18 (M18/2) Rat BD 1:300 
Anti-rat Cy3 Goat Jackson (112-165-167) 1:300 
 
2.3.3 Devises and specific materials 
Table 38: Devises and specific materials 
Items Supplier 
ABI 7500 fast Applied Biosystems (Darmstadt) 
Acid washed glass beads (<106 µm) Sigma-Aldrich (Munich) 
Aluminum crimp seals (diam. 11 mm) Supelco (USA) 
Aluminum crimp seals (diam. 20 mm) Supelco (USA) 
Amp for agarose gels (Power Pac) Bio Rad (Munich) 
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Items Supplier 
BioPhotometer Eppendorf (Wesseling-Berzdorf) 
Butyl-rubber stoppers (diam. 11 mm) Supelco (USA) 
Butyl-rubber stoppers (diam. 20 mm) Geo-Mocrobial Technologies (USA) 
Cannulas B. Braun (Melsungen) 
Crimper (diam. 11 mm) VWR (Darmstadt) 
Crimper (diam. 20 mm) VWR (Darmstadt) 
Cryotome Leica Biosystems (Wetzlar) 
Cryo-tubes Thermo Fisher Scientific biosciences (St. Leon-Rot) 
Decrimper (diam. 20 mm) VWR (Darmstadt) 
Dialysis membrane (pore size: 0.025 µm) Merck, Millipore (Darmstadt) 
Diagnostic slides (10 wells, 76 x 25 x 1 mm) Thermo Fisher Scientific biosciences (St. Leon-Rot) 
1.5 ml DNA loBind tubes Eppendorf (Wesseling-Berzdorf) 
Electroporation cuvette (1mm) Peqlab (Erlangen) 
Electroporation device (Micro Pulser) Bio Rad (Munich)  
Epi Centrifuge (5430 R) Eppendorf (Wesseling-Berzdorf) 
FACSCANTO II  BD (Franklin Lakes, USA) 
FACS tubes Hartenstein (Würzburg) 
Filter Millex (0.22 µm) Merck (Darmstadt) 
Filter Millex (0.45 µm) Merck (Darmstadt) 
Gel documentation chamber Bio Rad (Munich) 
Glass slides (cover) Marienfeld Laboratory Glassware (Lauda-Königshofen) 
Gnoto cages Han, Bioscape (Emmendingen) 
Incubator (Heraeus oven) Thermo Fisher Scientific biosciences (St. Leon-Rot) 
Laminar flow (Safe 2020) Thermo Fisher Scientific biosciences (St. Leon-Rot) 
LightCycler480 Multiwell Plate 96, white Roche (Mannheim) 
LightCycler96 Roche (Mannheim) 
40 µm mesh (cell strainer) BD FalconTM (USA) 
NanoDrop Thermo Fisher Scientific biosciences (St. Leon-Rot) 
NucleoSipn Gel and PCR Clean-up kit Macherey-Nagel (Düren) 
NucleoSipn Plasmid kit Macherey-Nagel (Düren) 
Parafilm BEMIS (USA) 
Peqstar 2x gradient cycler Peqlab (Erlangen) 
Plasmid Plus Midi Kit Qiagen (Hilden) 
Screw cap plastic tubes A. Hartenstein (Würzburg) 
1.5 ml plastic tubes (PCR grade) Eppendorf (Wesseling-Berzdorf) 
2 ml plastic tubes (PCR grade) Eppendorf (Wesseling-Berzdorf) 
15 ml plastic tubes Greiner Bio-One (Frickenhausen) 
50 ml plastic tubes Greiner Bio-One (Frickenhausen) 
Petri dishes Greiner Bio-One (Frickenhausen) 
Qiagen DNA (fast) stool kit Qiagen (Hilden) 
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Items Supplier 
Shaker (Certomat R) B. Braun Biotech international (Melsungen) 
Spectrophotometer (Sunrise) Tecan (Crailsheim) 
Superfrost Plus slides (75 x 25 x 1 mm) A.Hartenstein (Wuerzburg) 
Syringes B. Braun (Melsungen) 
Tissue lyzer Qiagen (Hilden) 
Vortex Scientific industries (USA) 
96-well ELISA plates (Brandplates) Brand (Wertheim) 
96-well plate for standard assays TPP (Trasadingen) 
Wheaton glass serum bottles (1.5 ml) Sigma-Aldrich (Munich) 
Wheaton glass serum bottles (100 ml) Sigma-Aldrich (Munich) 
Zirconia/silica beads (0.1 mm) Roth (Karlsruhe)  
Zirconia-beads (0.7 mm) Roth (Karlsruhe) 
 
2.4 Microbiological methods 
2.4.1 Preparation of bacterial cryo-stocks (S. Tm and E. coli strains) 
One bacterial colony was picked from a LB agar plate containing the appropriate antibiotic and was 
subsequently cultured in 5 ml of LB medium supplemented with the selective antibiotic. The bacterial 
culture was performed in glass tubes and incubated overnight (o/n) at 37°C in a wheel rotor. The 
following day, the o/n culture was transferred to a 15 ml plastic tube and spun down (15 min; 4°C; 
4,000 x g). After the removal of the supernatant, the bacterial cell pellet was resuspended in 1 ml of 
peptone-glycerol broth, transferred into cryo-tubes and stored at -80°C. 
2.4.2 Bacterial culture for in vivo experiments 
S. Tm strains were streaked on LB agar plates containing a selective antibiotic, whereas C. rodentium 
was streaked on MacConkey (Oxoid) plates without antibiotic. 2 - 3 colonies were used to inoculate 
3 ml starter cultures containing either LB medium with 0.3 M NaCl for S. Tm cultures or LB medium 
without supplements for C. rodentium cultures. Starter cultures were incubated for 12 h at 37°C in a 
wheel rotor. 2 ml subcultures in either LB medium with 0.3 M NaCl or regular LB medium were 
subsequently inoculated with 100 µl of the starter cultures and further incubated for 4 h at 37°C in a 
wheel rotor. In order to harvest cells, subcultures were centrifuged (2 min; 4°C; 9,660 x g), the 
supernatant was discarded and the cell pellet was resuspended in the same volume 1x PBS as the 
subculture. 50 µl aliquots of cell suspension were aliquoted in 1.5 ml plastic tubes and stored on ice 
until oral gavage. In order to determine the exact inoculum size, dilutions of the inoculum in sterile 
1x PBS (10-4 and 10-6) were additionally plated on MacConkey agar plates.  
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Clostridium difficile DH196 spores that were used for infection were prepared by Prof. Hapfelmeier’s 
group (Studer et al. 2016). Helicobacter typhlonius CCUG48335T used for the reversible colitis was 
prepared by Prof. Mueller’s group (Brasseit et al. 2016). 
2.4.3 In vitro growth assay of S. Tm strains 
Bacteria from -80°C cryo-stocks were streaked on LB agar plates without antibiotics and grown o/n at 
37°C. 3 individual colonies were used to inoculate aerobic starter cultures containing 5 ml of M9 
medium without antibiotics. Starter cultures were performed in glass tubes and incubated for 12 h at 
37°C in a wheel rotor. Aerobic as well as anaerobic subcultures with a starting OD600 of 0.02 were 
subsequently carried out in 10 ml M9 medium with and without nitrate (20 mM). For testing S. Tm 
strains deficient in ethanolamine utilization, M9 medium was additionally supplemented with 
ethanolamine (5 mM) and tetrathionate (40 mM) as indicated in the experiments. Aerobic 
subcultures were performed in glass Erlenmeyer flaks sealed with aluminum foil, whereas anaerobic 
subcultures were conducted in 100 ml Wheaton glass serum bottles with pre-reduced medium (pre-
reduction for at least 2 days under anoxic conditions: 3% H2, rest N2). The amount of starter culture 
required to meet a final OD600 of 0.02 was spun down (10 min; 4°; 1,677 x g), imported in the 
anaerobic tent, resuspended in pre-reduced medium and used to inoculate anaerobic subcultures. 
The 100 ml culture bottles were plugged with a butyl-rubber stopper, exported, sealed with an 
aluminum crimp seals (diam. 20 mm) using a crimper and gassed (7% H2, 10% CO2, rest N2). Both 
aerobic and anaerobic cultures were incubated at 37°C under constant shaking at 180 rpm. 1 ml 
samples for OD600 measurement and for the determination of nitrate concentrations were taken at 
the indicated time points using a syringe. After the photometric OD600 measurement in plastic 
cuvettes, samples were transferred into 1.5 ml plastic tubes. In order to pellet cells, tubes were 
subsequently centrifuged (5 min; RT; 4,293 x g). The supernatant was transferred to a new 1.5 ml 
plastic tube and stored at -20°C until measurement of nitrate concentrations. 
2.4.4 In vitro competition assay 
S. Tm strains from -80°C cryo-stocks were streaked out on LB plates without antibiotics and 
incubated o/n at 37°C. 3 colonies were picked and resuspended in 100 µl of either LB or M9 medium 
without antibiotic using sterile 1.5 ml plastic tubes. The bacterial suspension was used to inoculate 
starter cultures which were incubated for 12 h at 37°C in a wheel rotor. The starter cultures were 
performed in glass tubes containing 5 ml of either LB or M9 medium without antibiotics. 
Subsequently, co-cultures were prepared in mucin broth as described by (Lopez et al. 2012). Briefly, 
starter cultures of the competing strains were mixed in a 1:1 ratio with a starting OD600 of 0.05 of 
each strain and used to inoculate 14 ml cultures with either plain mucin broth or mucin broth 
containing 40 mM nitrate. For competition assays between S. Tm strains deficient in nitrate 
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respiration and S. Tm strains deficient in nitrate and tetrathionate respiration, the mucin broth was 
additionally supplemented with histidine (500 mg/l) to enhance growth and with tetrathionate (40 
mM). The cultures were incubated in 15 ml plastic tubes and incubated statically for 24 h at 37°C. In 
order to determine CFUs of the strains, 100 µl samples of the 24 h cultures were taken at t=0 h and 
t=24 h, diluted in sterile 1x PBS (down to 10-4 – 10-6) and plated on LB agar plates containing the 
respective selective antibiotics for individual strains (for streptomycin a concentration of 50 µg/ml 
was used, other concentrations as indicated in Table 34).  
2.4.5 Preparation of starter inocula for growth assays of Oligo-MM12 strains 
The cecum of a male C57BL/6J mouse stably associated with the Oligo-MM12 bacteria was aseptically 
dissected under anoxic conditions (anaerobic tent: 3% H2, rest N2) and transferred into a sterile 50 ml 
plastic tube. 20 ml of sterile 1x PBS were added and the bacteria were flushed out of the cecum by 
gently shaking. The bacterial suspension was subsequently filtered through a 40 µm nylon mesh (cell 
strainer) into a sterile 50 ml plastic tube. An equal amount of a 20% glycerol-palladium solution was 
added (final glycerol concentration of 10%) and 1 ml aliquots in 1.5 ml Wheaton glass serum bottles 
were prepared. The bottles were sealed with a butyl-rubber stopper and an aluminum crimp seal as 
well as finally stored at -80°C. All plastic ware and solutions used were already pre-reduced for at 
least 2 days in the anaerobic tent. 
2.4.6 In vitro growth assay of Oligo-MM12 strains 
A 1 ml aliquot of frozen starter inoculum for in vitro growth curves (2.4.5) was thawed in 150 ml of 
pre-warmed 5% VirkonS. The sterile glass bottle was imported in the anaerobic tent, the aluminum 
crimp seal was opened with a screw driver and the butyl-rubber stopper was removed with a sterile 
forceps. Subsequently, 50 µl of bacterial suspension were added to a 100 ml Wheaton glass serum 
bottle filled with 10 ml of anaerobic Akkermansia medium without mucin, and the glass bottle was 
sealed with a butyl-rubber stopper (diam. 20 mm) and exported. Depending on the experiment, the 
medium was also supplemented with nitrate, dipyridyl or DTPA at concentrations indicated in the 
experiments. After the export, the bottles were sealed with aluminum crimp seals and gassed (7% H2, 
10% CO2, rest N2). The cultures were incubated at 37°C under constant shaking and 1 ml samples 
were anaerobically removed at the indicated time points using a 1 ml syringe. 100 µl of the sample 
were used to determine the OD600 and the residual 900 µl were transferred to 2 ml plastic tubes and 
spun down (10 min; RT; 11,000 x g). With increasing OD600, there was less culture volume used for 
pelleting cells (OD600 of 0.350-0.699: 450 µl, OD600 of 0.700-1.049: 300 µl and OD600 above 1.050: 90 
µl). The supernatant was discarded and the bacterial cell pellet was stored at -20°C until extraction of 
genomic DNA (gDNA). All devices, supplements and media used were already reduced for at least 2 
days in the anaerobic tent.  
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2.4.7 Chromazurol S (CAS) agar assay for siderophore production 
Strains from -80°C cryo-stocks were streaked on LB agar plates containing the appropriate antibiotic 
and grown o/n at 37°C (no antibiotics for Yersinia control strains). 2 - 3 individual colonies were 
picked in order to inoculate 5 ml starter cultures containing LB medium without antibiotics. The 
starter cultures were performed in glass tubes and incubated for 12 h at 37°C in a wheel rotor. 1 ml 
of starter culture were spun down (10 min; 4°C; 2,415 x g), the supernatant was discarded and the 
pellet was resuspended in 1 ml of sterile and ice-cold 1x PBS. The bacteria in 1x PBS were diluted to 
an OD600 of 0.1 and 5 µl of diluted bacteria were spotted on CAS agar plates and incubated at 37°C for 
48 h. The diameters of the colony as well as the diameter of the colony + the orange CAS halo were 
measured and the CAS-reactive ring was calculated in mm according to the formula: 0.5 x [(diameter 
of colony + CAS halo) – diameter of colony]. 
2.4.8 Generation of chemo-competent cells 
200 ml of LB medium were inoculated with 10 ml of an o/n culture of E.coli DH5α (1:20) and 
incubated at 37°C under constant shaking at 180 rpm until an OD600 of 0.4 – 0.6 was reached. Cells 
were briefly chilled on ice and centrifuged (10 min; 4°C; 5,000 x g) in 50 ml plastic tubes. The 
supernatant was discarded und the pellets were resuspended in 60 ml of ice-cold TFB1 buffer. After 
10 min incubation on ice, the cells were centrifuged again (10 min; 4°C; 5,000 x g), the supernatant 
was discarded and the pellets were resuspended in 8 ml of ice-cold TFB2 buffer. 200 µl of cell 
suspension were finally aliquoted in pre-cooled 1.5 ml plastic tubes, snap frozen in liquid nitrogen 
and stored at -80°C until usage. 
2.4.9 Generation of electro-competent cells  
50 ml subcultures in LB medium containing appropriate supplements (refer to 2.5.9.2 and 2.5.9.4) 
were incubated at either 30°C or 37°C under constant shaking at 180 rpm until an OD600 of around 
0.5 was reached. Subcultures were subsequently transferred into 50 ml plastic tubes, chilled on ice 
for 10 min and centrifuged (15 min; 4°C; 1,677 x g). The supernatants were discarded and the pellets 
were resuspended in 1 ml of ice-cold 10% glycerol, transferred to 1.5 ml plastic tubes and mixed by 
vortexing. Subsequently, cells were washed 5 times with ice-cold 10% glycerol [centrifugation (1 min; 
4°C; full speed), discarding the supernatant and resuspending the cell pellet again in 1 ml of ice-cold 
10% glycerol]. Finally, the electro-competent cells were resuspended in 80 µl of 10% glycerol and 
directly transferred into pre-cooled electroporation cuvettes. Cells were chilled on ice until 
electroporation. 
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2.5 Molecular biological and biochemical methods 
2.5.1 Agarose gel electrophoresis 
1 – 2% agarose gels supplemented with ethidium bromide (0.1 µl/ml) were prepared in 1x TAE buffer 
and run for 30 min at 100 V. Usually, 10 µl of the DNA sample was mixed with 10x loading dye and 
loaded. The following standards: GeneRuler 1kb DNA ladder or GeneRuler DNA ladder mix (100 bp) 
were used as DNA markers. Gels were visualized under UV light using a gel documentation chamber. 
2.5.2 Lipocalin-2 (LCN-2) ELISA (mouse lipocalin-2/NGAL detection kit (R&D, DY1857)) 
96-well ELISA plates were coated with 50 µl/well of lipocalin-2 capture antibody (Table 35) and 
incubated o/n at 4°C in a humid chamber. After 3 washing steps with washing buffer (0.05% Tween-
20 in 1x PBS), the plates were blocked for 1 h at RT with 50 µl/well of blocking buffer (2% BSA in 1x 
PBS). The plates were washed again 3 times and samples were subsequently added in duplicates (50 
µl/well, undiluted in PBT, 1:20 and 1:200 in 1x PBS). In order to quantify LCN-2 amounts, standard 
curves with a starting concentration of 50 ng/ml of LCN-2 were prepared (duplicates, 1:3 dilutions in 
blocking buffer). The plates were then incubated for 1 h at RT and washed again 6 times. 50 µl/well 
of LCN-2 detection antibody (Table 35) were added and the plates were incubated again for 1 h at RT, 
followed by 6 washing steps. Subsequently, 100 µl/well of HRP-streptavidin (1:1,000 diluted in 1x 
PBS) were added following 1 h of incubation and 6 washing steps. The plates were finally developed 
in the dark for 30 - 45 min using 100 µl/well of ABTS substrate (1 mg ABTS in 10 ml of 0.1 M NaH2PO4, 
pH 4 + 5 µl of H2O2). Finally, the absorbance was measured at 405 nm with a spectrophotometer 
(Tecan, Sunrise). 
2.5.3 Cloning of 16S rRNA full length sequences into pJET1.2 cloning vector 
Plasmids listed in Table 5 have been described previously (Brugiroux et al. 2016) as indicated or were 
constructed as described below (pMB1 + 2, pMB4 - 6): For construction of pMB1 - 5, bacterial 16S 
rRNA full length gene sequences were amplified by polymerase chain reaction (PCR) using DreamTaq 
Master mix with one initial denaturation step at 95°C for 5 min, followed by 35 cycles with one cycle 
consisting of 95°C for 30 sec, 50°C for 30 sec and 72°C for 1 min and one final elongation step at 72°C 
for 10 min. For construction of pMB6, PCR reaction was performed using Q5Tm Hot Start High-Fidelity 
polymerase which has proofreading activity (initial denaturation step at 98°C for 30 sec followed by 
35 cycles with one cycle being 98°C for 10 sec, 50°C for 30 sec and 72°C for 35 sec and one final 
elongation step at 72°C for 2 min). 100 ng of bacterial gDNA was used as template. The gDNAs of S. 
Tm and C. rodentium were provided by B. Stecher, the gDNAs of C. difficile and C. scindens were 
provided by Nicolas Studer (University of Bern) and the gDNA of H. typhlonius was provided by 
Martin Faderl (University of Bern). PCR reactions were performed using a Peqstar 2x gradient cycler 
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using 125 nM of each primer: fD1 and fD2 (250 nM for PCR reaction with Q5 polymerase) as well as 
250 nM of the primer rP1 (500 nM for PCR reaction with Q5 polymerase) (Table 32). The reaction 
volume was 50 µl. 5 µl were loaded on a 1% agarose gel to visualize successful 16S rDNA 
amplification. The residual 45 µl were purified using the NucleoSpin Gel and PCR Clean-up kit 
(Macherey-Nagel) according to the manufacturer’s instructions and subsequently cloned into the 
high-copy expression vector pJET1.2 using the CloneJETTM PCR kit. Briefly, 2 µl of PCR-amplified 16S 
rRNA gene were blunted in a 18 µl reaction using the provided 2x reaction buffer, nuclease free 
water and 1 µl of DNA blunting enzyme. The blunting reaction was performed at 70°C for 5 min. The 
blunted PCR product was then inserted into the pJET1.2 cloning vector using 50 ng of vector and 1 µl 
of the provided T4 DNA ligase. The ligation mix was briefly vortexed and incubated for 30 min at RT. 
The ligation mix was finally transformed into chemo-competent E. coli DH5α as described below 
(2.5.4). 
Correct insertion of a full length 16S rRNA gene was check by PCR using 5 µl of boiled 1:20 diluted 
cultures used for stocking and DreamTaq Master mix (20 µl reaction volume, reaction condition as 
described above). Plasmid DNA of clones harboring 16S rRNA full length sequences was extracted 
using the NucleoSpin plasmid extraction kit (Macherey-Nagel) and finally sequenced using the 
pJet1.2 specific primers pJet1-FP and pJet1-RP (Table 32). Sanger sequencing was performed at 
GATC, Germany. Sequences were analyzed using the software CLC DNA workbench 6.0.2 (CLC bio, 
Denmark). 
2.5.4 Transformation chemo-competent cells  
Plasmids were transformed in chemo-competent DH5α cells (2.4.8). 100 µl of chemo-competent 
DH5α cells were thawed on ice and 5 µl of ligation reaction were added. The cells were gently mixed 
and incubated on ice for 30 min. Hereafter, cells were heat shocked at 37°C for 45 sec and 
immediately cooled on ice for 2 min. 800 µl of LB medium were subsequently added and the cells 
were incubated at 37°C for 1 h under constant shaking at 650 rpm. Cells were then centrifuged (2 
min; RT; 8,117 x g), the supernatant was partially discarded and the cell pellet was resuspended in 
the residual supernatant (50 - 100 µl). In order to select for pJET1.2 positive cells, 50 µl of cell 
suspension were plated on LB agar plates containing ampicillin (100 µg/ml). Positive clones were 
cryo-stocked as described previously (2.4.1) and stored at -80°C.  
2.5.5 Total DNA extraction of fecal and cecal microbiota 
Fecal and cecal DNA was directly extracted from samples stored in 2 ml plastic tubes at -80°C using 
the Qiagen DNA (fast) stool kit. The provided protocol was followed including additional 
modifications. First, samples were thawed and mixed with 150 µl of acid washed glass beads (<106 
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µm), 150 µl of zirconia-beads (0.7 mm) as well as 700 µl of Inhibit Ex buffer. The samples were then 
lyzed for 3 min at 50 Hz in a tissuelyzer, incubated at 95°C for 5 min, lyzed again (50 Hz, 5 min) and 
centrifuged (1 min; RT; 11,300 x g). The supernatant was transferred into a fresh 2 ml plastic tube 
and kept on ice. In order to increase the lysis efficiency of Gram-positive bacteria, the pellets were 
resuspended in 200 µl of sterile and DNA free lysis buffer including lysozyme (Table 27) and 
incubated for 30 min at 37°C. Subsequently, 500 µl of Inhibit Ex buffer were added, following lysis (50 
Hz, 5 min), incubated at 95°C, lyzed (50 Hz ,5 min) again and centrifuged (1 min; RT; 11,300 x g). The 
supernatant was added to the supernatant that was previously harvested and kept on ice. 26 µl of 
proteinase K (provided solution) were pipetted into a fresh 2 ml plastic tube and 700 µl of total 
supernatant as well as 700 µl of AL buffer were added. Samples were vortexed for 15 sec and 
incubated at 70°C for 10 min. Hereafter, samples were briefly centrifuged in order to remove any 
drops from the lid and 700 µl of ethanol (96% p.a.) were added. Samples were then vortexed again, 
briefly centrifuged and loaded onto QIAamp spin columns. The DNA bound to the filter matrix was 
subsequently washed using the buffers AW1 and AW2 and finally eluted in 100 µl of pre-warmed ATE 
buffer (70°C). The DNA concentration was determined by NanoDrop.  
2.5.6 DNA extraction from bacterial cell pellets harvested from in vitro cultures 
gDNA from bacterial cell pellets was extracted as described previously (Turnbaugh et al. 2009, Ubeda 
et al. 2012). The bacterial cell pellet stored in a 2 ml plastic tube at -20°C was resuspended in 500 µl 
of extraction buffer (Table 28), 210 µl of sterile filtered 20% SDS and 500 µl of a 
phenol:chloroform:isoamylalcohol (25:24:1) mixture. 1 ml of zirconica / silica beads (0.1 mm 
diameter) was added. The sample was lyzed at 50 Hz for 4 min in a tissuelyzer at RT and subsequently 
centrifuged (5 min; RT; 11,300 x g). The upper phase was transferred into a fresh 2 ml plastic tube 
and 500 µl of phenol:chloroform:isoamylalcohol (25:24:1) mixture were added. The sample was 
mixed by inversion (2 - 3 times) and centrifuged (5 min; RT; 11,300 x g). The supernatant (~ 500 µl) 
was transferred into a fresh 2 ml tube and 1 ml of ethanol (96% p.a.) + 50 µl of NaAcetat (3M) were 
added and the sample was mixed by inversion (2 - 3 times), subsequently centrifuged (30 min; 4°C; 
13,148 x g) and the supernatant was discarded. The DNA pellet was resuspended in 500 µl of ice-cold 
70% ethanol and mixed again by inversion. After centrifugation (15 min; 4°C; 13,148 x g), the 
supernatant was discarded and the DNA pellet was air-dried (until dry under laminar airflow). The 
DNA pellet was finally resuspended in 50 µl of 10 mM Tris-HCl pH8 and the nucleic acid concentration 
was determined by NanoDrop. 
2.5.7 Colorimetric quantification of nitrite concentrations 
S. Tm culture supernatant processed as detailed in section 2.4.3 and colorimetric quantification of 
nitrite concentrations was performed as described by (Miranda et al. 2001). Briefly, 50 µl of the 
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sample (undiluted, 1:10 as well as 1:100) were transferred in wells of a 96-well plate. 50 µl of 1:1.5 
serial dilutions of a NaNO2 with known concentrations (50 µM down to 7 µM) were used as a 
standard curve. 25 µl of a 1:1 mixture of 2% sulfanilamide in 3 M HCl and 0.1% N-(1-
NaphThyl)ethylenediamine dihydrochloride monomethanolate (NEDD) in ddH2O were added to each 
well. The plate was incubated in the dark at 37°C for 30 min and the absorbance at 540 nm was 
measured using a spectrometer (Tecan, Sunrise).  
2.5.8 Hydrolysis probe based quantitative real-time PCR (qPCR) 
2.5.8.1 Design of specific primers and hydrolysis probes 
16S rRNA full length gene sequences of bacteria used in this study were aligned using CLC DNA 
Workbench 6.0.2 (CLC bio, Denmark) in order to identify hypervariable regions that are unique for 
each strain. Subsequently, specific primers and a hydrolysis probe were designed for each strain 
using the software Primer Express 3 (MGB protocol, Applied Biosystems, Life Technologies, USA; 
Table 30) and checked against the aligned 16S rRNA genes to ensure specificity. In order to enable 
duplex quantitative real-time PCR experiments, the hydrolysis probes were either labeled with 6-
carboxyfluoresceine (FAM) or 6-carboxyhexafluoresceine (HEX) at the 5’ end. Additionally, every 
probe was conjugated with the black hole quencher 1 (BHQ1) at the 3’ end. There was no other 
additional chemical modification which might improve performance of MGB probes. All primers and 
hydrolysis probes were synthesized by Metabion International AG (Germany), delivered freeze dried 
and were either desalted (primers) or HPLC purified (hydrolysis probes). The quality was controlled 
by mass check (primer length: 18 – 28 nt; probe length: 15 – 25 nt.) 
2.5.8.2 Preparation of plasmid DNA for standards curves 
Linearized plasmids harboring full length 16S rRNA gene sequences were used as DNA templates for 
the standard curves used for absolute quantification. E. coli DH5α harboring the respective plasmid 
was grown in LB medium supplemented with ampicillin (50 - 100 ml o/n cultures) and plasmids were 
purified using the Plasmid Plus Midi Kit (QIAGEN) according to the manufacturer’s instructions. 30 µg 
of plasmid DNA were subsequently linearized in 100 µl o/n reactions at 37°C using 10x reaction 
buffers and endonucleases (20 units) to linearize the plasmids that have no recognition site within 
the 16S rRNA full length gene sequence (Table 5). After digesting, plasmids were purified using the 
NucleoSpin Gel and PCR Clean-up kit (Macherey-Nagel) according to the provided protocol. The final 
concentrations of the linearized plasmids were determined by NanoDrop. Agarose gel 
electrophoresis (1% agarose) was performed in order to verify complete linearization of the 
plasmids.  
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2.5.8.3 Determination of 16S rRNA gene copy numbers 
10 ng/µl stocks of each plasmid were prepared and the 16S rRNA gene copy numbers per µl were 
calculated: (i) the number of nucleotides of the plasmid was defined; (ii) the approximate molecular 
mass of the dsDNA was determined according to the formula: (number of nucleotides x 607.4) + 
157.9; (iii) the gene copy numbers/µl of a 10 ng/µl stock were calculated: ((10 x 10-9)/molecular mass 
of dsDNA) x (6.022 x 1023); (iv) 10 fold dilutions were prepared: range: 108 - 10-2 gene copies/µl; the 
DNA was diluted in yeast t-RNA solution (100 ng/µl) and 1.5 ml DNA loBind tubes (Eppendorf) were 
used. The dilutions were stored at -20°C.  
2.5.8.4 qPCR reaction conditions 
qPCR reactions were performed in white LightCycler480 Multiwell Plate 96 plates using the thermo 
cycler LightCycler96 and the FastStart Essential DNA Probes Master reaction kit. The reaction volume 
was 20 µl and the following conditions were applied: (i) an initial denaturation step at 95°C for 10 
min followed by (ii) 45 cycles (95°C for 15 sec and 60°C for 1 min). qPCR reactions were performed 
with 5 ng template DNA as well as with 300 nM of each primer and 250 nM of the corresponding 
probe. The fluorescence for each cycle was recorded after each step.  
Standard curves were run once in triplicates in order to evaluate the performance of the primer / 
probe combinations in mono- and duplexed qPCR reactions (Table 39). In further experiments, 
standard curves were reproduced by the LightCycler96 software 1.1 (Roche, Switzerland) based on 
one single DNA standard with known DNA quantity and the efficiency derived from the standard 
curve that was run initially. DNA samples from feces or cecal content were run in duplicates. The 
quantification cycle (Cq) as well as the baseline were automatically determined by the LightCycler96 
software 1.1 (Roche, Switzerland). 
2.5.8.5 Titration of primers and probes as well as template DNA concentrations 
Different concentrations of forward and reverse primers as well as hydrolysis probes (100 – 500 nM) 
were tested with 2 different amounts of linearized plasmid DNA (2.5 x 106 and 2.5 x 102 16S rRNA 
gene copies). Optimal concentrations of forward and reverse primers (300 nM each) as well as of 
hydrolysis probe (250 nM) were derived from qPCR reaction with YL2_Exonucl._fwd/rev with 
Probe_YL2, YL44_Exonucl._fwd/rev with Probe_YL44, YL45_Exonucl._fwd/rev with Probe_YL45, 
YL58_Exonucl._fwd/rev with Probe_YL58, Isol46_Exonucl._fwd/rev with Probe_Isol46, 
Isol49_Exonucl._fwd/rev with Probe_Isol49, Isol48_Exonucl._fwd/rev with Probe_Isol48. The 
titration of primers and probes was performed using the thermocycler ABI 7500 fast.  
In order to determine the optimal quantity of template DNA, qPCR reactions with 1:2 dilutions of 25 
ng of fecal DNA were performed in triplicates. The 1:2 dilutions of template DNA resulted in parallel 
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amplification curves. 5 ng of template DNA were found to be an optimal quantity that yields results 
within the dynamic range of the qPCR assay (Cq over 15 cycles) and were subsequently used as 
template amount for all further qPCR reactions. This titration experiment was performed with one 
primer / probe combination that targets a strain that is highly abundant in fecal DNA samples 
(‘Bacteroides caecimuris I48’).  
2.5.8.6 Evaluation of qPCR efficiency and establishment of a duplex qPCR assay  
The efficiency of each primer / probe combination was calculated based on the slope of standard 
curves with 1:10 dilutions of linearized plasmids harboring specific 16S rRNA gene sequences (qPCR 
efficiency: (10(-1/slope of standard curve)-1) x 100). DNA amounts for standard curves were titrated down until 
the assay was dynamic: around 3.3 Cqs decrement between 1:10 dilutions and high endpoint 
fluorescence levels. Efficient qPCR reactions were within the range of 90 - 110% efficiency 
(duplication of the DNA amount per qPCR cycle) which guaranteed accurate determination of gene 
copy numbers. Standard curves were performed in mono- and duplex qPCR reactions in order to rule 
out any mutually inhibitory effects between the duplexed primers and probe combinations. For 
duplex reactions, assays with similar qPCR efficiencies and endpoint fluorescence levels were 
combined.  
2.5.8.7 Validation of specificity and determination of the limit of detection 
Besides testing the specificity in silico using the aligned 16S rRNA gene sequences, the strain-
specificity of all primer / probe combinations was additionally investigated with plasmid pools 
harboring all 16S rRNA gene sequences excluding the one that was tested (2.5 x 106 gene copies per 
linearized plasmid per µl).  
The limit of detection of each primer / probe combination was either the LOD95 (amount of template 
DNA that results in a positive signal in 95% of the qPCR runs), the assay specific limit of detection or 
the gene copy number determined from late unspecific amplification using plasmid pools. The 
highest value was set to be the limit of detection. The LOD95 was determined by titrating standard 
curves down to 2.5 x 10-2 gene copies. The percentage of signals that were above threshold was 
subsequently determined for each DNA template quantity. These data were used for a sigmoidal 
curve fit (plot: % positives against DNA template amount; GraphPad Prism 5, GraphPad Software, 
Inc., USA) and the LOD95 was determined by interpolation. If the standard curve went out of the 
dynamic range (clearly less than 3.3 Cqs decrement between 1:10 dilutions and inhibited endpoint 
fluorescence levels) before reaching DNA amounts for the determination of the LOD95, an assay 
specific limit of detection was set.  
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2.5.9 Generation of gene deletion mutants in S. Tm by λ red recombination 
2.5.9.1 Generation of PCR fragments 
For in frame gene deletions, antibiotic-resistance markers were inserted into the chromosome of S. 
Tm applying λ red recombination. The procedure was described by (Datsenko and Wanner 2000). 
Briefly, PCR reactions were performed using the Peqstar 2x gradient cycler, FastStart Taq polymerase 
with 10x MgCL2 reaction buffer, dNTPs (200 µM of each nucleotide), 5 - 50 ng of template DNA and 
oligonucleotides (200 nM each) that amplify an antibiotic-resistance cassette as well as FRT sites for 
gene deletion from one of the following plasmids: pKD3 (cat: chloramphenicol resistance) or pKD4 
(aphT: kanamycin resistance) (Table 4). The primers harbored 5’ extensions (59 bp) that were 
homologous to sequences upstream of the start codon and downstream of the stop codon of the 
gene of interest (Table 31). The total volume of the PCR reaction was 4 x 50 µl and the following 
cycling conditions were used: one initial denaturation step at 95°C for 6 min followed by: (i) five 
cycles with one cycle being 95°C for 30 sec, 55°C for 30 sec and 72°C for 2 min, (ii) 25 cycles with one 
cycle consisting of 95°C for 30 sec, 65°C for 30 sec and 72°C for 2 min and (iii) a final elongation step 
at 72°C for 10 min. PCR products were pooled, visualized on a 1% agarose gel to ensure successful 
amplification of the antibiotic cassette (5 µl loaded) and purified by ethanol precipitation: 1/10 
volume of 3 M NaAcetat (ddH2O solution) as well as 2 volumes of ice-cold ethanol (96% p.a.) were 
added to the pooled PCR product, following centrifugation (15 min; 4°C; 13,148 x g). The supernatant 
was discarded and the pellet was resuspended in 500 µl of ice-cold 70% ethanol and centrifuged 
again (15 min; 4°C; 13,148 x g). After discarding the supernatant, the pellet was subsequently air-
dried at 37°C and resuspended in 22 µl of nuclease free ddH20 (Gibco).  
In order to desalt the DNA, the ethanol precipitated PCR product was dialyzed for 60 min against 
ddH20 (Ampuwa) using petri dishes and a dialysis membrane (pore size: 0.025 µm). The DNA 
concentration was determined by NanoDrop.  
2.5.9.2 Electroporation of electro-competent S. Tm harboring pKD46 
S. TmWT harboring the plasmid pKD46 (Datsenko and Wanner 2000) were streaked on LB agar plates 
containing ampicillin and were incubated o/n at 30°C. 2 - 3 colonies were subsequently used to 
inoculate starter cultures containing 10 ml of LB medium supplemented with ampicillin that were 
incubated o/n at 30°C and 180 rpm. In order to generate electro-competent cells, starter cultures 
were used to inoculate subcultures in LB medium supplemented with 10 mM L-(+)-arabinose and 
ampicillin that were grown at 30°C under constant shaking at 180 rpm. Further steps are detailed in 
section 2.4.9. 
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Subsequently, 80 µl of electro-competent cells were mixed with 5 - 10 µl of the PCR product 
containing the antibiotic cassette as well as the homologous flanking regions and transferred into 
pre-cooled electroporation cuvettes. Electroporation was performed at 1800 V for 5 msec. Cells were 
immediately recovered in 1 ml of pre-warmed (37°C) SOC medium and further incubated at 37°C and 
500 rpm for 1.5 h. Afterwards, 500 µl of the transformed cells were transferred into a new 1.5 ml 
plastic tube and further incubated o/n at RT. The residual 500 µl were reduced to around 50 µl 
(centrifugation and re-suspending in residual supernatant), plated on LB agar plates supplemented 
with the appropriate antibiotic (either chloramphenicol or kanamycin both 30 µg/ml) and incubated 
o/n at 37°C. Clones were re-streaked, cryo-stocked and PCR checked using the Dream Taq mastermix 
and 500 nM of each check-up primer (Table 31). The reaction volume of the PCR was 20 µl and 5 µl of 
boiled cells from o/n cultures that were 1:20 diluted with sterile nuclease free ddH2O (Gibco) were 
directly used as template. The following cycling conditions were applied: (i) 95°C for 5 min, (ii) 35 
cycles with one cycle being 95°C for 30 sec, either 55°C for 30 sec (narZ, narG, entA and eutC) or 56°C 
for 30 sec (napA) and 72°C for either 1 min (eutC), 2 min (entA), 3 min (napA) or 4 min (narZ and 
narG) and (iii) 72°C for 10 min. PCR products were run on a 1% agarose gel in order to confirm 
successful gene replacement. 
2.5.9.3 P22 transduction 
Preparation of P22-phage lysates. 3 ml cultures in either pure LB medium or LB medium containing 5 
mM CaCl2 were inoculated with 3 colonies of the donor strain that was picked from a LB agar plate 
supplemented with appropriate antibiotic. The cultures were grown o/n in glass tubes at 37°C in a 
wheel rotor. 10 µl of P22-phage (Schmieger 1972) lysate were transferred into a sterile 1.5 ml plastic 
tube and 500 µl of the o/n culture of the donor strain were added. The culture containing the P22-
phage lysate was subsequently transferred into a glass tube with aluminum lid and statically 
incubated at 37°C for 15 min. Afterwards, 5 ml of LB medium were added to the glass tube and 
further incubated o/n at 37°C under constant shaking at 180 rpm. The next day, 50 µl of chloroform 
were added to the glass tube following a 30 min incubation at RT. 2 ml of the culture were then 
transferred to a sterile 1.5 ml plastic tube and spun down (10 min; 4°C; 2,415 x g). The supernatant 
was filtered through a sterile 0.45 µm filter into a sterile screw cap plastic tubes and 10 µl of 
chloroform were added. The plastic tube was sealed with parafilm and stored at 8°C. In order to 
ensure sterility, 50 µl of the lysate were plated on a LB agar plate without antibiotics and incubated 
o/n at 37°C.  
P22-transduction. 3 colonies of the acceptor strain from a LB agar plate with appropriate antibiotic 
were used to inoculate cultures containing 3 ml of LB medium supplemented with 5 mM CaCl2. The 
cultures were grown o/n in glass tubes at 37°C on a wheel rotor. 10 µl of the P22-phage lysate of the 
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donor strain were transferred into a sterile 1.5 ml plastic tube, 100 µl of o/n culture of the acceptor 
strain were added and incubated statically for 15 min at 37°C. 900 µl of LB medium supplemented 
with 10 mM EGTA were subsequently added and the tube was incubated under constant shaking 
(550 rpm) for 1 h at 37°C. Finally, the cultures were centrifuged (3 min; RT; 8,117 x g), the 
supernatant was reduced to around 100 µl, the pellet was resuspended in the residual supernatant 
and 50 µl were plated on LB agar plates containing the appropriate antibiotic +/- 10 mM EGTA and 
incubated o/n at 37°C. In order to obtain phage free bacteria, clones were finally picked and re-
streaked for two times before cryo-stocking at -80°C. Successful transduction was confirmed by PCR 
using the same condition as described in section 2.5.9.2 (check-up PCR). 
2.5.9.4 Deletion of antibiotic-resistance markers using the Flp-recombinase  
Strains containing an antibiotic-resistance marker flanked by FRT sites that were generated by λ red 
recombination as described previously (2.5.9) were picked from LB plates containing the appropriate 
antibiotic. 3 colonies were used to inoculate 5 ml starter cultures that were grown o/n in a wheel 
rotor in LB medium containing the appropriate antibiotic. Subsequently, 50 ml subcultures in LB 
medium supplemented with the appropriate antibiotic were inoculated with 500 µl of starter culture 
(1:100 dilution) and grown at 37°C under constant shaking at 180 rpm until an OD600 of around 0.5 
was reached. Further steps of the preparation of electro-competent cells are described in section 
2.4.9. 
Subsequently, electro-competent cells were electroporated with 1 µg of pCP20 harboring the Flp-
recombinase (Table 4). The procedure of electroporation is described in section 2.5.9.2. After 
electroporation, the cells were immediately recovered in 1 ml of pre-warmed LB medium (30°C) and 
incubated at 30°C for 1.5h under constant shaking (500 rpm). The bacteria were then spun down (3 
min; RT; 6,708 x g), resuspended in 100 µl of supernatant and finally plated on LB agar plates 
containing ampicillin. Plates were incubated o/n at 30°C, the permissive temperature for pCP20. The 
next day, clones were re-streaked on LB agar plates and incubated o/n at 43°C, in order to induce 
expression of Flp-recombinase. The antibiotic sensitive strains in which recombination has occurred 
were identified by double picking on LB agar plates with and without the respective antibiotic and 
incubation at 37°C, in order to select for loss of pCP20. In order to confirm the loss of pCP20, the 
antibiotic sensitive strains were double plated again on LB agar plates with and without ampicillin 
(100 µg/ml) and incubated at 37°C. Clones that were ampicillin sensitive were cryo-stocked and 
stored at -80°C. Successful deletion of the antibiotic marker was confirmed by PCR according to the 
protocol described in section 2.5.9.2 (check-up PCR). 
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2.5.9.5 Construction of S. Tm mutants  
Construction of S.TmNi. (MBE7). In order to construct the nitrate respiration deficient S. Tm strain 
that that lacks the three main nitrate reductases (ΔnarZ, narG::cat, napA::aphT) (Lopez et al. 2012), 
the genes narZ, narG and napA were either deleted or in frame replaced by antibiotic resistance 
markers. First, single S. Tm mutant strains were generated (Table 3, MBE1: narZ::cat, MBE2: 
narG::cat and MBE3: napA::aphT) using λ red recombination as described in the previous section 
2.5.9. Briefly, antibiotic resistance genes were PCR amplified from plasmids (Table 4) using the ko-
primers listed in Table 31 and electroporated into S. TmWT harboring pKD46. Effective recombination 
was verified by PCR using the check-up primers and agarose gel electrophoresis (1% agarose). 
Subsequently, the narZ::cat allele from MBE-1 was transduced to S. TmWT by P22 transduction in 
order to create MBE4. Correct insertion was tested by PCR using the primers narZ fwd-check up / 
narZ rev-check up (Table 31). The narZ::cat allele of MBE4 was subsequently deleted using the FLP 
recombinase as described in section 2.5.9.4. The resulting strain MBE5 (ΔnarZ) was check by PCR 
using the primers narZ fwd-check up / narZ rev-check (Table 31). MBE5 was further transduced with 
P22-phage lysate of MBE2 in order to create MBE6 (ΔnarZ, narG::cat). Correct insertion was verified 
by PCR using the oligonucleotides narG fwd-check up / narG rev-check up. Finally, MBE6 was 
transduced with P22-phage lysate from MBE3 in order to construct MBE7 (ΔnarZ, narG::cat, 
napA::aphT). The correct genotype of MBE7 was assessed by PCR using the primers: narZ fwd-check 
up / narZ rev-check up, narG fwd-check up / narG rev-check up and napA fwd-check up / napA rev-
check up. Conditions of check-up PCR reactions are detailed in section 2.5.9.2 (check-up PCR). All 
strains are listed in Table 3. 
Construction of S.TmNi. + Te. (MBE8). In order to generate MBE8 that is deficient in nitrate and 
tetrathionate respiration, the ttrS::tet allele from S. Tm stain M961 (Δ sodCI, Δ sodCII, BCB4::tet from 
(Hensel et al. 1999)) was transduced to MBE7 by P22-transuction. The correct genotype of MBE8 
(ΔnarZ, narG::cat, napA::aphT, ttrS::tet) was verified by PCR using the primers: narZ fwd-check up / 
narZ rev-check up, narG fwd-check up / narG rev-check up, napA fwd-check up / napA rev-check up 
and ttrS fwd-check up / ttrS rev-check up. PCR conditions of check-up reactions are detailed in 
section 2.5.9.2 (check-up PCR). 
Construction of S.TmEntA (MBE10). MBE10 (S. Tm, entA::cat) that is deficient in siderophore 
production was constructed by P22-transduction of the entA::cat allele from MBE9 to S. TmWT. MBE9 
was generated previously by λ red recombination using pKD3 and the entA-fwd-ko / entA-rev-ko 
knock out primers (Table 31). Correct insertion of the entA::cat allele in MBE9 and MBE10 was 
assessed by PCR using entA fwd-check up / entA rev-check up primers (Table 31). Conditions of 
check-up PCR reactions are detailed in section 2.5.9.2 (check-up PCR). 
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Construction of S.TmEA. (MBE12). In order to construct MBE12 (S. Tm, eutC::aphT) that is deficient in 
ethanolamine utilization (Thiennimitr et al. 2011), eutC of S. TmWT harboring pKD46 was first replaced 
by a kanamycin resistance cassette performing λ red recombination using pKD4 as template and the 
knock out primers: eutC-fwd-ko / eutC-rev-ko. The genotype of the resulting strain MBE11 (S. Tm, 
eutC::aphT) was checked by PCR using the oligonucleotides: eutC fwd-check up / eutC rev-check up 
(Table 31). The allele eutC::aphT from MBE11 was finally P22-transduced to a fresh S. TmWT strain 
and verified by PCR using the primers: eutC fwd-check up / eutC rev-check up (Table 31). Conditions 
of check-up PCR reactions are detailed in section 2.5.9.2 (check-up PCR). 
2.5.10 Immuno-fluorescence staining 
PFA fixed cecum tips were taken form -80°C, cut in 7 µm sections using a cryotome (Leica) and fixed 
on cover glass slides by air-drying for 2 h at RT. Sections were subsequently fixed with 100 µl of 4% 
PFA for 5 min. After 3 washing steps with 1x PBS, sections were blocked with 100 µl of 10% normal 
goat serum in 1x PBS for 60 min at RT. Next, 100 µl of 10% normal goat serum containing 1.67 µg/ml 
of α-CD18 antibody (Table 37) were added and incubated for 60 min at RT. After 3 washing steps 
with 1x PBS, sections were additional stained for 30 min with 100 µl of 10% normal goat serum 
containing the secondary anti rat antibody conjugated with Cy3 (4.17 µg/ml, Table 37), DAPI (1 
µg/ml), SYTOX green (0,5 µM) and Phalloidin (22 pmol/ml). Sections were washed again 3 times with 
1x PBS, dried in the dark and mounted with a glass cover slip, Vectashield and nail varnish. Pictures 
were acquired using the confocal microscope TCS SP5 (Leica). 
2.6 Animal experiments 
2.6.1 Ethics  
All animal experiments performed at the Max von Pettenkofer Institut (MvP) of the Ludwig-
Maximilians-University Munich were reviewed and approved by the government of Oberbayern 
(55.2-1-54-2532-13-15). 
2.6.2 Generation of gnotobiotic Oligo-MM12 mice 
Germfree C57BL/6J mice were associated with the 12 Oligo-MM strains (Table 2) by oral and rectal 
inoculation, Clean Mouse Facility (CMF) of the University of Bern (Brugiroux et al. 2016). Oligo-MM12 
mice, also termed stable Defined Moderately Diverse Microbiota mouse (sDMDMm2) were bred 
under germfree conditions in flexible film isolators (Harlan Laboratories) in order to maintain the 
defined microbiota. Oligo-MM12 mice were also transferred to the gnotobiotic mouse facility of the 
MvP and to the ETHZ where mice were further bred under sterile conditions. Sterility was verified 
monthly by plating cecal content of sentinel mice on MacConkey (Oxoid), sheep blood (Oxoid) and 
Sabouraud dextrose (Oxoid) agar plates.  
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2.6.3 High fat diet and oleic acid supplementation 
Animal experiments and DNA extraction were performed by Sandra Wotzka, ETH Zurich. For high-fat 
diet, standard diet (KLIBA NAFAG, 3437) was switched to high-fat diet (Bio Serv, mouse high-fat diet) 
containing 20.5% protein, 36% fat and 35.7% carbohydrates. Oligo-MM12 mice receiving high-fat diet 
were euthanized 6, 12 and 24 h post diet switch and cecal content was harvested for DNA extraction. 
For oleic acid supplementation, Oligo-MM12 mice receiving standard diet were gavaged two times 
with 200 µl of oleic acid (Sigma) at time points 0 h and 4 h post initial gavage. Mice were sacrificed at 
6, 12 and 24 h post initial oleic acid gavage and cecal content was taken for subsequent DNA 
extraction. Oligo-MM12 mice fed with standard diet served as control. 
2.6.4 Infection of gnotobiotic Oligo-MM12 mice with S. Tm and C. rodentium 
One day prior to infection Oligo-MM12 mice were exported from the isolator in autoclaved 
gnotocages (Han, Bioscape) equipped with sterile ddH2O (Ampuwa), food, bedding and enrichment. 
On the day of infection the laminar flow was disinfected with a sporicidal disinfectant (5% VirkonS, 
30 min incubation). All instruments used (additional cage for handling, gavage needles and forceps in 
metal boxes) were previously enwrapped in tissues, autoclaved and imported under the laminar 
flow. In order to handle and manipulate Oligo-MM12 mice under germfree conditions, infections 
were performed by two persons. Mice were directly handled by person 1 who was equipped with 
sterile cloths and gloves whereas person 2 handled unsterile material and opened the gnotocage. For 
infection, mice were taken out of the gnotocage, placed on the sterile grid of a handling cage and 
subsequently infected by oral gavage with either 5 x 107 CFUs of S. Tm strains or 1 x 108 CFUs of C. 
rodentium DBS100 in 50 µl of sterile 1x PBS using sterile gavage needles and syringes. The mice were 
placed back into the gnotocage that was sealed with Hepa-filter top. The preparation of bacterial 
cultures for in vivo experiments is detailed in section 2.4.2. 
During the experiment, mice were monitored daily for signs of illness or suffering without taken 
them out of the cage because of high risk of contamination. The experiment was terminated 
prematurely, when individual mice showed signs of terminal illness according to a cumulative scoring 
system. At the end of the experiment, mice were euthanized by cervical dislocation. 
2.6.5 Infection of CD18-/- mice with S. Tm 
In order to break microbiota-mediated colonization resistance, CD18-/- mice B6.129S7-Itgb2tm2Bay 
(Scharffetter-Kochanek et al. 1998) which are associated with a specific pathogen free (SPF) 
microbiota were orally gavaged with 25 mg of streptomycin-sulfate in 0.05 ml of dH2O 24 h prior to 
infection with 5 x 107 CFUs of S. TmWT. The preparation of S. TmWT cultures for in vivo experiments is 
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detailed in section 2.4.2. Mice were euthanized at days 1 and 2 post infection by cervical dislocation 
and samples were taken.  
2.6.6 Infection of Oligo-MM12 mice with C. difficile 
Infections with C. difficile were performed by Nicolas Studer in Prof. Hapfelmeier’s group (University 
of Bern). Oligo-MM12 mice were orally inoculated with 1 x 103 spores of C. difficile DH196 (Studer et 
al. 2016) and fecal pellets were collected daily, to determine LCN-2 levels and to perform microbiota 
analysis. The mice were sacrificed at day 3 post infection. LCN-2 levels were measured in Bern. DNA 
of feces and cecal content was extracted by Nicolas Studer as described in section 2.5.5. Fecal DNA 
was sent to the MvP and microbiota analysis was performed by qPCR. 
2.6.7 Reversible colitis model: H. typhlonius infection and CD45RBhi T-cell transfer 
The reversible colitis model was established in Prof. Mueller’s lab (University of Bern) (Brasseit et al. 
2016). Mouse experiments shown in this study were performed by Martin Faderl. Briefly, germfree 
RAG1-/- mice were either cohoused with C57BL/6J Oligo-MM12 mice for 20 days in order to allow 
vertical bacterial transmission or were directly associated with the Oligo-MM12. 14 days prior to the 
adoptive transfer of 250,000 colitogenic CD4+ CD45RBhigh CD25- T-cells isolated from C57BL/6J 
wildtype mice, mice were orally inoculated with 2 x 108 CFUs of H. typhlonius CCUG48335T. In order 
to induce remission from colitis, mice were treated with 250 µg of α-CD4 antibody (or isotype as 
control) in 3 day intervals starting from day 24 post T-cell transfer. Mice were euthanized at day 34 
post T-cell transfer and intestinal content was collected. The DNA of the colon content was extracted 
by Martin Faderl and sent to the MvP for microbiota analysis by qPCR. LCN-2 levels were measured in 
Bern.  
2.6.8 Antibody mediated depletion of neutrophils 
Neutrophils were depleted as described in (Trautwein-Weidner et al. 2014). Briefly, Oliglo-MM12 
mice were treated with one dose of α-m Ly-6G (Table 36, 150 µg) or isotype control (intraperitoneal 
(i.p.)) one day before infection with 5 x 107 CFUs of S. TmWT. In addition, α-mouse G-CSF (Table 36, 10 
µg) or isotype control were daily administered via i.p. injections. 
2.6.9 Monitoring depletion of neutrophils by FACS  
3 - 4 drops of blood were directly collected from the tail vein in 1.5 ml of pre-cooled FACS buffer (1x 
PBS and 1% heat inactivated FCS) and kept on ice until erythrolysis. For lysing the erythrocytes, blood 
samples were centrifuged (2 min; 4°C; 1,677 x g), the supernatant was discarded and the cell pellet 
was resuspended in 1 ml of BD FACSTM Lysing Solution (1:10 diluted in ddH2O, Ampuwa) following 10 
min of incubation in the dark at RT. The blood cells were then centrifuged again (2 min; 4°C; 1,677 x 
g), the supernatant was discarded and the white blood cells were resuspended in FACS buffer (100 µl 
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per staining). Cells were subsequently stained with antibodies listed in Table 36 using the indicated 
dilutions (FC-block (α-CD16/CD32) also included). Antibodies were added and samples were 
incubated for 30 min at 4 °C, following a washing step with 200 µl of FACS buffer and centrifugation 
(5 min; 4°C; 1,677 x g). The supernatant was discarded and cells were resuspended in 200 µl of FACS 
buffer and transferred to FACS tubes. For staining dead cells, SYTOX red (5 nM) was added to the 
samples directly before measurement. In addition, compensation controls were performed with 
single stained BDTM CompBeads (BD) beads. The FACS analysis was performed with the FACSCANTO II 
(BD) and data were recorded using the BD FACSDivaTM software (BD). Data were analyzed by Dr. 
Tamas Dolowschiak using the FlowJo software.  
2.6.10 Collection of mouse tissues 
Sampling of feces during the course of the experiments was performed by two persons under sterile 
conditions as described previously in 2.6.4. Feces and cecal content was collected in sterile 1.5 ml 
plastic tubes. Salmonella loads in feces, cecal content, mesenteric lymphnodes, liver and spleen 
(taken post mortem) were determined by plating appropriate dilutions (undiluted, 1:200 and 
1:40,000) on MacConkey agar plates (Oxoid) containing streptomycin (100 µg/ml). Samples 
containing C. rodentium were plated on MacConkey agar plates without antibiotics. Feces and cecal 
content for DNA extraction were also taken and stored in 2 ml PCR grade plastic tubes at -80°C until 
DNA extraction and subsequent microbiota analysis. Tissues of cecum, colon, small intestine, liver as 
well as spleen were embedded in O.C.T (Sakura, Torrance), subsequently frozen in liquid nitrogen 
and stored at -80°C until histology. Cecal content was also resuspended in PBT for LCN-2 ELISA. 
2.6.11 Hematoxylin eosin (HE) staining and histopathology  
Tissues embedded in O.C.T were directly taken from the -80°C freezer, and 5 µm cross-sections were 
prepared using a cryotome (Leica) and transferred onto Superfrost Plus glass slides. The sections 
were air dried for at least 24 h at RT, fixed in Wollman solution (95% ethanol, 5% acetic acid) for 30 
sec, washed with flowing tap water for 1 min and rinsed with dH2O. Subsequently, the sections were 
incubated in Vector’s Hämalaun solution for 20 min and rinsed again with tap water for 5 min 
(blueing). The slides were hereafter dipped 1 - 2 times in de-staining solution (70% ethanol, 1% HCl), 
washed with flowing tap water for 5 min and rinsed with dH2O, 70% and 90% ethanol. The cross-
sections were then stained with alcoholic eosin y solution for 20 sec and rinsed again with dH2O. The 
cross-sections were then dehydrated in 90% and 100% ethanol as well as xylene and finally mounted 
using coverslips and Rotimount (Roth).  
Histopathology of cecal tissues was performed microscopically with H&E stained cross-sections as 
described previously (Stecher et al. 2007). Briefly, the cecal pathology score is based on formation of 
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submucosal edema (0 - 3), infiltration of polymorphonucelar neutrophils (PMNs) (0 - 4), loss of goblet 
cells (0 - 3) and epithelial damage (0 - 3). The combined pathological score was subsequently 
determined by summing up scores: 0 – 3: no pathological change, 4 – 8: mild inflammation, 9 – 13: 
severe inflammation.  
2.7 Bioinformatics and statistics 
2.7.1 RAST automated gene annotation 
The assembled bacterial genomes were annotated using the RAST (Rapid Annotations 
using Subsystems Technology) online server, an automatic annotation service based on manually 
curated subsystems and on protein families (Aziz et al. 2008). 
2.7.2 Statistics  
CFU data, LCN-2 levels, CAS halo and pathoscores were expressed as median. More than two 
different groups were compared to each other using Kruskal-Wallis test, with Dunn’s multiple 
comparison test. Two groups were compared using the Mann Whitney test (Prism 5; GraphPad 
Software, San Diego, CA, USA).  
The percentage of individual bacteria was expressed as mean +/- standard deviation (SD). Differences 
between groups were compared using a two-way ANOVA, with Bonferroni posttest (Prism 5; 
GraphPad Software, San Diego, CA, USA). Growth curves and data from immune-fluorescence 
microscopy were also shown as mean +/- SD. Differences between multiple samples at one time 
point were compared using 1 way ANOVA with Bonferroni’s multiple comparison test. The difference 
between two groups was compared using unpaired t test (Prism 5; GraphPad Software, San Diego, 
CA, USA). 
To analyze clustering of qPCR data, both a qualitative measure (Pearson) and a quantitative one 
(Bray-Curtis) were used to calculate distance matrices containing dissimilarity values for each 
pairwise comparison. Strength and statistical significance of sample grouping were determined 
applying the nonparametric Adonis method based on the permutational multivariate ANOVA 
(PERMANOVA), together with the parametric significance test PERMDISP, which analyzes 
multivariate homogeneity of group dispersions. The used scripts are available in QIIME (Caporaso et 
al. 2010). 
In all cases, p values < 0.05 were considered as statistically significant. 
Fold changes in absolute abundance were calculated with absolute values that were normalized to a 
million gene copies determined by universal probe. 
Results 
55 
 
3. Results 
3.1 Establishment of a qPCR assay for specific detection and quantification of 
bacterial strains 
3.1.1 General considerations: SYBR green versus hydrolysis probe based qPCR 
It was initially planned to establish a SYBR green based qPCR assay. This assay relies on two specific 
primers that target variable regions in the bacterial 16s rRNA gene and a fluorescent dye (SYBR 
green) that intercalates into double stranded DNA (dsDNA) and allows quantification of the PCR 
amplicon. First, endpoint PCR reactions were performed in order to investigate and improve primer 
specificity by applying different annealing temperatures and DMSO concentrations. Unfortunately, 
these protocols were not transferrable to the qPCR system because of different reaction conditions 
e.g. the DMSO concentration in the mastermix was unknown in the SYBR green master mix. On top of 
that, pioneering SYBR green qPCR runs proved that most primer pairs performed inefficiently (out of 
the range between 90 - 110% efficiency). Another downside was that primer dimers resulted in false 
positive results because SYBR green intercalates unspecifically in dsDNA. Since bacteria were 
differentiated based on polymorphisms in the 16S rRNA gene which limits positioning of primers, it 
was very likely that the primers formed dimers.  
In order to increase the efficiency and to avoid the issue of primer dimers, a hydrolysis probe based 
qPCR assay for absolute quantification of bacterial strains was established. Therefore new primers 
and fluorescently labeled hydrolysis probes were designed using the software Primer Express 3 
(Applied Biosystems). The hydrolysis probe, a third oligonucleotide that binds within the amplicon, 
further increased specificity. Indeed, this strategy finally resulted in efficient and specific detection of 
bacterial strains in gnotobiotic mice. 
3.1.2 Design of strain-specific primers and hydrolysis probes  
16S rRNA gene sequences of 12 Oligo-MM strains, 7 ASF strains as well Salmonella enterica serovar 
Typhimurium, Citrobacter rodentium (DBS100), Helicobacter typhlonius (CCUG48335T), Clostridium 
difficile (DH196), Clostridium scindens (ATCC35704), Escherichia coli (Mt1B1), Streptococcus danieliae 
(ERD01G) and Staphylococcus xylosus (33R13C) were aligned using CLC DNA Workbench 6.0.2 (CLC 
bio, Denmark) and 9 hypervariable (V) regions were subsequently identified. V regions were localized 
and positioned according to (Chakravorty et al. 2007) with V regions spanning the following 
nucleotide position: V1: 69 - 99, V2: 137 - 242, V3: 433 - 497, V4: 576 - 682, V5: 822 - 879, V6: 986 - 
1043, V7: 1117 - 1173, V8: 1243 - 1294 and V9: 1435 - 1465. The positioning is based on the 16S rRNA 
gene of E. coli published by (Brosius et al. 1978). Strain-specific primers and hydrolysis probes 
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targeted hypervariable regions V1 - V5 and V7 (Table 30, Figure 42). Primers and hydrolysis probes 
were either constructed for experiments shown in this study or for experiments performed in 
collaboration: the qPCR assay for Clostridium scindens (ATCC35704) was designed for infection 
experiments with Clostridium difficile (DH196) performed in collaboration with Prof. Siegfried 
Hapfelmeier and Nicolas Studer. The qPCR assays for the 7 ASF strains as well as Escherichia coli 
(Mt1B1), Streptococcus danieliae (ERD01G) and Staphylococcus xylosus (33R13C) were designed for 
experiments performed in collaboration with Sandrine Brugiroux and Simone Herp. 
3.1.3 Optimization of primer and hydrolysis probe concentrations 
In order to determine suitable concentrations of qPCR primers and hydrolysis probes, 
oligonucleotides were titrated (100 - 500 nM) using two different DNA template amounts (2,500,000 
and 250 gene copies). The lowest primer and probe concentrations enabling early detection (low 
quantification cycle) using high and low DNA template amounts were regarded as optimal and finally 
chosen. Optimal qPCR performance was obtained using 300 nM of each primer and 250 nM of the 
corresponding hydrolysis probe (Figure 3). The titration test was performed with the following 
primer / probe combinations: YL2_Exonucl._fwd/rev with Probe_YL2, YL44_Exonucl._fwd/rev with 
Probe_YL44, YL45_Exonucl._fwd/rev with Probe_YL45, YL58_Exonucl._fwd/rev with Probe_YL58, 
Isol46_Exonucl._fwd/rev with Probe_Isol46, Isol49_Exonucl._fwd/rev with Probe_Isol49, 
Isol48_Exonucl._fwd/rev with Probe_Isol48. The example shown in (Figure 3) is representative for all 
primer and probe titration experiments.  
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Figure 3: Optimization of primer and hydrolysis probe concentrations. Different concentrations (100 - 500 
nM) of (A) forward and reverse primers as well as (B) hydrolysis probes were tested with different amounts of 
linearized plasmid template DNA (250 (red) and 2,500,000 (blue) gene copies). An equimolar concentration of 
forward and reverse primers was applied for qPCR reactions. In order to optimize the primer concentrations, 
the concentration of the probe was kept constant (200 nM) and the primers were titrated. The optimal primer 
concentration was found to be 300 nM. The optimal concentration of the hydrolysis probe (250 nM) was 
identified with qPCR reactions using 300 nM of each primer. qPCR reactions shown in this example were 
performed with the following primer / probe combinations: Isol48_Exonucl._fwd/rev with Probe_Isol48 and 
YL44_Exonucl._fwd/rev with Probe_YL44 and respective template DNA. Dashed lines indicate optimal primer 
and probe concentrations. 
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3.1.4 Multiplexing and qPCR performance  
Duplex qPCR reactions were performed order to increase speed and lower costs of the qPCR assays. 
A duplex qPCR reaction is based on two differently labeled hydrolysis probes (FAM or HEX), targeting 
different strains to be detected within one qPCR reaction. For duplex reactions, primers and probes 
with similar qPCR efficiencies and endpoint fluorescence levels were combined. In addition, in order 
to guarantee detection of low amounts of DNA template, duplex qPCR reactions were performed 
targeting trace amounts of template A in the presents of excessive DNA amounts of template B and 
vice versa (Figure 4C,D). qPCR efficiencies, R2 values, slopes and Y-intercepts listed in Table 39 are all 
derived from standard curves with 10-fold dilutions of template DNA performed in either mono- or 
duplex qPCR reactions (Figure 4A). Plasmid pools were used to determine unspecific amplification. 
Since evaluation of primers and hydrolysis probes was based on plasmid DNA, gDNA was additionally 
applied to verify detection of real strains (Figure 4B).  
 
Figure 4: Example of qPCR performances. (A) A standard curve was performed in triplicates with 10-fold 
dilutions of linearized plasmid ranging from 2,500,000 - 0.025 copies. Amplification curves with a distance of 
around 3.33 cycles were observed between 10-fold dilutions down to 2.5 copies (1 - 7), whereas 0.25 (8) and 
0.025 copies could not be detected by the qPCR assay (ASF502_Exonucl.3_fwd/rev and Probe3_ASF502(SB2)). 
(B) Specificity test with plasmid pools with an equimolar mixture of either all plasmids (pool all; 2,500,000 
copies / strain), or a mixture including all but the DNA of the strain to be tested (pool -) and genomic DNA 
(gDNA). NTC: non template control. (C) and (D) control experiment for duplex assays: The amount of template 
DNA of either assay A or B was kept at 25,000 gene copies whereas the template amount of the duplex partner 
was diluted in 10-fold steps to 2.5 gene copies. 1 - 5: 25,000 - 2.5 gene copies; the standard curves were 
performed in duplicates.  
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Table 39: Performance of primer / probe combinations in mono and duplex qPCR reactions 
qPCR assay partners 
(targeted strain) 
Standard curve (duplex) Standard curve (monoplex) LOD^ 
Sl.* Y-int.# E§ R2$ Sl. Y-int. E R2 
Isol46_Exonucl.2_fwd/._3rev 
Probe3_Isol46  
(Clostridium innocuum I46) 
-3.25 38.73 103% 0.99 -3.48 39.89 94% 1 100 
Isol49_Exonucl._fwd/rev 
Probe_Isol49 
(Lactobacillus reuteri I49) 
-3.41 37.04 96% 1 -3.37 36.59 98% 0.99 306 
YL58_Exonucl._fwd/rev 
Probe_YL58  
(Blautia coccoides YL58) 
-3.60 39.65 90% 0.98 -3.31 38.74 101% 1 113 
YL27_Exonucl.2_fwd/.2_rev 
Probe2_YL27  
(‘Muribaculum intestinale’ 
YL27) 
-3.26 35.16 103% 0.99 -3.25 34.93 103% 0.99 4 
YL31_Exonucl.2_fwd/.3_rev 
Probe2_YL31  
(Flavonifractor plautii YL31) 
-3.47 40.54 94% 1 -3.49 40.82 93% 0.99 4 
(LOD95) 
YL32_Exonucl.2_fwd/.2_rev 
Probe2_YL32  
(Clostridium clostridioforme 
YL32) 
-3.55 35.95 91% 1 -3.47 35.45 94% 0.99 4 
KB18_Exonucl.2_fwd/.2_rev 
Probe2_KB18 
(‘Acutalibacter muris’ KB18) 
-3.24 40.83 104% 0.99 -3.39 41.24 97% 0.99 1 
(LOD95) 
YL44_Exonucl._fwd/rev 
Probe_YL44  
(Akkermansia muciniphila 
YL44) 
-3.27 38.82 102% 0.99 -3.32 39.36 100% 1 10 
KB1_Exonucl._fwd/rev 
Probe_KB1  
(Enterococcus faecalis KB1) 
-3.51 41.41 93% 0.99 -3.49 41.29 93% 1 25 
(as. sp.) 
YL2_Exonucl._fwd/rev 
Probe_YL2  
(Bifidobacterium longum 
subsp. animalis YL2) 
-3.17 40.79 107% 0.98 -3.39 41.81 97% 1 13 
(LOD95) 
YL45_Exonucl._fwd/rev 
Probe_YL45  
(‘Turicimonas caecimuris’ 
YL45) 
-3.39 41.64 97% 0.99 -3.13 40.76 109% 0.99 2 
(LOD95) 
Isol48_Exonucl._fwd/rev 
Probe_Isol48  
(‘Bacteroides caecimuris’ I48) 
-3.48 39.57 94% 0.99 -3.27 38.23 102% 0.99 21 
ASF356_Exonucl.2_fwd/.2_rev 
Probe2_ASF356 
(Clostridium spp. ASF356)  
-3.32 41.16 100% 0.99 -3.21 40.93 105% 0.99 5 
ASF361_Exonucl._fwd/rev 
Probe_ASF361 
(Lactobacillus murinus ASF361) 
-3.58 38.70 90% 1 -3.32 37.78 100% 0.98 11 
ASF457_Exonucl._fwd/rev 
Probe_ASF457 
(Mucispirillum schaedleri 
ASF457)  
-3.12 39.12 109% 1 -3.39 41.05 97% 1 9 
ASF519_Exonucl._fwd/rev 
Probe_ASF519 
(Parabacteroides goldsteinii 
ASF519) 
-3.42 38.38 96% 1 -3.37 38.09 98% 0.99 25 
(as. sp.) 
ASF360_Exonucl.4_fwd/.4_rev 
Probe4_ASF360 
(Lactobacillus intestinalis 
ASF360)  
-3.29 36.78 101% 1 -3.28 37.10 102% 1 25 
(as. sp.) 
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qPCR assay partners 
(targeted strain) 
Standard curve (duplex) Standard curve (monoplex) LOD^ 
Sl.* Y-int.# E§ R2$ Sl. Y-int. E R2 
ASF500_Exonucl._fwd/rev 
Probe_ASF500 
(Pseudoflavonifactor spp. 
ASF500) 
-3.36 37.17 99% 0.99 -3.38 37.14 98% 0.99 31 
ASF502_Exonucl.3_fwd/.3_rev 
Probe3_ASF502(SB2) 
(Clostridium spp. ASF502) 
NA NA NA NA -3.58 38.71 90% 0.97 5 
 
Salmo_Exonucl._fwd/rev 
Probe_Salmo 
(Salmonella Typhimurium) 
NA NA NA NA -3.22 37.04 104% 0.99 25 
(as. sp.) 
C.rod_Exonucl._fwd/rev 
Probe_C.rod 
(Citrobacter rodentium) 
NA NA NA NA -3.65 37.06 90% 1 2500 
(as. sp.) 
H.typh_Exonucl.2_fwd/.2_rev 
Probe2_H.typhlonius 
(Helicobacter typhlonius) 
NA NA NA NA -3.34 39.02 99% 0.99 4 
(LOD95) 
C.diff_Exonucl._fwd/rev 
Probe_C.difficile 
(Clostridium difficile) 
NA NA NA NA -3.26 36.52 103% 0.98 25 
(as. sp.) 
E.coli_Exonucl._fwd/rev 
Probe_E.coli(Mt1B1) 
(Escherichia coli) 
NA NA NA NA -3.16 35.83 107% 1 25 
(as. sp.) 
Strep._Exonucl._fwd/rev 
Probe_Strep.daniel. 
(Streptococcus danieliae ) 
NA NA NA NA -3.34 38.68 99% 1 3 
Staph._Exonucl._fwd/rev 
Probe_Staph.xylosus 
(Staphylococcus xylosus) 
NA NA NA NA -3.46 40.98 95% 1 25 
(as. sp.) 
C.scin_Exonucl._fwd/rev 
Probe_C.scindens 
(Clostridium scindens) 
NA NA NA NA -3.45 39.68 95% 1 25 
(as. sp.) 
Univ_Exonucl.3_fwd/rev 
Probe2_Univ.  
(all strains but C.diff.) 
NA NA NA NA -3.36 35.69 99% 1 2500 
Univ_Exonucl.3_fwd/rev 
Probe3_Univ.  
(C.diff. + C.scind. + Oligo-MM) 
NA NA NA NA -3.40 38.97 97% 1 2500 
*Sl.: slope of the standard curve; #Y-int.: Y-intercept of the standard curve; §E: qPCR efficiency; in case qPCR 
efficiency is 100%, the DNA amount will double per qPCR cycle; $R2: Regression coefficient (a value of 1 
indicates a perfect fit between the regression line of the standard curve and the data points); the qPCR assays 
were validated with standard curves performing either mono- or duplex qPCR reactions; ^LOD: limit of 
detection that was either (i) the LOD95 (DNA template amount that results in above threshold signals in 95% of 
the qPCR runs, determined with duplex qPCR reactions), (ii) the assay specific limit (as. sp.): until the qPCR 
assay is dynamic (around 3.3 Cqs decrement between 1:10 dilutions and high endpoint fluorescence levels), or 
(iii) if higher, the gene copy number derived from unspecific amplification with pooled plasmid DNA of the 
remaining strains; for the Univ qPCR assay, the LOD is the gene copy number derived from signals of the non 
template control (NTC); NA: not available. 
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3.2 Composition and characteristics of the Oligo-MM12 
3.2.1 Selection of strains constituting the Oligo-Mouse-Microbiota (Oligo-MM12) 
12 Bacterial strains that constitute the Oligo-MM (Figure 5; Table 2) were isolated from the intestinal 
content of specific pathogen free (SPF) mice as described in (Brugiroux et al. 2016). Isolation was 
performed by Yvonne Loetscher, Ricco Robbiani and Sandrine Brugiroux. The aim was to establish a 
model microbiota that covers the main bacterial phyla of the intestinal microbiota of laboratory 
mice. Finally, 12 strains that grew reliably after freezing were selected. Remarkably, these 12 strains 
covered 5 main phyla. 6 strains could be assigned to the phylum Firmicutes (‘Acutalibacter muris’ 
KB18, Flavonifractor plautii YL31, Clostridium clostridioforme YL32, Blautia coccoides YL58, 
Clostridium innocuum I46, Lactobacillus reuteri I49 and Enterococcus faecalis KB1), two strains to the 
Bacteroidetes (‘Bacteroides caecimuris’ I48, ‘Muribaculum intestinale’ YL27), one strain to the 
Actinobacteria (Bifidobacterium longum subsp. animalis YL2), one strain to the β-Proteobacteria 
(‘Turicimonas muris’ YL45) and one strain to the Verrucomicrobia (Akkermansia muciniphila YL44) 
(Figure 5). It is worth mentioning that ‘Muribaculum intestinale’ YL27 is a member of a novel family 
(‘Muribaculaceae’) and that the strains KB18 and YL45 are representatives of novel genera within the 
Lachnospiraceae (‘Acutalibacter muris’) and Sutterellaceae (‘Turicimonas muris’), respectively. Strain 
I48 is proposed to be a novel species (‘Bacteroides caecimuris’). Additional information of taxonomic 
classification is detailed in (Brugiroux et al. 2016). Protocols of bacterial culture and cryopreservation 
were established by Sandrine Brugiroux (PhD thesis of Sandrine Brugiroux).  
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Figure 5: 12 strains constituting the Oligo-Mouse-Microbiota (Oligo-MM12). Gram-staining and light 
microscopy (100-fold magnification, oil immersion) of individually grown strains in liquid culture is shown 
(Brugiroux et al. 2016). Color code based on phylogeny of Oligo-MM12 strains: blue: Actinobacteria, orange: 
Bacteroidetes, red: Proteobacteria, purple: Verrucomicrobia and green: Firmicutes. Representatives of the 
Bacteroidetes, Proteobacteria and Verrucomicrobia phyla (‘Bacteroides caecimuris‘ I48, ‘Muribaculum 
intestinale‘ YL27, ‘Turicimonas caecimuris‘ YL45 and Akkermansia muciniphila YL44) stained Gram-negative. 
Bifidobacterium longum subsp. animalis YL2 (Actinobacteria) as well as Enterococcus faecalis KB1, Lactobacillus 
reuteri I49 and Blautia coccoides YL58 (Firmicutes) appear Gram-positive. In contrast, the other Firmicutes 
strains (Flavonifractor plautii YL31, Clostridium clostridioforme YL32, ‘Acutalibacter muris‘ KB18 and Clostridium 
innocuum I46) are stained Gram-negative or Gram-variable. Scale bar: 10 µm.  
 
3.2.2 The Oligo-MM12 matures and stably colonizes germfree mice 
In order to monitor early colonization of the Oligo-MM12 and its changes in composition over time, 
germfree C57BL/6J AGR2+/- mice which develop a wild type like mucus layer (Bergström et al. 2014) 
were inoculated with a frozen mixture of Oligo-MM12 strains. Feces was taken at the indicated time 
points (Figure 6A) and the microbiota composition was analyzed using strain-specific qPCR. 
Microbiota was clustered in 3 different stages (maturation stage): early: day 1, intermediate: from 
days 2 - 4 post inoculation (p.in.) and stable: after day 6 p.in. (Figure 6; Table 40). Clustering by 
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maturation stage was significant, according to Bray Curtis (p<0.001, Adonis) and Pearson (p<0.001, 
Adonis) correlation with 66% (Bray Curtis) and 78% (Pearson) of variation explained. Additional 
PERMDISP analyses based on Bray Curtis and Pearson distance matrices revealed statistically 
significant differences in microbiota composition between early, intermediate and stable maturation 
stage (Figure 6B,C). The initial early stage at day 1 p.in. was dominated by Akkermansia muciniphila 
YL44 (mean: 64.01% +/- standard deviation: 27.68%), ‘Bacteroides caecimuris‘ I48 (27.38% +/- 
28.42%) and Bifidobacterium longum subsp. animalis YL2 (6.36% +/- 2.69%). The Firmicutes, 
‘Muribaculum intestinale‘ YL27 as well as ‘Turicimonas caecimuris‘ YL45 were less abundant in this 
early stage. The most prevalent strain of the second stage of maturation, the intermediate stage, was 
‘Bacteroides caecimuris‘ I48 (75.70% +/- 8.29%). Its presence was significantly increased compared to 
early stage (p<0.001, two-way ANOVA with Bonferroni posttest). ‘Turicimonas caecimuris‘ YL45 and 
‘Muribaculum intestinale‘ YL27 increased by trend in this stage. The relative abundance of the 
Firmicutes was not altered, only Flavonifractor plautii YL31 slightly increased. Compared to early 
phase, the relative abundance of Akkermansia muciniphila YL44 (13.07% +/- 6.16%) significantly 
decreased (p<0.001, two-way ANOVA with Bonferroni posttest). Remarkably, the abundance of 
Bifidobacterium longum subsp. animalis YL2 dropped down to (1.40% +/- 1.56%) in this intermediate 
stage. From day 7 post inoculation on, the composition of the Oligo-MM12 was considered to be 
stable (Figure 6). The most abundant strains in this stage were ‘Bacteroides caecimuris‘ I48 (57.52% 
+/- 9.31%), Akkermansia muciniphila YL44 (21.97% +/- 8.84%) and ‘Muribaculum intestinale‘ YL27 
(12.85% +/- 3.16%). In comparison to intermediate stage the relative abundance of ‘Bacteroides 
caecimuris‘ I48 decreased, whereas the relative abundance of ‘Muribaculum intestinale‘ YL27 and 
Akkermansia muciniphila YL44 increased (p<0.001, two-way ANOVA with Bonferroni posttest). The 
relative abundance of ‘Turicimonas caecimuris‘ YL45 and the Firmicutes was not changed compared 
to intermediate stage, whereas Bifidobacterium longum subsp. animalis YL2 was hardly detectable in 
stable stage. ‘Acutalibacter muris‘ KB18 was only detectable in the inoculum, and undetectable or 
very close to the limit of detection in fecal DNA samples during all stages of maturation. The relative 
abundance of the Oligo-MM12 strains in all 3 stages of maturation is summarized in (Table 40). 
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Figure 6: Changes in Oligo-MM12 community composition over time after inoculation of germfree mice. 
Germfee (GF) C57BL/6J AGR2+/- which exhibit wildtype like mucus layer (Bergström et al. 2014) were orally and 
rectally inoculated with freshly thawed cryostocks containing the Oligo-MM12 strains and housed in a germfree 
isolator. (A) Fecal samples were sampled at the indicated time points (GF - day 99 post inoculation), the fecal 
DNA was extracted using a modified protocol for DNA stool kit (Qiagen) and microbiota composition was 
analyzed by qPCR. Microbiota composition is shown as relative abundance and is expressed as % of cumulated 
16S rRNA gene copy numbers (% of total 16S rRNA gene copies). Cluster analysis based on Bray Curtis (B) or 
Pearson (C) distance matrices visualized as PCoA plots. Fecal microbiota samples were grouped by maturation 
stage of the Oligo-MM12 in ‘early’ (day 1 post inoculation), ‘intermediate’ (days 2, 3 and 4 post inoculation) and 
‘stable’ (from days 7 post inoculation on) which was significant, according to Bray Curtis (p<0.001, Adonis) and 
Pearson (p<0.001, Adonis) with 66% (Bray Curtis) and 78% (Pearson) of variation explained. PERMDISP analyses 
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based on Bray Curtis and Pearson distance matrices revealed statistically significant differences in microbiota 
composition between early, intermediate and stable (*p<0.05, *** p<0.001). 
 
Table 40: Relative abundance of individual Oligo-MM12 strains at different maturation stages 
Strain 
Mean % of cumulated 16S rRNA gene copy 
numbers (+/- SD) 
Maturation grade 
early intermediate stable 
‘Bacteroides caecimuris’ I48 27.38  (28.42) 
75.70a  
(8.29) 
57.52b,c  
(9.31) 
‘Muribaculum intestinale’ YL27 0* 2.25  (3.57) 
12.85b,c 
(3.16) 
Akkermansia muciniphila YL44 64.01  (27.68) 
13.07a 
(6.16) 
21.97b,c 
(8.84) 
‘Turicimonas caecimuris’ YL45 0.89  (1.02) 
4.74  
(1.23) 
5.26  
(1.36) 
Lactobacillus reuteri I49 0.02  (0.02) 
0.05  
(0.03) 
0.01  
(0.02) 
Enterococcus faecalis KB1 0.50  (0.20) 
0.07  
(0.05) 
0.001  
(0.003) 
Blautia coccoides YL58 0.07  (0.13) 
0.43  
(0.28) 
0.46  
(0.12) 
Clostridium innocuum I46 0.27  (0.12) 
0.12  
(0.03) 
0.05  
(0.02) 
Flavonifractor plautii YL31 0.48  (0.86) 
1.61  
(0.42) 
0.89  
(0.50) 
Clostridium clostridioforme YL32 0.02  (0.02) 
0.53  
(0.33) 
0.96  
(0.44) 
‘Acutalibacter muris’ KB18 0* 0.01  (0.03) 
0.02  
(0.05) 
Bifidobacterium longum subsp.  
animalis YL2 
6.36  
(2.69) 
1.40  
(1.56) 
0.01  
(0.02) 
Significant differences between groups are indicated with a for early vs intermediate, b for early vs stable and c 
for intermediate vs stable; p values were less than 0.001, two-way ANOVA with Bonferroni posttest. Values are 
indicated as mean % of cumulated 16S rRNA gene copy numbers +/- standard deviation (SD). Early: n=4, 
intermediate: n=12, stable n=24. *Very low abundant. 
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3.2.3 The Oligo-MM12 is vertically transmitted and remains stable over 6 filial generations 
It was further investigated whether the Oligo-MM12 that stably colonizes mice is vertically 
transmitted from parental mice to offspring and whether the consortium is stable over filial 
generations. By breeding C57BL6/J mice associated with Oligo-MM12 in germfree isolators and 
analyzing fecal DNA by qPCR, it could be shown that the Oligo-MM12 is vertically transmitted after a 
single gavage of Oligo-MM12 strains. Moreover, the composition of the Oligo-MM12 was stable over 
at least 6 filial generations. Bifidobacterium longum subsp. animalis YL2 was not detected in fecal 
samples and ‘Acutalibacter muris‘ KB18 was detectable in samples of the parental (P) and filial 
generation 1 (F2 - F6 below limit of detection; Figure 7; Table 41). Although the composition of the 
microbiota was stable overall, there were statistically significant alterations in relative abundance of 
‘Bacteroides caecimuris‘ I48 and Akkermansia muciniphila YL44 between generations F1 - F4 (Table 
41). Of note, P and F1 generation were housed at the CMF in Bern and F2 – F6 at the gnotobiotic 
facility of the MvP in Munich. 
Cluster analysis was performed on relative abundance of the strains. According to Bray Curtis 
(p<0.001, Adonis) and Pearson (p<0.005, Adonis) distance matrices, grouping of microbiota 
composition by generations was significant, with 65% (Bray Curtis) and 77% (Pearson) of variation 
explained (Figure 7B,C). Non parametric PERMDISP procedure revealed that the Oligo-MM12 
composition of the P generation differed compared to the filial generations (Figure 7B,C). There was 
also a significant difference in microbiota composition between generations F3 and F4 (p<0.05, non 
parametric PERMDISP procedure according to Pearson correlation). However, according to Bray 
Curtis distance there was no statistically significant difference between Oligo-MM12 communities of 
the filial generations, indicating that the Oligo-MM12 remains relatively stable over generations. 
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Figure 7: The Oligo-MM12 is vertically transmitted and stable over 6 filial generations. (A) C57BL/6J mice 
associated with the Oligo-MM12 consortium were bred in germfree isolators until filial generation 6 (F6). The 
inoculation of the parental generation (P) as well as the breeding of F1 generation took place at the CMF in 
Bern. The generations F2 – F6 were subsequently bred at the gnotobiotic mouse facility of the MvP in Munich. 
Fecal samples were collected, the fecal DNA was extracted and qPCR was performed in order to determine the 
microbiota composition in each generation. Microbiota composition is shown as relative abundance and is 
expressed as % of cumulated 16S rRNA gene copy numbers (% of total 16S rRNA gene copies). Cluster analysis 
based on Bray Curtis (B) or Pearson (C) distance matrices visualized as PCoA plots. Grouping by generations was 
significant, according to Bray Curtis (p<0.001, Adonis) and Pearson (p<0.005, Adonis) with 65% (Bray Curtis) and 
77% (Pearson) of variation explained. PERMDISP analyses based on Bray Curtis and Pearson distance matrices 
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revealed statistically significant differences in microbiota composition between groups, especially between the 
parental and the filial generations (* p<0.05, ** p<0.01, *** p<0.001). 
 
Table 41: Stability of Oligo-MM12 community over consecutive mouse filial generations 
Strain 
Mean % of cumulated 16S rRNA gene copies (+/- SD) 
Generations 
P F1 F2 F3 F4 F6 
‘Bacteroides caecimuris’ I48 49.09 (11.00) 
51.38 
(4.67) 
61.96a 
(3.87) 
57.38b 
(3.04) 
67.17c 
(3.16) 
65.23 
(4.19) 
‘Muribaculum intestinale’ YL27 12.63 (0.98) 
10.89 
(1.14) 
9.15 
(0.94) 
10.21 
(0.34) 
10.16 
(1.30) 
12.23 
(2.28) 
Akkermansia muciniphila YL44 28.60 (11.77) 
28.36 
(4.70) 
21.17a 
(3.36) 
23.90b 
(2.60) 
16.73c 
(2.43) 
15.84 
(2.08) 
‘Turicimonas caecimuris’ YL45 5.32 (0.83) 
4.97 
(0.89) 
3.40 
(0.30) 
2.83 
(0.45) 
2.30 
(0.50) 
3.22 
(0.59) 
Lactobacillus reuteri I49 0.05 (0.01) 
0.03 
(0.04) 
0.11 
(0.06) 
0.21 
(0.07) 
0.06 
(0.03) 
0.05 
(0.02) 
Enterococcus faecalis KB1 0.08 (0.03) 
0.08 
(0.04) 
0.01 
(0.01) 
0.05 
(0.02) 
0.02 
(0.01) 0* 
Blautia coccoides YL58 1.03 (0.11) 
0.77 
(0.11) 
0.45 
(0.16) 
0.86 
(0.24) 
0.73 
(0.11) 
0.53 
(0.07) 
Clostridium innocuum I46 0.13 (0.04) 
0.06 
(0.02) 
0.07 
(0.04) 
0.09 
(0.03) 
0.09 
(0.04) 
0.11 
(0.04) 
Flavonifractor plautii YL31 2.06 (0.33) 
2.19 
(0.53) 
2.02 
(0.24) 
2.25 
(0.14) 
1.77 
(0.12) 
2.00 
(0.65) 
Clostridium clostridioforme YL32 0.94 (0.06) 
1.27 
(0.72) 
1.67 
(0.38) 
2.24 
(0.65) 
0.99 
(0.14) 
0.82 
(0.50) 
‘Acutalibacter muris’ KB18 0.10 (0.13) 
0.01 
(0.03) DTL DTL DTL DTL 
Bifidobacterium longum subsp.  
animalis YL2 DTL DTL DTL DTL DTL DTL 
Significant differences between groups are indicated with a for F1 vs F2, b for F2 vs F3 and c for F3 vs F4; p 
values were less than 0.001, except: YL44 F2 vs F3 p<0.05, two-way ANOVA with Bonferroni posttest. There 
were no statistically significant difference in microbiota composition between P and F1 and between F4 and F6. 
Values are expressed as mean % of cumulated 16S rRNA gene copy numbers +/- standard deviation (SD). P: 
n=2, F1: n=5, F2: n=11, F3: n=6, F4: n=6, F6: n=8. DTL: below limit of detection. *Very low abundant. 
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3.2.4 The composition of the Oligo-MM12 is comparable between different animal facilities 
The Oligo-MM12 was designed to be used as a standardized mouse microbiota that can be easily 
distributed and shared between different laboratories, in order to generate isobiotic mice. C57BL6/J 
mice associated with the Oligo-MM12 were generated at the CMF in Bern in 2012 and distributed to 
the Mvp in Munich as well as to the ETHZ and further bred in germfree isolators. To investigate 
differences in microbiota composition between the different facilities, fecal samples were obtained 
and analyzed using the same DNA extraction protocol and strain-specific qPCR (Figure 8). Overall, the 
Oligo-MM12 composition was comparable between the CMF (mice from isolators or individually 
ventilated cages (IVC)), the MvP or the ETHZ. However, statistically significant differences in relative 
abundance of ‘Bacteroides caecimuris‘ I48, ‘Muribaculum intestinale‘ YL27, Akkermansia muciniphila 
YL44 and ‘Turicimonas caecimuris‘ YL45 were observed between animal facilities (Table 42). 
Compared to the Oligo-MM12 composition of mice bred at the MvP, the microbiota composition of 
the CMF-IVC differed the most (Figure 8; Table 42). ‘Bacteroides caecimuris‘ I48 was around 17% less 
abundant in CMF-IVC (p<0.001, two-way ANOVA with Bonferroni posttest), whereas the relative 
abundance of ‘Muribaculum intestinale‘ YL27, Akkermansia muciniphila YL44 and ‘Turicimonas 
caecimuris‘ YL45 was increased (p<0.001, two-way ANOVA with Bonferroni posttest; Table 42; Figure 
8). Bifidobacterium longum subsp. animalis YL2 was not detectable in fecal samples taken in the CMF 
and MvP. Bifidobacterium longum subsp. animalis YL2 could be detected in one sample of the ETHZ, 
but was otherwise under the limit of detection. ‘Acutalibacter muris‘ KB18 was below the limit of 
detection in Oligo-MM12 mice of the MvP. 
In addition, cluster analysis was performed on relative abundance of the strains. According to Bray 
Curtis (p<0.001, Adonis) and Pearson (p<0.001, Adonis) distance matrices, grouping of microbiota 
composition by the different animal facilities was significant, with 53% (Bray Curtis) and 72% 
(Pearson) of variation explained (Figure 8B,C). The Oligo-MM12 compositions of the different facilities 
clustered similarly (Figure 8B,C). However, non parametric PERMDISP procedure according to Bray 
Curtis revealed significant differences (p<0.01) between microbiota compositions of mice bred at the 
MvP and CMF-IVC. Additionally based on Pearson, the Oligo-MM12 composition of the MvP was 
significantly different compared to the Oligo-MM12 compositions of mice bred at the ETHZ and CMF 
(p<0.01, non parametric PERMDISP procedure; Figure 8B,C). There was no statically significant 
difference in microbiota composition between the CMF and ETHZ (Figure 8B,C). 
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Figure 8: Composition of Oligo-MM12 between different animal facilities. Fecal sample from mice associated 
with the Oligo-MM12 were sampled, the DNA was extracted using the same DNA extraction protocol (modified 
stool kit, Qiagen) and qPCR was performed in order to determine the microbiota composition. (A) Oligo-MM12 
composition of mice from different animal facilities. Microbiota composition is shown as relative abundance 
and is expressed as % of cumulated 16S rRNA gene copy numbers (% of total 16S rRNA gene copies). * Limit of 
detection. Cluster analysis based on Bray Curtis (B) or Pearson (C) distance matrices visualized as PCoA plots. 
Fecal microbiota samples were grouped by different animal facilities which was significant, according to Bray 
Curtis (p<0.001, Adonis) and Pearson (p<0.001, Adonis) with 53% (Bray Curtis) and 72% (Pearson) of variation 
explained. PERMDISP analyses based on Bray Curtis and Pearson distance matrices revealed statistically 
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significant differences in microbiota composition especially between the MvP and CMF as well as ETHZ 
(** p<0.01). 
 
Table 42: Oligo-MM12 composition in different animal facilities 
Strain 
Mean % of cumulated 16S rRNA gene copy numbers  
(+/- SD) 
Animal facilities 
CMF MvP CMF-IVC ETHZ 
‘Bacteroides caecimuris’ I48 50.72 (5.99) 
62.92a 
(4.88) 
45.55b,d 
(5.38) 
58.70c,e,f 
(9.66) 
‘Muribaculum intestinale’ YL27 11.39 (1.32) 
10.34 
(1.81) 
15.39b,d 
(3.44) 
13.55e 
(2.34) 
Akkermansia muciniphila YL44 28.42 (6.15) 
19.46a 
(4.11) 
26.82d 
(4.76) 
20.57c,f 
(6.75) 
‘Turicimonas caecimuris’ YL45 5.07 (0.82) 
3.03 
(0.60) 
6.07d 
(1.83) 
3.05f 
(0.93) 
Lactobacillus reuteri I49 0.03 (0.03) 
0.10 
(0.07) 
0.06 
(0.04) 
0.06 
(0.03) 
Enterococcus faecalis KB1 0.08 (0.03) 
0.01 
(0.02) 
0.04 
(0.04) 
0.001 
(0.004) 
Blautia coccoides YL58 0.84 (0.16) 
0.60 
(0.22) 
1.46 
(0.73) 
0.95 
(0.46) 
Clostridium innocuum I46 0.08 (0.04) 
0.09 
(0.04) 
0.13 
(0.06) 
0.33 
(0.44) 
Flavonifractor plautii YL31 2.15 (0.46) 
2.01 
(0.38) 
3.12 
(0.87) 
1.69 
(0.75) 
Clostridium clostridioforme YL32 1.17 (0.61) 
1.43 
(0.69) 
1.05 
(1.22) 
1.04 
(0.58) 
‘Acutalibacter muris’ KB18 0.04 (0.07) DTL 
0.33 
(0.22) 
0.06 
(0.09) 
Bifidobacterium longum subsp.  
animalis YL2 DTL DTL DTL 
0.004 
(0.011) 
Significant differences between groups are indicated with a for CMF vs MvP, b for CMF vs CMF-IVC, c for CMF 
vs ETHZ, d for MvP vs CMF-IVC, e MvP vs ETHZ and f CMF-IVC vs ETHZ; p values were less than 0.001, except: 
YL27 CMF vs CMF-IVC p<0.01, YL27 MvP vs ETHZ p<0.01 and YL45 CMF-IVC vs ETHZ p<0.05, two-way ANOVA 
with Bonferroni posttest. Values are expressed as mean % of cumulated 16S rRNA gene copy numbers +/- 
standard deviation (SD). CMF: n=7, MvP: n=31, CMF-IVC: n=16, ETHZ: n=8. DTL: limit of detection. 
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3.2.5 High-fat diet as well as oleic acid supplementation shift Oligo-MM12 composition 
In this section the influence of high-fat (HF) diet and oleic acid (OA) supplementation on the Oligo-
MM12 composition was investigated. Thus, C57BL/6J mice associated with the Oligo-MM12 were 
either fed with standard diet, HF diet or with a standard diet supplemented with OA. Mice were then 
sacrificed at 6, 12 and 24 h post diet change, cecal content was harvested and DNA was extracted 
using the modified Stool kit (Qiagen). DNA was subsequently sent to the MvP for microbiota analysis 
by qPCR. Animal experiments and DNA extraction were performed by Sandra Wotzka, ETHZ.  
The microbiota composition was comparable between groups 6 h post diet change (Figure 9A). At 
this time point, samples clustered together irrespective of diet fed (Figure 9B). Grouping of 
microbiota composition by different diet and time point was significant, according to Bray Curtis 
(p<0.001, Adonis) and Pearson (p<0.001, Adonis) distance matrices, with 86% (Bray Curtis) and 98% 
(Pearson) of variation explained (Figure 9B,C). Remarkably, starting from 12 h after diet change, the 
Oligo-MM12 composition of the HF and OA group clustered apart from each other (Figure 9B), 
whereas Oligo-MM12 composition of the standard diet group still clustered together with time points 
6 and 24 h. In more detail, the relative abundance of ‘Bacteroides caecimuris‘ I48 decreased 24 h 
after feeding HF or standard diet supplemented with OA compared to standard diet from 62.77% +/- 
2.70% to 26.48% +/- 9.07% and 14.03% +/- 6.80%, respectively (p<0.001, two-way ANOVA with 
Bonferroni posttest; Table 43; Figure 9A). The lower abundance of ‘Bacteroides caecimuris‘ I48 after 
OA supplementation compared to HF was also statistically significant (p<0.001, two-way ANOVA with 
Bonferroni posttest; Table 43). In contrast, compared to standard diet, the relative abundance of 
Akkermansia muciniphila YL44 increased around 35% after feeding HF and 43% after supplementing 
OA (p<0.001, two-way ANOVA with Bonferroni posttest; Table 43; Figure 9A). There was significantly 
more Akkermansia muciniphila YL44 present 24 h after supplementing OA compared to HF diet 
(p<0.05, two-way ANOVA with Bonferroni posttest; Table 43). The number of total bacteria was 
constant during the course of the experiment and independent of diet.  
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Figure 9: Oligo-MM12 responds to changes in diet. Oligo-MM12 mice were either fed with standard (ST) diet, 
high-fat (HF) or standard diet supplemented with oleic acid (OA). Mice were sacrificed 6, 12 and 24 h after diet 
change and cecal content was harvest for subsequent DNA extraction and microbiota analysis by qPCR. (A) 
Analysis of microbiota composition in cecal content. Microbiota composition is shown as relative abundance 
and expressed as % of cumulated 16S rRNA gene copy numbers (% of total 16S rRNA gene copies). The amount 
of absolute 16S rRNA gene copies (determined by an universal primer / probe combination) is illustrated as 
black dots (right y axis). Cluster analysis based on Bray Curtis (B) or Pearson (C) distance matrices visualized as 
PCoA plots. Microbiota samples were grouped by different diet and time point which was significant, according 
to Bray Curtis (p<0.001, Adonis) and Pearson (p<0.001, Adonis) with 86% (Bray Curtis) and 98% (Pearson) of 
variation explained. 
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Table 43: Influence of high-fat diet and oleic acid supplementation on Oligo-MM12 composition 
Strain 
Mean % of cumulated 16S rRNA gene copy numbers 
(+/- SD) 
different diets (24h post diet change) 
standard high-fat oleic acid 
‘Bacteroides caecimuris’ I48 62.77 (2.70) 
26.48a 
(9.07) 
14.03b,c 
(6.80) 
‘Muribaculum intestinale’ YL27 8.16 (1.25) 
7.95 
(1.22) 
12.86 
(2.84) 
Akkermansia muciniphila YL44 21.27 (2.43) 
56.61a 
(9.93) 
63.80b,c 
(8.72) 
‘Turicimonas caecimuris’ YL45 2.78 (0.24) 
2.60 
(0.57) 
5.30 
(1.74) 
Lactobacillus reuteri I49 0.05 (0.02) 
0.05 
(0.04) 
0.12 
(0.04) 
Enterococcus faecalis KB1 0* 0.01 (0.01) 
0.01 
(0.01) 
Blautia coccoides YL58 0.64 (0.13) 
0.76 
(0.12) 
0.32 
(0.10) 
Clostridium innocuum I46 0.06 (0.01) 
0.09 
(0.02) 
0.12 
(0.07) 
Flavonifractor plautii YL31 2.06 (0.50) 
3.01 
(0.64) 
2.54 
(0.95) 
Clostridium clostridioforme YL32 2.04 (0.25) 
1.41 
(0.56) 
0.91 
(0.18) 
‘Acutalibacter muris’ KB18 0.17 (0.16) 
1.06 
(0.54) 0* 
Bifidobacterium longum subsp. 
animalis YL2 0* 
0.003 
(0.005) 0* 
Significant differences between groups are indicated with a for standard vs high fat, b for standard vs oleic acid 
and c for high-fat vs oleic acid; p values were less than 0.001, except: YL44 high-fat vs oleic acid p<0.05, two-
way ANOVA with Bonferroni posttest. For the calculation of mean % values 24 h post diet change were used. 
Values are expressed as mean % of cumulated 16S rRNA gene copy numbers +/- standard deviation (SD). 
Standard: n=3, high-fat: n=4, oleic acid: n=3. * Very low abundant. 
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3.3 The Oligo-MM12 is a tool to study inflammation induced dysbiosis 
3.3.1 Infection with wild type S. Typhimurium causes severe colitis and dysbiosis  
Wildtype S. Typhimurium (S. TmWT) induces acute gut inflammation which triggers dysbiosis (Stecher 
et al. 2007). To date, studies investigating Salmonella-induced dysbiosis are based on human derived 
or not well defined murine microbiota, or use antibiotic pre-treated mice where the microbiota is 
already manipulated by antibiotic application before infection (Barthel et al. 2003, Barman et al. 
2008, Ganesh et al. 2013) and might therefore generate biased datasets. In order to establish a new 
model for Salmonella-induced colitis, we address the influence of Salmonella infection on mice 
associated with Oligo-MM12, a well-defined model microbiota consisting of murine bacterial isolates 
without antibiotic treatment prior to infection.  
C57BL/6J mice associated with the Oligo-MM12 consortium were infected with 5 x 107 CFUs of either 
S. TmAvir or S. TmWT without antibiotic treatment prior to infection. On each day post infection (p.i.) 
groups of mice (infection with S. TmAvir: day 1 p.i. n=5, day 2 p.i. n=5, day 3 p.i. n=6, day 4 p.i. n=6; 
infection with S. TmWT: day 1 p.i. n=5, day 2 p.i. n=5, day 3 p.i. n=7, day 4 p.i. n=7) were sacrificed and 
samples were taken for further analyses (Figure 10A). The avirulent Salmonella strain S. TmAvir that 
lacks functional type 3 secretion systems 1 and 2 (ΔinvG; sseD::aphT) was not able to induce colitis 
(Figures 10B; 11B). In stark contrast, mice infected with S. TmWT exhibited colitis starting at day 3 p.i. 
leading to profound colitis observed at day 4 p.i. that was accompanied by severe cecal pathology 
and a lipocalin-2 (LCN-2) peak of approximately 1,900 ng per mg cecal content (Figures 10B; 11B). 
Interestingly, the Oligo-MM12 provided colonization resistance against S. TmAvir and S. TmWT, since 
Salmonella loads were significantly less in cecal content at day 1 p.i. compared to day 3 and day 4 p.i. 
(p<0.05 and p<0.01, Kruskal-Wallis test with Dunn's multiple comparison test; Figure 11A). At day 
1 p.i., S. TmAvir exhibited higher loads in cecum than S. TmWT (p<0.05, Mann Whitney test), whereas S. 
TmWT was significantly more abundant at day 3 p.i. (p<0.01, Mann Whitney test) and increased 
further at day 4 p.i.. S. TmWT caused systemic infection and was already detected in mesenteric 
lymphnodes at day 1 p.i. as well as in liver and spleen as shown previously (Stecher et al. 2007). In 
contrast, S. TmAvir failed to systemically infect C57BL/6J mice associated with the Oligo-MM12 (Figure 
11C-E). Remarkably, shifts in microbiota composition coincided with strong inflammation after 
infection with S. TmWT, whereas S. TmAvir did not induce dysbiosis (Figure 10C). 
Cluster analyses further supported this first observation. Since S. TmWT induced inflammation in 
Oligo-MM12 mice, inflammation was categorized according to inflammation grade and cecal 
pathology: (i) non-inflamed (no colitis, pathoscore: 0 - 3, uninfected – day 2 p.i.), (ii) intermediate 
(moderate colitis, pathoscore: 3 - 9, day 3 p.i.) and (iii) inflamed (profound colitis, pathoscore: > 9, 
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day 4 p.i.) (Figures 10B; 12C,D; 13C,D). Because no pathological changes were apparent after 
infection with S. TmAvir (Figures 10B; 11B), samples were simply grouped by days p.i.. According to 
Bray Curtis (p<0.002, Adonis) and Pearson (p<0.004, Adonis) distance matrices, grouping of 
microbiota composition in cecal content after infection with S. TmAvir by days post infection was 
statistically significant, with 41% (Bray Curtis) and 65% (Pearson) of the variation explained. 
According to both distance matrices, there was no statistically significant difference in overall 
microbiota composition between all 4 days p.i. with S. TmAvir (p>0.05, non parametric PERMDISP 
procedure; Figure 12A,B). After infection with S. TmWT, grouping of microbiota composition by 
inflammation grade was also statistically significant according to Bray Curtis (p<0.001, Adonis) and 
Pearson (p<0.001, Adonis) distance matrices, with 97% (Bray Curtis) and 98% (Pearson) of variation 
explained (Figure 12C,D). There were significant difference between all groups of grades of 
inflammation, according Pearson (p<0.001 and p<0.01, non parametric PERMDISP procedure; Figure 
12D). According to Bray Curtis, the uninflamed group was different compared to intermediate group 
(p<0.001, non parametric PERMDISP procedure; Figure 12C) and there was a statistically significant 
difference between the intermediate and the inflamed group (p<0.01, non parametric PERMDISP 
procedure; Figure 12C).  
The same trend was observed in fecal microbiota composition: Grouping of fecal microbiota 
composition after S. TmAvir infection by days post infection was significant, according to Bray Curtis 
(p<0.001, Adonis) and Pearson (p<0.001, Adonis) distance matrices, with 68% (Bray Curtis) and 93% 
(Pearson) explained. There was no statistically significant difference in overall microbiota 
composition between all 4 days p.i. with S. TmAvir (p>0.05, non parametric PERMDISP procedure 
based on Bray Curtis and Pearson; Figure 13A,B). As it was observed in cecal content, grouping of the 
microbiota composition after infection with S. TmWT by inflammation grade was statistically 
significant according to Bray Curtis (p<0.001, Adonis) and Pearson (p<0.001, Adonis) distance 
matrices, with 98% (Bray Curtis) and 100% (Pearson) of variation explained (Figure 13C,D). There 
were significant differences between all groups of grades of inflammation, according to Pearson 
(p<0.01 and p<0.05, non parametric PERMDISP procedure; Figure 13D). According to Bray Curtis, the 
uninflamed group was different compared to the inflamed group (p<0.01, non parametric PERMDISP 
procedure; Figure 13C) and there was a statistically significant difference between the intermediate 
and the inflamed group (p<0.05, non parametric PERMDISP procedure; Figure 13C). 
Taken together, S. TmAvir was unable to induce inflammation and concomitant dysbiosis, whereas S. 
TmWT induced colitis starting at day 3 p.i.. Inflammation was additionally paralleled with drastic 
changes in microbiota composition at day 4 p.i. with S. TmWT. 
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Figure 10: S. TmWT causes severe colitis and dysbiosis at day 4 post infection. (A) Experimental set-up: Oligo-
MM12 mice were orally infected with 5 x 107 CFUs of either S. TmAvir or S. TmWT. Animals were euthanized at 
days 1, 2, 3 and 4 p.i. and samples were taken: feces (F), cecal content (Cec). As control, there was also a fecal 
sample taken at d0 before infection. (B) Cecal pathology determined by microscopy of HE stained cecal 
sections. Colitis was observed at d4 p.i. with S. TmWT, whereas infection with S. TmAvir did not induce colitis. (C) 
Analysis of microbiota composition in cecal content (upper panel) and feces (lower panel). Microbiota 
composition is shown as relative abundance and expressed as % of cumulated 16S rRNA gene copy numbers (% 
of total 16S rRNA gene copies). The amount of absolute 16S rRNA gene copies (determined by an universal 
primer / probe combination) is illustrated as black dots (right y axis). Shifts in microbiota composition and 
drops in total bacteria paralleled with increased colitis following infection with S. TmWT. * limit of detection. 
Statistical analysis of cecal pathology was performed using Kruskal-Wallis test with Dunn’s multiple comparison 
test (*** p<0.001, ** p<0.01).  
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Figure 11: Course of enteric S. Tm infection and systemic dissemination. For experimental set-up refer to 
Figure 10A. Organs were additionally taken at the indicated time points. (A) Salmonella loads in cecal content 
(CFUs S. Tm / g content). (B) Lipolcalin-2 (LCN-2) amount in cecal content measured by ELISA (ng / mg cecal 
content) (C) – (E) Systemic dissemination of Salmonella to mesenteric lymphnodes, liver and spleen (CFUs / 
organ). Statistical analysis between groups was performed using Kruskal-Wallis test with Dunn's multiple 
comparison test. Differences between groups (S. TmWT vs S. TMAvir) at one given time point were compared 
using Mann Whitney test (* p<0.05, ** p<0.01, *** p<0.001). Dashed lines: DTL: limit of detection (mLN: 10 
CFUs, liver: 60 CFUs, spleen: 20 CFUs). 
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Figure 12: Clustering of Oligo-MM12 composition in cecal content after infection with either S. TmAvir or S. 
TmWT. Cluster analysis based on Bray Curtis or Pearson distance matrices visualized as PCoA plots. (A) and (B) 
clustering of Oligo-MM12 composition after infection with S. TmAvir. Microbiota samples from cecal content 
were grouped by days post infection since inflammation was absent. Grouping by days p.i. with S. TmAvir was 
significant, according to Bray Curtis (p<0.002, Adonis) and Pearson (p<0.004, Adonis) with 41% (Bray Curtis) and 
65% (Pearson) of variation explained. PERMDISP analyses based on Bray Curtis and Pearson distance matrices 
revealed no statistically significant differences in microbiota composition in cecal content between days post 
infection with S. TmAvir (p>0.05). (C) and (D) Oligo-MM12 composition after infection with S. TmWT. Since S. TmWT 
caused inflammation, microbiota samples from cecal content were grouped according to inflammation grade 
(non-inflamed: days 1 + 2 p.i., intermediate: day 3 p.i. and inflamed: day 4 p.i.). Grouping by inflammation 
grade after infection with S. TmWT was significant, according to Bray Curtis (p<0.001, Adonis) and Pearson 
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(p<0.001, Adonis) with 97% (Bray Curtis) and 98% (Pearson) of variation explained. PERMDISP analyses based 
on Bray Curtis and Pearson distance matrices revealed statistically significant differences in microbiota 
composition of cecal content between all 3 inflammation grades (** p<0.01, *** p<0.001, n.s.: not significant). 
 
 
Figure 13: Clustering of Oligo-MM12 composition in feces after infection with either S. TmAvir or S. TmWT. 
Cluster analysis based on Bray Curtis or Pearson distance matrices visualized as PCoA plots. (A) and (B) 
clustering of Oligo-MM12 composition after infection with S. TmAvir. Fecal microbiota samples were grouped by 
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days post infection since inflammation was absent. Grouping by days p.i. with S. TmAvir was significant, 
according to Bray Curtis (p<0.001, Adonis) and Pearson (p<0.001, Adonis) distance matrices, with 68% (Bray 
Curtis) and 93% (Pearson) of variation explained. PERMDISP analyses based on Bray Curtis and Pearson 
distance matrices revealed no statistically significant differences in fecal microbiota composition between days 
post infection with S. TmAvir (p>0.05). (C) and (D) Oligo-MM12 composition after infection with S. TmWT. Since S. 
TmWT caused inflammation, fecal microbiota samples were grouped according to inflammation grade (non-
inflamed: uninfected + days 1 + 2 p.i., intermediate: day 3 p.i. and inflamed: day 4 p.i.). Grouping by 
inflammation grade after infection with S. TmWT was significant, according to Bray Curtis (p<0.001, Adonis) and 
Pearson (p<0.001, Adonis) with 98% (Bray Curtis) and 100% (Pearson) of variation explained. PERMDISP 
analyses based on Bray Curtis and Pearson distance matrices revealed statistically significant differences in 
fecal microbiota composition between all 3 inflammation grades (* p<0.05, ** p<0.01, n.s.: not significant). 
 
3.3.2. Performance of individual Oligo-MM12 strains during S. TmWT induced colitis 
Oligo-MM12 strains might be outcompeted by invading S. TmWT, that selectively uses nutrients such 
as anaerobic electron acceptors or ethanolamine which are present in an inflammatory milieu 
(Winter et al. 2010, Thiennimitr et al. 2011, Lopez et al. 2012). Moreover, individual Oligo-MM12 
strains could be directly killed by neutrophils infiltrating at the site of inflammation (Loetscher et al. 
2012). 
In order to better understand and characterize microbiota shifts observed at day 4 p.i. with S. TmWT, 
fold changes in absolute abundance of Oligo-MM12 strains were calculated (day 1 versus day 4 p.i.). 
Calculations were based on absolute reads per 1 million gene copies determined by universal probe. 
8,000 – 9,000 fold increase of S. TmWT in both cecal content and feces was observed (Figure 14). S. 
TmWT dominated the microbiota at day 4 p.i. (Salmonella ‘blooms’ (Stecher et al. 2012)). Remarkably, 
the individual members of the Oligo-MM12 performed differently in the presence of S. TmWT induced 
inflammation. The Oligo-MM12 strains were grouped in 3 categories according to their decreasing or 
increasing abundance during Salmonella ‘blooms’: (i) depleted, strains that decrease massively; (ii) 
intermediate, bacteria that remained stable during S. TmWT induced colitis and (iii) enriched, strains 
which abundance increased during inflammation. The grouping in the 3 categories was consistent 
between cecal content and feces. Depleted bacteria were mainly Gram-negatives and belonged to 
the phyla Bacteroidetes, Verrucomicrobia and Proteobacteria: ‘Muribaculum intestinale‘ YL27, 
‘Turicimonas caecimuris‘ YL45, Akkermansia muciniphila YL44 and ‘Bacteroides caecimuris‘ I48. The 
Gram-variable Firmicute Clostridium clostridioforme YL32 was also depleted during strong colitis. 
However, the Gram-positive or Gram-variable strains Blautia coccoides YL58, Flavonifractor plautii 
YL31 and Clostridium innocuum I46, that belong to the Firmicutes phylum decreased less and were 
assigned to the intermediate group. One has to mention here, that Blautia coccoides YL58 was 
mostly under the detection limit of the qPCR assay at day 4 p.i. with S. TmWT and that low baseline 
abundance before infection of this strain accounts for lower fold changes between day 1 and day 4 
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p.i. with S. TmWT. Interestingly, Lactobacillus reuteri I49 and Enterococcus faecalis KB1, both Gram-
positive bacteria were increased under inflammatory conditions and were grouped the third category 
(Figure 14). Bifidobacterium longum subsp. animalis YL2 and ‘Acutalibacter muris’ KB18 were below 
the limit of detection of the respective qPCR assay. 
The absolute abundance of the strains after infection with S. TmWT was also in line with relative 
abundance expressed as mean % of cumulated 16S rRNA gene copy numbers. S. TmWT dominated the 
microbiota at day 4 p.i. with a relative abundance of 96.18% +/- 3.09% in cecal content and 97.64% 
+/- 2.14% in feces (Figure 10C; Tables 44; 46). In stark contrast, the S. TmAvir failed to dominate and 
its relative abundance remained below 1% (Tables 45; 47). Looking at the microbiota composition 
during S. TmWT ‘blooms’, there were drastic and statistically significant drops in relative abundance of 
‘Muribaculum intestinale‘ YL27, ‘Bacteroides caecimuris‘ I48 and Akkermansia muciniphila YL44 
between day 1 and day 4 (p<0.001, two-way ANOVA with Bonferroni posttest; Table 44). The relative 
abundance of Clostridium clostridioforme YL32 at day 4 p.i. was also reduced by trend and 
‘Turicimonas caecimuris‘ YL45 was close to the limit of detection (Tables 44; 46). The relative 
abundance of Blautia coccoides YL58, Flavonifractor plautii YL31 and Clostridium innocuum I46 
(intermediate group) was also reduced at day 4 p.i. (Tables 44; 46). Whereas, Lactobacillus reuteri I49 
and Enterococcus faecalis KB1 increased by trend in relative abundance at day 4 p.i. (Tables 44; 46).  
There was already moderate expansion of S. TmWT observed starting at day 3 p.i. (Tables 44; 46). The 
relative abundance of ‘Bacteroides caecimuris‘ I48 in cecal content and feces started to decrease 
from day 3 p.i. on (p<0.001, two-way ANOVA with Bonferroni posttest; Tables 44; 46) but was still 
the dominating strain in cecal content (52.75% +/- 15.21%) and feces (57.94% +/- 7.48%). The relative 
abundance of ‘Muribaculum intestinale‘ YL27 and ‘Turicimonas caecimuris‘ YL45 was quite stable 
between the days 1 - 3 p.i. (Tables 44; 46). Interestingly, the relative abundance of Akkermansia 
muciniphila YL44 increased between day 2 and day 3 p.i. of around 14% in cecal content (p<0.001, 
two-way ANOVA with Bonferroni posttest; Table 44) and 6% in feces (p<0.001, two-way ANOVA with 
Bonferroni posttest; Table 46). An increased relative abundance of Clostridium clostridioforme YL32 
between day 2 and day 3 p.i. was also observed (p<0.05, two-way ANOVA with Bonferroni posttest; 
Table 46). This might indicate that both strains Akkermansia muciniphila YL44 and Clostridium 
clostridioforme YL32 could profit from mild inflammation. The relative abundance of Blautia 
coccoides YL58, Flavonifractor plautii YL31, Clostridium innocuum I46 (intermediate group) as well as 
Lactobacillus reuteri I49 and Enterococcus faecalis KB1 (enriched group) was not significantly altered 
during this early stage of infection (days 1 - 3 p.i; Tables 44; 46). 
Infection with S. TmAvir did not induce dysbiosis at day 4 p.i. and no Salmonella ‘blooms’ were 
observed (Figure 10C). However, there were slight but statistically significant fluctuations in relative 
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abundance of ‘Bacteroides caecimuris‘ I48 and ‘Muribaculum intestinale‘ YL27 during the course of 
infection with S. TmAvir (Tables 45; 47). Fluctuations were also observed in relative abundance of 
Akkermansia muciniphila YL44. It peaked at day 3 p.i. in cecal content and at day 1 p.i. in feces 
(Tables 45; 47).  
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Figure 14: The performance of individual Oligo-MM12 members during inflammation. Oligo-MM12 mice were 
infected with 5 x 107 CFUs of S. TmWT. The experimental set-up is detailed in Figure 10A (same data used for 
fold-change calculations). Fold-changes in absolute abundance between day 1 and day 4 post infection were 
calculated with absolute values that were normalized to a million gene copies determined by universal probe. 
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Fold changes in microbiota composition were determined in (A) cecal content and (B) feces and ranked 
according to decreasing abundance (red: highly decreased, green: less affected or enriched). Bacteria were 
subsequently grouped in 3 categories: depleted: bacteria that were highly depleted during Salmonella 
‘blooms’; intermediate: Oligo-MM12 strains that were stable or decreased less during Salmonella induced 
colitis; enriched: strains that were enriched during inflammation. * Limit of detection. 
 
Table 44: Relative abundance of Oligo-MM12 strains in cecal content after infection with S. TmWT 
Strain 
Mean % of cumulated 16S rRNA gene copy numbers 
(+/- SD) 
Days post infection with S. TmWT 
Day 1 Day 2 Day 3 Day 4 
‘Bacteroides caecimuris’ I48 73.40 (2.20) 
71.71 
(0.82) 
52.75a,c 
(15.21) 
1.15b,c 
(1.47) 
‘Muribaculum intestinale’ YL27 9.24 (1.48) 
11.94 
(1.88) 
8.36 
(1.46) 
0.01b,c 
(0.01) 
Akkermansia muciniphila YL44 7.05 (1.91) 
4.79 
(0.80) 
18.88a,c 
(4.49) 
0.17b,c 
(0.38) 
‘Turicimonas caecimuris’ YL45 2.50 (0.52) 
2.33 
(0.81) 
2.14 
(0.61) 0* 
Lactobacillus reuteri I49 0.04 (0.01) 
0.06 
(0.03) 
0.05 
(0.03) 
0.65 
(1.34) 
Enterococcus faecalis KB1 0.01 (0.01) 
0.01 
(0.004) 
0.02 
(0.03) 
0.18 
(0.19) 
Blautia coccoides YL58 1.15 (0.32) 
0.53 
(0.10) 
0.90 
(0.47) 
0.07 
(0.16) 
Clostridium innocuum I46 0.11 (0.03) 
0.08 
(0.02) 
0.08 
(0.05) 
0.01 
(0.02) 
Flavonifractor plautii YL31 1.75 (0.24) 
2.20 
(0.26) 
4.39 
(3.38) 
1.50 
(1.28) 
Clostridium clostridioforme YL32 4.72 (0.75) 
5.90 
(1.11) 
7.40 
(3.23) 
0.09b 
(0.15) 
‘Acutalibacter muris’ KB18 DTL DTL DTL DTL 
Bifidobacterium longum subsp.  
animalis YL2 DTL DTL DTL DTL 
S. Tm 0.02 (0.02) 
0.47 
(0.23) 
5.03c 
(7.81) 
96.18b,c 
(3.09) 
Significant differences between a day 2 vs day 3, b day 3 vs day 4 and c time point vs day 1 are indicated; p 
values were less than 0.001, except: S. Tm day 1 vs day 3 p<0.05, two-way ANOVA with Bonferroni posttest. 
There were no significant differences between day 1 vs day 2. Values are expressed as mean % of cumulated 
16S rRNA gene copy numbers +/- standard deviation (SD). Day 1 p.i.: n=5, day 2 p.i.: n=5, day 3 p.i.: n=7, day 4 
p.i.: n=7. DTL: limit of detection. * Very low abundant. 
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Table 45: Relative abundance of Oligo-MM12 strains in cecal content after infection with S. TmAvir 
Strain 
Mean % of cumulated 16S rRNA gene copy numbers  
(+/- SD) 
Days post infection with S. TmAvir 
Day 1 Day 2 Day 3 Day 4 
‘Bacteroides caecimuris’ I48 69.54 (2.91) 
72.02 
(2.33) 
68.25b 
(6.10) 
70.18 
(3.97) 
‘Muribaculum intestinale’ YL27 10.60 (1.34) 
13.65a 
(1.86) 
11.09 
(0.71) 
10.97 
(2.35) 
Akkermansia muciniphila YL44 9.06 (2.38) 
4.96a 
(1.06) 
12.51b,d 
(5.39) 
9.56c 
(2.02) 
‘Turicimonas caecimuris’ YL45 2.36 (0.35) 
2.05 
(0.27) 
2.10 
(0.33) 
2.05 
(0.37) 
Lactobacillus reuteri I49 0.07 (0.04) 
0.01 
(0.02) 
0.03 
(0.03) 
0.08 
(0.03) 
Enterococcus faecalis KB1 0.02 (0.01) 0* 0* 0* 
Blautia coccoides YL58 0.74 (0.09) 
0.52 
(0.07) 
0.52 
(0.08) 
0.60 
(0.18) 
Clostridium innocuum I46 0.11 (0.03) 
0.06 
(0.02) 
0.07 
(0.01) 
0.08 
(0.02) 
Flavonifractor plautii YL31 1.93 (0.31) 
1.65 
(0.12) 
1.87 
(0.25) 
1.86 
(0.51) 
Clostridium clostridioforme YL32 5.34 (0.52) 
4.73 
(0.49) 
3.01 
(1.10) 
3.88 
(0.64) 
‘Acutalibacter muris’ KB18 DTL DTL DTL DTL 
Bifidobacterium longum subsp.  
animalis YL2 DTL DTL DTL DTL 
S. Tm 0.22 (0.17) 
0.34 
(0.12) 
0.55 
(0.14) 
0.74 
(0.12) 
Significant differences between a day 1 vs day 2, b day 2 vs day 3, c day 3 vs day 4 and d time point vs day 1 are 
indicated; p values were less than 0.001, except: YL27 day 1 vs day 2 p<0.05, I48 day 2 vs day 3 p<0.01, YL44 
day 3 vs day 4 p<0.05 and YL44 day 1 vs day 3 p<0.01, two-way ANOVA with Bonferroni posttest. There were 
no significant differences between day 1 vs day 4. Values are expressed as mean % of cumulated 16S rRNA 
gene copy numbers +/- standard deviation (SD). Day 1 p.i.: n=5, day 2 p.i.: n=5, day 3 p.i.: n=6, day 4 p.i.: n=6. 
DTL: limit of detection. * Very low abundant.  
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Table 46: Relative abundance of Oligo-MM12 strains in feces after infection with S. TmWT 
Strain 
Mean % of cumulated 16S rRNA gene copy numbers (+/- SD) 
Days post infection with S. TmWT 
Uninf. Day 1 Day 2 Day 3 Day 4 
‘Bacteroides caecimuris’ I48 67.17 (3.16) 
60.69a 
(6.31) 
67.44b 
(3.03) 
57.94c,e 
(7.48) 
0.12d,e 
(0.26) 
‘Muribaculum intestinale’ YL27 10.16 (1.30) 
10.30 
(1.26) 
11.51 
(1.35) 
10.65 
(2.62) 0
d,e* 
Akkermansia muciniphila YL44 16.73 (2.43) 
20.92a 
(4.58) 
13.55b,e 
(3.17) 
19.45c 
(4.36) 
0.001d,e 
(0.004) 
‘Turicimonas caecimuris’ YL45 2.30 (0.50) 
2.56 
(0.28) 
2.50 
(0.49) 
2.17 
(0.70) DTL 
Lactobacillus reuteri I49 0.06 (0.03) 
0.07 
(0.02) 
0.07 
(0.04) 
0.08 
(0.05) 
0.59 
(0.52) 
Enterococcus faecalis KB1 0.02 (0.01) 
0.03 
(0.02) 
0.01 
(0.004) 
0.01 
(0.01) 
0.37 
(0.38) 
Blautia coccoides YL58 0.73 (0.11) 
1.43 
(0.47) 
0.74 
(0.17) 
0.96 
(0.43) DTL 
Clostridium innocuum I46 0.09 (0.04) 
0.08 
(0.02) 
0.06 
(0.02) 
0.09 
(0.03) 
0.02 
(0.05) 
Flavonifractor plautii YL31 1.77 (0.12) 
2.31 
(0.16) 
2.20 
(0.23) 
2.43 
(0.63) 
0.93 
(1.29) 
Clostridium clostridioforme YL32 0.99 (0.14) 
1.59 
(0.55) 
1.48 
(0.61) 
4.54c,e 
(2.95) 
0.33d 
(0.66) 
‘Acutalibacter muris’ KB18 DTL DTL DTL DTL DTL 
Bifidobacterium longum subsp. 
animalis YL2 DTL DTL DTL DTL DTL 
S. Tm DTL 0.02 (0.02) 
0.44 
(0.10) 
1.67 
(0.67) 
97.64d,e 
(2.14) 
Significant differences between a uninf. vs d1, b day 1 vs day 2, c day 2 vs day 3, d day 3 vs day 4 and e time 
point vs uninf. are indicated; p values were less than 0.001, except: YL44 uninf. vs d1 p<0.01, YL32 day 2 vs day 
3 in p<0.05, YL44 uninf. vs day 2 p<0.05 and YL32 uninf. vs day 3 p<0.01, two-way ANOVA with Bonferroni 
posttest. Values are expressed as mean % of cumulated 16S rRNA gene copy numbers +/- standard deviation 
(SD). Uninf.: n=6, day 1 p.i.: n=5, day 2 p.i.: n=5, day 3 p.i.: n=7, day 4 p.i.: n=7; Uninf.: uninfected. DTL: limit of 
detection; * very low abundant. 
 
 
 
 
 
 
 
Results 
88 
 
Table 47: Relative abundance of Oligo-MM12 strains in feces after infection with S. TmAvir 
Strain 
Mean % of cumulated 16S rRNA gene copy numbers (+/- SD) 
Days post infection with S. TmAvir 
Uninf. Day 1 Day 2 Day 3 Day 4 
‘Bacteroides caecimuris’ I48 67.17 (3.16) 
59.46a 
(3.63) 
64.11b 
(4.37) 
65.12 
(7.64) 
73.19c,d 
(5.43) 
‘Muribaculum intestinale’ YL27 10.16 (1.30) 
9.47 
(1.01) 
14.12b,d 
(3.09) 
11.08 
(1.91) 
9.36 
(2.31) 
Akkermansia muciniphila YL44 16.73 (2.43) 
24.55a 
(3.83) 
14.87b 
(0.98) 
16.33 
(6.31) 
11.17c,d 
(2.66) 
‘Turicimonas caecimuris’ YL45 2.30 (0.50) 
1.98 
(0.17) 
2.20 
(0.46) 
2.20 
(0.44) 
2.37 
(0.26) 
Lactobacillus reuteri I49 0.06 (0.03) 
0.08 
(0.04) 
0.01 
(0.01) 
0.06 
(0.04) 
0.12 
(0.03) 
Enterococcus faecalis KB1 0.02 (0.01) 
0.02 
(0.02) 
0.01 
(0.004) 
0.01 
(0.02) 
0.003 
(0.005) 
Blautia coccoides YL58 0.73 (0.11) 
0.93 
(0.34) 
0.61 
(0.29) 
1.16 
(1.21) 
0.79 
(0.19) 
Clostridium innocuum I46 0.09 (0.04) 
0.08 
(0.02) 
0.05 
(0.02) 
0.13 
(0.09) 
0.06 
(0.02) 
Flavonifractor plautii YL31 1.77 (0.12) 
2.33 
(0.15) 
1.90 
(0.32) 
1.66 
(0.23) 
1.38 
(0.73) 
Clostridium clostridioforme YL32 0.99 (0.14) 
0.83 
(0.24) 
1.79 
(1.33) 
1.79 
(0.71) 
1.05 
(0.32) 
‘Acutalibacter muris’ KB18 DTL DTL DTL DTL DTL 
Bifidobacterium longum subsp. 
animalis YL2 DTL DTL DTL DTL DTL 
S. Tm DTL 0.26 (0.26) 
0.33 
(0.07) 
0.47 
(0.15) 
0.52 
(0.11) 
Significant differences between a uninf. vs day 1, b day 1 vs day 2, c day 3 vs day 4 and d time point vs uninf. 
are indicated; p values were less than 0.001, except: YL27 and I48 day 1 vs day 2 p<0.01 as well as YL27 uninf. 
vs day 2 p<0.01, two-way ANOVA with Bonferroni posttest. There were no significant differences between day 
2 vs day 3 and uninf. vs day 3. Values are expressed as mean % of cumulated 16S rRNA gene copy numbers +/- 
standard deviation (SD). Uninf.: n=6, day 1 p.i.: n=5, day 2 p.i.: n=5, day 3 p.i.: n=6, day4 p.i.: n=6; Uninf.: 
uninfected. DTL: limit of detection. 
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3.4 Towards understanding the mechanisms causing shifts in microbiota 
composition 
3.4.1 Influence of Type 3 secretion systems (T3SS) 1 and 2 
3.4.1.1 Both T3SSs are necessary to cause colitis and dysbiosis 
Next, the contribution of T3SS-1 and T3SS-2 that are encoded on the Salmonella pathogenicity 
islands 1 and 2 (SPI-1 and -2), respectively were investigated using Salmonella mutant strains lacking 
either a functional T3SS-1: S. TmSPI-1 (Kaniga et al. 1994) or a functional T3SS-2: S. TmSPI-2 (Hapfelmeier 
et al. 2004). Oligo-MM12 mice were infected with 5 x 107 CFUs of either S. TmSPI-1 or S. TmSPI-2 and 
scarified at day 4 p.i.. Data were subsequently compared to infection experiments with S. TmAvir 
(ΔinvG, sseD::aphT) and S. TmWT shown in Figure 10 (Figures 15; 16; 17). As already shown before, 
infection with S. TmAvir that lacks functional T3SS-1 and 2 did not to induce dysbiosis at day 4 p.i. 
(Figure 10). The same was true for S. TmSPI-1 that is deficient in secreting effector proteins via T3SS-1 
(Figure 15). Interestingly, S. TmSPI-2 that has a functional T3SS-1 but is deficient in T3SS-2 was able to 
induce dysbiosis in 1 out of 5 mice (Figure 15). Again, dysbiosis correlated with cecal pathology 
(Figure 15B) and elevated LCN-2 levels (Figure 16B). Mice infected with S. TmAvir and S. TmSPI-1 showed 
almost no cecal pathology and LCN-2 levels close to the limit of detection, whereas mice infected 
with S. TmSPI-2 already displayed moderate colitis and elevated LCN-2 levels at day 4 p.i.. The animal 
infected with S. TmSPI-2 that exhibited a dysbiotic microbiota even showed profound colitis and high 
LCN-2 levels comparable to mice infected with S. TmWT (Figures 15; 16B). Regarding Salmonella loads 
in cecal content, S. TmSPI-2 loads were significantly higher than compared to S. TmAvir (p<0.05, Kruskal-
Wallis test with Dunn's multiple comparison test; Figure 16A). There was no statistically significant 
difference in colonization of mesenteric lymphnodes, liver or spleen at day 4 p.i. between S. TmSPI-1 
and S. TmSPI-2 (Figure 16C-E). Compared to S. TmAvir, CFUs of S. TmSPI-1 and S. TmSPI-2 in mesenteric 
lymphnodes were increased by trend which was comparable in liver as well as in spleen. Compared 
to S. TmAvir, S. TmWT showed significantly increase in tissue loads at systemic sites (Kruskal-Wallis test 
with Dunn's multiple comparison test; Figure 16C-E). Interestingly, the relative cecum size which is 
also a measure for inflammation (rel. cecal weight negatively correlates with inflammation) of mice 
infected with S. TmSPI-2 was comparable to the relative cecum size of mice infected with S. TmWT 
(Figure 16F), indicating that a functional T3SS-1 is crucial for the induction of inflammation in Oligo-
MM12 mice. In contrast, the relative cecum size of Oligo-MM12 mice infected with either S. TmAvir (no 
T3SS-1 + 2) or S. TmSPI-1 (no T3SS-1) was significantly increased at day 4 p.i. compared to relative 
cecum size of mice infected with S. TmWT (p<0.01, p<0.05, Kruskal-Wallis test with Dunn's multiple 
comparison test; Figure 16F). 
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Figure 15: Salmonella requires functional T3SS-1 and T3SS-2 to induce dysbiosis at day 4 p.i.. (A) Experimental 
set-up: Oligo-MM12 mice were orally infected with 5 x 107 CFUs of either S. TmAvir (ΔinvG, sseD::aphT), S. TmSPI-1 
(ΔinvG), S. TmSPI-2 (sseD::aphT) or with S. TmWT. Data from infections with S. TmAvir and S. TmWT originate from 
the previous experiment (Figure 10). Mice were sacrificed at day 4 p.i. and samples were taken for analysis. 
There was also a fecal control sample taken before infection. (B) Cecal pathology determined by evaluation of 
HE stained tissue sections. (C) Analysis of microbiota composition in feces (left) and cecal content (right) at day 
4 p.i. with different Salmonella mutant strains. Microbiota composition is shown as relative abundance and 
expressed as % of cumulated 16S rRNA gene copy numbers (% of total 16S rRNA gene copies). The amount of 
absolute 16S rRNA gene copies (determined by an universal primer / probe combination) is illustrated as black 
dots (the right y axis). * Limit of detection. Statistical analysis of cecal pathology was performed using Kruskal-
Wallis test with Dunn’s multiple comparison test (*** p<0.001, ** p<0.01). # Animal that exhibited dysbiotic 
microbiota after infection with S. TmSPI-2. 
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Figure 16: The contribution of SPI-1 and SPI-2 T3SSs to systemic colonization at day 4 p.i.: For experimental 
set-up refer to Figure 15A. Organs were additionally taken at the indicated time points. (A) Salmonella loads in 
cecal content at day 4 p.i. (CFUs S. Tm / g content). (B) Lipolcalin-2 (LCN-2) amount in cecal content at day 4 p.i. 
measured by ELISA (ng / mg cecal content) (C) – (E) Systemic Salmonella in mesenteric lymphnodes, liver and 
spleen (CFUs per organ). (F) Relative cecum weight at day 4 p.i. expressed as % of body weight. Statistical 
analysis between groups was performed using Kruskal-Wallis test with Dunn's multiple comparison test (* 
p<0.05, ** p<0.01, *** p<0.001). # Animal that exhibited dysbiotic microbiota after infection with S. TmSPI-2. 
Dashed lines: DTL: limit of detection (mLN: 10 CFUs, liver: 60 CFUs, spleen: 20 CFUs). 
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In order to correlate shifts in microbiota composition with the presence of a functional T3SS-1 and 2, 
samples were grouped according to the S. Tm mutant strains (uninf., S. TmAvir, S. TmSPI-1, S. TmSPI-2 and 
S. TmWT, Figure 17) and cluster analysis was performed. Grouping of fecal microbiota composition 
and microbiota composition in cecal content by infection with different Salmonella strains was 
significant, according to Bray Curtis (p<0.001, Adonis) and Pearson (p<0.001, Adonis) distance 
matrices, with 86% (in feces, Bray Curtis and Pearson) as well as 84% (in cecal content, Bray Curtis) 
and 85% (in cecal content, Pearson) of variation explained. As already mentioned, the fecal 
microbiota composition at day 4 p.i. with S. TmWT (functional T3SS-1 + 2) which displayed dysbiosis 
that was characterized by a domination of Salmonella and the presence of some ‘intermediate’ and 
‘enriched’ Oligo-MM12 strains (Figures 10; 14) significantly differed compared to the microbiota 
composition before infection and after infection with S. TmAvir (no functional T3SS-1 and 2, non 
parametric PERMDISP procedure; Figure 17A,B). Interestingly, microbiota composition in cecal 
content after infection with S. TmSPI-1 (no functional T3SS-1) and S. TmAvir was also significantly 
different compared to the microbiota composition at day 4 post infection with S. TmWT (non 
parametric PERMDISP procedure; Figure 17D). 1 out of 5 samples infected with S. TmSPI-2 (functional 
T3SS-1) even clustered together with the dysbiotic microbiota of S. TmWT infected animals (Figure 
17C,D). These data indicate that both, T3SS-1 and T3SS-2 synergistically contribute to Salmonella 
induced dysbiosis and that the T3SS-1 might be of more importance.  
The mean relative abundance of S. TmSPI-1 and S. TmAvir at day 4 p.i. was comparable and less than 1% 
in feces and cecal content, whereas the relative abundance of S. TmSPI-2 was around 20% (Tables 48; 
49). This increase was significant compared to the relative abundance of S. TmSPI-1 and S. TmAvir (two-
way ANOVA with Bonferroni posttest; Tables 48; 49). Besides the increased relative abundance of S. 
TmSPI-2, the relative abundance of ‘Bacteroides caecimuris‘ I48 was decreased (around -20%) post 
infection with S. TmSPI-2 compared to infection with S. TmSPI-1 (p<0.001, two-way ANOVA with 
Bonferroni posttest; Tables 48; 49). The relative abundance of the residual Oligo-MM12 strains was 
comparable at day 4 p.i. with S. TmSPI-1 and S. TmSPI-2. Comparing the Oligo-MM12 composition post 
infection with S. TmSPI-2 and S. TmWT, the relative abundance of ‘Bacteroides caecimuris‘ I48, 
‘Muribaculum intestinale‘ YL27 and Akkermansia muciniphila YL44 was significantly decreased post 
infection with S. TmWT (two-way ANOVA with Bonferroni posttest; Tables 48; 49), again underlining a 
synergistic effect of the both type three secretion systems on the microbiota.  
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Figure 17: Cluster analysis of Oligo-MM12 after infection with S. TmWT and S. Tm mutant strains deficient in 
T3SSs. Cluster analysis is based on Bray Curtis or Pearson distance matrices and visualized as PCoA plots. (A) 
and (B) clustering of fecal Oligo-MM12 composition after infection with S. Tm strains. Fecal microbiota samples 
were grouped by infection with different S. Tm strains. Grouping by infection with different S. Tm strains was 
significant, according to Bray Curtis (p<0.001, Adonis) and Pearson (p<0.001, Adonis) with 86% (Bray Curtis, 
Pearson) of variation explained. Additional PERMDISP analyses based on Bray Curtis and Pearson distance 
matrices revealed statistically significant differences in fecal microbiota composition after infection with S. 
TmAvir, S. TmWT and uninfected samples (** p<0.01, *** p<0.001). (C) and (D) clustering of Oligo-MM12 
uninf. S.TmAvir
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composition after infection with S. Tm strains in cecal content. Microbiota samples from cecal content were 
grouped by infection with different S. Tm strains. Grouping was significant, according to Bray Curtis (p<0.001, 
Adonis) and Pearson (p<0.001, Adonis) with 84% (Bray Curtis) and 85% (Pearson) of variation explained. 
Additional PERMDISP analyses based on Pearson distance matrix revealed statistically significant differences in 
microbiota composition in cecal content after infection with S. TmAvir, S. TmSPI-1 and S. TmWT (* p<0.05, ** 
p<0.01). 
 
Table 48: Relative abundance of Oligo-MM12 strains in feces at day 4 after infection with different 
S. Tm strains deficient in functional T3SSs. 
Strain 
Mean % of cumulated 16S rRNA gene copy numbers (+/- SD) 
Day 4 post infection with Salmonella mutants (feces) 
Uninf. S. TmAvir S. TmSPI-1 S. TmSPI-2 S. TmWT 
‘Bacteroides caecimuris’ I48 53.96 (4.97) 
73.19a 
(5.43) 
57.02d 
(6.97) 
39.80b,e,g 
(22.55) 
0.12c,f,h,i 
(0.26) 
‘Muribaculum intestinale’ YL27 20.53 (3.23) 
9.36 
(2.31) 
15.84 
(2.21) 
14.14 
(8.09) 0
c,h,i* 
Akkermansia muciniphila YL44 17.27 (2.85) 
11.17 
(2.66) 
20.00 
(7.35) 
14.68 
(9.37) 
0.001c,f,h,i 
(0.004) 
‘Turicimonas caecimuris’ YL45 3.23 (0.35) 
2.37 
(0.26) 
2.76 
(0.67) 
2.16 
(1.27) DTL 
Lactobacillus reuteri I49 0.09 (0.02) 
0.12 
(0.03) 
0.02 
(0.02) 
0.45 
(0.83) 
0.59 
(0.52) 
Enterococcus faecalis KB1 0.002 (0.01) 
0.003 
(0.01) 0* 
0.004 
(0.01) 
0.37 
(0.38) 
Blautia coccoides YL58 1.11 (0.14) 
0.79 
(0.19) 
0.48 
(0.19) 
0.88 
(0.59) DTL 
Clostridium innocuum I46 0.10 (0.02) 
0.06 
(0.02) 
0.05 
(0.01) 
0.12 
(0.08) 
0.02 
(0.05) 
Flavonifractor plautii YL31 2.27 (0.24) 
1.38 
(0.73) 
2.17 
(0.35) 
2.73 
(0.79) 
0.93 
(1.29) 
Clostridium clostridioforme YL32 1.44 (0.37) 
1.05 
(0.32) 
0.93 
(0.12) 
3.92 
(4.24) 
0.33 
(0.66) 
‘Acutalibacter muris’ KB18 DTL DTL DTL DTL DTL 
Bifidobacterium longum subsp.  
animalis YL2 DTL DTL DTL DTL DTL 
S. Tm DTL 0.52 (0.11) 
0.71 
(0.12) 
21.12b,e,g 
(41.29) 
97.64c,f,h,i 
(2.14) 
Significant differences between a uninf. vs S. TmAvir, b uninf. vs S. TmSPI-2, c uninf. vs S. TmWT, d S. TmAvir vs S. 
TmSPI-1, e S. TmAvir vs S. TmSPI-2, f S. TmAvir vs S. TmWT, g S. TmSPI-1 vs S. TmSPI-2, h S. TmSPI-1 vs S. TmWT and i S. TmSPI-2 
vs S. TmWT are indicated; p values were less than 0.001, except: I48 uninf. vs S. TmSPI-2 p<0.01, YL44 S. TmAvir vs 
S. TmWT p<0.05 and YL27 S. TmSPI-2 vs S. TmWT p<0.01, two-way ANOVA with Bonferroni posttest. There were no 
significant differences between uninf. vs S. TmSPI-1. Values are expressed as mean % of cumulated 16S rRNA 
gene copy number +/- standard deviation (SD). S. TmSPI-1: no functional T3SS-1, S. TmSPI-2: no functional T3SS-2 
and S. TmAvir: no functional T3SSs-1 and -2. Uninf.: n=4, S. TmAvir: n=6, S. TmSPI-1: n=5, S. TmSPI-2: n=5, S. TmWT: 
n=7; Uninf.: uninfected; DTL: limit of detection; * very low abundant. 
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Table 49: Relative abundance of Oligo-MM12 strains in cecal content at day 4 after infection with 
different S. Tm strains deficient in functional T3SSs. 
Strain 
Mean % of cumulated 16S rRNA gene copy numbers 
(+/- SD) 
Day 4 post infection with Salmonella mutants  
S. TmAvir S. TmSPI-1 S. TmSPI-2 S. TmWT 
‘Bacteroides caecimuris’ I48 70.18 (3.97) 
63.48 
(5.31) 
44.14a,c 
(24.94) 
1.15b,d,e 
(1.47) 
‘Muribaculum intestinale’ YL27 10.97 (2.35) 
16.36 
(2.18) 
11.27 
(6.53) 
0.01b,d,e 
(0.01) 
Akkermansia muciniphila YL44 9.56 (2.02) 
12.50 
(3.25) 
14.55 
(8.15) 
0.17d,e 
(0.38) 
‘Turicimonas caecimuris’ YL45 2.05 (0.37) 
2.64 
(0.11) 
1.93 
(1.20) 0* 
Lactobacillus reuteri I49 0.08 (0.03) 
0.01 
(0.004) 
0.07 
(0.07) 
0.65 
(1.34) 
Enterococcus faecalis KB1 0* 0* 0* 0.18 (0.19) 
Blautia coccoides YL58 0.60 (0.18) 
0.37 
(0.07) 
0.27 
(0.17) 
0.07 
(0.16) 
Clostridium innocuum I46 0.08 (0.02) 
0.07 
(0.02) 
0.07 
(0.05) 
0.01 
(0.02) 
Flavonifractor plautii YL31 1.86 (0.51) 
1.79 
(0.21) 
2.27 
(0.36) 
1.50 
(1.28) 
Clostridium clostridioforme YL32 3.88 (0.64) 
1.94 
(0.11) 
4.01 
(2.58) 
0.09 
(0.15) 
‘Acutalibacter muris’ KB18 DTL DTL DTL DTL 
Bifidobacterium longum subsp. 
animalis YL2 DTL DTL DTL DTL 
S. Tm 0.74 (0.12) 
0.83 
(0.15) 
21.43a,c 
(42.44) 
96.18b,d,e 
(3.09) 
Significant differences between a S. TmAvir vs S. TmSPI-2, b S. TmAvir vs S. TmWT, c S. TmSPI-1 vs S. TmSPI-2, d S. TmSPI-1 
vs S. TmWT and e S. TmSPI-2 vs S. TmWT are indicated; p values were less than 0.001, except: YL27 S. TmAvir vs S. 
TmWT p<0.05, YL44 S. TmSPI-1 vs S. TmWT p<0.05 as well as S. TmSPI-2 vs S. TmWT: YL27 p<0.05 and YL44 p<0.01, 
two-way ANOVA with Bonferroni posttest. There were no significant differences between S. TmAvir vs S. TmSPI-1. 
Values are expressed as mean % of total bacteria +/- the standard deviation (SD). S. TmSPI-1: no T3SS-1, S. TmSPI-
2: no functional T3SS-2 and S. TmAvir: no functional T3SS-1 and -2. S. TmAvir: n=6, S. TmSPI-1: n=5, S. TmSPI-2: n=5, S. 
TmWT: n=7; DTL: limit of detection; * very low abundant. 
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3.4.1.2 The Oligo-MM12 is resilient to infection with S. TmSPI-2 
In order to study the capability of the Oligo-MM12 to recover from inflammation induced dysbiosis 
(resilience), Oligo-MM12 mice were infected with 5 x 107 CFUs of S. TmSPI-2 and fecal samples were 
taken until day 21 p.i. to monitor microbial composition and LCN-2 levels. S. TmSPI-2 was chosen 
because it can induce dysbiosis in a fraction of animals (Figure 15C) and the mice only developed 
moderate colitis (Figure 15B). It could be additionally show previously that mice do not develop 
fulminant systemic infection and that the mice survive long-term infection (Endt et al. 2010). This is 
in stark contrast to S. TmWT which induces severe colitis and systemic infection that is life threatening 
already at day 4 p.i.. As expected, mice did not show signs of disease during the course of infection 
with S. TmSPI-2. S. TmSPI-2 colonized well (108 CFUs per g feces) and was not cleared from the gut until 
day 21 p.i. (Figure 19A). CFUs of S. TmSPI-2 in mesenteric lymphnodes were still elevated at day 21 p.i. 
and comparable to the level observed at day 4 p.i. (Figures 16C; 19B). S. TmSPI-2 was additionally still 
detectable in spleen and liver at day 21 p.i. (Figure 19B) and levels were comparable to day 4 p.i. 
(Figure 16D,E). This indicates that S. TmSPI-2 is not cleared after infection from Oligo-MM12 mice. For 
unknown reasons, fecal LNC-2 levels were elevated before infection. LCN-2 levels decreased during 
the course of infection (Figure 18B). Looking at the microbiota composition, S. TmSPI-2 was not able to 
shift the microbiota composition drastically (Figure 18C). However, according to cluster analyses by 
days post infection, the microbiota clustered differently at day 4 p.i. (Figure 18D,E) which coincided 
with a transient increase of Akkermansia muciniphila YL44 (Figure 18C). The grouping was significant, 
according to Bray Curtis (p<0.001, Adonis) and Pearson (p<0.007, Adonis) distance matrices, with 
76% (Bray Curtis) as well as 92% (Pearson correlation) of variation explained. Further non parametric 
PERMDISP analyses revealed significant differences in microbiota composition between days 4 and 5, 
5 and 6 as well as between days 14 and 21 (according to Bray Curtis; Figure 18D). According to 
Pearson, there was also a significant difference in microbial composition between days 5 and 6, 3 and 
6 as well as between 14 and 21 (non parametric PERMDISP procedure; Figure 18E). Interestingly, 
there was no statistical significant difference in microbial composition between day 21 and the Oligo-
MM12 composition before infection. This indicates the potential of the Oligo-MM12 to fully recover 
from transient S. TmSPI-2 induced dysbiosis. 
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Figure 18: The Oligo-MM12 is resilient to long-term infection with S. TmSPI-2. (A) Experimental set-up: Oligo-
MM12 mice were infected with 5 x 107 CFUs of S. TmSPI-2 (sseD::aphT) and housed in gnotocages. During the 
course of the experiment feces (F) was taken under sterile conditions (for microbiota analysis and Lipocalin-2 
ELISA) and mice were finally euthanized at day 21 p.i.. There was also a fecal control sample taken at day 0 
before infection (uninf.). (B) Lipolcalin-2 (LCN-2) levels in feces measured by ELISA (ng / mg feces). (C) 
Microbiota composition is shown as relative abundance and expressed as % of cumulated 16S rRNA gene copy 
numbers (% of total 16S rRNA gene copies). The amount of absolute 16S rRNA gene copies (determined by an 
universal primers / probe combination) is illustrated as black dots (right y axis). * Limit of detection. Cluster 
0
2
4
6
8
10
20
40
60
80
100
uninf. d3 d4 d5 d6 d14 d21
100
101
102
103
104
105
106
107
16s
rR
NA
gene
copies/
5
ng
fecalD
N
A
Bifidobacterium longum
subsp. animalis YL2*
‘Acutalibacter muris‘ KB18*
Clostridium clostridioforme  YL32
Flavonifractor plautii  YL31
Clostridium innocuum  I46
Blautia coccoides  YL58
Enterococcus faecalis  KB1
Lactobacillus reuteri  I49
‘Turicimonas caecimuris‘ YL45
Akkermansia muciniphila  YL44
‘Muribaculum intestinale‘ YL27
‘Bacteroides caecimuris‘ I48
Bacteroidetes
Verrucomicrobia
Proteobacteria
Actinobacteria
Firmicutes
*Limit of detection
S. TmSPI-2
d3 d4 d5 d6 d14 d21uninf.
**** *
d3 d4 d5 d6 d14 d21uninf.
******
d3 d4 d5 d6 d7 d10 d12 d14 d17 d19 d21
1
10
100
1000 **
*
LC
N-
2
(ng
/m
g
fe
ce
s)
uninf.
Lipocalin-2
Infection with S. TmSPI-2
Bray_Curtis PCoA - PC1 vs PC2
PC
2 
-
 
Pe
rc
en
t v
ar
ia
tio
n
 
ex
pl
ai
n
ed
 
1.
88
%
PC1 - Percent variation explained 98.07%
PC
2 
-
 
Pe
rc
en
t v
ar
ia
tio
n 
ex
pl
ai
ne
d 
10
.
01
%
PC1 - Percent variation explained 76.66%
Pearson PCoA - PC1 vs PC2
*
A B
C
D E
uninf. d3 d4 d5 d6 d7 d10 d12 d14 d17 d19 d21 p.i.
Feces (microbiota composition, LCN-2)
%
of
to
ta
l 1
6S
 
rR
N
A 
ge
n
e
 
co
pi
e
s
Results 
98 
 
analysis is based on Bray Curtis (D) or Pearson (E) distance matrices and visualized as PCoA plots. Fecal 
microbiota samples were grouped by days post infection with S. TmSPI-2 which was significant, according to Bray 
Curtis (p<0.001, Adonis) and Pearson (p<0.007, Adonis) with 76% (Bray Curtis) and 92% (Pearson) of variation 
explained. PERMDISP analyses based on Bray Curtis and Pearson distance matrices revealed statistically 
significant differences in fecal microbiota composition between days post infection with S. TmSPI-2 (* p<0.05, ** 
p<0.01). However, there was no statistically significant difference between day 21 p.i. (n=2) and the day before 
infection (n=4). 
 
 
Figure 19: The Oligo-MM12 do not clear S. TmSPI-2 until day 21 post infection. The experimental set-up is 
detailed in Figure 18A. (A) Salmonella loads in feces. Feces was sampled at the indicated time points and CFUs / 
g feces were determined by plating. (B) Systemic Salmonella in mesenteric lymphnodes (mLN), liver and spleen 
(CFUs per organ) at day 21 p.i.. (C) Relative cecum weight at day 21 p.i. expressed as % of body weight. Dashed 
lines: DTL: limit of detection (mLN: 10 CFUs, liver: 60 CFUs, spleen: 20 CFUs). 
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3.4.2 Influence of altered environmental conditions during colitis on the microbiota 
3.4.2.1 In vitro testing of Salmonella strains deficient in anaerobic respiration, siderophore 
production and ethanolamine utilization  
3.4.2.1.1 S. TmNi. (ΔnarZ; narG::cat; napA::aphT) is incapable of nitrate respiration 
In order to investigate the importance of nitrate respiration during Salmonella ‘blooms’ in Oligo-
MM12 mice and concomitant microbiota shifts, three genes essential for nitrate respiration narZ, 
narG and napA (Lopez et al. 2012) were deleted in S. Tm. S. Tm possesses three nitrate reductases 
encoded by the narGHI (nitrated reductase A), narZYV (nitrate reductase Z) and napABC (periplasmic 
nitrate reductase) gene clusters. While nitrate reductase Z is constitutively expressed, nitrate 
reductase A (low affinity) and the periplasmic nitrate reductase (high affinity) are expressed under 
anaerobic conditions. Especially, the high affinity periplasmic nitrate reductase is important for 
Salmonella during colitis (Vázquez-Torres and Bäumler 2016). 
Successful replacement of the genes in S. TmNi. by antibiotic resistance markers was verified by PCR 
(data not shown) and the phenotype of S. TmNi. was tested in vitro. Under aerobic conditions, S. TmNi. 
in minimal M9 medium showed similar growth compared to S. TmWT (Figure 20A). This was 
independent of the presence of nitrate (20 mM). None of the two strains reduced nitrate to nitrite 
when oxygen was present. Remarkably, under anaerobic conditions S. TmNi. showed a growth 
disadvantage compared to S. TmWT when nitrate was supplemented to the M9 medium (Figure 20B). 
In contrast to S. TmWT, S. TmNi. failed to reduce nitrate to nitrite under anaerobic conditions (Figure 
20B). S. TmNi. was additionally outcompeted by S. TmWT which grew 5 times better in mucin broth 
supplemented with nitrate (40 mM). There was no competitive advantage in plain mucin broth 
without nitrate (Figure 20C). This indicates that S. TmNi. is unable to respire nitrate and that the 
genetic manipulation of the strain just affected nitrate respiration genes since S. TmNi. grew as good 
as S. TmWT under aerobic conditions. 
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Figure 20: S. TMNi. is unable to respire nitrate and has a growth disadvantage compared to S. TmWT in 
medium supplemented with nitrate. (A) and (B) growth curves of S. TmWT and S. TmNi. with and without NO3- 
(20 mM) under aerobic (+O2) as well as anaerobic conditions (-O2; 7% H2, 10% CO2, rest N2) are shown. Bacteria 
were grown in M9 minimal medium with glucose. Data for growth curves without NO2- measurement (left 
curves) originate from 3 independent experiments and are shown as the mean +/- standard deviation of n 
experiments (n=3 except: t=6, 8 n=2). N.s.: not significant (p>0.05, 1 way ANOVA with Bonferroni’s multiple 
comparison test at the given time point). Growth curves with NO2- measurement (right curves) show the results 
of one single experiment that is representative for three independent experiments. Samples were taken after 
0, 2, 4, 6 and 8 h as well as over night (o/n). (C) Competitive index: S. TmWT vs S. TmNi.. Bacterial o/n starter 
cultures in either LB (n=6 from individual colonies) or M9 minimal medium (n=5) were used to inoculate 24 h 
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co-cultures in mucin broth with (S/C MUC + NO3- 40 mM) or without NO3- (S/C MUC) as described (Lopez et al. 
2012). Box and whiskers blot (whiskers from min to max). ** p<0.01 (Mann-Whitney U test). 
 
3.4.2.1.2 S. TmNi. + Te. (ΔnarZ; narG::cat; napA::aphT; ttrS::tet) shows impaired growth in anaerobic 
tetrathionate broth 
Besides nitrate, tetrathionate is also an anaerobic electron acceptor used by Salmonella during 
inflammation (Winter et al. 2010). In order to abolish tetrathionate respiration in addition to nitrate 
respiration, ttrS which is part of a two-component regulatory system essential for expression of 
tetrathionate reductase (Hensel et al. 1999) was replaced by a tetracycline resistance cassette. The 
genetic modification of S. TmNi. + Te. was verified by PCR (data not shown) and an in vitro competition 
experiment (S. TmNi. vs S. TmNi. + Te.) in mucin broth with or without tetrathionate (40 mM) was 
performed. In order to enhance the growth of S. TmNi. and S. TmNi. + Te. which are both auxotrophic for 
histidine (SL1344 Salmonella background), the mucin broth was additionally supplement with 
histidine (500 mg/l). When tetrathionate was added, S. TmNi. + Te. was outcompeted by trend and S. 
TmNi. grew 2.5 times better than S. TmNi. + Te. as described previously (Winter et al. 2010). However 
when tetrathionate was absent, both strains grew equally well (Figure 21). This indicates that S. TmNi. 
+ Te. is not able to profit from tetrathionate respiration. 
 
Figure 21: S. TmNi. + Te. is outcompeted by S. TmNi. in the presence of tetrathionate under anaerobic 
conditions. Competitive index: LB starter cultures of S. TmNi. as well as S. TmNi. + Te were used to inoculate 24 h 
competition cultures in mucin broth supplemented with histidine (500 mg/l) with or without tetrathionate (40 
mM). Competitive index with or without tetrathionate was not significantly different (p=0.12, Mann Whitney 
test). Data are expressed as the median of 3 experiments. 
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3.4.2.1.3 S. TmEntA (entA::cat) is impaired in siderophore secretion 
Iron is scarce and even more restricted in the inflamed gut e.g. via host mediated LCN-2 production, 
which sequesters siderophores such as enterochelin (Raffatellu et al. 2009). However, Salmonella 
manages to overcome iron-limitation mediated by LCN-2 secretion using a glycosylated derivative of 
enterochelin termed salmochelin that cannot be inactivated by LCN-2 (Raffatellu et al. 2009). In 
order to investigate the role of siderophore mediated iron acquisition, entA which is a 2,3-
dihydroxybenzoic acid (DHB) biosynthetic enzyme involved in the production of salmochelin and 
enterochelin (Caza et al. 2015, Pakarian and Pawelek 2016) was replaced by a chloramphenicol 
resistance cassette. The knock in of the resistance cassette was confirmed by PCR (data not shown) 
and the mutant phenotype was characterized in vitro using Chromazurol S (CAS) agar plates. CAS 
together with Hexadecyltrimethylammonium (HDTMA) complexes ferric iron (Fe3+) (blue color). In 
the presence of siderophores, iron can be sequestered from the complex and the agar turns into an 
orange color. Compared to S. TmWT, S. TmEntA grew equally well in LB starter cultures (Figure 22A) 
indicating no other genetic alteration then entA::cat. When spotted on CAS – agar plates, the halo of 
S. TmEntA was smaller than S. TmWT (Figure 22B).  
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Figure 22: S. TmEntA is unable to acquire iron via siderophore secretion. (A) OD600 of 12h LB starter cultures of 
S. TmEntA as well as S. TmWT used for CAS agar assay (n=3; p=0.1, Mann Whitney test). (B) left, CAS agar plate 
with bacterial spots: + cont: positive control (HB 1852S WA-CS), - cont: negative control (WA-TS (ybtA::aphT)), 
S. TmWT and S. TmEntA. Right, quantification of orange CAS – halo in mm. Experiments were performed with 3 
individual cultures (n=3). Data are shown as the median of 3 experiments.  
 
3.4.2.1.4 S. TmEA (eutC::aphT) exhibits reduced growth on ethanolamine under anaerobic 
conditions in the presence of tetrathionate 
Ethanolamine is the preferred energy source of S. Tm during tetrathionate respiration(Price-Carter et 
al. 2001). EutC, which encodes a subunit of ethanolamine ammonia lyase, an enzyme essential for 
ethanolamine utilization (Roof and Roth 1988, Roof and Roth 1989, Thiennimitr et al. 2011) was 
replaced by a kanamycin resistance cassette. The genetic modification in S. TmEA was verified by PCR 
and the mutant phenotype was tested in vitro. S. TmEA and S. TmWT showed the same growth kinetics 
in anaerobic M9 medium containing glucose (Figure 23B). When ethanolamine was the sole electron 
source (no tetrathionate added), S. TmEA as well as S. TmWT almost showed no growth under 
anaerobic conditions. Remarkably, when the electron acceptor tetrathionate was added S. TmWT 
trended to grow better compared to S. TmEA (Figure 23A). This indicates that S. TmEA cannot benefit 
from ethanolamine as good as S. TmWT does.  
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Figure 23: S. TmEA shows reduced growth compared to S. TmWT in M9 + ethanolamine (EA) supplemented 
with tetrathionate. (A) OD600 of S. TmEA and S. TmWT in anaerobic M9 without glucose (- gluc) containing 5 mM 
ethanolamine with and without tetrathionate (S4O62-, 40 mM, n=4). Difference between the growth of S. TmEA 
and S. TmWT at 32 h in M9 + ethanolamine supplemented with S4O62- was not statistically significant (n.s., 
p>0.05, 1 way ANOVA with Bonferroni’s multiple comparison test). (B) OD600 of S. TmEA and S. TmWT in 
anaerobic M9 containing glucose (+ gluc) but no ethanolamine or S4O62- (n=3). Samples were taken after 0, 4, 8, 
24, 28, 32 h. Data are expressed as the mean of n experiments +/- standard deviation. 
 
3.4.2.2 Dysbiosis following Salmonella ‘blooms’ is fueled by anaerobic respiration. 
So far, the contribution of anaerobic respiration, ethanolamine utilization and iron availability to 
Salmonella ‘blooming’ has been investigated using the streptomycin pre-treated colitis mouse model 
(Raffatellu et al. 2009, Winter et al. 2010, Thiennimitr et al. 2011, Lopez et al. 2012). In this this 
study, we verify the observed effects using the Oligo-MM12 that exhibits colitis upon S. Tm infection 
without antibiotic pre-treatment. We further investigate the relative importance of anaerobic 
respiration, ethanolamine utilization and iron availability during different stage of Salmonella 
ecosystem invasion and ‘blooming’ and monitor the performance of individual commensal strains 
during colitis. 
Thus, groups of Oligo-MM12 mice were infected with 5 x 107 CFUs of either S. TmEntA (entA::cat; 
deficient in enterochelin / salmochelin production, n=6), S. TmNi. + Te. (ΔnarZ; narG::cat; napA::aphT; 
ttrS::tet; deficient in nitrate and tetrathionate respiration, n=6), S. TmNi. (ΔnarZ; narG::cat; 
napA::aphT; deficient in nitrate respiration, n=5), S. TmEA (eutC::aphT; deficient in ethanolamine 
utilization, n=6) or S. TmWT (n=7). Feces was taken at different days after infection in order to monitor 
microbiota composition and determine LCN-2 levels as marker for gut inflammation. Mice were 
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sacrificed at day 4 p.i., feces and cecal content were harvested for microbiota analysis, cecal 
pathology was scored and systemic Salmonella loads were determined (Figure 24A). All Salmonella 
strains colonized the gut of Oligo-MM12 mice equally well, only the S. TmEA significantly reduced loads 
at day 3 p.i. compared to S. TmWT (p<0.01, Kruskal-Wallis test with Dunn's multiple comparison test; 
Figure 25A). All mutant strains induced severe colitis by day 4 p.i. (Figure 25B) with high and 
comparable LCN-2 levels (Figure 24B). There was no difference in relative cecum size and systemic 
Salmonella loads at day 4 p.i. (Figure 25C-F) between groups. However, S. TmNi. + Te. exhibited less 
cecal pathology compared to S. TmWT (p<0.001, Kruskal-Wallis test with Dunn's multiple comparison 
test; Figure 25B). Nevertheless, this indicates that all S. Tm mutant strains were able to induce colitis 
at day 4 p.i.. Interestingly, the fecal and cecal microbiota was different after infection with S. TmNi. + 
Te.. No domination of Salmonella (≥ 50% of total microbiota composition) after infection with S. TmNi. 
+ Te. was observed (Figures 24D,E; 26B,C). However, when tetrathionate respiration was still 
functional, 3 out 6 samples were dominated by Salmonella after infection with S. TmNi. (Figures 
24D,E; 26B,C), indicating an additive effect of both systems. Only 2 of 6 samples were dominated by 
S. TmEA underlining the importance of ethanolamine for anaerobic respiration (Figures 24D,E; 26B,C). 
Mice infected with S. TmEntA however showed a similar abundance of samples dominated by 
Salmonella compared to S. TmWT at day 4 p.i. (Figures 24D,E; 26B,C). This demonstrates that iron 
acquisition via siderophores might play a minor role during late stage of infection, whereas anaerobic 
respiration was of major importance. In all samples during late stages of infection, domination by 
Salmonella paralleled with decreased total 16S rRNA copies per 5 ng template DNA (Figure 24C-E).  
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Figure 24: Environmental factors supporting dysbiosis meditated by Salmonella ‘blooms’ during 
inflammation. (A) Experimental set-up: Oligo-MM12 were orally infected with 5 x 107 of different Salmonella 
strains: S. TmEntA, S. TmNi. + Te., S. TmNi. or S. TmWT. Feces (F) for microbiota analysis and LCN-2 ELISA was taken 
before infection and at days 1, 3 and 4 p.i.. Cecal content (Cec) was additionally taken at day 4 p.i.. (B) 
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content). (C) – (E) Analysis of microbiota composition in feces and cecal content at the indicated time points. 
Microbiota composition is shown as relative abundance and expressed as % of cumulated 16S rRNA gene copy 
numbers (% of total 16S rRNA gene copies). The amount of absolute 16S rRNA gene copies (determined by an 
universal primer / probe combination) is illustrated as black dots (right y axis). * Or dashed line: limit of 
detection (DTL). 
 
In order to further entangle the relative contribution of anaerobic respiration, ethanolamine 
utilization and iron acquisition via siderophores to Salmonella ‘blooming’, microbiota samples were 
subsequently clustered by infection with S. Tm strains shown in Figure 24A. At early stages of 
infection (uninfected + day 3 p.i.) grouping of fecal microbiota composition by infection with 
different Salmonella strains was significant, according to Bray Curtis (p<0.002, Adonis) and Pearson 
(p<0.001, Adonis) distance matrices, with 40% as well as 51% of variation explained. At this early 
stage, only S. TmWT managed to dominate the 2 out of 7 samples and constitute ≥ 30% of total 
microbiota composition in 1 sample (Figures 24C; 26A). Non parametric PERMDISP analysis revealed 
that at day 3 p.i., the microbiota composition after infection with S. TmWT was different compared to 
uninfected and also different compared to microbiota composition of mice infected with S. TmEntA, S. 
TmNi. + Te., S. TmNi. and S. TmEA (Figure 26A). At day 3 p.i., there was no significant difference in 
microbiota composition between uninfected samples and samples infected with S. TmEntA, S. TmNi. + 
Te., S. TmNi. and S. TmEA (Figure 26A).  
During late stages of infection (day 4 p.i.), fecal samples and cecal content were analyzed. Grouping 
of fecal microbiota composition by infection with different Salmonella strains was significant, 
according to Bray Curtis (p<0.003, Adonis) and Pearson (p<0.003, Adonis) distance matrices, with 
39% as well as 48% of variation explained (Figure 26B). Grouping of microbiota composition in cecal 
content by infection with different Salmonella strains was also significant, according to Bray Curtis 
(p<0.004, Adonis) and Pearson correlation (p<0.002, Adonis), with 41% as well as 45% of variation 
explained (Figure 26C). Remarkably, the Oligo-MM12 composition after infection with S. TmWT as well 
as S. TmEntA clustered separately (Figure 26B,C). Most of the samples were dominated by S. TmWT or S. 
TmEntA. The percentage of S. TmEntA was ≥ 30% of total microbiota composition at day 4 p.i. for all 
mice (Figure 26B,C), indicating that iron acquisition via siderophores might be negligible for the 
induction of dysbiosis during late stages of infection. The following ranking according to mean % of 
Salmonella observed in feces and cecal content underlines the importance of anaerobic respiration 
and ethanolamine utilization during Salmonella ‘blooming’ and concomitant dysbiosis at day 4 p.i.: S. 
TmWT (78.10% +/- 40.29% in feces and 83.65% +/- 34.48% in cecal content) > S. TmEntA (78.84% +/- 
24.90% in feces and 73.69% +/-25.50% in cecal content) > S. TmNi. (52.99% +/- 48.85 in feces and 
63.71% +/- 43.29% in cecal content) > S. TmEA (36.42% +/- 47.24% in feces and 41.36% +/- 43.58% in 
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cecal content) > S. TmNi. + Te. (3.46% +/- 4.48% in feces and 10.10% +/- 14.35% in cecal content) (Tables 
50; 51).  
Again, Salmonella ‘blooming’ correlated with decreased relative abundance of ‘Bacteroides 
caecimuris‘ I48, ‘Muribaculum intestinale‘ YL27 and Akkermansia muciniphila YL44 with the lowest 
relative abundance observed after infection with S. TmWT and S. TmEntA (Tables 50; 51). Remarkably, 
the relative abundance of Clostridium clostridioforme YL32 increased post infection with S. TmEA 
compared to S. TmWT. This difference was statistically significant in cecal content samples (rel. 
abundance of YL32: 21.40% +/- 20.91% p.i. with S. TmEA and 2.65% +/- 4.86% p.i. with S. TmWT; 
p<0.05, two-way ANOVA with Bonferroni posttest; Table 51). Furthermore, according to two-way 
ANOVA with Bonferroni posttest, there were no statistically significant differences in relative 
abundance of individual Oligo-MM12 strains at day 4 p.i. between S. TmEntA vs S. TmWT and S. TmNi. vs 
S. TmEA in feces and between S. TmEntA vs S. TmNi. and S. TmEntA vs S. TmWT in cecal content (Tables 50; 
51), again indicating a lower priority of iron acquisition via siderophores and an additive effect of 
nitrate and tetrathionate respiration at later stages of infection. It is also worth mentioning that in 
this experiment S. TmWT failed to dominate the Oligo-MM12 in 2 out of 8 samples (Figure 24D,E). This 
is in contrast to previous experiments where S. TmWT dominated the Oligo-MM12 in 7 out of 7 mice at 
day 4 p.i. (Figure 10C).  
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Figure 25: Salmonella mutants deficient in siderophore production, anaerobic respiration and ethanolamine 
utilization show similar colonization kinetics and systemic dissemination compared to S. TmWT. For 
experimental set-up refer to Figure 24A. Organs were additionally taken at the indicated time points. (A) 
Salmonella loads in feces and cecal content at days 1, 3 and 4 p.i. (CFUs S. Tm / g content). (B) Cecal pathology 
determined by microscopy of HE stained tissue sections. (C) – (E) Systemic Salmonella in mesenteric 
lymphnodes, liver and spleen (CFUs / organ) at day 4 p.i.. (F) Relative cecum weight at day 4 p.i. expressed as % 
of body weight. Values are indicated as median. Statistical analysis between groups was performed using 
Kruskal-Wallis test with Dunn's multiple comparison test (* p<0.05, ** p<0.01, *** p<0.001). Dashed lines: DTL: 
limit of detection (mLN: 10 CFUs, liver: 60 CFUs, spleen: 20 CFUs). 
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Figure 26: Cluster analysis of Oligo-MM12 composition after infection with S. TmWT and Salmonella strains 
deficient in siderophore production, anaerobic respiration as well as ethanolamine utilization. Cluster 
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analysis is based on Bray Curtis or Pearson distance matrices and visualized as PCoA plots. (A) Clustering of 
fecal Oligo-MM12 composition before infection and day 3 post infection with S. Tm strains. Fecal microbiota 
samples were grouped by infection with different S. Tm strains which was significant, according to Bray Curtis 
(p<0.002, Adonis) and Pearson (p<0.001, Adonis) with 40% (Bray Curtis) and 51% (Pearson) of variation 
explained. PERMDISP analyses based on Bray Curtis and Pearson distance matrices revealed statistically 
significant differences in fecal microbiota composition between Oligo-MM12 infected with S. TmWT and all other 
S. Tm strains (* p<0.05, ** p<0.01, *** p<0.001). (B) Clustering of fecal Oligo-MM12 composition at day 4 post 
infection with S. Tm strains. Fecal microbiota samples were grouped by infection with different S. Tm strains 
which was significant, according to Bray Curtis (p<0.003, Adonis) and Pearson (p<0.003, Adonis) with 39% (Bray 
Curtis) and 48% (Pearson) of variation explained. PERMDISP analyses based Pearson distance matrix revealed 
statistically significant differences in fecal microbiota composition between Oligo-MM12 infected with S. TmEntA, 
S. TmNi. and S. TmEA (* p<0.05). (C) Clustering of Oligo-MM12 composition in cecal content at day 4 post 
infection with S. Tm strains. Samples from were grouped by infection with different S. Tm strains which was 
significant, according to Bray Curtis (p<0.004, Adonis) and Pearson (p<0.002, Adonis) with 41% (Bray Curtis) and 
45% (Pearson) of variation explained. PERMDISP analyses based on Bray Curtis and Pearson distance matrices 
revealed statistically significant differences in microbiota composition of cecal content between Oligo-MM12 
infected with S. Tm strains (* p<0.05, *** p<0.001). Red square: microbiota is dominated by S. Tm (≥	50%); 
orange square: S. Tm accounts for ≥ 30% of total microbiota composition.  
 
Table 50: Relative abundance of Oligo-MM12 strains after infection with S. Tm mutant strains 
deficient in iron acquisition via siderophores, anaerobic respiration and ethanolamine utilization in 
feces 
Strain 
Mean % of cumulated 16S rRNA gene copy numbers (+/- SD) 
Day 4 post infection with Salmonella mutant strains (feces) 
S. TmEntA S. TmNi. + Te. S. TmNi. S. TmEA S. TmWT 
‘Bacteroides caecimuris’ I48 3.87 (8.67) 
53.37a 
(22.05) 
26.06b,d 
(35.90) 
23.85e 
(21.14) 
5.46f,g 
(11.65) 
‘Muribaculum intestinale’ YL27 5.17 (7.61) 
11.95 
(5.56) 
5.29 
(6.78) 
15.15 
(11.45) 
4.10 
(7.60) 
Akkermansia muciniphila YL44 7.37 (10.02) 
24.31 
(13.17) 
12.99 
(22.67) 
10.35 
(8.16) 
5.51 
(14.66) 
‘Turicimonas caecimuris’ YL45 0.31 (0.48) 
3.34 
(1.70) 
1.04 
(1.51) 
2.79 
(2.26) 
0.44 
(1.15) 
Lactobacillus reuteri I49 0.07 (0.11) 
0.01 
(0.01) 
0.01 
(0.02) 
0.19 
(0.13) 
0.01 
(0.02) 
Enterococcus faecalis KB1 0.01 (0.01) 
0.002 
(0.004) 
0.03 
(0.04) 
0.003 
(0.01) 
0.02 
(0.01) 
Blautia coccoides YL58 0.08 (0.12) 
0.31 
(0.13) 
0.18 
(0.19) 
0.79 
(0.64) 
0.13 
(0.21) 
Clostridium innocuum I46 0.06 (0.10) 
0.07 
(0.03) 
0.06 
(0.07) 
0.15 
(0.12) 
0.04 
(0.08) 
Flavonifractor plautii YL31 2.69 (2.81) 
1.05 
(0.35) 
1.02 
(1.05) 
2.07 
(1.79) 
1.50 
(3.20) 
Clostridium clostridioforme YL32 1.52 (1.48) 
2.15 
(1.66) 
0.34 
(0.40) 
8.23 
(10.37) 
4.71 
(12.52) 
‘Acutalibacter muris’ KB18 DTL DTL DTL DTL DTL 
Bifidobacterium longum subsp. 
animalis YL2 DTL DTL DTL DTL DTL 
S. Tm 78.84 (24.90) 
3.46a 
(4.48) 
52.99b,d 
(48.85) 
36.42c,e 
(47.24) 
78.10f,g,h 
(40.29) 
Significant differences between a S. TmEntA vs S. TmNi. + Te., b S. TmEntA vs S. TmNi., c S. TmEntA vs S. TmEA, d S. TmNi. + 
Te. vs S. TmNi., e S. TmNi. + Te. vs S. TmEA, f S. TmNi. + Te. vs S. TmWT, g S. TmNi. vs S. TmWT and h S. TmEA vs S. TmWT are 
indicated; p values were less than 0.001, except: S. TmEntA vs S. TmNi.: I48 p<0.05 and S. Tm p<0.01, I48 S. TmNi. + 
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Te. vs S. TmNi. p<0.01, I48 S. TmNi. + Te. vs S. TmEA p<0.01 and S. TmNi. vs S. TmWT: I48 p< 0.05 and S. Tm p<0.01, 
two-way ANOVA with Bonferroni posttest. There were no significant differences between S. TmEntA vs S. TmWT 
and S. TmNi. vs S. TmEA. Values are expressed as mean % of cumulated 16S rRNA gene copy numbers +/- 
standard deviation (SD). S. TmEntA: no siderophore production (n=7), S. TmNi. + Te.: no nitrate and tetrathionate 
respiration (n=6), S. TmNi.: no nitrate respiration (n=6), S. TmEA: no ethanolamine utilization (n=6), S. TmWT 
(n=8). DTL: limit of detection. 
Table 51: Relative abundance of Oligo-MM12 strains after infection with S. Tm mutant strains 
deficient in iron acquisition via siderophores, anaerobic respiration and ethanolamine utilization in 
cecal content. 
Strain 
Mean % of cumulated 16S rRNA gene copy numbers (+/- SD) 
Day 4 post infection with Salmonella mutants (cecum) 
S. TmEntA S. TmNi. + Te. S. TmNi. S. TmEA S. TmWT 
‘Bacteroides caecimuris’ I48 1.94 (3.19) 
35.23a 
(20.48) 
14.17c 
(18.27) 
13.61d 
(17.17) 
4.41e 
(11.66) 
‘Muribaculum intestinale’ YL27 1.93 (1.85) 
12.02 
(2.38) 
4.97 
(6.24) 
7.74 
(7.41) 
1.79 
(4.29) 
Akkermansia muciniphila YL44 6.67 (11.83) 
26.27a 
(6.69) 
9.06 
(12.69) 
10.53 
(7.85) 
5.02e 
(11.77) 
‘Turicimonas caecimuris’ YL45 0.41 (0.68) 
2.91 
(1.14) 
1.03 
(1.43) 
1.79 
(1.66) 
0.54 
(1.17) 
Lactobacillus reuteri I49 0 0.04 (0.07) 0 
0.14 
(0.13) 
0.01 
(0.02) 
Enterococcus faecalis KB1 0.07 (0.14) 
0.002 
(0.004) 
0.01 
(0.01) 
0.02 
(0.04) 
0.02 
(0.03) 
Blautia coccoides YL58 0.06 (0.07) 
0.53 
(0.20) 
0.15 
(0.18) 
0.44 
(0.37) 
0.05 
(0.13) 
Clostridium innocuum I46 0.004 (0.01) 
0.09 
(0.03) 
0.05 
(0.07) 
0.15 
(0.20) 
0.01 
(0.04) 
Flavonifractor plautii YL31 9.55 (11.22) 
4.74 
(4.15) 
4.07 
(5.25) 
2.84 
(3.38) 
1.86 
(3.87) 
Clostridium clostridioforme YL32 5.69 (8.67) 
8.07 
(5.35) 
2.79 
(3.16) 
21.40 
(20.91) 
2.65h 
(4.86) 
‘Acutalibacter muris’ KB18 DTL DTL DTL DTL DTL 
Bifidobacterium longum subsp. 
animalis YL2 DTL DTL DTL DTL DTL 
S. Tm 73.69 (25.50) 
10.10a 
(14.35) 
63.71c 
(43.29) 
41.36b,d,f 
(43.58) 
83.65e,g,h 
(34.48) 
Significant differences between a S. TmEntA vs S. TmNi. + Te., b S. TmEntA vs S. TmEA, c S. TmNi. + Te. vs S. TmNi., d S. 
TmNi. + Te. vs S. TmEA, e S. TmNi. + Te. vs S. TmWT, f S. TmNi. vs S. TmEA, g S. TmNi. vs S. TmWT and h S. TmEA vs S. TmWT 
are indicated; p values were less than 0.001, except: YL44 S. TmEntA vs S. TmNi.  + Te. p<0.05, I48 S. TmNi. + Te. vs S. 
TmNi. p<0.05, I48 S. TmNi. + Te. vs S. TmEA p<0.05, YL44 S. TmNi. + Te. vs S. TmWT p<0.01, S. Tm S. TmNi. vs S.TmEA 
p<0.01, S. Tm S. TmNi. vs S. TmWT p<0.05 and YL32 S. TmEA vs S. TmWT p<0.05, two-way ANOVA with Bonferroni 
posttest. There were no significant differences between S. TmEntA vs S. TmNi. and S. TmEntA vs S. TmWT. Values are 
expressed as mean % of cumulated 16 S rRNA gene copy numbers +/- standard deviation (SD). S. TmEntA: no 
siderophore production (n=7), S. TmNi. + Te.: no nitrate and tetrathionate respiration (n=6), S. TmNi.: no nitrate 
respiration (n=6), S.TmEA: no ethanolamine utilization (n=6), S. TmWT (n=8). DTL: limit of detection. 
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3.4.2.3 The performance of single Oligo-MM12 strains during inflammation correlates with 
the presence of fitness genes 
Next, fold differences in absolute abundance (fold changes) of each Oligo-MM12 strain and 
Salmonella between day 0 (uninfected) and day 4 p.i. with S. TmWT, S. TmEntA, S. TmNi. + Te., S. TmNi. and 
S. TmEA were calculated (Table 53). In this experiment, the Oligo-MM12 strains could be grouped in 
strains that are depleted, intermediate or enriched during severe S. TmWT induced colitis (Figure 14; 
Table 53). In order to obtain more functional information about the performance of individual Oligo-
MM12 strains during S. Tm induced inflammation in the gut, RAST (Rapid Annotations using 
Subsystems Technology) from draft genomes was performed prioritizing the following functional 
groups (subsystems): nitrogen metabolism / nitrate and nitrite ammonification, ethanolamine (EA) 
utilization, iron acquisition, siderophore, dormancy and sporulation (Table 52). Genome mining was 
performed by Debora Garzetti. Remarkably, genomes of the Oligo-MM12 strains that were depleted 
during severe S. TmWT induced inflammation, in particular Akkermansia muciniphila YL44, 
‘Bacteroides caecimuris’ I48, ‘Muribaculum intestinale’ YL27 and ‘Turicimonas caecimuris’ YL45 in 
general did barely harbor the above mentioned subsystems (Tables 52; 53). ‘Turicimonas caecimuris’ 
YL45 harbored putative genes for nitrate respiration and Akkermansia muciniphila YL44 harbored 
genes for siderophores. Clostridium clostridioforme YL32 which is also depleted during severe colitis 
but which was increased upon moderate colitis at day 3 p.i. with S. TmWT (Table 46; Figure 10B,C) 
harbored genes for ferric iron ABC transporters, nitrite reductase and sporulation genes (Tables 52; 
53). In addition, the absolute abundance of Clostridium clostridioforme YL32 between day 0 and day 
4 p.i. with S. TmEntA, S. TmNi. + Te. and S. TmEA even increased (Table 53), suggesting that Clostridium 
clostridioforme YL32 might benefit from inflammation. Oligo-MM12 strains that were assigned to the 
intermediate group (Blautia coccoides YL58, Flavonifractor plautii YL31 and Clostridium innocuum 
I46) all harbored sporulation genes (especially Blautia coccoides YL58 and Flavonifractor plautii YL31) 
and additionally iron utilization genes (Tables 52; 53). The genome of Flavonifractor plautii YL31 
contained also ethanolamine utilization genes and Blautia coccoides YL58 harbored nitrate 
respiration genes. Fold changes of Blautia coccoides YL58, Flavonifractor plautii YL31 and Clostridium 
innocuum I46 between day 0 and day 4 p.i. with S. TmWT, S. TmEntA, S. TmNi. + Te., S. TmNi. and S. TmEA 
were comparable (Table 53). The two Oligo-MM12 strains that were enriched during colitis 
(Enterococcus faecalis KB1 and Lactobacillus reuteri I49) did almost harbor no sporulation genes. 
Enterococcus faecalis KB1 harbored genes for ethanolamine utilization and siderophores, whereas 
Lactobacillus reuteri I49 harbored genes for nitrate respiration (Tables 52; 53). The absolute 
abundance of Lactobacillus reuteri I49 between day 0 and day 4 p.i. increased slightly p.i. with S. 
TmEntA and S. TmEA and the absolute abundance of Enterococcus faecalis KB1 was increased after 
infections with S. TmWT, S. TmEntA, S. TmNi. and S. TmEA (Table 53).  
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Taken together, Oligo-MM12 strains that were depleted during severe colitis in general harbored no 
or few genes involved in sporulation, ethanolamine utilization, iron uptake or nitrate respiration. 
Strains that persisted during severe inflammation or decreased moderately (intermediate group) 
especially harbored sporulation genes. There were additionally genes for iron uptake, ethanolamine 
utilization and nitrate respiration in this group. Strains that were enriched during severe colitis 
mostly harbored genes for nitrate respiration, ethanolamine utilization and iron uptake. There were 
almost no genes related to dormancy or sporulation present in this enriched group. 
 
Table 52: Functional groups (subsystems) of the Oligo-MM12 determined by RAST automated 
annotation. 
Subsystem Putative gene 
Oligo-MM12 strains 
Depleted Intermediate Enriched DTL 
YL
44 
I 
48 
YL
27 
YL
45 
YL
32 
YL
58 
YL
31 
I 
46 
KB
1 
I 
49 
KB
18 
YL
2 
Nitrogen 
metabolism 
nitrate and 
nitrite 
ammonific. 
Nitrite reductase probable 
[NAD(P)H] subunit (EC 1.7.1.4) 
    + +       
Nitrate/nitrite transporter    +      +   
Respiratory nitrate reductase 
alpha chain (EC 1.7.99.4) 
   +      +   
Respiratory nitrate reductase 
gamma chain (EC 1.7.99.4) 
   +      +   
Respiratory nitrate reductase 
delta chain (EC 1.7.99.4) 
   +      +   
Respiratory nitrate reductase beta 
chain (EC 1.7.99.4) 
   +      +   
  Cytochrome c552 precursor (EC 
1.7.2.2) 
   +         
  Cytochrome c-type heme lyase 
subunit nrfF, nitrite reductase 
complex assembly 
   +         
  Cytochrome c-type heme lyase 
subunit nrfG, nitrite reductase 
complex assembly 
   +         
  Ferredoxin-type protein NapF 
(periplasmic nitrate reductase) 
   +         
  Ferredoxin-type protein NapG 
(periplasmic nitrate reductase) 
   +         
  Nitrate ABC transporter, ATP-
binding protein 
   +         
  Nitrate/nitrite response regulator 
protein 
   +         
  Nitrate/nitrite sensor protein (EC 
2.7.3.-) 
   +         
  NrfC protein    +         
  NrfD protein    +         
  Periplasmic nitrate reductase 
precursor (EC 1.7.99.4) 
   +         
  Polyferredoxin NapH (periplasmic 
nitrate reductase) 
   +         
EA 
utilization 
Ethanolamine utilization 
polyhedral-body-like protein EutN 
      +  +    
Ethanolamine sensory 
transduction histidine kinase 
      +  +    
Ethanolamine permease       +  +    
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Subsystem Putative gene 
Oligo-MM12 strains 
Depleted Intermediate Enriched DTL 
YL
44 
I 
48 
YL
27 
YL
45 
YL
32 
YL
58 
YL
31 
I 
46 
KB
1 
I 
49 
KB
18 
YL
2 
Ethanolamine two-component 
response regulator 
      +  +    
Ethanolamine utilization protein 
similar to PduL 
      +  +    
ATP:Cob(I)alamin 
adenosyltransferase (EC 2.5.1.17) 
      +      
Ethanolamine utilization protein 
similar to PduA/PduJ 
      +  +    
Ethanolamine utilization protein 
EutA 
      +  +    
Ethanolamine utilization protein 
similar to PduV 
      +  +    
Ethanolamine utilization protein 
EutJ 
      +      
Acetate kinase (EC 2.7.2.1)       +  +    
Ethanolamine ammonia-lyase 
light chain (EC 4.3.1.7) 
      +  +    
Ethanolamine utilization protein 
similar to PduT 
      +      
Ethanolamine ammonia-lyase 
heavy chain (EC 4.3.1.7) 
      +  +    
Ethanolamine utilization 
polyhedral-body-like protein EutL 
      +  +    
Ethanolamine utilization 
polyhedral-body-like protein 
EutM 
        +    
Protein clustered with 
ethanolamine utilization 
        +    
Iron 
acquisition 
Ferric iron ABC transporter, ATP-
binding protein 
    + +  +     
Two-component sensor kinase, 
associated with ferric iron 
transporter 
    +        
Two-component response 
regulator, associated with ferric 
iron transporter, 
    +        
Ferric iron ABC transporter, iron-
binding protein 
    + +  +     
Ferric iron ABC transporter, 
permease protein 
    + +  +     
Sidero-
phore 
Uncharacterized iron compound 
ABC uptake transporter, 
permease protein 
      +      
Iron compound ABC uptake 
transporter substrate-binding 
protein 
+      +  +    
Iron compound ABC uptake 
transporter ATP-binding protein 
+      +  +    
Iron compound ABC uptake 
transporter permease protein 
+      +  +    
Dormancy 
and sporul. 
FIG006789: Stage V sporulation 
protein 
        +  +  
Protein of unknown function 
identified by role in sporulation 
(SpoVG) 
    + + +      
RNA polymerase sporulation 
specific sigma factor SigE 
    + + +      
RNA polymerase sporulation 
specific sigma factor SigF 
    + + +      
RNA polymerase sporulation 
specific sigma factor SigG 
    + + +      
RNA polymerase sporulation 
specific sigma factor SigH 
     +       
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Subsystem Putative gene 
Oligo-MM12 strains 
Depleted Intermediate Enriched DTL 
YL
44 
I 
48 
YL
27 
YL
45 
YL
32 
YL
58 
YL
31 
I 
46 
KB
1 
I 
49 
KB
18 
YL
2 
RNA polymerase sporulation 
specific sigma factor SigK 
    + + +      
Spore cortex-lytic enzyme 
precursor 
          +  
Spore cortex-lytic enzyme, lytic 
transglycosylase SleB 
      +    +  
Spore cortex-lytic enzyme, N-
acetylglucosaminidase SleL (EC 
3.2.1.-) 
      +    +  
Spore germination protein GerKA       +    +  
Spore germination protein GerKB           +  
Spore germination protein GerKC       +    +  
Spore germination protein YpeB       +    +  
Spore maturation protein A     + + + +   +  
Spore maturation protein B     + + + +   +  
Sporulation sigma-E factor 
processing peptidase (SpoIIGA) 
    + + +      
Stage 0 sporulation two-
component response regulator 
(Spo0A) 
    + + +    +  
Stage II sporulation protein D 
(SpoIID) 
    + + +      
Stage II sporulation protein P     + + +      
Stage II sporulation protein 
related to metaloproteases 
(SpoIIQ) 
    + +       
Stage II sporulation protein 
required for processing of pro-
sigma-E (SpoIIR) 
    + + +      
Stage II sporulation serine 
phosphatase for sigma-F 
activation (SpoIIE) 
     + +      
Stage III sporulation protein AA     + + +      
Stage III sporulation protein AB     + + +      
Stage III sporulation protein AC     + + +      
Stage III sporulation protein AD     + + +      
Stage III sporulation protein AE     + + +    +  
Stage III sporulation protein AF     +        
Stage III sporulation protein AG     + + +      
Stage III sporulation protein AH     + + +      
Stage III sporulation protein D     + + +      
Stage IV sporulation pro-sigma-K 
processing enzyme (SpoIVFB) 
      +      
Stage IV sporulation protein A     + + +      
Stage IV sporulation protein B     + + +      
Stage V sporulation protein AA 
(SpoVAA) 
     +       
Stage V sporulation protein AB 
(SpoVAB) 
     +       
Stage V sporulation protein AC 
(SpoVAC) 
    + + +      
Stage V sporulation protein AD 
(SpoVAD) 
    + + +      
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Subsystem Putative gene 
Oligo-MM12 strains 
Depleted Intermediate Enriched DTL 
YL
44 
I 
48 
YL
27 
YL
45 
YL
32 
YL
58 
YL
31 
I 
46 
KB
1 
I 
49 
KB
18 
YL
2 
Stage V sporulation protein AE 
(SpoVAE) 
    + + +      
Stage V sporulation protein AF 
(SpoVAF) 
    +        
Stage V sporulation protein B     + + +    +  
Stage V sporulation protein T, 
AbrB family transcriptional 
regulator (SpoVT) 
    + + +      
 
Table 53: Fold difference in absolute abundance (fold change) of Oligo-MM12 strains between d0 
(uninfected) vs d4 p.i. with different Salmonella strains 
Strain 
Fold change d0 vs d4 p.i. Putative genes for: 
S. TmWT S. TmEntA S.TmNi.+Te. S. TmNi. S. TmEA 
Iron 
AC 
Nitrate EA Spor. 
YL44 -76 -2 2 -2 -3 + - - - 
I48 -943 -40 1 -3 -5 - - - - 
YL27 -2043 -43 1 -2 -2 - - - - 
YL45 -1398 -121 -1 -3 -2 - +++ - - 
YL32 -245 2 3 -3 3 ++ + - +++ 
          
YL58 -11 -6 -2 -2 -2 + + - +++ 
YL31 -37 2 -1 -1 -1 ++ - +++ +++ 
I46 -3 -1 -1 -1 -2 + - - + 
          
KB1 18 14 -1 14 2 + - +++ + 
I49 -1 2 -5 -2 2 - ++ - - 
          
KB18 DTL DTL DTL DTL DTL - - - +++ 
YL2 DTL DTL DTL DTL DTL - - - - 
S. Tm 208,819 190,248 3,065 96,323 4,727     
Fold changes between day 0 (uninfected) and day 4 p.i. were calculated with absolute 16S rRNA gene copy 
numbers per 5 ng template DNA determined by qPCR that were normalized to a million gene copies 
determined by universal probe. Oligo-MM12 strains were group as in Figure 14 in depleted, intermediate and 
enriched after infection with S. TmWT. + ≤ 3 putative genes (Table 52), ++ 4 - 5 putative genes (Table 52) and 
+++ more than 5 putative genes (Table 52). Iron AC: iron acquisition, Nitrate: nitrate respiration, EA: 
ethanolamine utilization, Spor.: sporulation, DTL: limit of detection. 
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3.4.3 Influence of innate immune system on microbiota composition during colitis 
3.4.3.1 Depletion of neutrophils does not prevent dysbiosis and Salmonella ‘blooming’ 
Neutrophil infiltration is a hallmark of Salmonella-induced colitis (Loetscher et al. 2012). In order to 
assess whether neutrophils are involved in dysbiosis upon Salmonella-induced colitis, neutrophils 
were depleted using α-Ly6G and α-G-CSF antibodies and mice were infected with S. TmWT (Figure 
29A). Antibody mediated depletion was confirmed by FACS analysis gating on CD45+, SYTOX-, CD3-, 
CD11b+, Ly-6G+, Ly-6C-intermediate cells (Figure 27) and immuno-fluorescence microscopy (Figure 
28). Besides the control mice (treated with isotype control), only mice with confirmed neutrophil 
depletion were included in the analysis (46% of mice in depleted group).  
Before infection as well as at day 3 p.i. with S. TmWT, Oligo-MM12 compositions were comparable 
between mice that had received isotype or depletion antibodies (Figure 29C,D,E). Remarkably, 
depletion of neutrophils favored Salmonella ‘blooming’ at day 4 p.i.. 4 out of 6 samples were 
dominated by Salmonella and inflammation was also increased (Figure 29B,C), whereas the Oligo-
MM12 from mice that had received isotype antibodies (neutrophils still present) were protected. 
Domination of Salmonella coincided with decreased amounts of overall bacteria (Figure 29C). 
Dysbiosis observed at day 4 p.i. correlated well with cluster analysis where fecal microbiota of 
antibody-depleted mice clustered separately (Figure 29D,E). Grouping of fecal microbiota 
composition by treatment with different antibodies and days post infection was significant, according 
to Bray Curtis (p<0.002, Adonis) and Pearson (p<0.001, Adonis) distance matrices, with 63% (Bray 
Curtis) as well as 70% (Pearson) of variation explained. LCN-2 levels were highly elevated at day 4 p.i. 
in mice that had received either isotype or depletion antibodies. Interestingly, depletion of 
neutrophils increased LCN-2 levels compared to control at day 4 p.i. by trend (Figure 29B). This trend 
was also observed in CD18-/- mice (deficient in extravasation of neutrophils) associated with a SPF 
microbiota that were infected with S. TmWT (day 1 p.i.) after streptomycin treatment (Figure 31B).  
Antibody mediated depletion of neutrophils did not change the abundance of S. TmWT in feces and 
cecal content during the course of infection (Figure 30A). However, CD18-/- mice showed significantly 
more Salmonella in cecal content compared to CD18+/- mice at day 1 p.i. with S. TmWT (p<0.05, 
Kruskal-Wallis test with Dunn’s multiple comparison test; Figure 31A). Systemic Salmonella loads in 
mesenteric lymphnodes were higher after antibody mediated depletion of neutrophils at day 4 p.i. 
(p<0.01, Kruskal-Wallis test with Dunn’s multiple comparison test; Figure 30B). However, systemic 
Salmonella loads in liver and spleen in antibody depleted and CD18-/- mice were not significantly 
different. There was a tendency that the absence of neutrophils favors Salmonella expansion in these 
organs (Figures 30; 31). Taken together, this data suggest that neutrophils play a protective role 
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against systemic Salmonella infection and do not contribute to Salmonella-induced dysbiosis and 
‘blooming’. 
 
Figure 27: Confirmation of neutrophil depletion by FACS. Successful depletion of neutrophils was confirmed 
by FACS gating on CD45+, SYTOX-, CD3-, CD11b+, Ly-6G+, Ly-6C-intermediate (Ly-6Gint) cells. Left, example for 
isotype control; right, example for successful neutrophil depletion.  
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Figure 28: Quantification of neutrophils at the epithelium and in the gut lumen by immuno-fluorescence 
microscopy. CD18-positive neutrophils at the epithelium (A) and in the lumen (B) were antibody-stained and 
quantified by counting neutrophils present in 245 x 245 µm squares. Data are expressed as the mean. 
Statistical analysis was performed using unpaired t test (*** p<0.001). Iso.: isotype control group; Dpl.: 
neutrophil-depleted group. 
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Figure 29: Neutrophils protect Oligo-MM12 from S. Tm induced dysbiosis. (A) Experimental set-up: Oligo-MM12 
were treated with one dose of α-Ly6G antibody (150 µg) or isotype control one day before infection with S. 
TmWT (5 x 107 CFUs). In addition, α-G-CSF antibody (10 µg) or isotype control were daily administered starting 
from day -1 until day 3 p.i. with S. TmWT. All antibodies were given via the intraperitoneal route. (B) Lipocalin-2 
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levels in feces and cecal content (ng / mg content; * p<0.05, ** p<0.01, Kruskal-Wallis test with Dunn's multiple 
comparison test). (C) Analysis of microbiota composition in feces. Microbiota composition is shown as relative 
abundance and expressed as % of cumulated 16S rRNA gene copy numbers (% of total 16S rRNA gene copies). 
The amount of absolute 16S rRNA gene copies (determined by an universal primer / probe combination) is 
illustrated as black dots (right y axis). Cluster analysis is based on Bray Curtis (D) or Pearson (E) distance 
matrices and visualized as PCoA plots. Fecal microbiota samples were grouped by infection with S. TmWT and 
antibody mediated depletion of neutrophils (or isotype control) which was significant, according to Bray Curtis 
(p<0.002, Adonis,) and Pearson (p<0.001, Adonis,) with 63% (Bray Curtis) and 70% (Pearson) of variation 
explained. PERMDISP analyses based on Pearson distance matrices revealed statistically significant differences 
in fecal microbiota composition between day 3 and day 4 p.i. in the control group and there was also a 
difference between day 4 p.i. control group and day 3 p.i. depleted group (* p<0.05, ** p<0.01). 
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Figure 30: Influence of neutrophil depletion on the course of Salmonella infection and pathogenesis. For 
experimental set-up refer to (Figure 29A). (A) Salmonella loads in feces (F) and cecal content (cec) at days 1, 2, 
3 and 4 p.i. (CFUs S. Tm / g content). Statistical analysis between multiple groups was performed using Kruskal-
Wallis test with Dunn's multiple comparison test (* p<0.05, ** p<0.01). (B) – (D) Systemic Salmonella loads in 
mesenteric lymphnodes, liver and spleen at day 4 p.i. (CFUs / organ). (F) Relative cecum weight at day 4 p.i. 
expressed as % of body weight. Statistical analysis between two groups was performed using Mann Whitney 
test (* p<0.05, ** p<0.01). Dashed lines: DTL: limit of detection (mLN: 10 CFUs, liver: 60 CFUs, spleen: 20 CFUs). 
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Figure 31: CD18-/- mice display elevated Salmonella loads in the cecum at day 1 post infection with S. Tm. 
C57BL/6J WT (blue), C57BL/6J CD18+/- (orange) and C57BL/6J CD18-/- (brown) mice were pre-treated with one 
single dose of streptomycin (50 µl of 0.5 g/ml stock by oral gavage) and were infected one day later with 5 x 107 
CFUs of S. TmWT. At day 1 and day 2 post infection (p.i.) mice were euthanized and samples were prepared. (A) 
S. TmWT loads in the cecum (CFUs / g content). (B) Lipocalin-2 levels (ng / mg cecal content). (C) – (E) 
Transmigration of S. TmWT into mesenteric lymphnodes, liver and spleen (CFUs / organ). (F) Relative cecum 
weight at day 4 p.i. expressed as % of body weight. *p<0.05, Kruskal-Wallis test with Dunn’s multiple 
comparison test. Dashed lines: DTL: limit of detection (mLN: 10 CFUs, liver: 60 CFUs, spleen: 20 CFUs). 
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3.5 Comparing the influence of infections with other enteric pathogens and T-cell-
induced colitis on Oligo-MM12 composition. 
In order to compare dysbiosis and the performance of individual commensal strains upon infection 
with S. Tm, Citrobacter rodentium and Clostridium difficile as well as T-cell-induced colitis, we used 
gnotobiotic C57BL/6J mice associated with the Oligo-MM12 and aimed to identify unbiased and 
general aspects of dysbiosis induced by gut inflammation.  
3.5.1 Citrobacter rodentium infection does not lead to dysbiosis in Oligo-MM12 mice 
For infection, 8 Oligo-MM12 mice were distributed in 3 gnotocages (2 x n=3 and 1 x n=2) and orally 
infected with 1 x 108 CFUs of Citrobacter rodentium DBS100 (C. rodentium) in a one day interval. This 
procedure was performed, in order to avoid daily opening of gnotocages for sampling of feces. Feces 
was taken at the indicated time points for microbiota analysis, determination of C. rodentium CFUs 
and for LCN-2 quantification until mice were sacrificed at day 42 p.i.. C. rodentium colonized 
efficiently already at day 1 p.i. with 3.14 x 107 CFUs peaking at day 11 p.i. with 1.26 x 108 CFUs in 
feces. After day 11 p.i., C. rodentium loads started to decline until plateauing from day 19 p.i. on with 
8.15 x 106 CFUs, where they remained until day 42 p.i. (Figure 32A). The colonization with C. 
rodentium correlated with increased fecal LCN-2 levels starting from day 7 p.i. on. LCN-2 levels 
peaked around day 15 and day 16 p.i. and decreased afterwards. This is in line with a previous study 
showing highest colitis at day 14 p.i. (Gustafsson et al. 2013). From day 23 p.i. on, LCN-2 levels were 
below or close to the detection limit, indicating resolution of intestinal inflammation (Figure 32B). C. 
rodentium induced around 4 times less LCN-2 at day 15 p.i. (around 500 ng/mg feces) compared to S. 
TmWT at day 4 p.i. (Figure 11B). Moreover, C. rodentium infection failed to induce dysbiosis during the 
course of the experiment. C. rodentium levels were less than 1% of total microbiota (Figure 32C). The 
relative cecum weight at day 42 post infection with C. rodentium was comparable to the relative 
cecum weight at day 4 p.i. with S. TmAvir (Figure 16F), indicating no pathological changes (Figure 33D). 
There were low levels of C. rodentium found in mesenteric lymph nodes, liver or spleen tissues at day 
42 p.i. (Figure 33A-C). 
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Figure 32: Course of Citrobacter rodentium infection in Oligo-MM12 mice. 8 Oligo-MM12 mice were distributed 
in 3 sterile gnotocages (2 x n=3, 1 x n=2) and infected with 1 x 108 CFUs of C. rodentium (DBS 100) in a 1 day 
interval. Feces was sampled at the indicated time point in order to determine C. rodentium loads, to analyze 
microbiota composition and to determine LCN-2 levels. (A) C. rodentium loads in feces day 0 – day 38 p.i. and 
cecal content day 42 p.i. (CFUs S. Tm / g content). Mice from different gnotocages are colored differently. (B) 
Lipolcalin-2 (LCN-2) amount in feces day 0 - day 37 p.i. and cecal content day 42 p.i. measured by ELISA (ng / mg 
content). (C) Analysis of fecal microbiota composition. Microbiota composition is shown as relative abundance 
and expressed as % of cumulated 16S rRNA gene copy numbers (% of total 16S rRNA gene copies). The amount 
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of absolute 16S rRNA gene copies (determined by an universal primer / probe combination) is illustrated as 
black dots (right y axis). * Limit of detection (DTL). 
 
 
Figure 33: Systemic Citrobacter rodentium loads at day 42 p.i.. (A) – (C) Systemic C. rodentium loads in 
mesenteric lymphnodes, liver and spleen (CFUs / organ) determined at day 42 p.i.. (D) Relative cecum weight at 
day 42 p.i. expressed as % of body weight. Dashed lines: DTL: limit of detection (mLN: 10 CFUs, liver: 60 CFUs, 
spleen: 20 CFUs). 
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3.5.2 Clostridium difficile infection shifts Oligo-MM12 composition at day 3 p.i. 
All infections with Clostridium difficile DH196 (C. difficile) were performed by Nicolas Studer of Prof. 
Hapfelmeier`s group (University of Bern). Feces or cecal content were taken at the indicated time 
points (Figure 34) and DNA was extracted by Nicolas Studer using the modified stool kit from Qiagen. 
Plating of intestinal contents as well as LCN-2 ELISA was also performed by Nicolas Studer. The 
extracted intestinal DNA was subsequently sent to Munich and the microbiota was analyzed by qPCR.  
Briefly, Oligo-MM12 mice were orally infected with 103 of C. difficile DH196 spores in 100 µl of sterile 
PBS and samples were taken at the indicated time points (Figure 35). C. difficile colonized Oligo-MM12 
mice starting from day 1 p.i. (1.61 x 105 CFUs) on with 4.29 x 107 CFUs at day 3 p.i. (Figure 34A). 
Colonization with C. difficile also paralleled with elevated LCN-2 levels (Figure 34B). Looking at the 
microbiota composition, C. difficile shifted the Oligo-MM12 composition at day 3 p.i. and dominated 2 
out of 5 samples (Figure 35A). Shifts were mainly characterized by decreased relative abundance of 
‘Bacteroides caecimuris‘ I48 and ‘Muribaculum intestinale‘ YL27 and increased relative abundance of 
Firmicutes strains especially Clostridium innocuum I46 and Akkermansia muciniphila YL44 (Figure 
35A). Cluster analysis was additionally performed. Grouping of microbiota composition by days and 
infection was significant, according to Bray Curtis (p<0.001, Adonis) and Pearson (p<0.001, Adonis) 
distance matrices, with 66% as well as 76% of variation explained. The Oligo-MM12 composition of 
samples from uninfected mice as well as infected mice clustered together until day 1 p.i. (Figure 
35B,C). At day 3 p.i. with C. difficile, the Oligo-MM12 composition clustered significantly different 
(Non parametric PERMDISP procedure; Figure 35B,C). Further details of microbiota composition are 
shown in section 3.5.4. 
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Figure 34: Clostridium difficile loads and Lipocalin-2 levels in Oligo-MM12 mice. (A) C. difficile loads in feces 
(uninfected and day 1 p.i.) and in cecal content (day 3 p.i.; CFUs / g content). (B) Lipolcalin-2 (LCN-2) amount in 
feces (uninfected and day 1 p.i.) and in cecal content (day 3 p.i.) measured by ELISA (ng / g content). DTL: limit 
of detection. 
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Figure 35: Clostridium difficile shifts Oligo-MM12 composition at day 3 p.i.: Oligo-MM12 mice were infected 
with 1 x 103 spores of C. difficile DH196 and kept in individually ventilated cages during the course of the 
experiment. In order to analyze microbiota composition, feces was taken before infection as well as at day 
1p.i.. Cecal content was additionally harvested at day 3 p.i.. (A) Analysis of microbiota composition in feces and 
cecal content. Microbiota composition is shown as relative abundance and expressed as % of cumulated 16S 
rRNA gene copy numbers (% of total 16S rRNA gene copies). The amount of absolute 16S rRNA gene copies 
(determined by an universal primer / probe combination) is illustrated as black dots (right y axis). Clustering of 
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Oligo-MM12 composition in feces and cecal content after oral infection with 1 x 103 CFUs of C. difficile DH196 
spores is based on Bray Curtis (B) or Pearson (C) distance matrices and visualized as PCoA plots. Microbiota 
samples were grouped by infection with C. difficile or uninfected and days p.i. which was significant, according 
to Bray Curtis (p<0.001, Adonis) and Pearson (p<0.001, Adonis) with 66% (Bray Curtis) and 76% (Pearson) of 
variation explained. PERMDISP analyses based on Bray Curtis and Pearson distance matrices revealed 
statistically significant differences in fecal microbiota composition especially between day 3 p.i. with C. difficile 
and earlier time points (* p<0.05, ** p<0.01, *** p<0.001). 
 
3.5.3 Reversible, T-cell-induced colitis in RAG1-/- mice associated with the Oligo-MM12 and 
Helicobacter typhlonius induced mild microbiota shifts 
The reversible colitis model (Brasseit et al. 2016) was established in the laboratory of Prof. Mueller 
(University of Bern) and all mouse experiments shown here were conducted by Martin Faderl. Briefly, 
RAG1-/- Oligo-MM12 mice that were either generated by cohousing germfree RAG-/- with Oligo-MM12 
donor mice or by direct association of germfree RAG1-/- with the Oligo-MM12 consortium were 
gavaged with 2 x 108 CFUs of Helicobacter typhlonius CCUG48335T (H. typhlonius). 14 days later 
colitogenic CD45RBhi T-cells or PBS were adoptively transferred. In order to induce remission of 
colitis, mice were treated with α–CD4 antibodies (or isotype control) in 3 days intervals starting from 
day 24 post t-cell transfer. Mice were euthanized at day 34 post T-cell transfer and samples were 
prepared (Figure 36). Fecal DNA was extracted by Martin Faderl using the modified stool kit (Qiagen) 
and samples were sent to Munich for microbiota analysis by qPCR. LCN-2 levels were also 
determined in Bern.  
At day 34 post T-cell transfer, RAG-/- Oligo-MM12 mice associated with H. typhlonius showed elevated 
LCN-2 levels after treatment with α–CD4 antibodies or isotype, whereas mice which were only 
associated with H. typhlonius missing CD45RBhi T-cells (PBS group) were uninflamed (Figure 37). 
Antibody mediated CD4+ T-cell depletion had no significant effect on LCN-2 levels and Inflammation. 
Inflammation correlated with moderate shifts in Oligo-MM12 composition observed in the CD45RBhi + 
α–CD4 antibody or isotype control groups. However, shifts were very mild and characterized by 
increasing relative abundance of Clostridium innocuum I46 and Enterococcus faecalis KB1 (Figure 
38A). Grouping of microbiota composition by treatment (PBS, CD45RBhi + α–CD4 antibody, CD45RBhi 
+ isotype) was not significant, according to both Bray Curtis (p=0.091, Adonis) and Pearson 
correlation (p=0.201, Adonis), with only 12% as well as 14% of variation explained. There was no 
statistically significant difference between groups (p>0.05, Non parametric PERMDISP procedure; 
Figure 38B,C). This further indicates that microbiota shifts observed in this model were rather subtle. 
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Figure 36: Reversible colitis model: germfree RAG1-/- mice were either cohoused with C57BL/6J Oligo-MM12 
mice for 20 days in order to allow vertical bacterial transmission or were directly associated with the Oligo-
MM12 (not shown in scheme). 14 days prior to the adoptive transfer of colitogenic CD45RBhi T-cells or PBS 
(control), mice were orally (p.o.) inoculated with 2 x 108 CFUs of H. typhlonius CCUG48335T (H. typh.). In order 
to induce remission of colitis, mice were treated with α-CD4 antibody (or isotype control) in 3 days intervals 
starting from day 24 post T-cell transfer. Mice were euthanized at day 34 post T-cell transfer and intestinal 
content was collected. 
 
 
Figure 37: Lipocalin-2 amounts in RAG-/- Oligo-MM12 mice transferred with CD45RBhi T-cells or PBS control 
with α-CD4 antibody or isotype treatment. Lipocalin-2 (LCN-2) levels in feces at day 34 post T-cell transfer 
measured by ELISA (ng / g feces). DTL: limit of detection. Statistical analysis between groups was performed 
using Kruskal-Wallis test with Dunn's multiple comparison test (* p<0.05, ** p<0.01). 
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Figure 38: Oligo-MM12 composition slightly shifts during colitis in RAG1-/- Oligo-MM12 mice associated with 
Helicobacter typhlonius and colitogenic T-cells. For experimental set-up refer to Figure 36. (A) Analysis of fecal 
microbiota composition at day 34 post T-cell transfer. Microbiota composition is shown as relative abundance 
and expressed as % of cumulated 16S rRNA gene copy numbers (% of total 16S rRNA gene copies). The amount 
of absolute 16S rRNA gene copies (determined by an universal primer / probe combination) is illustrated as 
black dots (right y axis). LCN-2 levels are indicated as white dots (ng / g feces, 2nd right y-axis). The limit of 
detection (DTL) of the LCN-2 ELISA is marked as white line. Cluster analysis of Oligo-MM12 composition in 
intestinal content after infection with H. typhlonius and transfer of colitogenic T-cell as well as α-CD4 antibody 
(or isotype control) is based on Bray Curtis (B) or Pearson (C) distance matrices and visualized as PCoA plots. 
Microbiota samples were grouped by treatment (PBS, CD45RBhi + α–CD4 antibody, CD45RBhi + isotype) which 
was not significant, according to both Bray Curtis (p=0.091, Adonis) and Pearson (p=0.201, Adonis) distance 
matrices, with only 12% as well as 14% of variation explained. PERMDISP analyses based on Bray Curtis and 
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Pearson distance matrices revealed no statistically significant differences in Oligo-MM12 composition after 
different treatments (p>0.05). 
 
3.5.4 Comparison of the impact of infections with S. Tm, C. rodentium and C. difficile as 
well as T-cell-induced colitis on the Oligo-MM12 composition 
Next, the impact of infections with different enteric pathogens and T-cell-induced colitis on Oligo-
MM12 composition was compared. All laboratories used C57BL/6J mice stably associated with the 
Oligo-MM12 consortium. Baseline compositions of uninfected mice between labs slightly differed 
(non parametric PERMDISP procedure; Figure 39B,C). At baseline, there was already H. typhlonius 
present in Oligo-MM12 mice used for the reversible colitis model. However, Oligo-MM12 composition 
was similar between laboratories, since the Oligo-MM12 composition grouped by infection and days 
post infection clustered together. Only the Oligo-MM12 composition of mice housed in the MvP 
(Munich) clustered separately (Figure 39B,C). Grouping of microbiota composition by infection with 
different pathogens and days post infection was significant, according to both Bray Curtis (p<0.001, 
Adonis) and Pearson (p<0.001, Adonis) distance matrices, with 84% as well as 89% of variation 
explained. Oligo-MM12 composition after infections with C. rodentium at day 15 and day 16 p.i., S. 
TmWT at day 3 p.i. as well as after H. typhlonius infection with consecutive CD45RBhi T-cell transfer 
plus α-CD4 or isotype antibody were still comparable to their respective baseline microbiota 
composition. Interestingly, only S. Tm and C. difficile were able to ‘bloom’ and dominate the 
microbiota at day 4 and day 3 p.i., respectively (Figure 39). Oligo-MM12 composition at day 4 p.i. with 
S. TmWT as well as at day 3 p.i. with C. difficile clustered apart from each other and differed also 
significantly compared to baseline microbiota and Oligo-MM12 compositions after infection with C. 
rodentium and after T-cell-induced colitis (non parametric PERMDISP procedure; Figure 39B,C).  
Domination of Salmonella with 97.64% +/- 2.14% (mean % +/- SD) and C. difficile with 38.77% +/- 
32.58% of total microbiota was accompanied by drastically decreased fold changes in absolute 
abundance as well as relative abundance of ‘Bacteroides caecimuris‘ I48 and ‘Muribaculum 
intestinale‘ YL27 between non-inflamed (baseline) and inflamed (Tables 54; 55). On the Contrary, 
both strains were still at the baseline level post infection with C. rodentium or H. typhlonius together 
with CD45RBhi T-cell transfer (Table 54). C. rodentium only constituted 0.05% +/- 0.09% and H. 
typhlonius 0.87% +/- 1.56% of total microbiota (Table 55). In contrast to infection with S. TmWT at day 
4 p.i., Akkermansia muciniphila YL44 was not decreased and seemed even to profit from infection 
with C. difficile at day 3 p.i. (Figure 39A). The abundance of ‘Turicimonas caecimuris‘ YL45 and 
Clostridium clostridioforme YL32 was decreased after infection with S. TmWT and C. difficile but 
remained unchanged after infection with C. rodentium and slightly increased after H. typhlonius 
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infection together with CD45RBhi T-cell transfer (Table 54). The abundance of Blautia coccoides YL58 
and Flavonifractor plautii YL31, strains that stay constant during inflammation (Figure 14) was rather 
unchanged after infection with C. difficile, C. rodentium or H. typhlonius together with CD45RBhi T-cell 
transfer (Table 54). Remarkably, compared to baseline the abundance of Clostridium innocuum I46 
was increased after infection with C. difficile and H. typhlonius together with CD45RBhi T-cell transfer 
representing 3.30% +/- 3.03% as well as 4.29% +/- 5.38% of total microbiota composition (Tables 54; 
55; Figure 39A). This increase was absent after infection with Salmonella or C. rodentium. 
Enterococcus faecalis KB1 and Lactobacillus reuteri I49, also increased after Salmonella induced 
inflammation (Figure 14) and benefited from infection with C. difficile and H. typhlonius together 
with CD45RBhi T-cell transfer (KB1: both, I49 only C. difficile; Table 54; Figure 39A). Additionally, 
‘Acutalibacter muris‘ KB18 was detected in samples from Prof. Hapfelmeier’s (Bern H) and Prof. 
Mueller’s (Bern M) laboratories. The abundance of KB18 was decreased after infection with C. 
difficile and H. typhlonius together with CD45RBhi T-cell transfer (Table 54).  
Taken together, S. Tm and C. difficile were able to induce severe dysbiosis characterized by 
decreasing abundance of Gram-negatives and an expansion of Enterococcus faecalis KB1 and 
Lactobacillus reuteri I49. S. Tm even dominated the microbiota with 97.64% of total microbiota 
composition. In stark contrast, C. rodentium failed to shift the Oligo-MM12 composition and H. 
typhlonius together with CD45RBhi T-cell transfer induced moderate microbiota shifts. C. difficile as 
well as H. typhlonius together with CD45RBhi T-cell transfer facilitated the growth of Clostridium 
innocuum I46. In addition, C. difficile infection might also be important for the expansion of 
Akkermansia muciniphila YL44. 
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Figure 39: Comparison of the impact of infections with S. Tm, C. difficile and C. rodentium as well as colitis 
induced by colitogenic T-cells on the Oligo-MM12 composition. (A) Analysis of microbiota composition in 
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intestinal content (feces: Munich, Bern M, Bern H baseline; cecal content: Bern H day 3 p.i.). Microbiota 
composition is shown as relative abundance and expressed as % of cumulated 16S rRNA gene copy numbers (% 
of total 16S rRNA gene copies). Baseline Oligo-MM12 compositions in the laboratories of Prof. Stecher (MvP, 
Munich), Prof. Hapfelmeier (Bern H) and Prof. Mueller (Bern M) before CD45RBhi T-cell transfer were compared 
to the Oligo-MM12 composition after infection with different enteric pathogens or CD45RBhi T-cell transfer as 
indicated. Cluster analysis of Oligo-MM12 composition in intestinal content after infection with different 
pathogens is based on Bray Curtis (B) or Pearson (C) distance matrices and visualized as PCoA plots. Microbiota 
samples were grouped by infection with different pathogens and days post infection which was significant, 
according to both Bray Curtis (p<0.001, Adonis) and Pearson (p<0.001, Adonis) distance matrices, with 84% as 
well as 89% of variation explained. PERMDISP analyses based on Bray Curtis and Pearson distance matrices 
revealed statistically significant differences in Oligo-MM12 composition especially after infection with S. TmWT 
(day 4 p.i.), C. difficile (C. diff., day 3p.i.) and other pathogens and time points (* p<0.05, ** p<0.01, *** 
p<0.001). 
 
Table 54: Fold difference in absolute abundance (fold change) of individual Oligo-MM12 strains 
observed after infection with different enteric pathogens and T-cell-induced colitis 
Strain 
Infection 
S. TmWT 
(F d1 vs F d4) 
C. difficile 
(F d1 vs Cec d3) 
H. typh.+CD45RBhi 
(uninfl. vs infl.) 
C. rodentium 
(F d1 vs Fd 15+16) 
Akkermansia muciniphila YL44 -6,945 1 -1 -1 
‘Bacteroides caecimuris’ I48 -5,811 -154 1 1 
‘Muribaculum intestinale’ YL27 -5,799 -168 -1 -2 
‘Turicimonas caecimuris’ YL45 -4,105 -49 -1 -1 
Clostridium clostridioforme YL32 -317 -14 2 1 
     
Blautia coccoides YL58 -44 1 -1 -1 
Flavonifractor plautii YL31 -10 -4 -1 -2 
Clostridium innocuum I46 -2 13 3 -1 
     
Enterococcus faecalis KB1 13 25 5 1 
Lactobacillus reuteri I49 14 4 1 1 
     
‘Acutalibacter muris’ KB18 DTL -474 -172 DTL 
Bifidobacterium longum subsp. 
animalis YL2 DTL 19 DTL DTL 
     
S. TmWT 9,032 - - - 
C. difficile - 41,783 - - 
H. typhlonius - - -1 - 
C. rodentium - - - -1 
Fold changes between different time points post infection as indicated in brackets were calculated with 
absolute values that were normalized to a million gene copies determined by universal probe. Bacteria were 
grouped in categories as in Figure 14: bacteria that were depleted by pathogen induced inflammation (YL44, 
I48, YL27, YL45 and YL32); Oligo-MM12 strains that coped better with colitis (YL58, YL31 and I46); strains that 
were enriched during inflammation (KB1 and I49); strains that were hardly detected by qPCR (KB18 and YL2) 
and pathogens. DTL: limit of detection. 
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Table 55: Relative abundance of Oligo-MM12 strains in intestinal content after infection with 
different enteric pathogens and T-cell-induced colitis 
Strain 
mean % of cumulated 16 S rRNA gene copy numbers  
(+/- SD) 
Inflammation induced by infection with 
S. Tm C. difficile H. typh. + 
CD45RBhi/Iso 
C. rodentium 
‘Bacteroides caecimuris’ I48 0.12 (0.26) 
0.81 
(1.05) 
40.44b,d 
(11.95) 
70.11c,e,f 
(2.98) 
‘Muribaculum intestinale’ YL27 0* 0.26 (0.40) 
9.29 
(5.91) 
13.68c,e 
(1.65) 
Akkermansia muciniphila YL44 0.001 (0.004) 
38.15a 
(38.15) 
29.73b 
(6.83) 
6.29e,f 
(1.24) 
‘Turicimonas caecimuris’ YL45 DTL 1.45 (2.70) 
5.96 
(1.40) 
3.71 
(0.84) 
Lactobacillus reuteri I49 0.59 (0.52) 
0.85 
(1.70) 
0.88 
(2.50) 
0.06 
(0.03) 
Enterococcus faecalis KB1 0.37 (0.38) 
1.39 
(0.96) 
2.51 
(8.18) 0* 
Blautia coccoides YL58 DTL 5.94 (7.52) 
2.58 
(3.01) 
1.02 
(0.15) 
Clostridium innocuum I46 0.02 (0.05) 
3.30 
(3.03) 
4.29 
(5.38) 
0.12 
(0.04) 
Flavonifractor plautii YL31 0.93 (1.29) 
8.55 
(16.46) 
2.34 
(0.67) 
2.01 
(0.54) 
Clostridium clostridioforme YL32 0.33 (0.66) 
0.21 
(0.32) 
1.10 
(0.94) 
2.95 
(1.49) 
‘Acutalibacter muris’ KB18 DTL 0.08 (0.17) 
0.01 
(0.04) DTL 
Bifidobacterium longum subsp. 
animalis YL2 DTL 
0.23 
(0.48) DTL DTL 
Pathogen 97.64 (2.14) 
38.77a 
(32.58) 
0.87b,d 
(1.56) 
0.05c,e 
(0.09) 
Oligo-MM12 after infections with S. TmWT, H. typhlonius (H. typh.) + CD45RBhi + isotype antibody and C. 
rodentium (C. rod.) was analyzed using fecal DNA. DNA from cecal content was used to determine the Oligo-
MM12 composition after infection with C. difficile (C. diff.). Significant differences between a S. Tm vs C. diff., b 
S. Tm vs H. typh., c S. Tm vs C. rod., d C. diff. vs H. typh., e C. diff. vs C. rod. and f H. typh. vs C. rod. are 
indicated; p values were less than 0.001, except: YL27 S. Tm vs C. rod. p<0.01 and YL27 C. diff. vs C. rod. p<0.05, 
two-way ANOVA with Bonferroni posttest. Values are expressed as mean % of cumulated 16 S rRNA gene copy 
numbers +/- standard deviation (SD). The microbiota was analyzed at the following days post infection: S. Tm: 
day 4 p.i. (n=7), C. difficile day 3 p.i. (n=5), H. typhlonius + CD45RBhi + isotype control antibody: day 34 p.i. 
(n=11) and C. rodentium: days 15 + 16 p.i. (n=6). * Very low abundant. DTL: limit of detection. 
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4. Discussion 
4.1 The Oligo-MM12, a novel consortium of gut commensals applicable for studies of 
host-microbe interactions 
Since the gut microbiota is highly complex, different gnotobiotic animal models have been developed 
in the past years ranging from low complexity with only one or two gut commensals to more complex 
communities (Freter and Abrams 1972, Klaasen et al. 1991, Bry et al. 1996, Dewhirst et al. 1999, 
Mahowald et al. 2009, Becker et al. 2011, McNulty et al. 2011) which enabled host-microbe 
interaction studies. These models microbiota were either collections of bacterial isolates from 
humans or were based on murine bacterial isolates, like the Altered Schaedler Flora (ASF). One has to 
take into account that phenotypes observed in animals associated with human bacteria (humanized 
animal models) might be biased because mutualistic microbiota-host effects mediated by long-term 
co-evolution between host-specific bacteria and host are missing and that different genetic 
backgrounds between humans and mice might additionally impact on bacterial colonization (Wos-
Oxley et al. 2012). Therefore, gnotobiotic mice associated with murine bacterial isolates, like the ASF 
would be more suitable for host-microbe interaction studies. However, the ASF is currently not 
available in public strain collections due to intellectual property rights.  
To this end, we have established a novel and highly defined model microbiota that consists of 12 
murine bacterial isolates, termed the Oligo-Mouse-Microbiota (Oligo-MM12) which can be easily 
applied to germfree mice and stably colonizes over filial generations. Remarkably, the bacterial 
consortium covers representatives of 5 eubacterial phyla including a novel family (‘Muribaculaceae’), 
genera (‘Acutalibacter muris’ and ‘Turicimonas muris’) and species (‘Bacteroides caecimuris‘ I48). 
Since the Oligo-MM12 strains grow reliably after freezing, the microbiota can be shipped and shared 
between different research facilities and can be therefore used as platform for comparable host-
microbe interaction studies. Moreover, the Oligo-MM12 strains are also included in the Mouse 
Intestinal Bacterial Collection (miBC) and are available to the research community (Lagkouvardos et 
al. 2016). Strain-specific FISH was additionally established. Moreover, the genome of each Oligo-
MM12 strain has been sequenced which enables correlations of phenotypes with gene functions. In 
addition, I have established strain-specific qPCR assays for quantification of individual Oligo-MM12 
strains making the Oligo-MM12 a valuable and versatile research tool for fast and affordable 
investigations.  
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4.1.1 Strain-specific quantitative real-time PCR enables reliable, fast and affordable 
quantification of individual Oligo-MM12 strains 
Strain-specific qPCR assays targeting hypervariable regions of the 16S rRNA gene (Figures 42) are 
now available for all Oligo-MM12 strains and enable fast microbiota analyses. In the past years, strain 
identification based on hypervariable regions of the 16S rRNA gene has become a method of choice 
since culturing of anaerobic gut commensals is challenging (Brown et al. 2013) and not suitable for 
determination of relative microbiota composition. In addition, powerful next generation 16S rRNA 
gene amplicon sequencing (NGAS) techniques were developed which enable strain identification in 
samples of unknown constitution. However, NGAS are biased by PCR errors, variable regions 
targeted, analysis pipelines used and depend on quality as well as completeness of reference 
databases such as SILVA or greengenes (Hiergeist et al. 2015), http://greengenes.lbl.gov/, 
https://www.arb-silva.de/). Therefore, novel species which are not yet included in a reference data 
base might not be detected or mistakenly attributed to wrong taxa. Thus, the novel Oliog-MM12 
strains ‘Acutalibacter muris’ KB18, ‘Muribaculum intestinale’ YL27 and ‘Bacteroides caecimuris‘ I48 
were assigned to Ruminococcaceae; Incertae Sedis (KB18), Bacteroidales; Incertae Sedis (YL27) and 
Bacteroides (I48) using SILVA data base (PhD thesis of Sandrine Brugiroux). In addition, the sensitivity 
of NGAS is relatively low. We obtained 10,000 sequencing reads per gram of intestinal content (1011 
bacteria per gram intestinal content) which translates into a detection limits of 107 CFUs per gram of 
intestinal content.  
Therefore, highly strain-specific, hydrolysis probe based qPCR assays were designed in this study 
which enable quantification of individual community members. Initial attempts to establish a SYBR 
green based qPCR protocol operating with only to specific primers were not successful because qPCR 
specificity and efficiency were not acceptable. The major problem was the design of strain-specific 
primer sets that target a short hypervariable region of the 16S rRNA gene and perform efficiently. 
Nevertheless, SYBR green based qPCR was used previously in other models (Barman et al. 2008, 
Ganesh et al. 2013). A third oligonucleotide, the hydrolysis probe together with new primers 
designed using the software Primer Express 3 (Applied Bio), finally increased strain-specificity and 
improved qPCR efficiency. Compared to NGAS, qPCR is affordable, faster, doesn’t depend on 
bioinformatical analysis tools and detects bacterial strains down to an abundance of 104 – 105 
CFUs / g intestinal content (Brugiroux et al. 2016) which is 100 – 1,000 times more sensitive 
compared to NGAS. However, like NGAS, qPCR is biased by the DNA extraction method which can 
yield different Gram-negative / Gram-positive ratios according to the lysis efficiency of the DNA 
extraction method (data not shown) and doesn’t allow to detect contaminations because it enables 
only detection of specifically targeted bacteria. One has to take into account that both methods, 
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NGAS and qPCR, are biased concerning the 16S rRNA gene copy number per genome. Since bacteria 
have different copy numbers of 16S rRNA gene operons, the actual abundance of individual 
commensals might be miss-calculated. For this reasons, one should consider normalizing the 16S 
rRNA gene copy numbers per amount of 16S rRNA operon numbers present in the genome or 
additionally using DNA and 16S rRNA gene independent methods, in order to verify NGAS or qPCR 
results. Strain-specific FISH that targets ribosomal rRNA would be an option. Nevertheless, strain-
specific qPCR is a valuable method for studying changes in bacterial composition upon different 
treatments or disturbances. 
4.1.2 The Oligo-MM12 as a tool to study kinetics of microbiota maturation as well as shifts 
in microbial composition and phenotypes upon changes in diet 
We studied colonization kinetics of the Oligo-MM12 once administered orally in germfree mice 
(Figure 6). Interestingly, we observed 3 maturation stages (early, intermediate and stable). The 
microbiota adopted a stable composition after 7 days post inoculation. At the early stage (day 1 post 
inoculation), the microbiota was dominated by Akkermansia muciniphila YL44, ‘Bacteroides 
caecimuris‘ I48 and Bifidobacterium longum subsp. animalis YL2 and relative abundance of 
Enterococcus faecalis KB1 was also elevated (Figure 6; Table 40). At this stage, these specific Oligo-
MM12 strains might profit from direct access to the host mucus which might be especially 
metabolized by Akkermansia muciniphila YL44 (Derrien et al. 2004). In addition, oxygen that might be 
present in the gut of germfree mice lacking microbiota derived butyrate which renders the 
epithelium hypoxic (Rivera-Chávez et al. 2016) might promote growth of Enterococcus faecalis KB1. 
Enterococcus faecalis KB1 has been shown to expand in aerobic liquid culture (data shown in MD 
thesis of Patrick Schiller). Oxygen might be additionally tolerated by Bifidobacterium longum subsp. 
animalis YL2 (Andriantsoanirina et al. 2013). Along this line, Martin and co-workers also identified 
Bifidobacterium species as early colonizers of the infant gut (Martin et al. 2016). Obligate anaerobic 
members, e.g. ‘Bacteroides caecimuris‘ I48 might thrive later when oxygen is consumed. During early 
colonization, accessibility of dietary nutrients plays a role during microbiota maturation. It could be 
shown that the abundance of Bacteroidetes and Bifidobacterium was predominant in infants after 
weaning and transition to table foods (Fallani et al. 2011, Koenig et al. 2011) and later also 
abundance of Firmicutes such as Clostridium spp. increased (Bergström et al. 2014). Thus, the 
maturation of the Oligo-MM12 partially resembles the maturation of the human microbiota.  
During the intermediate stage (days 2 - 4 post inoculation), there was a peak in relative abundance of 
‘Bacteroides caecimuris‘ I48 and also relative abundance of ‘Turicimonas caecimuris‘ YL45, 
‘Muribaculum intestinale‘ YL27 and Flavonifractor plautii YL31 increased by trend. The relative 
abundance of Akkermansia muciniphila YL44 and Bifidobacterium longum subsp. animalis YL2 
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dropped compared to the early stage (Figure 6; Table 40). A further decrease in oxygen 
concentration and altered mucus structure and composition upon bacterial colonization might be the 
reasons for this microbiota shift. The mucus layer is divided in a tight inner layer which serves a 
barrier and a loose outer layer which is colonized by bacteria (Johansson et al. 2008). Interestingly, 
Johansson and colleagues further observed that colonization of germfree mice with conventional 
microbiota led to the development of a tight inner and a loose outer mucus layer which coincided 
with increased abundance of Bacteroidetes and decreased abundance of Firmicutes in the distal 
colon during early colonization (Johansson et al. 2015), suggesting that new niches for intestinal 
commensals become available during the maturation of the mucus layer.  
From day 7 post inoculation on, the Oligo-MM12 composition stabilized. At this stage, Bifidobacterium 
longum subsp. animalis YL2 and Enterococcus faecalis KB1 were hardly detectable (limit of detection: 
13 and 25 16S rRNA gene copy number per 5 ng template DNA, respectively). ‘Muribaculum 
intestinale‘ YL27 and Akkermansia muciniphila YL44 expanded and the relative abundance of 
‘Bacteroides caecimuris‘ I48 was reduced, but ‘Bacteroides caecimuris‘ I48 was still the dominating 
species. The relative abundance of other Firmicutes and ‘Turicimonas caecimuris‘ YL45 was 
comparable to intermediate stage (Figure 6; Table 40). Remarkably, ‘Acutalibacter muris‘ KB18 was 
only detected in the inoculum indicating that this strain was outcompeted by the residual Oligo-
MM12 commensals at least under housing conditions in our facility. According to qPCR based 
microbiota analyses, 10 out of 12 Oligo-MM12 strains were detected when the microbiota has fully 
matured. Bifidobacterium longum subsp. animalis YL2 and ‘Acutalibacter muris‘ KB18 (limit of 
detection: 1 16S rRNA gene copy number per 5 ng template DNA) were below the limit of detection 
of the respective qPCR assay during the stable stage.  
Since this characteristic maturation kinetic of the microbiota was observed after colonizing germfree 
mice with the Oligo-MM12 consortium, this model could be further used to conduct mechanistic 
studies of microbe-host or microbe-microbe interactions during early colonization of a germfree 
host. On the one hand the structure and composition of the mucus layer (Johansson et al. 2015), 
direct microbe-microbe interactions and increased oxygenation (Rivera-Chávez et al. 2016) might 
shape microbial composition during early colonization. On the other hand also the maturation of the 
host immune system during colonization including secretion of antimicrobial peptides and IgA, 
cytokine production as well as induction of certain T- and B-cells might be involved in shaping the 
microbiota composition (Macpherson and Uhr 2004, Cash et al. 2006, Atarashi et al. 2008, Vaishnava 
et al. 2008, Sonnenberg et al. 2012, Atarashi et al. 2013). Transcriptomics of the host epithelium and 
RNAseq of the Oilig-MM12 during early colonization could shed more light on host-microbe 
interaction during early colonization. 
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Moreover, we switched standard diet to high-fat (HF) diet and supplemented oleic acid (OA) and 
monitored to Oligo-MM12 composition at 6, 12, 24 h post diet change. HF and OA increased relative 
abundance of Akkermansia muciniphila YL44 and lowered abundance of ‘Bacteroides caecimuris‘ I48 
compared to standard diet (Figure 9; Table 43). This is in line with a previous study in mice were HF 
and high sugar (HS) diet also increased relative abundance of Firmicutes and Verrucomicrobia as well 
as decreased abundance of Bacteroidetes (Carmody et al. 2015). A study conducted with 
malnourished and healthy children revealed that HF diet caused also a decrease in Bacteroidetes and 
an increase in Proteobacteria (E. coli and Klebsiella spp.) in human infants (Monira et al. 2011). In 
addition, Microbiome analysis of obese individuals revealed decreased abundance of Bacteroidetes, 
Bifidobacterium and butyrate producing Firmicutes as well as higher abundance of Actinobacteria 
and Lactobacillus spp. (Duncan et al. 2008, Armougom et al. 2009, Turnbaugh et al. 2009, Million et 
al. 2012). This change in microbiota composition might be attributed to a lower content of non-
digestible carbohydrate (fiber) in HF / HS diet, which is usually fermented by commensals in the 
lower gastro-intestinal tract (Walker et al. 2011). 
Interestingly, the presence of Akkermansia renders the host more susceptible to infection with S. Tm 
(Ganesh et al. 2013). However, parallels between different diets, changes in microbiota composition 
and susceptibility to enteric infection need to be studied elsewhere in more detail. 
4.1.3 The Oligo-MM12 that is stable over several generations and between animal facilities 
is a robust model microbiota for the research community 
By breeding mice associated with the Oligo-MM12 under germfree conditions, we showed that the 
microbiota is vertically transmitted from parental (P) to filial (F) generations. Remarkably, the Oligo-
MM12 composition was stable over at least 6 generations (Figure 7). Bifidobacterium longum subsp. 
animalis YL2 was not detected in any generation and ‘Acutalibacter muris‘ KB18 could be only 
detected at low levels in fecal samples from the P and F1 generation (Table 41). According to cluster 
analysis, especially the Oligo-MM12 composition of the P generation was different compared to that 
of the F generations (Figure 7B,C). Here, it is worth mentioning that the Oligo-MM12 mice were 
generated at the CMF in Bern (generations P and F1) and later distributed to the MvP in Munich 
(generations F2 – F6) and also to the ETHZ. Thus, different housing conditions and chow might be the 
reason for the slight differences in overall microbiota composition observed between the parental 
and filial generations as described previously (Rausch et al. 2016). There were additional fluctuations 
of relative abundance of ‘Bacteroides caecimuris‘ I48 and Akkermansia muciniphila YL44 between the 
generations F1 – F4 (Table 41). However, these differences in microbial composition were subtle and 
thus the overall Oligo-MM12 composition was considered as robust over 6 generations. 
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The Oligo-MM12 was designed as a reductionist model for host-microbe interaction studies that is 
available to a broad research community. So far, the Oligo-MM12 is already established at different 
animal facilities. Therefore, we next wanted to investigate the influence of different housing 
conditions on the overall Oligo-MM12 composition, because a similar microbiota composition 
between animal facilities is a prerequisite for comparability of data. Thus, microbiota composition of 
Oligo-MM12 mice housed at the CMF in Bern (either in isolators or in individually ventilated cages 
(IVC)), in the ETHZ and the MvP in Munich were compared in this study (Figure 8). All qPCR based 
microbiota analyses were conducted by one person in order to minimize variability and to attribute 
subtle changes in microbial composition to different housing conditions. There were only minor 
differences in relative abundance of individual Oligo-MM12 strains of mice housed at the CMF and 
ETHZ (Table 42) and overall, β-analysis revealed that samples from different facilities were in one 
cluster (Figure 8C). In contrast, the overall Oligo-MM12 composition of mice housed at the MvP 
clustered slightly apart from samples of mice housed at the CMF and ETHZ (Figure 8D,C). 
Interestingly, ‘Acutalibacter muris‘ KB18 was only detected in mice housed at the CMF and ETHZ. 
These differences might be attributed to differences in chow used in the different housing facilities 
(MvP: ssniff; CMF and ETHZ: KLIBA NAFAG). Nevertheless, since overall Oligo-MM12 composition was 
highly similar between housing facilities, we conclude that the Oligo-MM12 is a highly defined and 
stable model microbiota that can be used to obtain reproducible analyses between different 
research facilities.  
4.2 The influence of Salmonella-induced gut inflammation on the indigenous 
microbiota in the Olgio-MM12 model 
S. Tm invades the gut ecosystem in a stepwise manner. It has been postulated that there are several 
stages of gut ecosystem invasion until S. Tm induces full blown disease (Figure 2) (Ferreyra et al. 
2014): first S. Tm has to break CR that is conferred by the indigenous microbiota. This initial step can 
be facilitated by antibiotic intake (Barthel et al. 2003, Ng et al. 2013, Rivera-Chávez et al. 2016). Once 
CR is broken the pathogen expands in the gut, it induces inflammation and outcompetes the resident 
microbiota by profiting from the nutritional environment of an inflammatory gut milieu and escapes 
host defense mechanisms (Raffatellu et al. 2009, Winter et al. 2010, Thiennimitr et al. 2011, Lopez et 
al. 2012). However, until now it is unclear which mechanisms underlying ecosystem invasion and 
Salmonella ‘blooming’ is the most important and how gut inflammation impacts on individual 
commensal species of a healthy gut microbiota.  
Here, mechanisms underlying Salmonella-induced ‘blooming’ and the impact of inflammation on 
individual commensal bacteria were investigated using the novel Oligo-MM12 consortium. To our 
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knowledge this is the first study that prioritizes the importance of anaerobic respiration, iron 
acquisition via siderophores and ethanolamine utilization by S. Tm during ‘blooms’ and concomitant 
dysbiosis using a defined gnotobiotic mouse model. Until now, it remains further elusive how 
infiltrating neutrophils, which might directly kill commensals and S. Tm, impact on the microbiota 
during Salmonella-induced colitis. Therefore, we compared the contribution of an altered nutritional 
environment of an inflammatory gut milieu and potential neutrophil-mediated killing of commensals 
to Salmonella-‘blooms’ and concomitant microbiota shifts. Furthermore, data how gut inflammation 
impacts on individual bacterial species are scarce. Here we performed detailed analyses how single 
Oiligo-MM12 commensals ‘perform’ during severe Salmonella-induced colitis and correlate survival 
with putative fitness genes of the commensals including sporulation, iron acquisition, anaerobic 
respiration and ethanolamine utilization.  
We show that the Oilgo-MM12 serve as excellent tool to study this questions. S. Tm expands in Oligo-
MM12 mice and induces severe colitis accompanied by systemic infection and drastic microbiota 
shifts by days 3 - 4 p.i. without antibiotic pre-treatment (Figures 10; 11). Interestingly, the Oligo-
MM12 mediates CR during early stages of infection (day 1 p.i.). However, after 2 days, S. Tm can 
further expand and finally ‘blooms’ at day 4 p.i.. Because of this step-wise infection process, Oligo-
MM12 mice manifest as ideal model to mechanistically study different stages of pathogen-mediated 
ecosystem invasion (Figure 40). The Oligo-MM12 is composed of defined murine isolates which 
guarantees long-term co-evolution between mouse commensals and the murine host. Other 
Salmonella colitis models rely on antibiotic pre-treatment prior to infection which breaks CR 
mediated by the microbiota (Barthel et al. 2003), are not well defined (Barman et al. 2008) or are 
based on a humanized microbiota (Ganesh et al. 2013). These model might be excellent for studying 
the impact of Salmonella infection on the host, however since the Oligo-MM12 is not antibiotic pre-
treated and well defined our model might be more suitable for studying microbe-pathogen and 
microbe-microbe interaction during S. Tm induced colitis. 
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Figure 40: The Oligo-MM12 is a useful tool to study Salmonella ecosystem invasion. Mice associated with the 
Oligo-MM12 were infected with 5 x 107 CFUs of S. Tm without antibiotic pre-treatment before infection. The 
microbiota confers colonization resistance (CR) at early stages of infection (day 1 p.i.). S. Tm starts to expand 
from day 2 p.i. on and induces already mild inflammation and slight changes in microbial composition at day 3 
p.i. (pathogen expansion). Remarkably, S. Tm dominates the microbiota at day 4 p.i. and induces severe colitis 
accompanied by massive dysbiosis and overall decrease in total bacteria (right y axis). This is not observed upon 
infection with an avirulent S. Tm strain. Since the microbiota composition is not disrupted by antibiotics, this 
model is excellent for studying the impact of S. Tm ecosystem invasion on individual commensals of the gut 
microbiota in a defined setting. 
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4.2.1 Profiling the performance of Oligo-MM12 strains in the presence of Salmonella-
induced gut inflammation during ecosystem invasion 
To our knowledge, this is the first study that shows the impact of gradual Salmonella-ecosystem 
invasion that is accompanied by inflammation on individual species of a normal gut microbiota using 
a gnotobiotic mouse model based on a highly defined consortium consisting of mouse-adapted 
bacterial strains.  
Upon infection with S. TmWT, Oligo-MM12 mice exhibited severe colitis at day 4 p.i.. Inflammation 
onset was already observed at day 3 p.i. (Figures 10; 11). Induction of colitis was dependent on 
functional Type 3 secretion systems (T3SS) because infection with an avirulent Salmonella strain S. 
TmAvir which is deficient in functional T3SS-1 and 2 failed to induce colitis in this model (Figures 10B; 
11B). Although T3SS-1 and 2 synergistically contribute to inflammation and Salmonella ‘blooming’, 
T3SS-1 seems to be of major importance (Figures 15; 16; 17). This observation is in line with previous 
S. Tm infection experiments conducted with streptomycin pre-treated C57BL/6J mice (Hapfelmeier et 
al. 2005) and FvB mice (Barman et al. 2008). Exacerbating inflammation was categorized in 3 stages 
according to inflammation grade and cecal pathology: non-inflamed (no colitis, pathoscore: 0 - 3, 
uninfected - day 2 p.i.), intermediate (moderate colitis, pathoscore: 3 - 9; day 3 p.i.) and inflamed 
(profound colitis, pathoscore: > 9; day 4 p.i.) (Figure 10B). Cluster analyses revealed that the Oligo-
MM12 composition in feces and cecal content differed at all stages of infection with S. TmWT (Figures 
12C,D; 13C,D).  
S. TmWT started to expand at day 3 p.i. (Figure 10C; Tables 44; 46). Since no antibiotics were applied 
prior to infection, this pathogen expansion might be fueled by microbiota derived hydrogen as shown 
previously (Maier et al. 2013). This hypothesis could be investigated by infecting Oligo-MM12 mice 
with Salmonella strains deficient in hydrogenases and additional monitoring of S. TmWT expansion at 
day 3 p.i. Co-infection experiments with a hydrogenase mutant S. Tm strain and S. TmWT could 
additionally be performed. Pathogen expansion was accompanied by increased cecal pathology 
(Figure 10B) and moderate changes in microbiota composition (Figures 10C; 12C,D; 13C,D). This 
change was characterized by decreased relative abundance of ‘Bacteroides caecimuris‘ I48 as well as 
increased relative abundance of Akkermansia muciniphila YL44 and Clostridium clostridioforme YL32 
(Tables 44; 46). One could hypothesize that reduced amounts of ‘Bacteroides caecimuris‘ I48 could 
increase the accessibility to host mucus structures which might favor growth of Akkermansia 
muciniphila YL44 (Derrien et al. 2004).  
Interestingly, Akkermansia muciniphila has been shown to further promote Salmonella pathology by 
affecting the mucosal barrier disturbing host-mucus homoeostasis (Ganesh et al. 2013) which might 
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be an additional early microbiota dependent mechanism (besides microbiota derived hydrogen) that 
primes Salmonella ‘blooming’. Additional S. Tm infection experiments with Olgio-MM11 mice lacking 
Akkermansia muciniphila YL44 could strengthen this hypothesis. Remarkably, compared to standard 
diet, HF diet and OA supplementation increased relative abundance of Akkermansia muciniphila YL44 
whereas relative abundance of ‘Bacteroides caecimuris‘ I48 was decreased (Figure 9). Therefore, 
these changes in nutrition might render to host more susceptible to Salmonella infection. This 
hypothesis is currently further investigated in the laboratory of Prof. Hardt (ETH, Zurich). The relative 
abundance of Clostridium clostridioforme YL32 in feces was also increased at day 3 p.i. with S. TmWT 
(Table 46). It could be demonstrated that a Clostridium clostridioforme strain was able to attach to 
and invade colonic epithelium cells which was followed by the induction of pro-inflammatory 
cytokines (Ohkusa et al. 2009). This induction of pro-inflammatory cytokines may further promote 
inflammation and thereby fuel Salmonella growth. This data suggest that during early stages of 
infection, S. Tm induces an inflammatory tone in the gut by favoring the growth of potentially 
colitogenic members of the indigenous microbiota. This increased inflammatory tone precedes 
pathogen ‘blooming’ and concomitant collateral damage of the microbiota. 
At day 4 p.i. with S. TmWT, full blown colitis and Salmonella ‘blooms’ were apparent (Figure 10). 
Absolute abundance of Salmonella increased around 8,000 – 9,000 fold in feces and cecal content 
(Figure 14). S. TmWT dominated the microbiota during this late stage of infection (more than 96% of 
total bacteria in feces and cecal content) which correlated with severe dysbiosis and decreased 
abundance of bacteria in the gut measured as total 16S rRNA gene copy numbers (Figure 10; Table 
44; 46). This decrease in overall bacteria upon S. Tm induced inflammation was also observed 
previously (Stecher et al. 2007). It has to be mentioned here, that the number of total bacteria was 
determined using an universal primer / probe combination targeting all Oligo-MM12 strains and 
Salmonella. Besides bacterial DNA, DNA recovered from the inflamed gut contains variable fractions 
of eukaryotic DNA extracted from shed epithelial cells (Sellin et al. 2014) and infiltrating neutrophils 
(Loetscher et al. 2012). Eukaryotic DNA cannot be distinguished from bacterial DNA. Therefore, less 
bacterial template DNA is applied for the qPCR assay which might mistakenly lead to 
underestimation of bacterial 16S rRNA gene copy numbers. Nevertheless, individual members of the 
Oligo-MM12 performed differently in the presence of S. TmWT-induced gut inflammation. Oligo-MM12 
strains were subsequently grouped in 3 categories, according to their increasing or decreasing 
abundance during Salmonella-induced colitis: depleted, intermediate and enriched (Figure 14). 
Especially absolute and relative abundance of Gram-negative strains belonging to the phyla 
Bacteroidetes, Proteobacteria and Verrucomicrobia: ‘Bacteroides caecimuris‘ I48, ‘Muribaculum 
intestinale‘ YL27, ‘Turicimonas caecimuris‘ YL45 and Akkermansia muciniphila YL44 as well as of the 
Gram-variable Firmicute Clostridium clostridioforme YL32 were highly reduced during full blown 
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S. Tm-induced colitis (Figure 14; Tables 44; 46). The strains that were assigned to the intermediate 
group: Blautia coccoides YL58, Flavonifractor plautii YL31 and Clostridium innocuum I46 belonged to 
the phylum Firmicutes and stained Gram-positive or Gram-variable. These strains could be more 
resistant to inflammation as relative and absolute abundance were less reduced during colitis (Figure 
14; Tables 44; 46). Remarkably, absolute abundance of Lactobacillus reuteri I49 and Enterococcus 
faecalis KB1, both Gram-positive Firmicutes increased during S. Tm-induced gut inflammation (Figure 
14). Bifidobacterium longum subsp. animalis YL2 and ‘Acutalibacter muris’ KB18 were below limit of 
detection of the respective qPCR assay even before onset of colitis. These strains might therefore by 
outcompeted by the residual Oligo-MM12 strains under MvP housing conditions.  
Interestingly, most observations are in line with previous studies based on streptomycin pre-treated 
mice, 129/SVJ mice, humanized C3H mice or FvB mice (Table 1) showing decreased abundance of 
Bacteroides spp., Verrucomicrobia (Akkermansia muciniphila), Firmicutes, Barnesiella spp. and 
Clostridium spp. as well as increased abundance of Salmonella and Enterococcus spp. (Stecher et al. 
2007, Barman et al. 2008, Ganesh et al. 2013, Kaiser et al. 2013) during Salmonella-induces colitis. 
However, in contrast to studies based on streptomycin pre-treated C57BL/6J mice performing 
competition experiments with Lactobacillus reuteri (L. reuteri RRRif) and wildtype Salmonella (Stecher 
et al. 2007) and on FvB mice (Barman et al. 2008) which report decreased abundance of Lactobacillus 
spp. upon Salmonella infection, the Oligo-MM12 strain Lactobacillus reuteri I49 increased during S. 
Tm-induced colitis.  
Lactobacillus reuteri strains can exert immune modulatory properties which contribute to 
suppression of inflammation. Therefore, L. reuteri is used as probiotic for treating inflammatory 
diseases (Thomas et al. 2016). Our observation that Lactobacillus reuteri I49 expands during 
pathogen induced inflammation further supports the applicability of L. reuteri as probiotic strain 
during inflammatory disease since this bacterium seems to withstand harsh inflammatory conditions. 
However, how Lactobacillus reuteri I49 exactly impacts on S. Tm-induced gut inflammation needs to 
be assessed experimentally. In addition to the Oligo-MM12, Oligo-MM11 mice lacking Lactobacillus 
reuteri I49 should be infected with S. TmWT and pro-inflammatory cytokine and LCN-2 levels as well as 
colitis scores should be compared between groups. These experiments might reveal possible immune 
modulatory effects of this strain. 
Enterococcus faecalis which, also seems to be adapted to inflammation, is on the one hand able to 
stimulate local mucosal immunity (Castro et al. 2016). On the other hand, Enterococcus faecalis is 
associated with disease, induction of pro-inflammatory cytokines (Diederich et al. 2016) and with the 
development of chronic intestinal inflammation which is accompanied by tissue damage caused by 
metalloprotease activity (Steck et al. 2011). Moreover, Enterococcus faecalis is able to form biofilms 
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which might render this strain more resistant to inflammation (Fabretti et al. 2006). Enterococcus 
faecalis can also be an opportunistic pathogen (Pham et al. 2014). Upon enteric infection with C. 
rodentium of Il22ra1tm1a/tm1a mice, commensal Enterococcus faecalis aggravated disease and caused 
systemic infection. This was dependent on fucosylation and on the diversity of anaerobic commensal 
symbionts that protected from Enterococcus faecalis out-growth, underlining the importance of a 
well-balanced microbiota which keeps opportunistic pathogens in check. Likewise, Enterococcus 
faecalis KB1 could also boost Salmonella pathology in the Oligo-MM12 model. This hypothesis could 
be tested with S. Tm infection of Oigo-MM11 mice lacking Enterococcus faecalis. Possible systemic 
Enterococcus faecalis levels as well as inflammation induced pathology should be compared between 
Oligo-MM12 and Oligo-MM11.  
Blautia coccoides YL58, Flavonifractor plautii YL31 and Clostridium innocuum I46 didn’t seem to 
benefit from severe colitis observed at day 4 p.i. with S. TmWT but decreased moderately in absolute 
and relative abundance. Interestingly, a previous study conducted by Tuovinen and colleagues 
showed that Blautia coccoides was able to induce TNF-alpha and IL-10 expression (Tuovinen et al. 
2013), indicating both an inflammatory and anti-inflammatory potential of this strain. Flavonifractor 
plautii has been shown to be involved in conversion of catechins a flavonoid subclass which is 
(together with its metabolites) beneficial for healthy (Kutschera et al. 2011). Clostridium innocuum is 
resistant to bile acids and was associated with the microbiota of an chronically inflamed gut 
(Wohlgemuth et al. 2011). This indicates that Blautia coccoides YL58 and Clostridium innocuum I46 
might contribute to inflammation.  
Absolute and relative abundance of ‘Bacteroides caecimuris‘ I48, ‘Muribaculum intestinale‘ YL27, 
‘Turicimonas caecimuris‘ YL45, Akkermansia muciniphila YL44 and Clostridium clostridioforme YL32 
decreased tremendously during full blown Salmonella-induced colitis. Since ‘Bacteroides caecimuris‘ 
I48, ‘Muribaculum intestinale‘ YL27 and ‘Turicimonas caecimuris‘ YL45 are novel species, so far 
knowledge about these bacterial strains is scarce. However, Ubeda and co-workers identified a 
protective effect of species belonging to the Barnesiella genus against vancomycin resistant 
Enterococcus infection (Ubeda et al. 2013). Since ‘Muribaculum intestinale‘ YL27 highly resembles 
Barnesiella, this Oligo-MM12 strain might be engaged in suppressing enterococcal ‘blooms’ during 
homoeostasis. Interestingly, Akkermansia muciniphila YL44 and Clostridium clostridioforme YL32 
which might have prepared the way for Salmonella-ecosystem invasion on earlier time points of 
infection were massively reduced during severe colitis at day 4 p.i.. 
In contrast, a Salmonella strain lacking functional T3SS-1 and 2 (S. TmAvir) was unable to induce colitis 
and concomitant dysbiosis during the course of infection in Oligo-MM12 mice (Figures 10; 11). This is 
in line with previous observations (Stecher et al. 2007). According to cluster analyses, there was no 
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difference in overall Oligo-MM12 composition in feces and cecal content at different days post 
infection with S. TmAvir (Figures 12A,B; 13A,B). However, there were minor but significant changes in 
relative abundance of Akkermansia muciniphila YL44 and ‘Bacteroides caecimuris‘ I48 in feces and 
cecal content. Especially, Akkermansia muciniphila YL44 was increased in cecal content at day 3 p.i. 
with S. TmAvir, whereas relative abundance of ‘Bacteroides caecimuris‘ I48 decreased (Tables 45; 47). 
This could be an effect mediated by the presence of Salmonella or could just simply be microbiota 
variations observed between different experiments since fluctuations in relative abundance of 
Akkermansia muciniphila YL44 and ‘Bacteroides caecimuris‘ I48 were also observed in studies of 
Oligo-MM12 stability over generations (Figure 7; Table 41). 
4.2.2 Performance of Oligo-MM12 strains in a colitic environment correlates with the 
presence fitness genes 
We hypothesized that the performance of individual Oligo-MM12 strains is dependent on certain 
fitness genes that were previously shown to enable survival or even provide Salmonella a benefit 
during colitis. Therefore, we mined annotated draft genomes of the Oligo-MM12 strains (Table 52). 
The analysis focused on putative genes that encompass anaerobic respiration (nitrogen metabolism / 
nitrate, nitrite ammonification), ethanolamine utilization, iron acquisition and siderophore 
production. These factors are important for pathogen expansion in an inflammatory milieu 
(Raffatellu et al. 2009, Winter et al. 2010, Thiennimitr et al. 2011, Lopez et al. 2012) and might 
therefore also contribute to survival of certain gut commensals. The presence of dormancy and 
sporulation genes was also investigated.  
Indeed, the performance of individual microbiota members in a colitic environment correlates with 
the presence of fitness genes, since Oligo-MM12 strains which were depleted during colitis hardly 
harbor any of the above motioned putative fitness genes and strains that seemed to benefit from 
colitis are potentially able to acquire iron via siderophores, utilize ethanolamine and respire 
anaerobically (Tables 52; 53). Previous studies showing ‘blooms’ of Enterobacteriaceae and 
Enterococcus species during gut inflammation or antibiotic induced perturbation of the microbiota 
are in line with our data (Stecher et al. 2010, Ubeda et al. 2010, Taur et al. 2012). We further extend 
these studies by confirming the presence of putative fitness genes in commensal bacteria other than 
Enterobacteriaceae which were already shown to be able to perform nitrate respiration and utilize 
ethanolamine (Bertin et al. 2011, Rendon et al. 2015).  
Moreover, we correlated the presence of sporulation genes with increased capability of resistance 
and therefore hypothesized that the potential of undergoing sporulation is an essential mechanism 
for the recovery from dysbiosis (resilience), since sporulation increases tolerance against stress such 
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as heat and hydrogen peroxide (Moeller et al. 2012). We therefore investigated the potential of the 
Oligo-MM12 to recover from Salmonella-induced dysbiosis using a Salmonella strain deficient in a 
functional T3SS-2 (S. TmSPI-2, Figure 18). In contrast to S. TmWT, S. TmSPI-2 doesn’t induce life 
threatening systemic infection (Endt et al. 2010). In addition, a previous experiment showed that in 
contrast to a Salmonella strain lacking functional T3SS-1 (S. TmSPI-1), S. TmSPI-2 is able to induce 
dysbiosis (Figures 15; 17) and that S. TmSPI-2 induced inflammation is milder compared to 
inflammation induced by S. TmWT (Figures 15B; 16B). Therefore, S. TmSPI-2 was used for a long-term 
infection of Oligo-MM12 mice. One has to mention that for unknown reasons LCN-2 levels were 
already elevated before infection with S. TmSPI-2 in this long-term experiment. Elevated LCN-2 levels 
could be attributed to increased stress which mice might suffer during export from the isolator and 
handling before infection. However, this could not be confirmed by respective control experiments 
(data not shown). Nevertheless, S. TmSPI-2 colonized Oligo-MM12 mice and was not outcompeted by 
the microbiota until day 21 p.i. (Figure 19A). According to cluster analyses, the Oligo-MM12 
composition was changed at day 4 p.i. (Figure 18D,E). Differences were mainly characterized by 
increased relative abundance of Salmonella and Akkermansia muciniphila YL44 (Figure 18C). 
However, major shifts in β-diversity were not observed. The minor shift in microbial composition was 
reverted back to that before infection (resilience). Unfortunately, the Oligo-MM12 shifts were only 
mild and the effect of spore forming and germination on resilience could not be further investigated 
using S. TmSPI-2. However, this experiment underlined the emergence of Akkermansia muciniphila 
YL44 in Salmonella-induced dysbiosis. 
Next, we wanted to experientially test that whether commensal bacteria profit from nitrate and iron 
limitation. Since we were not able to genetically modify any of the Oligo-MM12 strains, we performed 
an in vitro batch cultures in rich anaerobic medium without mucin using Oligo-MM12 bacteria 
recovered from cecal content. We simulated iron starvation during anti-microbial immune response 
by adding different concentrations of either dipyridyl or diethylenetriaminepentaacetic acid (DTPA). 
Anaerobic batch cultures supplemented with 10 mM of nitrate were additionally performed. 
Interestingly, iron starvation mediated by the application of 300 µM of dipyripyl which binds Fe2+ 
promoted outgrowth of Enterococcus faecalis KB1 and inhibited the growth of the residual Oligo-
MM12 strains at time point 8h post inoculation. In the presence of 100 µM of DTPA which sequesters 
Fe3+, Enterococcus faecalis KB1 growth was also promoted and additionally Clostridium innocuum I46 
and ‘Turicimonas caecimuris‘ YL45 were more abundant under this condition. In contrast to iron 
starvation, additional nitrate had no obvious effect on the Oligo-MM12 composition after 8h (data 
shown in MD thesis of Patrick Schiller), indicating that the Oligo-MM12 strains might be unable to 
respire nitrate during Salmonella-induced colitis. However, iron limitation might confer an additional 
fitness advantage especially to Enterococcus faecalis KB1 (likewise Salmonella) over the residual 
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microbiota. The importance of ethanolamine utilization and anaerobic tetrathionate respiration were 
not yet investigated using in vitro cultures.  
4.2.3 Investigating the contribution of anaerobic respiration, ethanolamine utilization and 
iron acquisition via siderophores to Salmonella ‘blooming’ and concomitant dysbiosis 
In order to investigate and to prioritize the effects of iron acquisition via siderophores, nitrate and 
tetrathionate respiration as well as ethanolamine utilization on Salmonella ‘blooms’ and concomitant 
dysbiosis, single infections of Oligo-MM12 mice with either S. TmWT, S. TmEntA, S. TmNi. + Te., S. TmNi. or S. 
TmEA were performed (Figure 24). To our knowledge, this is the first study that investigates the 
contribution of nutritional factors present in an inflammatory milieu to pathogen outgrowth and 
displacement of the indigenous microbiota during early Salmonella expansion phase and later 
pathogen ‘blooming’ using one defined gnotobiotic mouse model with mouse adapted strains. 
Interestingly, none of the Salmonella mutant strains induced dysbiosis at day 3 p.i., whereas S. TmWT 
already dominated 29% of the samples (≥ 50% of total microbiota composition, Figure 24C). This 
indicates that during early time points of infection anaerobic respiration, ethanolamine utilization 
and iron acquisition via siderophores synergistically contribute to early Salmonella ‘blooming’. 
Especially, ethanolamine might be important for early gut colonization since S. TmEA shows less CFUs 
at day 3 p.i. in feces compared to S. TmWT (Figure 25A). However, at day 4 p.i., nitrate and 
tetrathionate additively contribute the most to Salmonella blooms and concomitant dysbiosis. 
Ethanolamine utilization is also important during late stages of infection. However, iron acquisition 
via siderophores seems to be negligible for the induction of dysbiosis in this model (Figure 24D,E; 
Tables 50; 51). To this end, the importance of nutritional factors during severe Salmonella-induced 
colitis can be ranked as follows: nitrate and tetrathionate respiration > ethanolamine utilization > 
iron acquisition via siderophores. 
Ethanolamine is generated by breaking down phosphatidylethanolamine which is part of the 
mammalian as well as the bacterial cell membrane engaging phosphodiesterases (Proulx and Fung 
1969, Randle et al. 1969, Ansell et al. 1973, Larson et al. 1983). Thus, ethanolamine is an abundant 
nutrient in the gut that can serve as carbon and nitrogen source (Roof and Roth 1988). However, 
ethanolamine utilization is quite costly, since a micro-compartment containing toxic by-products and 
enzymes needed for ethanolamine utilization such as ethanolamine ammonia lyase encoded by 
eutBC (big and small subunits) which converts ethanolamine into acetaldehyde and ammonia 
(nitrogen source) in the presence of cobalamin, alcohol dehydrogenase encode by eutG which 
converts acetaldehyde to ethanol (carbon source) or aldehyde oxidoreductase encoded by eutE 
which converts acetaldehyde to acetyl-CoA (Krebs cycle) is established (Roof and Roth 1988, Roof 
and Roth 1989, Stojiljkovic et al. 1995, Garsin 2010). Thus, we believe that ethanolamine utilization is 
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only available for a subset of gut bacteria. Previous investigations showed the presence of genes 
needed for ethanolamine utilization in Actinobacteria spp., Proteobacteria, Enterobacteriaceae and 
Firmicutes like Enterococcus faecalis (Del Papa and Perego 2008, Fox et al. 2009, Tsoy et al. 2009), 
which is in line with our observation that Enterococcus faecalis KB1 and Flavonifractor plautii YL31 
are the only Oligo-MM12 strains which harbor genes for ethanolamine utilization (Tables 52; 53). 
Thus, this nutrient might selectively be consumed by Salmonella and possibly also by Enterococcus 
faecalis KB1 and Flavonifractor plautii YL31 during pathogen expansion when inflammation is not yet 
full blown and anaerobic electron acceptors might not yet be available. Interestingly, compared to S. 
TmWT, the relative abundance of Clostridium clostridioforme YL32 was increased in cecal content after 
infection with S. TmEA (Table 51). This observation is interesting, since relative abundance of 
Clostridium clostridioforme YL32 was also elevated at day 3 p.i. with S. TmWT (Table 46). Clostridium 
clostridioforme YL32 might benefit from ethanolamine during pathogen expansion and during late 
stages of infection with S. TmEA since unconsumed ethanolamine might still be available. However, 
we could not find putative functional genes for ethanolamine utilization by RAST automated genome 
annotation. An Additional in vitro culture assay could provide further evidence whether Clostridium 
clostridioforme YL32 is able to use ethanolamine. 
As a consequence of the antimicrobial immune response during Salmonella-induced colitis, nitrate 
and tetrathionate become available (Levitt et al. 1999, Furne et al. 2001, Szabó et al. 2007, Winter et 
al. 2010, Winter et al. 2013) and now further promote pathogen ‘blooming’ and dysbiosis at late 
stages of infection. The contribution of both anaerobic electron acceptors to Salmonella-induced 
disease was so important that a Salmonella strain lacking nitrate and tetrathionate respiration 
exhibited less cecal pathology compared to wildtype (Figure 25B). 
Iron is an essential micronutrient and important for replication of pathogens. Thus, the iron 
availability is tightly regulated by the host and free iron is scarce because it is bound to heme, or iron 
binding proteins such as transferrin, ferritin and lactoferrin (Birgegård and Caro 1984, Andrews 2000, 
Diaz-Ochoa et al. 2014). Therefore, bacteria evolved siderophores which have a high affinity to ferric 
iron (Fe3+) sequestering iron from host iron binding proteins (Neilands 1995, Griffiths 1999). Upon 
infection, the host can additionally limit iron availability by up regulation of the iron regulating 
hormone hepcidin which inactivates the iron exporter ferroportin and by secretion of the 
siderophore sequestering antimicrobial protein LCN-2 (Goetz et al. 2002, Flo et al. 2004, Nemeth et 
al. 2004, Armitage et al. 2011, Correnti and Strong 2012). In this study we investigated the 
contribution of siderophore production on Salmonella ‘blooming’ and the induction of dysbiosis. 
Interestingly, impaired acquisition of ferric iron via siderophores (enterochelin and salmochelin 
which is resistant to LCN-2 sequestration (Raffatellu et al. 2009)) did not obviously contribute to 
Discussion 
155 
 
Salmonella ‘blooms’ and dysbiosis (Figures 24; 26). However, other iron uptake mechanisms might be 
important. Thus, Bacteria could directly uptake ferrous iron (Fe2+) via Feo proteins. This mechanism 
might be important during early Salmonella ecosystem invasion when oxygenation is low and 
unbound iron can be found in contrast to the inflamed gut (Andrews et al. 2003, Diaz-Ochoa et al. 
2014). In addition, since Salmonella-induced colitis coincides with tissue damage (Figure 25B), 
Salmonella might also acquire iron from heme (Braun and Hantke 2011).  
It also needs to be mentioned here that in this set of experiment S. TmWT failed to dominate the 
microbiota in 2 out of 8 samples (Figure 24D,E) which is in contrast to previous experiments where S. 
TmWT was the dominating species in 100% of the samples (Figure 10C). Possible reasons for this 
effect could be that the Oligo-MM12 strains somehow evolved to a consortium that provides 
enhanced CR against S. TmWT infection or mice diversified despite germfree housing by accumulating 
environmental bacteria which might contribute to this increased CR. 16S rRNA gene amplicon 
sequencing using broad-range primers could give a hint for the presence of possible contaminants in 
the Oligo-MM12 consortium. New bacterial strains might be discovered which can protect from 
Salmonella-induced dysbiosis. 
4.2.4 ‘Nutrient-’ versus ‘killing-hypothesis’, the role of infiltrating neutrophils for 
Salmonella ‘blooming’ and dysbiosis 
So far, it is not understood whether pathogen-induced dysbiosis is caused indirectly by commensals 
being outcompeted by a pathogen which profits from the nutritional environment of an 
inflammatory milieu (‘nutrient-hypothesis’) or directly by host immune response mediated killing 
(‘killing-hypothesis’). 
Neutrophil infiltration in the inflamed gut lumen is a hallmark of Salmonella-induced colitis 
(Loetscher et al. 2012). It was hypothesized that neutrophils directly mediate killing of commensal 
gut microbes and thereby promote Salmonella ‘blooming’ and dysbiosis. In order to investigate this, 
neutrophils of Oligo-MM12 mice were directly depleted using antibodies against a neutrophil epitope 
(α-Ly6G) as well as antibodies against granulocyte-colony stimulating factor (α-G-CSF) (Trautwein-
Weidner et al. 2014) and additionally infected with S. TmWT (Figure 29A). It was quite surprising that 
the control mice exhibited by trend less LCN-2 levels compared to neutrophil-depleted mice. 
However, LCN-2 levels were elevated in both groups (Figure 29B). Salmonella loads in spleen and 
liver were increased by trend after antibody mediated depletion of neutrophils and also after S. TmWT 
infection of streptomycin pre-treated CD18-/- mice which are deficient in extravasation of neutrophils 
(Figures 30C,D; 31D,E). There were significantly higher Salmonella loads in mesenteric lymphnodes 
after antibody mediated depletion of neutrophils and S. TmWT additionally better colonized the guts 
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of streptomycin pre-treated CD18-/- mices (Figures 30B; 31A). The protective effect conferred by 
neutrophils is in line with a study previously conducted by Maier and co-workers which shows that 
neutrophils impose a tight bottle neck on Salmonella by NADPH-oxidase mediated killing of invading 
Salmonella (Maier et al. 2014).  
Interestingly, none of the microbiota samples from the isotype control group was dominated by 
Salmonella, whereas Salmonella ‘blooming’ was apparent in 4 out of 6 samples in neutrophil 
depleted Oligo-MM12 mice (Figure 29C). This indicates that, at least in this experimental setting, 
neutrophil depletion did not protect from Salmonella-induced dysbiosis and ‘blooms’. This is in stark 
contrast to our assumption that neutrophils might pave the way for Salmonella by directly killing 
other commensals or facilitating the production of anaerobic electron acceptors. To our knowledge, 
this study provides first evidence that neutrophils protect commensal gut microbes from pathogen 
‘blooming’ and dysbiosis and other mechanisms such as the altered nutritional environment or 
possible also increased oxygenation (Rivera-Chávez et al. 2016) are more important. This data 
strengthen the ‘nutrient-hypothesis’ rather than the ‘killing-hypothesis’. 
However, the absence of Salmonella ‘blooms’ and dysbiosis in isotype control (Figure 29C) mice was 
unexpected and in stark contrast to previous experiments where Salmonella dominated the 
microbiota (Figure 10C). Interestingly, such Salmonella ‘blooms’ were already absent in some mice 
infected with S. TmWT that served as controls for infection experiment with Salmonella mutant strains 
(Figure 24D,E). As consequence, we are setting up new Oligo-MM12 mice and are planning to repeat 
the neutrophil depletion experiment using this new Oligo-MM12 generation. Nevertheless, these 
experiments demonstrate that upon depletion of neutrophils a microbiota loses its ability to protect 
from Salmonella ‘blooms’ and concomitant dysbiosis. In other words, Salmonella ‘blooming’ and 
concomitant shifts in microbial composition might not be mediated by neutrophil-mediated killing of 
competing gut commensals. In fact, Salmonella benefits even more from an inflammatory milieu by 
selectively using anaerobic electron acceptors as well as ethanolamine and thereby outcompetes the 
indigenous microbiota during colitis (Figure 41). 
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Figure 41: Performance of single Oligo-MM12 strains during S. Tm induced colitis as well as known 
mechanisms underlining S. Tm ‘blooms’ and dysbiosis. A homeostatic Oligo-MM12 provides colonization 
resistance (CR) against S. Tm until day 1 p.i.. However, S. Tm already starts to expand at day 2 p.i. which 
increases the inflammatory tone at day 3 p.i.. This increased inflammatory tone coincides with increased 
relative abundance of Akkermansia muciniphila YL44 and Clostridium clostridioforme YL32. During pathogen 
expansion S. Tm might especially benefit from ethanolamine (EA) utilization. At later stages of infection (day 4 
p.i.), S. Tm induces severe gut inflammation and ‘blooms’. This was mainly powered by nitrate (NO3-) and 
tetrathionate (S4O62-) respiration as well as EA utilization. Interestingly, infiltrating neutrophils counteract 
Salmonella ‘blooming’ and seem to protect the microbiota from dysbiosis. When neutrophils fail to keep S. Tm 
in check, Salmonella ‘blooming’ and dysbiosis is apparent during late stages of infection. S. Tm induced 
dysbiosis of the Oligo-MM12 is characterized by an increased relative abundance of Enterococcus faecalis KB1 
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and Lactobacillus reuteri I49; stable or moderately decreased relative abundance of Blautia coccoides YL58, 
Flavonifractor plautii YL31 and Clostridium innocuum I46 as well as massively decreased relative abundance of 
‘Bacteroides caecimuris‘ I48, ‘Muribaculum intestinale‘ YL27, ‘Turicimonas caecimuris‘ YL45, Akkermansia 
muciniphila YL44 and Clostridium clostridioforme YL32. Bifidobacterium longum subsp. animalis YL2 and 
‘Acutalibacter muris‘ KB18 were already below the limit of detection of the specific qPCR assay in healthy Oligo-
MM12. 
 
4.3 Parallels between dysbiosis induced by enteric pathogens and chronic gut 
inflammation 
In this thesis, dysbiosis induced by infections with S. Tm, C. rodentium and C. difficile was compared 
to colitis induced by infection with H. typhlonius in a colitogenic CD45RBhi T-cell transfer model using 
the Oligo-MM12 as model for all experiments. These sets of experiments were conducted in 
collaboration with Prof. Hapfelmeier and Nicolas Studer (University of Bern) who performed infection 
experiments with C. difficile (Studer et al. 2016) as well as Prof. Mueller and Martin Faderl (University 
of Bern) who established the T-cell dependent colitis model that is based on the Oligo-MM12 (Brasseit 
et al. 2016).  
S. Tm and C. difficile were able to thrive in the inflamed gut and induced dysbiosis which was mainly 
characterized by decreased abundance of Gram-negative bacteria like ‘Bacteroides caecimuris‘ I48 
and ‘Muribaculum intestinale‘ YL27. Interestingly, the expansion of Enterococcus faecalis KB1 and 
Lactobacillus reuteri I49 was observed after infection with both enteric pathogens (Figure 39A). The 
inflammatory milieu created by infection with S. Tm and C. difficile might enhance growth of these 
Oligo-MM12 strains. Enterococcus faecalis was previously shown to harbor genes for ethanolamine 
utilization (Del Papa and Perego 2008) and might additionally acquire iron (Table 52). Besides 
Enterococcus faecalis KB1, Lactobacillus reuteri I49 might also withstand increased oxygenation 
during inflammation (Ianniello et al. 2015, Rivera-Chávez et al. 2016). Our data additionally suggest 
that Lactobacillus reuteri I49 might profit from nitrate respiration (Table 52). Inflammation induced 
by S. Tm and C. difficile coincided with reduced absolute abundance of total 16S rRNA gene copy 
numbers, indicating decreased abundance of gut microbes possibly meditated by outcompeting of 
commensals by the pathogens as observed previously (Stecher et al. 2007). Interestingly, infection 
with C. difficile led to increased relative abundance of Akkermansia muciniphila YL44 at day 3 p.i. 
which has been also observed at day 3 p.i. with S. Tm (Figures 10C; 35A; Table 46). Akkermansia 
muciniphila was previously shown to aggravate Salmonella infection by interfering with the mucus 
barrier and might benefit from mucin which might be more accessible during inflammation (Derrien 
et al. 2004, Ganesh et al. 2013).  
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Shifts in microbiota composition after C. difficile infection are in line with studies based on 
microbiota samples from human patient which observed increased abundance of Verrucomicrobia, 
Lactobacillus spp. and Enterococcus spp. as well as decreased abundance of Bacteroides spp. (Table 
1) (Manges et al. 2010, Seekatz and Young 2014), underlining the translational potential of Oligo-
MM12 derived data. Pathogenesis and out-growth of C. difficile in Oligo-MM12 mice might depend on 
bile acid metabolism, since secondary bile acids were able to inhibit spore germination (Theriot et al. 
2016). An unpublished investigation conducted by Studer and co-workers showed that mice 
colonized with Oligo-MM12 almost completely lack secondary bile acids. By adding Clostridium 
scindens, a secondary bile acid producer, to the Oligo-MM12 consortium, concentrations of secondary 
bile acids increased which paralleled with increased resistance against C. difficile induced disease 
(Studer et al. 2016). This in line with a previous study showing the protective effect of C. scindens by 
secondary bile acid production (Buffie et al. 2015). 
H. typhlonius infection of Rag-/- mice, associated with the Oilgo-MM12, together with transfer of 
colitogenic CD45RBhi T-cells induced inflammation (Figure 37; 38A). Remission of colitis was 
additionally mediated by the application of α-CD4 antibodies targeting colitogenic T-cells (Figure 36). 
However, colitis only induced slight shifts in Oligo-MM12 composition and the absolute abundance of 
gut bacteria was unchanged (Figure 38A). Especially, relative abundance of Clostridium innocuum I46 
and Enterococcus faecalis KB1 was increased after T-cell-induced colitis (Figure 38A; Table 55). 
Increased abundance of Clostridium innocuum I46 was also observed after infection with C. difficile 
(Figure 35A). Clostridium innocuum I46 which has been previously shown to be associated with an 
inflamed gut (Wohlgemuth et al. 2011) was additionally more resistant to S. Tm induced colitis and 
might play a central role in the pathogenesis of C. difficile, Salmonella and CD45RBhi T-cell-induced 
colitis by enhancing the inflammatory tone in the gut. Infection experiments with Oligo-MM11 mice 
without Clostridium innocuum I46 might shed more light on the importance of this commensal for 
pathogenesis. Spore formation might be a mechanism for sustained viability of Clostridium innocuum 
I46 during inflammation (Table 52). Microbiota changes during IBD have been characterized by 
decreased abundance of butyrate producing bacteria (Table 1) (Rajilic-Stojanovic et al. 2013, 
Takahashi et al. 2016). It might therefore be interesting to measure concentrations of short chain 
fatty (SCFA) like butyrate after onset of colitis in Oligo-MM12 mice. Decreased butyrate 
concentrations might lead to increased epithelial oxygenation (Rivera-Chávez et al. 2016) and favor 
not only pathogen growth but might also sustain expansion of aerotolerant commensals and inhibit 
obligate anaerobes. Therefore, aerotolerant Oligo-MM12 strains need to be identified and correlated 
with concentrations of butyrate during colitis and depletion in S. Tm-induced colitis. So far, aerobic 
batch cultures revealed that especially Enterococcus faecalis KB1 is able to grow in the presence of 
oxygen and outcompetes the residual Oligo-MM12 strains (data shown in MD thesis of Patrick 
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Schiller). The determination of SCFA concentrations might be also relevant in mice infected with 
other enteric pathogens. 
Infection of Oligo-MM12 mice with C. rodentium did not induce shifts in microbial composition, 
despite, C. rodentium infection induced inflammation, measured by LCN-2 levels (4 times less as after 
infection with S. Tm) between days 7 and 23 p.i. (Figure 32). LCN-2 levels declined after 23 days p.i. 
and C. rodentium was not outcompeted by the Oilgo-MM12. It seems that C. rodentium can be 
controlled by the Oligo-MM12 and possibly also by the immune response. Indeed, the microbiota has 
been previously shown to clear C. rodentium (Kamada et al. 2012). In this study C. rodentium was 
cleared in mice associated with a normal SPF microbiota by 21 p.i., whereas infection persisted in 
germfree mice. In addition, secretory IgA might be also involved in keeping C. rodentium in check 
(Endt et al. 2010). It would be interesting to investigate if single Oligo-MM12 strains alone or special 
consortia contribute to CR against C. rodentium. Moreover, it could be assessed weather CR is 
mediated by direct microbiota-pathogen interactions or indirectly by competition for nutrients or 
secretion of antimicrobial substances. According to Vong and colleagues, lactobacilli confer 
protection against C. rodentium (Vong et al. 2015). Thus, Lactobacillus reuteri I49 might be involved 
in providing CR against this enteric pathogen. C. rodentium induces EPEC like pathology in mice 
(Luperchio and Schauer 2001). However, since dysbiosis was not observed, correlations of C. 
rodentium / EPEC gut ecosystem invasion and microbiota shifts could not be performed. 
Collectively, this data suggest that key species among the Oligo-MM12 are positively or negatively 
correlated with inflammation caused by infection with different enteric pathogens and CD45RBhi T-
cell-induced colitis. Especially, ‘Bacteroides caecimuris‘ I48 and ‘Muribaculum intestinale‘ YL27, both 
belonging to the phylum Bacteroidetes, decreased during S. Tm and C. difficile-induced inflammation. 
In contrast, Enterococcus faecalis KB1 and Lactobacillus reuteri I49 benefited from colitis in all colitis 
models. Moreover, Akkermansia muciniphila YL44 expanded after early infection with S. Tm and 
infection with C. difficile. Relative abundance of Clostridium innocuum I46 was additionally increased 
after infection with C. difficile or T-cell-induced colitis. This increased abundance of key species might 
serve as future biomarker for inflammatory diseases. Furthermore, anti-inflammatory commensals 
can be explored and extended to potential therapeutics. Further investigations are needed if and 
how these increased key species impact on pathogenesis of enteric pathogens and chronic gut 
inflammation. 
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Figure 42: Strain-specific primer and hydrolysis probes targeting hypervariable regions of the 16S rRNA gene. 
27 16S rRNA gene sequences were aligned using the software CLC DNA Workbench 6.0.2 (CLC bio, Denmark) 
and hypervariable (V) regions were identified according to (Chakravorty et al. 2007). (A) V1 nucleotides: 69 – 
99, (B) and (C) V2 nucleotides: 137 – 242, (D) V3 nucleotides: 433 – 497, (E) V4 nucleotides: 576 – 682, (F) V5 
nucleotides: 822 – 879, (G) V7 nucleotides: 1117 – 1173, (H) homologous regions around V7. Primers and 
hydrolysis probes were designed to match strain-specific sequences with high variability and low consensus 
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between strains. For designing the universal primer / probe combination, a region with maximum homology 
was chosen. The binding sites of forward and reverse primers are marked in gray or white and black, 
respectively. The binding site of the hydrolysis probes is highlighted in pink. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Literature 
166 
 
 
Agus, A., J. Denizot, J. Thévenot, M. Martinez-Medina, S. Massier, P. Sauvanet, A. Bernalier-Donadille, 
S. Denis, P. Hofman and R. Bonnet (2016). "Western diet induces a shift in microbiota composition 
enhancing susceptibility to Adherent-Invasive E. coli infection and intestinal inflammation." Scientific 
reports 6. 
 
Aitken, S. L., M. J. Alam, M. Khaleduzzuman, S. T. Walk, W. L. Musick, V. P. Pham, J. L. Christensen, R. 
L. Atmar, Y. Xie and K. W. Garey (2015). "In the endemic setting, Clostridium difficile ribotype 027 is 
virulent but not hypervirulent." Infection Control & Hospital Epidemiology 36(11): 1318-1323. 
 
Ananthakrishnan, A. N. (2011). "Clostridium difficile infection: epidemiology, risk factors and 
management." Nature Reviews Gastroenterology and Hepatology 8(1): 17-26. 
 
Andrews, N. C. (2000). "Iron homeostasis: insights from genetics and animal models." Nature 
Reviews Genetics 1(3): 208-217. 
 
Andrews, S. C., A. K. Robinson and F. Rodríguez-Quiñones (2003). "Bacterial iron homeostasis." FEMS 
microbiology reviews 27(2-3): 215-237. 
 
Andriantsoanirina, V., S. Allano, M. J. Butel and J. Aires (2013). "Tolerance of Bifidobacterium human 
isolates to bile, acid and oxygen." Anaerobe 21: 39-42. 
 
Ansell, G. B., J. N. Hawthorne and R. M. C. Dawson (1973). Form and function of phospholipids, 
Elsevier Scientific Publishing Co. 
 
Antharam, V. C., E. C. Li, A. Ishmael, A. Sharma, V. Mai, K. H. Rand and G. P. Wang (2013). "Intestinal 
dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial 
diarrhea." Journal of clinical microbiology 51(9): 2884-2892. 
 
Armitage, A. E., L. A. Eddowes, U. Gileadi, S. Cole, N. Spottiswoode, T. A. Selvakumar, L.-P. Ho, A. R. 
Townsend and H. Drakesmith (2011). "Hepcidin regulation by innate immune and infectious stimuli." 
Blood 118(15): 4129-4139. 
 
Armougom, F., M. Henry, B. Vialettes, D. Raccah and D. Raoult (2009). "Monitoring bacterial 
community of human gut microbiota reveals an increase in Lactobacillus in obese patients and 
Methanogens in anorexic patients." PloS one 4(9): e7125. 
 
Atarashi, K., J. Nishimura, T. Shima, Y. Umesaki, M. Yamamoto, M. Onoue, H. Yagita, N. Ishii, R. Evans 
and K. Honda (2008). "ATP drives lamina propria TH17 cell differentiation." Nature 455(7214): 808-
812. 
 
Literature 
167 
 
Atarashi, K., T. Tanoue, K. Oshima, W. Suda, Y. Nagano, H. Nishikawa, S. Fukuda, T. Saito, S. 
Narushima and K. Hase (2013). "Treg induction by a rationally selected mixture of Clostridia strains 
from the human microbiota." Nature 500(7461): 232-236. 
 
Aziz, R. K., D. Bartels, A. A. Best, M. DeJongh, T. Disz, R. A. Edwards, K. Formsma, S. Gerdes, E. M. 
Glass and M. Kubal (2008). "The RAST Server: rapid annotations using subsystems technology." BMC 
genomics 9(1): 1. 
 
Baothman, O. A., M. A. Zamzami, I. Taher, J. Abubaker and M. Abu-Farha (2016). "The role of Gut 
Microbiota in the development of obesity and Diabetes." Lipids in Health and Disease 15(1): 1. 
 
Barbut, F., D. Decre, V. Lalande, B. Burghoffer, L. Noussair, A. Gigandon, F. Espinasse, L. Raskine, J. 
Robert and A. Mangeol (2005). "Clinical features of Clostridium difficile-associated diarrhoea due to 
binary toxin (actin-specific ADP-ribosyltransferase)-producing strains." Journal of medical 
microbiology 54(2): 181-185. 
 
Barman, M., D. Unold, K. Shifley, E. Amir, K. Hung, N. Bos and N. Salzman (2008). "Enteric 
salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract." Infection and 
immunity 76(3): 907-915. 
 
Barthel, M., S. Hapfelmeier, L. Quintanilla-Martínez, M. Kremer, M. Rohde, M. Hogardt, K. Pfeffer, H. 
Rüssmann and W.-D. Hardt (2003). "Pretreatment of mice with streptomycin provides a Salmonella 
enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host." 
Infection and immunity 71(5): 2839-2858. 
 
Baumgart, M., B. Dogan, M. Rishniw, G. Weitzman, B. Bosworth, R. Yantiss, R. H. Orsi, M. Wiedmann, 
P. McDonough and S. G. Kim (2007). "Culture independent analysis of ileal mucosa reveals a selective 
increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's 
disease involving the ileum." The ISME journal 1(5): 403-418. 
 
Bearson, S. M., H. K. Allen, B. L. Bearson, T. Looft, B. W. Brunelle, J. D. Kich, C. K. Tuggle, D. O. Bayles, 
D. Alt and U. Y. Levine (2013). "Profiling the gastrointestinal microbiota in response to Salmonella: 
low versus high Salmonella shedding in the natural porcine host." Infection, Genetics and Evolution 
16: 330-340. 
 
Becker, N., J. Kunath, G. Loh and M. Blaut (2011). "Human intestinal microbiota: Characterization of a 
simplified and stable gnotobiotic rat model." Gut microbes 2(1): 25-33. 
 
Berger, T., A. Togawa, G. S. Duncan, A. J. Elia, A. You-Ten, A. Wakeham, H. E. Fong, C. C. Cheung and 
T. W. Mak (2006). "Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection 
but not to ischemia-reperfusion injury." Proceedings of the National Academy of Sciences of the 
United States of America 103(6): 1834-1839. 
 
Bergström, A., T. H. Skov, M. I. Bahl, H. M. Roager, L. B. Christensen, K. T. Ejlerskov, C. Mølgaard, K. F. 
Michaelsen and T. R. Licht (2014). "Establishment of intestinal microbiota during early life: a 
Literature 
168 
 
longitudinal, explorative study of a large cohort of Danish infants." Applied and environmental 
microbiology 80(9): 2889-2900. 
 
Bergström, J. H., K. A. Berg, A. M. Rodríguez-Piñeiro, B. Stecher, M. E. Johansson and G. C. Hansson 
(2014). "AGR2, an endoplasmic reticulum protein, is secreted into the gastrointestinal mucus." PloS 
one 9(8): e104186. 
 
Bertin, Y., J. Girardeau, F. Chaucheyras-Durand, B. Lyan, E. Pujos-Guillot, J. Harel and C. Martin 
(2011). "Enterohaemorrhagic Escherichia coli gains a competitive advantage by using ethanolamine 
as a nitrogen source in the bovine intestinal content." Environmental microbiology 13(2): 365-377. 
 
Birgegård, G. and J. Caro (1984). "Increased ferritin synthesis and iron uptake in inflammatory mouse 
macrophages." Scandinavian journal of haematology 33(1): 43-48. 
 
Brasseit, J., E. Althaus-Steiner, M. Faderl, N. Dickgreber, L. Saurer, V. Genitsch, T. Dolowschiak, H. Li, 
D. Finke and W. Hardt (2016). "CD4 T cells are required for both development and maintenance of 
disease in a new mouse model of reversible colitis." Mucosal immunology 9(3): 689-701. 
 
Braun, V. and K. Hantke (2011). "Recent insights into iron import by bacteria." Current opinion in 
chemical biology 15(2): 328-334. 
 
Britton, R. A. and V. B. Young (2014). "Role of the intestinal microbiota in resistance to colonization 
by Clostridium difficile." Gastroenterology 146(6): 1547-1553. 
 
Brosius, J., M. L. Palmer, P. J. Kennedy and H. F. Noller (1978). "Complete nucleotide sequence of a 
16S ribosomal RNA gene from Escherichia coli." Proceedings of the National Academy of Sciences 
75(10): 4801-4805. 
 
Brown, J., W. M. De Vos, P. S. DiStefano, J. Doré, C. Huttenhower, R. Knight, T. D. Lawley, J. Raes and 
P. Turnbaugh (2013). "Translating the human microbiome." Nat Biotechnol 31(4): 304-308. 
 
Brugiroux, S., M. Beutler, C. Pfann, D. Garzetti, H.-J. Ruscheweyh, D. Ring, M. Diehl, S. Herp, Y. 
Lötscher and S. Hussain (2016). "Genome-guided design of a defined mouse microbiota that confers 
colonization resistance against Salmonella enterica serovar Typhimurium." Nature Microbiology 2: 
16215. 
 
Bry, L., P. G. Falk, T. Midtvedt and J. I. Gordon (1996). "A model of host-microbial interactions in an 
open mammalian ecosystem." Science 273(5280): 1380. 
 
Buffie, C. G., V. Bucci, R. R. Stein, P. T. McKenney, L. Ling, A. Gobourne, D. No, H. Liu, M. Kinnebrew 
and A. Viale (2015). "Precision microbiome reconstitution restores bile acid mediated resistance to 
Clostridium difficile." Nature 517(7533): 205-208. 
 
Literature 
169 
 
Buffie, C. G. and E. G. Pamer (2013). "Microbiota-mediated colonization resistance against intestinal 
pathogens." Nature Reviews Immunology 13(11): 790-801. 
 
Buttó, L. F. and D. Haller (2016). "Dysbiosis in intestinal inflammation: Cause or consequence." 
International Journal of Medical Microbiology. 
 
Caporaso, J. G., J. Kuczynski, J. Stombaugh, K. Bittinger, F. D. Bushman, E. K. Costello, N. Fierer, A. G. 
Pena, J. K. Goodrich and J. I. Gordon (2010). "QIIME allows analysis of high-throughput community 
sequencing data." Nature methods 7(5): 335-336. 
 
Carmody, R. N., G. K. Gerber, J. M. Luevano, D. M. Gatti, L. Somes, K. L. Svenson and P. J. Turnbaugh 
(2015). "Diet dominates host genotype in shaping the murine gut microbiota." Cell Host & Microbe 
17(1): 72-84. 
 
Carroll, I. M., T. Ringel-Kulka, J. P. Siddle and Y. Ringel (2012). "Alterations in composition and 
diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel 
syndrome." Neurogastroenterology & Motility 24(6): 521-e248. 
 
Cash, H. L., C. V. Whitham, C. L. Behrendt and L. V. Hooper (2006). "Symbiotic bacteria direct 
expression of an intestinal bactericidal lectin." Science 313(5790): 1126-1130. 
 
Caspari, D. and J. M. Macy (1983). "The role of carbon dioxide in glucose metabolism of Bacteroides 
fragilis." Archives of microbiology 135(1): 16-24. 
 
Castro, M. S., M. A. Molina, M. B. Azpiroz, A. M. Díaz, R. Ponzio, M. D. Sparo, M. A. Manghi and A. M. 
Canellada (2016). "Probiotic activity of Enterococcus faecalis CECT7121: effects on mucosal immunity 
and intestinal epithelial cells." Journal of Applied Microbiology. 
 
Caza, M., A. Garénaux, F. Lépine and C. M. Dozois (2015). "Catecholate siderophore esterases Fes, 
IroD and IroE are required for salmochelins secretion following utilization, but only IroD contributes 
to virulence of extra-intestinal pathogenic Escherichia coli." Molecular microbiology 97(4): 717-732. 
 
Chakravorty, S., D. Helb, M. Burday, N. Connell and D. Alland (2007). "A detailed analysis of 16S 
ribosomal RNA gene segments for the diagnosis of pathogenic bacteria." Journal of microbiological 
methods 69(2): 330-339. 
 
Cherepanov, P. P. and W. Wackernagel (1995). "Gene disruption in Escherichia coli: Tc R and Km R 
cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant." Gene 
158(1): 9-14. 
 
Chu, H., A. Khosravi, I. P. Kusumawardhani, A. H. Kwon, A. C. Vasconcelos, L. D. Cunha, A. E. Mayer, Y. 
Shen, W.-L. Wu and A. Kambal (2016). "Gene-microbiota interactions contribute to the pathogenesis 
of inflammatory bowel disease." Science 352(6289): 1116-1120. 
Literature 
170 
 
 
Chung, H., S. J. Pamp, J. A. Hill, N. K. Surana, S. M. Edelman, E. B. Troy, N. C. Reading, E. J. Villablanca, 
S. Wang and J. R. Mora (2012). "Gut immune maturation depends on colonization with a host-specific 
microbiota." Cell 149(7): 1578-1593. 
 
Clavel, T., I. Lagkouvardos, M. Blaut and B. Stecher (2016). "The mouse gut microbiome revisited: 
From complex diversity to model ecosystems." International Journal of Medical Microbiology. 
 
Cleary, J., L.-C. Lai, R. K. Shaw, A. Straatman-Iwanowska, M. S. Donnenberg, G. Frankel and S. Knutton 
(2004). "Enteropathogenic Escherichia coli (EPEC) adhesion to intestinal epithelial cells: role of 
bundle-forming pili (BFP), EspA filaments and intimin." Microbiology 150(3): 527-538. 
 
Collins, J., R. Borojevic, E. Verdu, J. Huizinga and E. Ratcliffe (2014). "Intestinal microbiota influence 
the early postnatal development of the enteric nervous system." Neurogastroenterology & Motility 
26(1): 98-107. 
 
Collins, J. W., C. Chervaux, B. Raymond, M. Derrien, R. Brazeilles, A. Kosta, I. Chambaud, V. F. Crepin 
and G. Frankel (2014). "Fermented dairy products modulate C. rodentium induced colonic 
hyperplasia." Journal of Infectious Diseases: jiu205. 
 
Correnti, C. and R. K. Strong (2012). "Mammalian siderophores, siderophore-binding lipocalins, and 
the labile iron pool." Journal of Biological Chemistry 287(17): 13524-13531. 
 
Datsenko, K. A. and B. L. Wanner (2000). "One-step inactivation of chromosomal genes in Escherichia 
coli K-12 using PCR products." Proceedings of the National Academy of Sciences 97(12): 6640-6645. 
 
Del Papa, M. F. and M. Perego (2008). "Ethanolamine activates a sensor histidine kinase regulating its 
utilization in Enterococcus faecalis." Journal of bacteriology 190(21): 7147-7156. 
 
Derrien, M., E. E. Vaughan, C. M. Plugge and W. M. de Vos (2004). "Akkermansia muciniphila gen. 
nov., sp. nov., a human intestinal mucin-degrading bacterium." International journal of systematic 
and evolutionary microbiology 54(5): 1469-1476. 
 
Dethlefsen, L., S. Huse, M. L. Sogin and D. A. Relman (2008). "The pervasive effects of an antibiotic on 
the human gut microbiota, as revealed by deep 16S rRNA sequencing." PLoS Biol 6(11): e280. 
 
Dewhirst, F. E., C.-C. Chien, B. J. Paster, R. L. Ericson, R. P. Orcutt, D. B. Schauer and J. G. Fox (1999). 
"Phylogeny of the defined murine microbiota: altered Schaedler flora." Applied and environmental 
microbiology 65(8): 3287-3292. 
 
Dewhirst, F. E., C. C. Chien, B. J. Paster, R. L. Ericson, R. P. Orcutt, D. B. Schauer and J. G. Fox (1999). 
"Phylogeny of the defined murine microbiota: altered Schaedler flora." Appl Environ Microbiol 65(8): 
3287-3292. 
Literature 
171 
 
 
Diaz-Ochoa, V. E., S. Jellbauer, S. Klaus and M. Raffatellu (2014). "Transition metal ions at the 
crossroads of mucosal immunity and microbial pathogenesis." Frontiers in Cellular and Infection 
Microbiology 4. 
 
Diederich, A.-K., K. A. Duda, F. Romero-Saavedra, R. Engel, O. Holst and J. Huebner (2016). "Deletion 
of fabN in Enterococcus faecalis results in unsaturated fatty acid auxotrophy and decreased release 
of inflammatory cytokines." Innate immunity: 1753425916639669. 
 
Donohoe, D. R., L. B. Collins, A. Wali, R. Bigler, W. Sun and S. J. Bultman (2012). "The Warburg effect 
dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation." Molecular 
cell 48(4): 612-626. 
 
Donohoe, D. R., D. Holley, L. B. Collins, S. A. Montgomery, A. C. Whitmore, A. Hillhouse, K. P. Curry, S. 
W. Renner, A. Greenwalt and E. P. Ryan (2014). "A gnotobiotic mouse model demonstrates that 
dietary fiber protects against colorectal tumorigenesis in a microbiota-and butyrate-dependent 
manner." Cancer discovery 4(12): 1387-1397. 
 
Duncan, S. H., G. Lobley, G. Holtrop, J. Ince, A. Johnstone, P. Louis and H. Flint (2008). "Human colonic 
microbiota associated with diet, obesity and weight loss." International journal of obesity 32(11): 
1720-1724. 
 
Eckburg, P. B., E. M. Bik, C. N. Bernstein, E. Purdom, L. Dethlefsen, M. Sargent, S. R. Gill, K. E. Nelson 
and D. A. Relman (2005). "Diversity of the human intestinal microbial flora." Science 308(5728): 
1635-1638. 
 
Endt, K., B. Stecher, S. Chaffron, E. Slack, N. Tchitchek, A. Benecke, L. Van Maele, J.-C. Sirard, A. J. 
Mueller and M. Heikenwalder (2010). "The microbiota mediates pathogen clearance from the gut 
lumen after non-typhoidal Salmonella diarrhea." PLoS pathogens 6(9): e1001097. 
 
Faber, F., L. Tran, M. X. Byndloss, C. A. Lopez, E. M. Velazquez, T. Kerrinnes, S.-P. Nuccio, T. Wangdi, 
O. Fiehn and R. M. Tsolis (2016). "Host-mediated sugar oxidation promotes post-antibiotic pathogen 
expansion." Nature. 
 
Fabretti, F., C. Theilacker, L. Baldassarri, Z. Kaczynski, A. Kropec, O. Holst and J. Huebner (2006). 
"Alanine esters of enterococcal lipoteichoic acid play a role in biofilm formation and resistance to 
antimicrobial peptides." Infection and immunity 74(7): 4164-4171. 
 
Faith, J. J., P. P. Ahern, V. K. Ridaura, J. Cheng and J. I. Gordon (2014). "Identifying gut microbe–host 
phenotype relationships using combinatorial communities in gnotobiotic mice." Science translational 
medicine 6(220): 220ra211-220ra211. 
 
Faith, J. J., N. P. McNulty, F. E. Rey and J. I. Gordon (2011). "Predicting a human gut microbiota’s 
response to diet in gnotobiotic mice." Science 333(6038): 101-104. 
Literature 
172 
 
 
Faith, J. J., F. E. Rey, D. O'Donnell, M. Karlsson, N. P. McNulty, G. Kallstrom, A. L. Goodman and J. I. 
Gordon (2010). "Creating and characterizing communities of human gut microbes in gnotobiotic 
mice." The ISME journal 4(9): 1094-1098. 
 
Falk, P. G., L. V. Hooper, T. Midtvedt and J. I. Gordon (1998). "Creating and maintaining the 
gastrointestinal ecosystem: what we know and need to know from gnotobiology." Microbiology and 
Molecular Biology Reviews 62(4): 1157-1170. 
 
Fallani, M., S. Amarri, A. Uusijarvi, R. Adam, S. Khanna, M. Aguilera, A. Gil, J. M. Vieites, E. Norin and 
D. Young (2011). "Determinants of the human infant intestinal microbiota after the introduction of 
first complementary foods in infant samples from five European centres." Microbiology 157(5): 1385-
1392. 
 
Ferreyra, J. A., K. M. Ng and J. L. Sonnenburg (2014). "The Enteric Two-Step: nutritional strategies of 
bacterial pathogens within the gut." Cellular microbiology 16(7): 993-1003. 
 
Flint, H. J., K. P. Scott, S. H. Duncan, P. Louis and E. Forano (2012). "Microbial degradation of complex 
carbohydrates in the gut." Gut microbes 3(4): 289-306. 
 
Flo, T. H., K. D. Smith, S. Sato, D. J. Rodriguez, M. A. Holmes, R. K. Strong, S. Akira and A. Aderem 
(2004). "Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating 
iron." Nature 432(7019): 917-921. 
 
Flockhart, L., K. Pintar, A. Cook, S. McEwen, R. Friendship, D. Kelton and F. Pollari (2016). 
"Distribution of Salmonella in Humans, Production Animal Operations and a Watershed in a FoodNet 
Canada Sentinel Site." Zoonoses and Public Health. 
 
Forbes, J. D., G. Van Domselaar and C. N. Bernstein (2016). "Microbiome Survey of the Inflamed and 
Noninflamed Gut at Different Compartments Within the Gastrointestinal Tract of Inflammatory 
Bowel Disease Patients." Inflammatory bowel diseases 22(4): 817-825. 
 
Fox, K. A., A. Ramesh, J. E. Stearns, A. Bourgogne, A. Reyes-Jara, W. C. Winkler and D. A. Garsin 
(2009). "Multiple posttranscriptional regulatory mechanisms partner to control ethanolamine 
utilization in Enterococcus faecalis." Proceedings of the National Academy of Sciences 106(11): 4435-
4440. 
 
Frank, D. N., A. L. S. Amand, R. A. Feldman, E. C. Boedeker, N. Harpaz and N. R. Pace (2007). 
"Molecular-phylogenetic characterization of microbial community imbalances in human 
inflammatory bowel diseases." Proceedings of the National Academy of Sciences 104(34): 13780-
13785. 
 
Freter, R. and G. D. Abrams (1972). "Function of various intestinal bacteria in converting germfree 
mice to the normal state." Infection and immunity 6(2): 119-126. 
Literature 
173 
 
 
Furne, J., J. Springfield, T. Koenig, E. DeMaster and M. D. Levitt (2001). "Oxidation of hydrogen sulfide 
and methanethiol to thiosulfate by rat tissues: a specialized function of the colonic mucosa." 
Biochemical pharmacology 62(2): 255-259. 
 
Ganesh, B. P., R. Klopfleisch, G. Loh and M. Blaut (2013). "Commensal Akkermansia muciniphila 
Exacerbates Gut Inflammation in Salmonella Typhimurium-Infected Gnotobiotic Mice." PloS one 8(9): 
e74963. 
 
Garsin, D. A. (2010). "Ethanolamine utilization in bacterial pathogens: roles and regulation." Nature 
Reviews Microbiology 8(4): 290-295. 
 
Gerlach, R. G., D. Jäckel, N. Geymeier and M. Hensel (2007). "Salmonella pathogenicity island 4-
mediated adhesion is coregulated with invasion genes in Salmonella enterica." Infection and 
immunity 75(10): 4697-4709. 
 
Geuking, M. B., J. Cahenzli, M. A. Lawson, D. C. Ng, E. Slack, S. Hapfelmeier, K. D. McCoy and A. J. 
Macpherson (2011). "Intestinal bacterial colonization induces mutualistic regulatory T cell 
responses." Immunity 34(5): 794-806. 
 
Godinez, I., T. Haneda, M. Raffatellu, M. D. George, T. A. Paixão, H. G. Rolán, R. L. Santos, S. 
Dandekar, R. M. Tsolis and A. J. Bäumler (2008). "T cells help to amplify inflammatory responses 
induced by Salmonella enterica serotype Typhimurium in the intestinal mucosa." Infection and 
immunity 76(5). 
 
Godinez, I., M. Raffatellu, H. Chu, T. A. Paixao, T. Haneda, R. L. Santos, C. L. Bevins, R. M. Tsolis and A. 
J. Bäumler (2009). "Interleukin-23 orchestrates mucosal responses to Salmonella enterica serotype 
Typhimurium in the intestine." Infection and immunity 77(1): 387-398. 
 
Goetz, D. H., M. A. Holmes, N. Borregaard, M. E. Bluhm, K. N. Raymond and R. K. Strong (2002). "The 
neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron 
acquisition." Molecular cell 10(5): 1033-1043. 
 
Goodman, A. L., G. Kallstrom, J. J. Faith, A. Reyes, A. Moore, G. Dantas and J. I. Gordon (2011). 
"Extensive personal human gut microbiota culture collections characterized and manipulated in 
gnotobiotic mice." Proceedings of the National Academy of Sciences: 201102938. 
 
Griffiths, E. (1999). "Iron in biological systems." Iron and infection. Wiley, Chichester, United 
Kingdom: 1-26. 
 
Gustafsson, J. K., N. Navabi, A. M. Rodriguez-Piñeiro, A. H. Alomran, P. Premaratne, H. R. Fernandez, 
D. Banerjee, H. Sjövall, G. C. Hansson and S. K. Lindén (2013). "Dynamic changes in mucus thickness 
and ion secretion during Citrobacter rodentium infection and clearance." 
 
Literature 
174 
 
Hapfelmeier, S., K. Ehrbar, B. Stecher, M. Barthel, M. Kremer and W.-D. Hardt (2004). "Role of the 
Salmonella pathogenicity island 1 effector proteins SipA, SopB, SopE, and SopE2 in Salmonella 
enterica subspecies 1 serovar Typhimurium colitis in streptomycin-pretreated mice." Infection and 
immunity 72(2): 795-809. 
 
Hapfelmeier, S. and W.-D. Hardt (2005). "A mouse model for S. typhimurium-induced enterocolitis." 
Trends in microbiology 13(10): 497-503. 
 
Hapfelmeier, S., B. Stecher, M. Barthel, M. Kremer, A. J. Müller, M. Heikenwalder, T. Stallmach, M. 
Hensel, K. Pfeffer and S. Akira (2005). "The Salmonella pathogenicity island (SPI)-2 and SPI-1 type III 
secretion systems allow Salmonella serovar typhimurium to trigger colitis via MyD88-dependent and 
MyD88-independent mechanisms." The Journal of Immunology 174(3): 1675-1685. 
 
Helaine, S., A. M. Cheverton, K. G. Watson, L. M. Faure, S. A. Matthews and D. W. Holden (2014). 
"Internalization of Salmonella by macrophages induces formation of nonreplicating persisters." 
Science 343(6167): 204-208. 
 
Hensel, M., A. P. Hinsley, T. Nikolaus, G. Sawers and B. C. Berks (1999). "The genetic basis of 
tetrathionate respiration in Salmonella typhimurium." Molecular microbiology 32(2): 275-287. 
 
Hiergeist, A., J. Gläsner, U. Reischl and A. Gessner (2015). "Analyses of intestinal microbiota: Culture 
versus Sequencing." ILAR Journal 56(2): 228-240. 
 
Hoffmann, C., D. A. Hill, N. Minkah, T. Kirn, A. Troy, D. Artis and F. Bushman (2009). "Community-
wide response of the gut microbiota to enteropathogenic Citrobacter rodentium infection revealed 
by deep sequencing." Infection and immunity 77(10): 4668-4678. 
 
Hoffmann, T. W., H.-P. Pham, C. Bridonneau, C. Aubry, B. Lamas, C. Martin-Gallausiaux, M. Moroldo, 
D. Rainteau, N. Lapaque and A. Six (2015). "Microorganisms linked to inflammatory bowel disease-
associated dysbiosis differentially impact host physiology in gnotobiotic mice." The ISME journal. 
 
Hoiseth, S. K. and B. Stocker (1981). "Aromatic-dependent Salmonella typhimurium are non-virulent 
and effective as live vaccines." 
 
Hooper, L. V., D. R. Littman and A. J. Macpherson (2012). "Interactions between the microbiota and 
the immune system." Science 336(6086): 1268-1273. 
 
Hooper, L. V. and A. J. Macpherson (2010). "Immune adaptations that maintain homeostasis with the 
intestinal microbiota." Nature Reviews Immunology 10(3): 159-169. 
 
Huang, Y.-L., C. Chassard, M. Hausmann, M. von Itzstein and T. Hennet (2015). "Sialic acid catabolism 
drives intestinal inflammation and microbial dysbiosis in mice." Nature communications 6. 
 
Literature 
175 
 
Ianniello, R., J. Zheng, T. Zotta, A. Ricciardi and M. Gänzle (2015). "Biochemical analysis of respiratory 
metabolism in the heterofermentative Lactobacillus spicheri and Lactobacillus reuteri." Journal of 
Applied Microbiology 119(3): 763-775. 
 
Johansson, M. E., H. E. Jakobsson, J. Holmén-Larsson, A. Schütte, A. Ermund, A. M. Rodríguez-Piñeiro, 
L. Arike, C. Wising, F. Svensson and F. Bäckhed (2015). "Normalization of host intestinal mucus layers 
requires long-term microbial colonization." Cell Host & Microbe 18(5): 582-592. 
 
Johansson, M. E., M. Phillipson, J. Petersson, A. Velcich, L. Holm and G. C. Hansson (2008). "The inner 
of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria." Proceedings of the 
National Academy of Sciences 105(39): 15064-15069. 
 
Kaiser, B. L. D., J. Li, J. A. Sanford, Y.-M. Kim, S. R. Kronewitter, M. B. Jones, C. T. Peterson, S. N. 
Peterson, B. C. Frank and S. O. Purvine (2013). "A multi-omic view of host-pathogen-commensal 
interplay in Salmonella-mediated intestinal infection." PloS one 8(6): e67155. 
 
Kaiser, P., M. Diard, B. Stecher and W. D. Hardt (2012). "The streptomycin mouse model for 
Salmonella diarrhea: functional analysis of the microbiota, the pathogen’s virulence factors, and the 
host’s mucosal immune response." Immunological reviews 245(1): 56-83. 
 
Kamada, N., Y.-G. Kim, H. P. Sham, B. A. Vallance, J. L. Puente, E. C. Martens and G. Núñez (2012). 
"Regulated virulence controls the ability of a pathogen to compete with the gut microbiota." Science 
336(6086): 1325-1329. 
 
Kaniga, K., J. C. Bossio and J. E. Galán (1994). "The Salmonella typhimurium invasion genes invF and 
invG encode homologues of the AraC and PulD family of proteins." Molecular microbiology 13(4): 
555-568. 
 
Kelly, C. J., L. Zheng, E. L. Campbell, B. Saeedi, C. C. Scholz, A. J. Bayless, K. E. Wilson, L. E. Glover, D. J. 
Kominsky and A. Magnuson (2015). "Crosstalk between microbiota-derived short-chain fatty acids 
and intestinal epithelial HIF augments tissue barrier function." Cell Host & Microbe 17(5): 662-671. 
 
Kenny, B., R. DeVinney, M. Stein, D. J. Reinscheid, E. A. Frey and B. B. Finlay (1997). 
"Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells." 
Cell 91(4): 511-520. 
 
Kerckhoffs, A. P., K. Ben-Amor, M. Samsom, M. E. van der Rest, J. de Vogel, J. Knol and L. M. 
Akkermans (2011). "Molecular analysis of faecal and duodenal samples reveals significantly higher 
prevalence and numbers of Pseudomonas aeruginosa in irritable bowel syndrome." Journal of 
medical microbiology 60(2): 236-245. 
 
Klaasen, H., J. Koopman, M. Van den Brink, H. Van Wezel and A. Beynen (1991). "Mono-association of 
mice with non-cultivable, intestinal, segmented, filamentous bacteria." Archives of microbiology 
156(2): 148-151. 
Literature 
176 
 
 
Koenig, J. E., A. Spor, N. Scalfone, A. D. Fricker, J. Stombaugh, R. Knight, L. T. Angenent and R. E. Ley 
(2011). "Succession of microbial consortia in the developing infant gut microbiome." Proceedings of 
the National Academy of Sciences 108(Supplement 1): 4578-4585. 
 
Kortman, G. A., M. L. Mulder, T. J. Richters, N. K. Shanmugam, E. Trebicka, J. Boekhorst, H. M. 
Timmerman, R. Roelofs, E. T. Wiegerinck and C. M. Laarakkers (2015). "Low dietary iron intake 
restrains the intestinal inflammatory response and pathology of enteric infection by food-borne 
bacterial pathogens." European journal of immunology 45(9): 2553-2567. 
 
Kotloff, K. L., J. P. Nataro, W. C. Blackwelder, D. Nasrin, T. H. Farag, S. Panchalingam, Y. Wu, S. O. Sow, 
D. Sur and R. F. Breiman (2013). "Burden and aetiology of diarrhoeal disease in infants and young 
children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-
control study." The Lancet 382(9888): 209-222. 
 
Krych, L., C. H. Hansen, A. K. Hansen, F. W. van den Berg and D. S. Nielsen (2013). "Quantitatively 
different, yet qualitatively alike: a meta-analysis of the mouse core gut microbiome with a view 
towards the human gut microbiome." PloS one 8(5): e62578. 
 
Kutschera, M., W. Engst, M. Blaut and A. Braune (2011). "Isolation of catechin-converting human 
intestinal bacteria." Journal of Applied Microbiology 111(1): 165-175. 
 
Lagkouvardos, I., R. Pukall, B. Abt, B. U. Foesel, J. P. Meier-Kolthoff, N. Kumar, A. Bresciani, I. 
Martínez, S. Just and C. Ziegler (2016). "The Mouse Intestinal Bacterial Collection (miBC) provides 
host-specific insight into cultured diversity and functional potential of the gut microbiota." Nature 
Microbiology 1: 16131. 
 
Larson, T., M. Ehrmann and W. Boos (1983). "Periplasmic glycerophosphodiester phosphodiesterase 
of Escherichia coli, a new enzyme of the glp regulon." Journal of Biological Chemistry 258(9): 5428-
5432. 
 
Lawley, T. D., D. M. Bouley, Y. E. Hoy, C. Gerke, D. A. Relman and D. M. Monack (2008). "Host 
transmission of Salmonella enterica serovar Typhimurium is controlled by virulence factors and 
indigenous intestinal microbiota." Infection and immunity 76(1): 403-416. 
 
Lawley, T. D., K. Chan, L. J. Thompson, C. C. Kim, G. R. Govoni and D. M. Monack (2006). "Genome-
wide screen for Salmonella genes required for long-term systemic infection of the mouse." PLoS 
Pathog 2(2): e11. 
 
Lawley, T. D., N. J. Croucher, L. Yu, S. Clare, M. Sebaihia, D. Goulding, D. J. Pickard, J. Parkhill, J. 
Choudhary and G. Dougan (2009). "Proteomic and genomic characterization of highly infectious 
Clostridium difficile 630 spores." Journal of bacteriology 191(17): 5377-5386. 
 
Literature 
177 
 
Levitt, M. D., J. Furne, J. Springfield, F. Suarez and E. DeMaster (1999). "Detoxification of hydrogen 
sulfide and methanethiol in the cecal mucosa." The Journal of clinical investigation 104(8): 1107-
1114. 
 
Ley, R. E., F. Bäckhed, P. Turnbaugh, C. A. Lozupone, R. D. Knight and J. I. Gordon (2005). "Obesity 
alters gut microbial ecology." Proceedings of the National Academy of Sciences of the United States 
of America 102(31): 11070-11075. 
 
Linnenbrink, M., J. Wang, E. A. Hardouin, S. Künzel, D. Metzler and J. F. Baines (2013). "The role of 
biogeography in shaping diversity of the intestinal microbiota in house mice." Molecular ecology 
22(7): 1904-1916. 
 
Liu, J. Z., S. Jellbauer, A. J. Poe, V. Ton, M. Pesciaroli, T. E. Kehl-Fie, N. A. Restrepo, M. P. Hosking, R. A. 
Edwards and A. Battistoni (2012). "Zinc sequestration by the neutrophil protein calprotectin 
enhances Salmonella growth in the inflamed gut." Cell Host & Microbe 11(3): 227-239. 
 
Loetscher, Y., A. Wieser, J. Lengefeld, P. Kaiser, S. Schubert, M. Heikenwalder, W.-D. Hardt and B. 
Stecher (2012). "Salmonella transiently reside in luminal neutrophils in the inflamed gut." PloS one 
7(4): e34812. 
 
Lopez, C. A., S. E. Winter, F. Rivera-Chávez, M. N. Xavier, V. Poon, S.-P. Nuccio, R. M. Tsolis and A. J. 
Bäumler (2012). "Phage-mediated acquisition of a type III secreted effector protein boosts growth of 
salmonella by nitrate respiration." MBio 3(3): e00143-00112. 
 
Luperchio, S. A. and D. B. Schauer (2001). "Molecular pathogenesis of Citrobacter rodentium and 
transmissible murine colonic hyperplasia." Microbes and Infection 3(4): 333-340. 
 
Lupp, C., M. L. Robertson, M. E. Wickham, I. Sekirov, O. L. Champion, E. C. Gaynor and B. B. Finlay 
(2007). "Host-mediated inflammation disrupts the intestinal microbiota and promotes the 
overgrowth of Enterobacteriaceae." Cell Host & Microbe 2(2): 119-129. 
 
Macpherson, A. J. and T. Uhr (2004). "Induction of protective IgA by intestinal dendritic cells carrying 
commensal bacteria." Science 303(5664): 1662-1665. 
 
Mahowald, M. A., F. E. Rey, H. Seedorf, P. J. Turnbaugh, R. S. Fulton, A. Wollam, N. Shah, C. Wang, V. 
Magrini and R. K. Wilson (2009). "Characterizing a model human gut microbiota composed of 
members of its two dominant bacterial phyla." Proceedings of the National Academy of Sciences 
106(14): 5859-5864. 
 
Maier, L., M. Diard, M. E. Sellin, E.-S. Chouffane, K. Trautwein-Weidner, B. Periaswamy, E. Slack, T. 
Dolowschiak, B. Stecher and C. Loverdo (2014). "Granulocytes Impose a Tight Bottleneck upon the 
Gut Luminal Pathogen Population during Salmonella Typhimurium Colitis." PLoS pathogens 10(12): 
e1004557. 
 
Literature 
178 
 
Maier, L., R. Vyas, C. D. Cordova, H. Lindsay, T. S. B. Schmidt, S. Brugiroux, B. Periaswamy, R. Bauer, A. 
Sturm and F. Schreiber (2013). "Microbiota-derived hydrogen fuels Salmonella typhimurium invasion 
of the gut ecosystem." Cell Host & Microbe 14(6): 641-651. 
 
Mallick, E. M., M. E. McBee, V. K. Vanguri, A. R. Melton-Celsa, K. Schlieper, B. J. Karalius, A. D. 
O’Brien, J. R. Butterton, J. M. Leong and D. B. Schauer (2012). "A novel murine infection model for 
Shiga toxin–producing Escherichia coli." The Journal of clinical investigation 122(11): 4012-4024. 
 
Manges, A. R., A. Labbe, V. G. Loo, J. K. Atherton, M. A. Behr, L. Masson, P. A. Tellis and R. Brousseau 
(2010). "Comparative metagenomic study of alterations to the intestinal microbiota and risk of 
nosocomial Clostridum difficile-associated disease." Journal of Infectious Diseases 202(12): 1877-
1884. 
 
Marchesi, J. and F. Shanahan (2007). "The normal intestinal microbiota." Curr Opin Infect Dis 20(5): 
508-513. 
 
Martin, R., H. Makino, A. C. Yavuz, K. Ben-Amor, M. Roelofs, E. Ishikawa, H. Kubota, S. Swinkels, T. 
Sakai and K. Oishi (2016). "Early-Life Events, Including Mode of Delivery and Type of Feeding, Siblings 
and Gender, Shape the Developing Gut Microbiota." PloS one 11(6): e0158498. 
 
Maurice, C. F., H. J. Haiser and P. J. Turnbaugh (2013). "Xenobiotics shape the physiology and gene 
expression of the active human gut microbiome." Cell 152(1): 39-50. 
 
McEllistrem, M. C., R. J. Carman, D. N. Gerding, C. Genheimer and L. Zheng (2005). "A hospital 
outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes." Clinical 
infectious diseases 40(2): 265-272. 
 
McNulty, N. P., T. Yatsunenko, A. Hsiao, J. J. Faith, B. D. Muegge, A. L. Goodman, B. Henrissat, R. 
Oozeer, S. Cools-Portier and G. Gobert (2011). "The impact of a consortium of fermented milk strains 
on the gut microbiome of gnotobiotic mice and monozygotic twins." Science translational medicine 
3(106): 106ra106-106ra106. 
 
Mead, P. S., L. Slutsker, V. Dietz, L. F. McCaig, J. S. Bresee, C. Shapiro, P. M. Griffin and R. V. Tauxe 
(1999). "Food-related illness and death in the United States." Emerging infectious diseases 5(5): 607. 
 
Million, M., M. Maraninchi, M. Henry, F. Armougom, H. Richet, P. Carrieri, R. Valero, D. Raccah, B. 
Vialettes and D. Raoult (2012). "Obesity-associated gut microbiota is enriched in Lactobacillus reuteri 
and depleted in Bifidobacterium animalis and Methanobrevibacter smithii." International journal of 
obesity 36(6): 817-825. 
 
Miranda, K. M., M. G. Espey and D. A. Wink (2001). "A rapid, simple spectrophotometric method for 
simultaneous detection of nitrate and nitrite." Nitric oxide 5(1): 62-71. 
 
Literature 
179 
 
Moeller, R., I. Vlašić, G. Reitz and W. L. Nicholson (2012). "Role of altered rpoB alleles in Bacillus 
subtilis sporulation and spore resistance to heat, hydrogen peroxide, formaldehyde, and 
glutaraldehyde." Archives of microbiology 194(9): 759-767. 
 
Monira, S., S. Nakamura, K. Gotoh, K. Izutsu, H. Watanabe, N. H. Alam, H. P. Endtz, A. Cravioto, S. Ali 
and T. Nakaya (2011). "Gut microbiota of healthy and malnourished children in Bangladesh." 
Frontiers in microbiology 2: 228. 
 
Narushima, S., K. Itoh, Y. Miyamoto, S.-H. Park, K. Nagata, K. Kuruma and K. Uchida (2006). 
"Deoxycholic acid formation in gnotobiotic mice associated with human intestinal bacteria." Lipids 
41(9): 835-843. 
 
Nataro, J. P. and J. B. Kaper (1998). "Diarrheagenic escherichia coli." Clinical microbiology reviews 
11(1): 142-201. 
 
Natividad, J. M., C. L. Hayes, J.-P. Motta, J. Jury, H. J. Galipeau, V. Philip, C. L. Garcia-Rodenas, H. 
Kiyama, P. Bercik and E. F. Verdu (2013). "Differential induction of antimicrobial REGIII by the 
intestinal microbiota and Bifidobacterium breve NCC2950." Applied and environmental microbiology 
79(24): 7745-7754. 
 
Neilands, J. (1995). "Siderophores: structure and function of microbial iron transport compounds." 
Journal of Biological Chemistry 270(45): 26723-26726. 
 
Nemeth, E., M. S. Tuttle, J. Powelson, M. B. Vaughn, A. Donovan, D. M. Ward, T. Ganz and J. Kaplan 
(2004). "Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its 
internalization." Science 306(5704): 2090-2093. 
 
Ng, K. M., J. A. Ferreyra, S. K. Higginbottom, J. B. Lynch, P. C. Kashyap, S. Gopinath, N. Naidu, B. 
Choudhury, B. C. Weimer and D. M. Monack (2013). "Microbiota-liberated host sugars facilitate post-
antibiotic expansion of enteric pathogens." Nature 502(7469): 96-99. 
 
Nguyen, T. L. A., S. Vieira-Silva, A. Liston and J. Raes (2015). "How informative is the mouse for 
human gut microbiota research?" Disease Models and Mechanisms 8(1): 1-16. 
 
Nicholson, J. K., E. Holmes, J. Kinross, R. Burcelin, G. Gibson, W. Jia and S. Pettersson (2012). "Host-
gut microbiota metabolic interactions." Science 336(6086): 1262-1267. 
 
Oh, P. L., A. K. Benson, D. A. Peterson, P. B. Patil, E. N. Moriyama, S. Roos and J. Walter (2010). 
"Diversification of the gut symbiont Lactobacillus reuteri as a result of host-driven evolution." The 
ISME journal 4(3): 377-387. 
 
Ohkusa, T., T. Yoshida, N. Sato, S. Watanabe, H. Tajiri and I. Okayasu (2009). "Commensal bacteria 
can enter colonic epithelial cells and induce proinflammatory cytokine secretion: a possible 
pathogenic mechanism of ulcerative colitis." Journal of medical microbiology 58(5): 535-545. 
Literature 
180 
 
 
Pakarian, P. and P. D. Pawelek (2016). "Intracellular co-localization of the Escherichia coli 
enterobactin biosynthetic enzymes EntA, EntB, and EntE." Biochemical and Biophysical Research 
Communications. 
 
Patel, J. C. and J. E. Galán (2005). "Manipulation of the host actin cytoskeleton by Salmonella—all in 
the name of entry." Current opinion in microbiology 8(1): 10-15. 
 
Pelludat, C. (1999). Molekulare Charakterisierung der Pathogenitätsinsel von Yersinia enterocolitica 
und ihr Einfluss auf die aktive Eisenaufnahme. 
 
Pham, T. A. N., S. Clare, D. Goulding, J. M. Arasteh, M. D. Stares, H. P. Browne, J. A. Keane, A. J. Page, 
N. Kumasaka and L. Kane (2014). "Epithelial IL-22RA1-mediated fucosylation promotes intestinal 
colonization resistance to an opportunistic pathogen." Cell Host & Microbe 16(4): 504-516. 
 
Portillo, F., J. W. Foster, M. E. Maguire and B. B. Finlay (1992). "Characterization of the micro-
environment of Salmonella typhimurium–containing vacuoles within MDCK epithelial cells." 
Molecular microbiology 6(22): 3289-3297. 
 
Price-Carter, M., J. Tingey, T. A. Bobik and J. R. Roth (2001). "The Alternative Electron Acceptor 
Tetrathionate Supports B12-Dependent Anaerobic Growth ofSalmonella enterica Serovar 
Typhimurium on Ethanolamine or 1, 2-Propanediol." Journal of bacteriology 183(8): 2463-2475. 
 
Price, M. N., P. S. Dehal and A. P. Arkin (2009). "FastTree: computing large minimum evolution trees 
with profiles instead of a distance matrix." Mol Biol Evol 26(7): 1641-1650. 
 
Proulx, P. and C. Fung (1969). "Metabolism of phosphoglycerides in E. coli IV. The positional 
specificity and properties of phospbolipase A." Canadian journal of biochemistry 47(12): 1125-1128. 
 
Quast, C., E. Pruesse, P. Yilmaz, J. Gerken, T. Schweer, P. Yarza, J. Peplies and F. O. Glöckner (2013). 
"The SILVA ribosomal RNA gene database project: improved data processing and web-based tools." 
Nucleic acids research 41(D1): D590-D596. 
 
Raffatellu, M., M. D. George, Y. Akiyama, M. J. Hornsby, S.-P. Nuccio, T. A. Paixao, B. P. Butler, H. Chu, 
R. L. Santos and T. Berger (2009). "Lipocalin-2 Resistance Confers an Advantage to< i> Salmonella 
enterica</i> Serotype Typhimurium for Growth and Survival in the Inflamed Intestine." Cell Host & 
Microbe 5(5): 476-486. 
 
Rajilic-Stojanovic, M., F. Shanahan, F. Guarner and W. M. de Vos (2013). "Phylogenetic analysis of 
dysbiosis in ulcerative colitis during remission." Inflammatory bowel diseases 19(3): 481-488. 
 
Randle, C. L., P. W. Albro and J. C. Dittmer (1969). "The phosphoglyceride composition of Gram-
negative bacteria and the changes in composition during growth." Biochimica et Biophysica Acta 
(BBA)-Lipids and Lipid Metabolism 187(2): 214-220. 
Literature 
181 
 
 
Rausch, P., M. Basic, A. Batra, S. C. Bischoff, M. Blaut, T. Clavel, J. Gläsner, S. Gopalakrishnan, G. A. 
Grassl and C. Günther (2016). "Analysis of factors contributing to variation in the C57BL/6J fecal 
microbiota across German animal facilities." International Journal of Medical Microbiology. 
 
Rendon, J., E. Pilet, Z. Fahs, F. Seduk, L. Sylvi, M. H. Chehade, F. Pierrel, B. Guigliarelli, A. Magalon and 
S. Grimaldi (2015). "Demethylmenaquinol is a substrate of Escherichia coli nitrate reductase A 
(NarGHI) and forms a stable semiquinone intermediate at the NarGHI quinol oxidation site." 
Biochimica et Biophysica Acta (BBA)-Bioenergetics 1847(8): 739-747. 
 
Rescigno, M., G. Rotta, B. Valzasina and P. Ricciardi-Castagnoli (2001). "Dendritic cells shuttle 
microbes across gut epithelial monolayers." Immunobiology 204(5): 572-581. 
 
Ridler, C. (2016). "IBD: Dysbiosis underlies CARD9 risk alleles in colitis." Nature Reviews 
Gastroenterology & Hepatology 13(6): 316-316. 
 
Ridlon, J. M., D.-J. Kang and P. B. Hylemon (2006). "Bile salt biotransformations by human intestinal 
bacteria." Journal of lipid research 47(2): 241-259. 
 
Rivera-Chávez, F., S. E. Winter, C. A. Lopez, M. N. Xavier, M. G. Winter, S.-P. Nuccio, J. M. Russell, R. C. 
Laughlin, S. D. Lawhon and T. Sterzenbach (2013). "Salmonella uses energy taxis to benefit from 
intestinal inflammation." PLoS Pathog 9(4): e1003267. 
 
Rivera-Chávez, F., L. F. Zhang, F. Faber, C. A. Lopez, M. X. Byndloss, E. E. Olsan, G. Xu, E. M. Velazquez, 
C. B. Lebrilla and S. E. Winter (2016). "Depletion of Butyrate-Producing Clostridia from the Gut 
Microbiota Drives an Aerobic Luminal Expansion of Salmonella." Cell Host & Microbe 19(4): 443-454. 
 
Roof, D. M. and J. R. Roth (1988). "Ethanolamine utilization in Salmonella typhimurium." Journal of 
bacteriology 170(9): 3855-3863. 
 
Roof, D. M. and J. R. Roth (1989). "Functions required for vitamin B12-dependent ethanolamine 
utilization in Salmonella typhimurium." Journal of bacteriology 171(6): 3316-3323. 
 
Rousseau, C., F. Levenez, C. Fouqueray, J. Doré, A. Collignon and P. Lepage (2011). "Clostridium 
difficile colonization in early infancy is accompanied by changes in intestinal microbiota 
composition." Journal of clinical microbiology 49(3): 858-865. 
 
Rupnik, M., M. H. Wilcox and D. N. Gerding (2009). "Clostridium difficile infection: new developments 
in epidemiology and pathogenesis." Nature Reviews Microbiology 7(7): 526-536. 
 
Russell, A. B., A. G. Wexler, B. N. Harding, J. C. Whitney, A. J. Bohn, Y. A. Goo, B. Q. Tran, N. A. Barry, 
H. Zheng and S. B. Peterson (2014). "A type VI secretion-related pathway in Bacteroidetes mediates 
interbacterial antagonism." Cell Host & Microbe 16(2): 227-236. 
Literature 
182 
 
 
Said, H. M. (2011). "Intestinal absorption of water-soluble vitamins in health and disease." 
Biochemical Journal 437(3): 357-372. 
 
Scharffetter-Kochanek, K., H. Lu, K. Norman, N. Van Nood, F. Munoz, S. Grabbe, M. McArthur, I. 
Lorenzo, S. Kaplan and K. Ley (1998). "Spontaneous skin ulceration and defective T cell function in 
CD18 null mice." The Journal of experimental medicine 188(1): 119-131. 
 
Schauer, D. and S. Falkow (1993). "Attaching and effacing locus of a Citrobacter freundii biotype that 
causes transmissible murine colonic hyperplasia." Infection and immunity 61(6): 2486-2492. 
 
Schauer, D. B., B. A. Zabel, I. F. Pedraza, C. M. O'Hara, A. G. Steigerwalt and D. J. Brenner (1995). 
"Genetic and biochemical characterization of Citrobacter rodentium sp. nov." Journal of clinical 
microbiology 33(8): 2064-2068. 
 
Schmieger, H. (1972). "Phage P22-mutants with increased or decreased transduction abilities." 
Molecular and General Genetics MGG 119(1): 75-88. 
 
Schulte, M. and M. Hensel (2016). "Models of intestinal infection by Salmonella enterica: 
introduction of a new neonate mouse model." F1000Research 5. 
 
Seekatz, A. M. and V. B. Young (2014). "Clostridium difficile and the microbiota." The Journal of 
clinical investigation 124(10): 4182-4189. 
 
Sellin, M. E., A. A. Müller, B. Felmy, T. Dolowschiak, M. Diard, A. Tardivel, K. M. Maslowski and W.-D. 
Hardt (2014). "Epithelium-Intrinsic NAIP/NLRC4 Inflammasome Drives Infected Enterocyte Expulsion 
to Restrict< i> Salmonella</i> Replication in the Intestinal Mucosa." Cell Host & Microbe 16(2): 237-
248. 
 
Simonyte, S. K., L. Vidman, P. Rydén and C. E. West (2016). "Emerging evidence of the role of gut 
microbiota in the development of allergic diseases." Current opinion in allergy and clinical 
immunology. 
 
Sokol, H., B. Pigneur, L. Watterlot, O. Lakhdari, L. G. Bermúdez-Humarán, J.-J. Gratadoux, S. Blugeon, 
C. Bridonneau, J.-P. Furet and G. Corthier (2008). "Faecalibacterium prausnitzii is an anti-
inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients." 
Proceedings of the National Academy of Sciences 105(43): 16731-16736. 
 
Sonnenberg, G. F., L. A. Monticelli, T. Alenghat, T. C. Fung, N. A. Hutnick, J. Kunisawa, N. Shibata, S. 
Grunberg, R. Sinha and A. M. Zahm (2012). "Innate lymphoid cells promote anatomical containment 
of lymphoid-resident commensal bacteria." Science 336(6086): 1321-1325. 
 
Literature 
183 
 
Sorg, J. A. and A. L. Sonenshein (2010). "Inhibiting the initiation of Clostridium difficile spore 
germination using analogs of chenodeoxycholic acid, a bile acid." Journal of bacteriology 192(19): 
4983-4990. 
 
Spees, A. M., T. Wangdi, C. A. Lopez, D. D. Kingsbury, M. N. Xavier, S. E. Winter, R. M. Tsolis and A. J. 
Bäumler (2013). "Streptomycin-induced inflammation enhances Escherichia coli gut colonization 
through nitrate respiration." MBio 4(4): e00430-00413. 
 
Stecher, B., M. Barthel, M. C. Schlumberger, L. Haberli, W. Rabsch, M. Kremer and W. D. Hardt 
(2008). "Motility allows S. Typhimurium to benefit from the mucosal defence." Cellular microbiology 
10(5): 1166-1180. 
 
Stecher, B., D. Berry and A. Loy (2013). "Colonization resistance and microbial ecophysiology: using 
gnotobiotic mouse models and single-cell technology to explore the intestinal jungle." FEMS 
microbiology reviews 37(5): 793-829. 
 
Stecher, B., S. Chaffron, R. Käppeli, S. Hapfelmeier, S. Freedrich, T. C. Weber, J. Kirundi, M. Suar, K. D. 
McCoy and C. von Mering (2010). "Like will to like: abundances of closely related species can predict 
susceptibility to intestinal colonization by pathogenic and commensal bacteria." PLoS Pathog 6(1): 
e1000711. 
 
Stecher, B., R. Denzler, L. Maier, F. Bernet, M. J. Sanders, D. J. Pickard, M. Barthel, A. M. Westendorf, 
K. A. Krogfelt and A. W. Walker (2012). "Gut inflammation can boost horizontal gene transfer 
between pathogenic and commensal Enterobacteriaceae." Proceedings of the National Academy of 
Sciences 109(4): 1269-1274. 
 
Stecher, B., S. Hapfelmeier, C. Müller, M. Kremer, T. Stallmach and W.-D. Hardt (2004). "Flagella and 
chemotaxis are required for efficient induction of Salmonella enterica serovar Typhimurium colitis in 
streptomycin-pretreated mice." Infection and immunity 72(7): 4138-4150. 
 
Stecher, B., R. Robbiani, A. W. Walker, A. M. Westendorf, M. Barthel, M. Kremer, S. Chaffron, A. J. 
Macpherson, J. Buer and J. Parkhill (2007). "Salmonella enterica serovar typhimurium exploits 
inflammation to compete with the intestinal microbiota." PLoS biology 5(10): e244. 
 
Stecher, B., R. Robbiani, A. W. Walker, A. M. Westendorf, M. Barthel, M. Kremer, S. Chaffron, A. J. 
Macpherson, J. Buer and J. Parkhill (2007). "Salmonella enterica serovar typhimurium exploits 
inflammation to compete with the intestinal microbiota." PLoS Biol 5(10): e244. 
 
Stecher, B., R. Robbiani, A. W. Walker, A. M. Westendorf, M. Barthel, M. Kremer, S. Chaffron, A. J. 
Macpherson, J. Buer, J. Parkhill, G. Dougan, C. von Mering and W. D. Hardt (2007). "Salmonella 
enterica Serovar Typhimurium Exploits Inflammation to Compete with the Intestinal Microbiota." 
PLoS Biol 5(10): e244. 
 
Literature 
184 
 
Steck, N., M. Hoffmann, I. G. Sava, S. C. Kim, H. Hahne, S. L. Tonkonogy, K. Mair, D. Krueger, M. 
Pruteanu and F. Shanahan (2011). "Enterococcus faecalis metalloprotease compromises epithelial 
barrier and contributes to intestinal inflammation." Gastroenterology 141(3): 959-971. 
 
Stefka, A. T., T. Feehley, P. Tripathi, J. Qiu, K. McCoy, S. K. Mazmanian, M. Y. Tjota, G.-Y. Seo, S. Cao 
and B. R. Theriault (2014). "Commensal bacteria protect against food allergen sensitization." 
Proceedings of the National Academy of Sciences 111(36): 13145-13150. 
 
Stelter, C., R. Käppeli, C. König, A. Krah, W.-D. Hardt, B. Stecher and D. Bumann (2011). "Salmonella-
induced mucosal lectin RegIIIβ kills competing gut microbiota." PloS one 6(6): e20749. 
 
Stojiljkovic, I., A. J. Bäumler and F. Heffron (1995). "Ethanolamine utilization in Salmonella 
typhimurium: nucleotide sequence, protein expression, and mutational analysis of the cchA cchB 
eutE eutJ eutG eutH gene cluster." Journal of bacteriology 177(5): 1357-1366. 
 
Stojiljkovic, I., V. Kumar and N. Srinivasan (1999). "Non-iron metalloporphyrins: potent antibacterial 
compounds that exploit haem/Hb uptake systems of pathogenic bacteria." Molecular microbiology 
31(2): 429-442. 
 
Stubbs, S., M. Rupnik, M. Gibert, J. Brazier, B. Duerden and M. Popoff (2000). "Production of actin-
specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile." FEMS Microbiology 
Letters 186(2): 307-312. 
 
Studer, N., L. Desharnais, M. Beutler, S. Brugiroux, M. A. Terrazos, L. Menin, C. M. Schürch, K. D. 
McCoy, S. A. Kuehne and N. P. Minton (2016). "Functional Intestinal Bile Acid 7α-Dehydroxylation by 
Clostridium scindens Associated with Protection from Clostridium difficile Infection in a Gnotobiotic 
Mouse Model." Frontiers in Cellular and Infection Microbiology 6. 
 
Szabó, C., H. Ischiropoulos and R. Radi (2007). "Peroxynitrite: biochemistry, pathophysiology and 
development of therapeutics." Nature reviews Drug discovery 6(8): 662-680. 
 
Takahashi, K., A. Nishida, T. Fujimoto, M. Fujii, M. Shioya, H. Imaeda, O. Inatomi, S. Bamba, A. Andoh 
and M. Sugimoto (2016). "Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal 
Microbial Community in Crohn's Disease." Digestion 93(1): 59-65. 
 
Taur, Y., J. B. Xavier, L. Lipuma, C. Ubeda, J. Goldberg, A. Gobourne, Y. J. Lee, K. A. Dubin, N. D. Socci 
and A. Viale (2012). "Intestinal domination and the risk of bacteremia in patients undergoing 
allogeneic hematopoietic stem cell transplantation." Clinical infectious diseases 55(7): 905-914. 
 
Theriot, C. M., A. A. Bowman and V. B. Young (2016). "Antibiotic-induced alterations of the gut 
microbiota alter secondary bile acid production and allow for Clostridium difficile spore germination 
and outgrowth in the large intestine." MSphere 1(1): e00045-00015. 
 
Literature 
185 
 
Thiennimitr, P., S. E. Winter, M. G. Winter, M. N. Xavier, V. Tolstikov, D. L. Huseby, T. Sterzenbach, R. 
M. Tsolis, J. R. Roth and A. J. Bäumler (2011). "Intestinal inflammation allows Salmonella to use 
ethanolamine to compete with the microbiota." Proceedings of the National Academy of Sciences 
108(42): 17480-17485. 
 
Thomas, C. M., D. Saulnier, J. K. Spinler, P. Hemarajata, C. Gao, S. E. Jones, A. Grimm, M. A. Balderas, 
M. D. Burstein and C. Morra (2016). "FolC2-mediated folate metabolism contributes to suppression 
of inflammation by probiotic Lactobacillus reuteri." Microbiologyopen. 
 
Trautwein-Weidner, K., A. Gladiator, S. Nur, P. Diethelm and S. LeibundGut-Landmann (2014). "IL-17-
mediated antifungal defense in the oral mucosa is independent of neutrophils." Mucosal 
immunology. 
 
Tsoy, O., D. Ravcheev and A. Mushegian (2009). "Comparative genomics of ethanolamine utilization." 
Journal of bacteriology 191(23): 7157-7164. 
 
Tuovinen, E., J. Keto, J. Nikkilä, J. Mättö and K. Lähteenmäki (2013). "Cytokine response of human 
mononuclear cells induced by intestinal Clostridium species." Anaerobe 19: 70-76. 
 
Turnbaugh, P. J., M. Hamady, T. Yatsunenko, B. L. Cantarel, A. Duncan, R. E. Ley, M. L. Sogin, W. J. 
Jones, B. A. Roe and J. P. Affourtit (2009). "A core gut microbiome in obese and lean twins." Nature 
457(7228): 480-484. 
 
Turnbaugh, P. J., V. K. Ridaura, J. J. Faith, F. E. Rey, R. Knight and J. I. Gordon (2009). "The effect of 
diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice." Science 
translational medicine 1(6): 6ra14-16ra14. 
 
Ubeda, C., V. Bucci, S. Caballero, A. Djukovic, N. C. Toussaint, M. Equinda, L. Lipuma, L. Ling, A. 
Gobourne and D. No (2013). "Intestinal microbiota containing Barnesiella species cures vancomycin-
resistant Enterococcus faecium colonization." Infection and immunity 81(3): 965-973. 
 
Ubeda, C., L. Lipuma, A. Gobourne, A. Viale, I. Leiner, M. Equinda, R. Khanin and E. G. Pamer (2012). 
"Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota 
of TLR-deficient mice." The Journal of experimental medicine 209(8): 1445-1456. 
 
Ubeda, C. and E. G. Pamer (2012). "Antibiotics, microbiota, and immune defense." Trends in 
immunology 33(9): 459-466. 
 
Ubeda, C., Y. Taur, R. R. Jenq, M. J. Equinda, T. Son, M. Samstein, A. Viale, N. D. Socci, M. R. van den 
Brink and M. Kamboj (2010). "Vancomycin-resistant Enterococcus domination of intestinal 
microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in 
humans." The Journal of clinical investigation 120(12): 4332-4341. 
 
Literature 
186 
 
Uchiya, K. i., M. A. Barbieri, K. Funato, A. H. Shah, P. D. Stahl and E. A. Groisman (1999). "A 
Salmonella virulence protein that inhibits cellular trafficking." The EMBO Journal 18(14): 3924-3933. 
 
Vaishnava, S., C. L. Behrendt, A. S. Ismail, L. Eckmann and L. V. Hooper (2008). "Paneth cells directly 
sense gut commensals and maintain homeostasis at the intestinal host-microbial interface." 
Proceedings of the National Academy of Sciences 105(52): 20858-20863. 
 
Valiente, E., M. Cairns and B. Wren (2014). "The Clostridium difficile PCR ribotype 027 lineage: a 
pathogen on the move." Clinical Microbiology and Infection 20(5): 396-404. 
 
van Nood, E., A. Vrieze, M. Nieuwdorp, S. Fuentes, E. G. Zoetendal, W. M. de Vos, C. E. Visser, E. J. 
Kuijper, J. F. Bartelsman and J. G. Tijssen (2013). "Duodenal infusion of donor feces for recurrent 
Clostridium difficile." New England Journal of Medicine 368(5): 407-415. 
 
Vázquez-Torres, A. and A. J. Bäumler (2016). "Nitrate, nitrite and nitric oxide reductases: from the 
last universal common ancestor to modern bacterial pathogens." Current opinion in microbiology 29: 
1-8. 
 
Vivinus-Nébot, M., G. Frin-Mathy, H. Bzioueche, R. Dainese, G. Bernard, R. Anty, J. Filippi, M.-C. Saint-
Paul, M. K. Tulic and V. Verhasselt (2014). "Functional bowel symptoms in quiescent inflammatory 
bowel diseases: role of epithelial barrier disruption and low-grade inflammation." Gut 63(5): 744-
752. 
 
Vong, L., L. J. Pinnell, P. Määttänen, C. W. Yeung, E. Lurz and P. M. Sherman (2015). "Selective 
enrichment of commensal gut bacteria protects against Citrobacter rodentium-induced colitis." 
American Journal of Physiology-Gastrointestinal and Liver Physiology 309(3): G181-G192. 
 
Voth, D. E. and J. D. Ballard (2005). "Clostridium difficile toxins: mechanism of action and role in 
disease." Clinical microbiology reviews 18(2): 247-263. 
 
Walker, A. W., J. Ince, S. H. Duncan, L. M. Webster, G. Holtrop, X. Ze, D. Brown, M. D. Stares, P. Scott 
and A. Bergerat (2011). "Dominant and diet-responsive groups of bacteria within the human colonic 
microbiota." The ISME journal 5(2): 220-230. 
 
Warny, M., J. Pepin, A. Fang, G. Killgore, A. Thompson, J. Brazier, E. Frost and L. C. McDonald (2005). 
"Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe 
disease in North America and Europe." The Lancet 366(9491): 1079-1084. 
 
Weisburg, W. G., S. M. Barns, D. A. Pelletier and D. J. Lane (1991). "16S ribosomal DNA amplification 
for phylogenetic study." Journal of bacteriology 173(2): 697-703. 
 
Willing, B. P., V. P. Singh and S. Proctor (2016). "Koch's postulates, microbial dysbiosis and 
inflammatory bowel disease." Clinical Microbiology and Infection. 
Literature 
187 
 
 
Winter, S. E. and A. J. Bäumler (2014). "Why related bacterial species bloom simultaneously in the 
gut: principles underlying the ‘Like will to like’concept." Cellular microbiology 16(2): 179-184. 
 
Winter, S. E., C. A. Lopez and A. J. Bäumler (2013). "The dynamics of gut-associated microbial 
communities during inflammation." EMBO reports 14(4): 319-327. 
 
Winter, S. E., P. Thiennimitr, M. G. Winter, B. P. Butler, D. L. Huseby, R. W. Crawford, J. M. Russell, C. 
L. Bevins, L. G. Adams and R. M. Tsolis (2010). "Gut inflammation provides a respiratory electron 
acceptor for Salmonella." Nature 467(7314): 426-429. 
 
Wohlgemuth, S., S. Keller, R. Kertscher, M. Stadion, D. Haller, S. Kisling, G. Jahreis, M. Blaut and G. 
Loh (2011). "Intestinal steroid profiles and microbiota composition in colitic mice." Gut microbes 
2(3): 159-166. 
 
Wos-Oxley, M. L., A. Bleich, A. P. Oxley, S. Kahl, L. M. Janus, A. Smoczek, H. Nahrstedt, M. C. Pils, S. 
Taudien and M. Platzer (2012). "Comparative evaluation of establishing a human gut microbial 
community within rodent models." Gut microbes 3(3): 234-249. 
 
Xavier, R. and D. Podolsky (2007). "Unravelling the pathogenesis of inflammatory bowel disease." 
Nature 448(7152): 427-434. 
 
Xiao, L., Q. Feng, S. Liang, S. B. Sonne, Z. Xia, X. Qiu, X. Li, H. Long, J. Zhang and D. Zhang (2015). "A 
catalog of the mouse gut metagenome." Nature biotechnology 33(10): 1103-1108. 
 
Yi, P. and L. Li (2012). "The germfree murine animal: an important animal model for research on the 
relationship between gut microbiota and the host." Veterinary microbiology 157(1): 1-7. 
 
Zheng, X., G. Xie, A. Zhao, L. Zhao, C. Yao, N. H. Chiu, Z. Zhou, Y. Bao, W. Jia and J. K. Nicholson (2011). 
"The footprints of gut microbial–mammalian co-metabolism." Journal of proteome research 10(12): 
5512-5522. 
 
Danksagung 
188 
 
Danksagung 
An dieser Stelle möchte ich mich besonders bei Prof. Dr. Bärbel Stecher bedanken, die mich exzellent 
während meiner Doktorarbeit betreut hat. Danke, dass man sich immer mit jeglichen Belangen an sie 
wenden konnte und stets Rat und konstruktive Kritik bekommen hat. Besonders möchte ich mich 
auch für das mir entgegengebrachte Vertrauen bedanken, welches ein freies und kreatives Arbeiten 
in einer sehr angenehmen Arbeitsatmosphäre ermöglichte. Auch möchte ich Dr. Hans Nitschko und 
Helga Mairhofer für ihren Ratschlag bezüglich quantitativer PCR, sowie Dr. Ombeline Rossier und 
Prof. Dr. Dr. Jürgen Heesemann für wertvolle Diskussionen danken. 
Des Weiteren möchte ich mich bei allen aktuellen und ehemaligen Mitarbeitern der AG Stecher 
bedanken: Lubov Nedialkova, Sandrine Brugiroux, Manuel Diehl, Diana Ring, Dr. Martin Köppel, 
Stefanie Spriewald, Simone Herp, Jana Glaser, Maja Sidstedt, Saib Hussain, Dr. Debora Garzetti, 
Tobias Baumgartner, Patrick Schiller, Philipp Münch, Artur Kibler, Claudia Eberl und Nancy Obeng. Ihr 
wart immer hilfsbereit und tolle Kollegen! Mein besonderer Dank geht dabei an Sandrine Brugiroux 
für die Heranführung an mein Thema, Diana Ring und Simone Herp für die gemeinsame 
Durchführung von Experimenten mit gnotobiotischen Mäusen, Dr. Debora Garzetti für alle 
bioinformatischen Belange, Patrick Schiller für in vitro Kulturdaten und Saib Hussain für die Zucht 
gnotobiotischer Mauslinien.  
Ich möchte mich zudem bei unseren Kollaborationspartnern: Prof. Christoph Mueller, Martin Faderl, 
Prof. Siegfried Hapfelmeier, Nicolas Studer, Prof. Wolf-Dietrich Hardt und Sandra Wotzka für die gute 
Zusammenarbeit bedanken. 
Mein besonderer Dank geht auch an meine Freunde und Familie, sowie an Marianne, die mich nicht 
nur kulinarisch während meiner Doktorarbeit unterstützt hat. 
 
 
 
 
 
 
 
Curriculum Vitae 
189 
 
Curriculum Vitae 
Personal data  
Name:  Markus Beutler 
Date of birth:  10.11.1985 
Place of birth:  Kelheim 
Nationality:  German 
 
Formation 
Since 10/2012 PhD student in the group ‘microbiota and infection’ of Prof. Barbara 
Stecher-Letsch, Ludwig-Maximilians-University, Munich, Germany 
 
10/2010 – 09/2012 Postgraduate studies: Master of Science in ‘Molecular Medicine’ (M.Sc.), 
Georg-August-University Göttingen, Germany 
Thesis: ‘The in vitro cardiovascular pharmacology of the Papuan small-
eyed snake (Micropechis ikaheka) and the taipan (Oxyuranus scutellatus 
canni).’ 
Thesis was conducted in the Cardiovascular Therapeutics Unit and the 
Australian Venom Research Unit, Department of Pharmacology, 
University of Melbourne, Australia 
 
10/2007 – 09/2010 Undergraduate studies: Bachelor of Science in ‘Biology’ (B.Sc.), University 
of Regensburg, Germany 
Thesis: ‘Störungen des RPE/EZM Komplexes bei Mäusen mit Mutationen 
im TIMP3 Gen.‘ 
 
09/2006 – 05/2007 Civilian service: Retex (social facility), Regensburg, Germany  
 
09/1997 – 06/2006 Secondary school: Johannes- Nepomuk- Gymnasium, Rohr in NdB, 
Germany 
 
 
 
 
 
Curriculum Vitae 
190 
 
Publications 
2016 Studer, N., L. Desharnais, M. Beutler, S. Brugiroux, M. A. Terrazos, L. 
Menin, C. M. Schürch, K. D. McCoy, S. A. Kuehne and N. P. Minton (2016). 
"Functional Intestinal Bile Acid 7α-Dehydroxylation by Clostridium 
scindens Associated with Protection from Clostridium difficile Infection in 
a Gnotobiotic Mouse Model." Frontiers in Cellular and Infection 
Microbiology 6. 
Brugiroux, S., M. Beutler, C. Pfann, D. Garzetti, H. Ruscheweyh, M. Diehl, 
D. Ring, Y. Lötscher, S. Hussain, R. Pukall, D. H. Huson, P. C. Münch, A. C. 
McHardy, K. D. McCoy, A. J. Macpherson, A. Loy, T. Clavel, D. Berry and B. 
Stecher. “Genome-guided modular design of a novel defined mouse 
microbiota that confers colonization resistance against Salmonella 
enterica serovar Typhimurium.” Nature Microbiology 2: 16215. 
2015 Spriewald, S., J. Glaser, M. Beutler, M. B. Koeppel and B. Stecher (2015). 
"Reporters for Single-Cell Analysis of Colicin Ib Expression in Salmonella 
enterica Serovar Typhimurium." PloS one 10(12): e0144647. 
2014 
 
 
 
 
Pla, D., O. K. Paiva, L. Sanz, M. Beutler, C. E. Wright, J. J. Calvete, D. J. 
Williams and J. M. Gutiérrez (2014). "Preclinical efficacy of Australian 
antivenoms against the venom of the small-eyed snake, Micropechis 
ikaheka, from Papua New Guinea: An antivenomics and neutralization 
study." Journal of proteomics 110: 198-208. 
Paiva, O., D. Pla, C. E. Wright, M. Beutler, L. Sanz, J. M. Gutiérrez, D. J. 
Williams and J. J. Calvete (2014). "Combined venom gland cDNA 
sequencing and venomics of the New Guinea small-eyed snake, 
Micropechis ikaheka." Journal of proteomics 110: 209-229. 
2013 Hupfeld, T., B. Chapuy, V. Schrader, M. Beutler, C. Veltkamp, R. Koch, S. 
Cameron, T. Aung, D. Haase and P. LaRosee (2013). "Tyrosinekinase 
inhibition facilitates cooperation of transcription factor SALL4 and ABC 
transporter A3 towards intrinsic CML cell drug resistance." British journal 
of haematology 161(2): 204-213. 
 
Conference 
presentations 
2015 Beutler, M., S. Brugiroux, S. Herp, D. Garzetti, P. Schiller, S. Hussain, D. 
Ring, K. D. McCoy, A. J. Macpherson and B. Stecher. “Investigating the 
mechanisms of Salmonella-induced dysbiosis using the Oligo-Mouse-
Microbiota model.” 8th Seeon Conference “Microbiota, Probiota and 
Host”, Seeon, Germany. Talk 
2014 Beutler, M., S. Brugiroux, S. Herp, S. Hussain, D. Ring, K. D. McCoy, A. J. 
Macpherson and B. Stecher. “Addressing the influence of S. Typhimurium 
induced gut inflammation on the Oligo-Mouse-Microbiota”. Gemeinsame 
Jahrestagung der Deutschen Gesellschaft für Hygiene und Mikrobiologie 
(DGHM) und der Vereinigung für Allgemeine und Angewandte 
Mikrobiologie (VAAM), Dresden, Germany. Poster 
Curriculum Vitae 
191 
 
Beutler, M., S. Brugiroux, S. Herp, S. Hussain, D. Ring, K. D. McCoy, A. J. 
Macpherson and B. Stecher. “Addressing the influence of S. Typhimurium 
induced gut inflammation on the Oligo-Mouse-Microbiota”. 7th Seeon 
Conference “Microbiota, Probiota and Host”, Seeon, Germany. Talk 
2013 Beutler, M., S. Brugiroux, M. Diehl, K. D. McCoy and B. Stecher. 
“Establishment of a specific hydrolysis probe quantification method for 
the Oligo-Mouse Microbiota model“. FEMS - 5th Congress of European 
Microbiologists, Leipzig, Germany. Poster 
 Beutler, M., S. Brugiroux, M. Diehl and B. Stecher. “Establishment of a 
specific hydrolysis probe quantification method for the Oligo-Mouse 
Microbiota model“. 6th Seeon Conference “Microbiota, Probiota and 
Host”, Seeon, Germany. Poster 
 
